{
  "meta": {
    "title": "45_Inicet_Nov_2024_Mock_Test-2_-_27-10-2024",
    "url": "https://brainandscalpel.vercel.app/45-inicet-nov-2024-mock-test-2-27-10-2024-39c8d121.html",
    "scrapedAt": "2025-11-29T17:23:46.859Z"
  },
  "questions": [
    {
      "id": 62109,
      "choices": [
        {
          "id": 247697,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Intercalated discs</span></span></span></p>"
        },
        {
          "id": 247698,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Macula densa</span></span></span></p>"
        },
        {
          "id": 247699,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Zonula occludens</span></span></span></p>"
        },
        {
          "id": 247700,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Hemidesmosomes</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 27-year-old man presents to the emergency department with profuse, watery diarrhea, severe dehydration, and vomiting for the past 24 hours. Physical examination reveals signs of dehydration, including dry mucous membranes and decreased skin turgor. Stool examination confirms the presence of Vibrio cholerae. Which of the following cellular structures is disrupted by the cholera toxin to cause watery diarrhea?</span></span></p>",
      "unique_key": "Q1890056",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Zonula occludens</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cholera toxin, produced by <strong>Vibrio cholerae</strong>, binds to the <strong>GM1 ganglioside receptor</strong> on intestinal epithelial cells (enterocytes), initiating endocytosis of the toxin. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The enzymatic <strong>A1 subunit</strong> activates <strong>adenylate cyclase</strong> through <strong>ADP-ribosylation</strong>, leading to increased <strong>cyclic AMP (cAMP)</strong> levels. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This results in activation of the <strong>cystic fibrosis transmembrane conductance regulator (CFTR)</strong>, which promotes a dramatic efflux of chloride ions and water, leading to <strong>watery diarrhea</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Additionally, <strong>Zona occludens toxin (Zot)</strong> disrupts the <strong>zonula occludens</strong>, which are the tight junctions between enterocytes, leading to reduced intestinal barrier function and increased intestinal permeability, further contributing to fluid loss.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-155159.jpg\" style=\"height:516px; width:775px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Intercalated discs</span></strong><span style=\"font-size:14.0pt\">: These are specialized connections found in cardiac muscle cells and are unrelated to the pathogenesis of cholera.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Macula densa</span></strong><span style=\"font-size:14.0pt\">: This structure is part of the nephron and plays a role in regulating renal blood flow and filtration rate. It is not involved in the pathophysiology of cholera.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Hemidesmosomes</span></strong><span style=\"font-size:14.0pt\">: These structures connect epithelial cells to the basement membrane. They are not involved in cholera toxin-induced diarrhea.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Cholera toxin&nbsp;</span></strong><span style=\"font-size:14.0pt\">acts by increasing <strong>cAMP</strong> in intestinal cells, leading to chloride and water secretion. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The <strong>zonula occludens</strong> (tight junctions) are disrupted, contributing to increased intestinal permeability and profuse, watery diarrhea. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Preventing dehydration is crucial in the management of cholera.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247699,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62360,
      "choices": [
        {
          "id": 248693,
          "text": "<p><span style=\"font-size:14.0pt;\">Valproate</span></p>"
        },
        {
          "id": 248694,
          "text": "<p><span style=\"font-size:14.0pt;\">Ethosuximide</span></p>"
        },
        {
          "id": 248695,
          "text": "<p><span style=\"font-size:14.0pt;\">Topiramate</span></p>"
        },
        {
          "id": 248696,
          "text": "<p><span style=\"font-size:14.0pt;\">Rufinamide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 7-year-old child with Lennox-Gastaut syndrome is experiencing frequent multifocal seizures and has a characteristic &lt;2.5 Hz spike-and-wave pattern on EEG. The neurologist decides to start an antiepileptic medication that can also be used for migraine prophylaxis and for managing alcohol cravings in adults. Which of the following drug is the neurologist thinking to start?</span></p>",
      "unique_key": "Q3364265",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Topiramate</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul><li><span style=\"font-size:14.0pt;\"><strong>Topiramate</strong> is an <strong>antiepileptic medication</strong> that is FDA-approved for treating <strong>Lennox-Gastaut syndrome</strong>.</span></li><li><span style=\"font-size:14.0pt;\">In addition to its anticonvulsant properties, <strong>topiramate</strong> is also used for <strong>migraine prophylaxis</strong> and has been shown to reduce <strong>alcohol cravings</strong> in adults.</span></li><li><span style=\"font-size:14.0pt;\">These multiple therapeutic effects make it an attractive option for conditions requiring diverse treatment approaches.</span></li></ul><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Valproate</strong>: <strong>Valproate</strong> is another antiepileptic that is effective for <strong>Lennox-Gastaut syndrome</strong> and other seizure types. It is also used for <strong>migraine prophylaxis</strong>, but it is not commonly used for managing <strong>alcohol cravings</strong>.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ethosuximide</strong>: <strong>Ethosuximide</strong> is effective for <strong>absence seizures</strong>, but it is not typically used for <strong>Lennox-Gastaut syndrome</strong> and does not have applications for <strong>migraine prophylaxis</strong> or <strong>alcohol cravings</strong>.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Rufinamide</strong>: <strong>Rufinamide</strong> is FDA-approved for <strong>Lennox-Gastaut syndrome</strong> but does not have indications for <strong>migraine prophylaxis</strong> or <strong>alcohol craving management</strong>, unlike <strong>topiramate</strong>.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul><li><span style=\"font-size:14.0pt;\"><strong>Topiramate </strong>is effective in treating <strong>Lennox-Gastaut syndrome</strong> and is also used for <strong>migraine prophylaxis</strong> and to reduce <strong>alcohol cravings</strong>.</span></li><li><span style=\"font-size:14.0pt;\">While <strong>valproate </strong>is also used in Lennox-Gastaut syndrome and migraine prevention, it is not typically used for managing <strong>alcohol cravings</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Ethosuximide </strong>is primarily for <strong>absence seizures</strong>, and <strong>rufinamide</strong> is limited to seizures without additional benefits for migraines or alcohol use disorders.</span></li></ul>",
      "correct_choice_id": 248695,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62117,
      "choices": [
        {
          "id": 247729,
          "text": "<p><span style=\"font-size:14.0pt;\">A-3, B-4, C-2, D-1</span></p>"
        },
        {
          "id": 247730,
          "text": "<p><span style=\"font-size:14.0pt;\">A-1, B-2, C-4, D-3</span></p>"
        },
        {
          "id": 247731,
          "text": "<p><span style=\"font-size:14.0pt;\">A-3, B-2, C-1, D-4</span></p>"
        },
        {
          "id": 247732,
          "text": "<p><span style=\"font-size:14.0pt;\">A-4, B-1, C-3, D-2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the following drugs with its corresponding mechanisms of action:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-160306.jpg\" alt=\"\" width=\"1000\" height=\"352\"></span></p>",
      "unique_key": "Q7939573",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) A-3, B-4, C-2, D-1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The correct matches for the drugs and their mechanisms of action are:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>A. Adalimumab</strong> - <strong>3. TNF-alpha antagonist</strong>: Adalimumab is a monoclonal antibody that targets and neutralizes tumor necrosis factor-alpha (TNF-alpha), reducing inflammation in conditions like rheumatoid arthritis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>B. Albiglutide</strong> - <strong>4. GLP-1 agonist</strong>: Albiglutide is a glucagon-like peptide-1 (GLP-1) agonist used in type 2 diabetes to stimulate insulin release in response to meals, helping to control blood glucose levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>C. Alogliptin</strong> - <strong>2. DPP-4 inhibitor</strong>: Alogliptin inhibits dipeptidyl peptidase-4 (DPP-4), prolonging the action of incretin hormones, which helps to lower blood glucose levels in type 2 diabetes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>D. Apremilast</strong> - <strong>1. PDE-4 inhibitor</strong>: Apremilast inhibits phosphodiesterase-4 (PDE-4), decreasing the production of inflammatory cytokines, and is used in the treatment of psoriasis and psoriatic arthritis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Adalimumab&nbsp;</strong>is a <strong>TNF-alpha antagonist</strong> used in autoimmune conditions like rheumatoid arthritis.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Albiglutide&nbsp;</strong>is a <strong>GLP-1 agonist</strong> used for glycemic control in type 2 diabetes.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Alogliptin&nbsp;</strong>is a <strong>DPP-4 inhibitor</strong> that prolongs incretin activity to manage diabetes.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Apremilast&nbsp;</strong>is a <strong>PDE-4 inhibitor</strong> used to reduce inflammation in <strong>psoriasis</strong> and <strong>psoriatic arthritis</strong>.</span></li></ul>",
      "correct_choice_id": 247729,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62400,
      "choices": [
        {
          "id": 248849,
          "text": "<p><span style=\"font-size:14.0pt;\">Absent end diastolic flow in the umbilical artery</span></p>"
        },
        {
          "id": 248850,
          "text": "<p><span style=\"font-size:14.0pt;\">Reversal of a wave in the ductus venosus</span></p>"
        },
        {
          "id": 248851,
          "text": "<p><span style=\"font-size:14.0pt;\">Pulsatility of the umbilical vein</span></p>"
        },
        {
          "id": 248852,
          "text": "<p><span style=\"font-size:14.0pt;\">Decreased pulsatility index (PI) of the uterine artery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 31-year-old woman at 33 weeks gestation presents for a routine ultrasound. The ultrasound shows fetal growth restriction, and Doppler studies are performed. Which of the following Doppler findings is not an indication for immediate delivery in a fetus with growth restriction?</span></p>",
      "unique_key": "Q8888625",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Decreased pulsatility index (PI) of the uterine artery</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">A <strong>decreased pulsatility index (PI) of the uterine artery</strong> is associated with better maternal blood flow to the placenta and is not an indication for delivery in cases of fetal growth restriction (FGR).</span></li><li><span style=\"font-size:14.0pt;\">The pulsatility index assesses resistance in blood flow, and a <strong>decreased PI</strong> generally suggests lower resistance, which can be seen in a well-functioning placental circulation.</span></li><li><span style=\"font-size:14.0pt;\">It is not a critical finding that would indicate the need for immediate delivery.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Absent end diastolic flow in the umbilical artery: </strong>Incorrect. <strong>Absent end diastolic flow</strong> is a serious finding that indicates increased placental resistance and impaired fetal blood flow. This is an indication for close monitoring and often immediate delivery if the condition worsens.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Reversal of a wave in the ductus venosus: </strong>Incorrect. <strong>Reversal of the a-wave in the ductus venosus</strong> is a late sign of fetal compromise and impending fetal demise. This finding typically indicates the need for immediate delivery.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Pulsatility of the umbilical vein: </strong>Incorrect. <strong>Pulsatility of the umbilical vein</strong> is a sign of impending fetal heart failure and is an indication for urgent delivery.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">In fetal growth restriction (FGR), <strong>decreased pulsatility index (PI) of the uterine artery</strong> is not an indication for immediate delivery.</span></li><li><span style=\"font-size:14.0pt;\">Critical Doppler findings that do suggest the need for immediate delivery include <strong>absent end diastolic flow in the umbilical artery</strong>, <strong>reversal of a wave in the ductus venosus</strong>, and <strong>pulsatility of the umbilical vein</strong>, all of which indicate significant fetal compromise.</span></li></ul>",
      "correct_choice_id": 248852,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62150,
      "choices": [
        {
          "id": 247861,
          "text": "<p><span style=\"font-size:14.0pt;\">Acid Citrate Dextrose</span></p>"
        },
        {
          "id": 247862,
          "text": "<p><span style=\"font-size:14.0pt;\">Citrate Phosphate Double Dextrose</span></p>"
        },
        {
          "id": 247863,
          "text": "<p><span style=\"font-size:14.0pt;\">Lithium heparin</span></p>"
        },
        {
          "id": 247864,
          "text": "<p><span style=\"font-size:14.0pt;\">Citrate Phosphate Dextrose Adenine-1 (CPDA-1)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old man is scheduled for elective surgery and requires a blood transfusion. To ensure the availability of compatible blood, the blood bank must store the donated blood units for several weeks before the procedure. The staff chooses a preservative solution that allows the blood to be stored for up to 35 days while maintaining cell viability. Which of the following preservatives is most appropriate for this purpose?</span></p>",
      "unique_key": "Q5665782",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Citrate Phosphate Dextrose Adenine-1 (CPDA-1)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>CPDA-1&nbsp;</strong>is the most suitable preservative solution for <strong>storing whole blood</strong> for <strong>up to 35 days</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Adenine:&nbsp;</strong>maintain <strong>ATP levels</strong> in the stored <strong>red blood cells</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Citrate:&nbsp;</strong>an <strong>anticoagulant</strong>, <strong>Phosphate: </strong>maintain the <strong>pH</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Acid Citrate Dextrose:&nbsp;</strong>ACD lacks adenine and phosphate, limiting RBC storage to about 21 days, which is too short for this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Citrate Phosphate Double Dextrose:&nbsp;</strong>CP2D lacks adenine, restricting blood storage to around 21 days, unsuitable for extended storage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Lithium Heparin:&nbsp;</strong>Used for laboratory testing, not for blood preservation, as it does not support RBC metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">CPDA-1 allows blood storage for up to 35 days by maintaining red blood cell viability and ATP levels.</span></li><li><span style=\"font-size:14.0pt;\">Preservative solution must:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Prevent clotting</span></li><li><span style=\"font-size:14.0pt;\">Maintain ATP levels in RBCs (to support membrane integrity and ion balance)</span></li><li><span style=\"font-size:14.0pt;\">Prevent hemolysis</span></li><li><span style=\"font-size:14.0pt;\">Minimize biochemical changes over time (\"storage lesions\")</span></li><li><span style=\"font-size:14.0pt;\">Allow storage for ≥ 35 days</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Summary</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_xEQYFCt.png\" width=\"1425\" height=\"512\"></span></p>",
      "correct_choice_id": 247864,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62214,
      "choices": [
        {
          "id": 248113,
          "text": "<p><span style=\"font-size:18px;\">Thromboembolic disease</span></p>"
        },
        {
          "id": 248114,
          "text": "<p><span style=\"font-size:18px;\">Breast cancer</span></p>"
        },
        {
          "id": 248115,
          "text": "<p><span style=\"font-size:18px;\">Cervical cancer</span></p>"
        },
        {
          "id": 248116,
          "text": "<p><span style=\"font-size:18px;\">Recent cesarean delivery in a lactating woman</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">A 28-year-old woman with one previous live birth presents to your clinic inquiring about the contraceptive implant, Implanon NXT, for long-term contraception. Which of the following is an absolute contraindication to using this contraceptive method?</span></p>",
      "unique_key": "Q2146580",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. B) Breast cancer</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>Breast cancer&nbsp;</strong>is an <strong>absolute contraindication</strong> for the use of hormonal contraceptives, including Implanon NXT, which releases <strong>etonogestrel</strong> (a progestin).</span></li><li><span style=\"font-size:18px;\">Hormonal contraceptives can potentially stimulate the growth of hormone-sensitive tumors, such as breast cancer, making it unsafe for patients with a current or past history of breast cancer.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Thromboembolic disease:&nbsp;</strong>Incorrect. While thromboembolic disease is a contraindication for <strong>estrogen-containing contraceptives</strong>, it is not an absolute contraindication for progestin-only methods like Implanon NXT.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Cervical cancer:&nbsp;</strong>Incorrect. Cervical cancer is not an absolute contraindication to the use of progestin-only contraceptives. Other factors would need to be evaluated, but Implanon NXT can generally be used.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Recent cesarean delivery in a lactating woman:</strong> Incorrect. Progestin-only contraceptives like Implanon NXT can be safely used in lactating women and immediately postpartum.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>Breast cancer&nbsp;</strong>is an <strong>absolute contraindication</strong> to the use of hormonal contraceptives, including Implanon NXT, because of the potential for hormone-driven tumor growth.</span></li><li><span style=\"font-size:18px;\">Progestin-only contraceptives are generally safe in patients without contraindications like breast cancer.</span></li></ul>",
      "correct_choice_id": 248114,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62362,
      "choices": [
        {
          "id": 248701,
          "text": "<p><span style=\"font-size:14.0pt;\">Protects the acid-labile drug from gastric acidity</span></p>"
        },
        {
          "id": 248702,
          "text": "<p><span style=\"font-size:14.0pt;\">Protects the gastric mucosa from irritant effects of certain drugs</span></p>"
        },
        {
          "id": 248703,
          "text": "<p><span style=\"font-size:14.0pt;\">Prolongs the half-life of the drug</span></p>"
        },
        {
          "id": 248704,
          "text": "<p><span style=\"font-size:14.0pt;\">Delivers drugs distal to the stomach</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old woman is prescribed a proton pump inhibitor (PPI) for chronic gastroesophageal reflux disease (GERD). The medication is provided as an enteric-coated tablet to ensure proper absorption. Which of the following is not an advantage of using enteric-coated tablets for drug delivery?</span></p>",
      "unique_key": "Q2194877",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Prolongs the half-life of the drug</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul><li><span style=\"font-size:14.0pt;\"><strong>Enteric coating </strong>is designed to protect the <strong>drug from the acidic environment</strong> of the stomach or to protect the <strong>gastric mucosa</strong> from the <strong>irritant effects</strong> of the drug.</span></li><li><span style=\"font-size:14.0pt;\">It also ensures that the drug is released in the <strong>intestine</strong> rather than in the stomach, which is useful for drugs that need to act <strong>distally</strong> or those that are <strong>acid-labile</strong>.</span></li><li><span style=\"font-size:14.0pt;\">However, <strong>enteric coating does not affect the half-life of a drug</strong>. The <strong>half-life</strong> is determined by <strong>metabolism</strong> and <strong>elimination</strong> processes in the body, such as liver metabolism and kidney excretion.</span></li></ul><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Protects the acid-labile drug from gastric acidity</strong>: This is <strong>true</strong>. Enteric coating shields <strong>acid-labile</strong> drugs, like <strong>omeprazole</strong>, from being degraded in the <strong>acidic environment</strong> of the stomach.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Protects the gastric mucosa from irritant effects of certain drugs</strong>: This is <strong>true</strong>. For drugs that can irritate the <strong>gastric lining</strong> (e.g., <strong>NSAIDs</strong>), enteric coating can help minimize direct exposure to the stomach, reducing the risk of <strong>gastritis</strong> or <strong>ulceration</strong>.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Delivers drugs distal to the stomach</strong>: This is <strong>true</strong>. Enteric-coated drugs are designed to <strong>bypass the stomach</strong> and release the <strong>active ingredient</strong> in the <strong>small intestine</strong> or beyond, ensuring that the drug reaches its intended site of action without being degraded by stomach acid.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul><li><span style=\"font-size:14.0pt;\"><strong>Enteric coating </strong>is used to <strong>protect acid-labile drugs</strong> from <strong>gastric acidity</strong>, <strong>protect the stomach lining</strong>, and <strong>target drug delivery</strong> to the <strong>intestine</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Enteric coating does not affect the drug’s half-life</strong>, which is influenced by <strong>metabolic</strong> and <strong>elimination pathways</strong> in the body.</span></li></ul>",
      "correct_choice_id": 248703,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62158,
      "choices": [
        {
          "id": 247893,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type I - IgE-mediated mast cell degranulation</span></span></p>"
        },
        {
          "id": 247894,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type II - Antibody-dependent cell lysis</span></span></p>"
        },
        {
          "id": 247895,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type III - Immune complex deposition</span></span></p>"
        },
        {
          "id": 247896,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type IV - T-cell mediated activation of macrophages and cytotoxic T cells</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old patient develops skin rashes after coming into contact with poison ivy while hiking. Which type of hypersensitivity reaction is most likely responsible for his symptoms, and what is the primary mechanism involved? </span></span></p>",
      "unique_key": "Q7136093",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>D)</strong> <strong>Type IV - T-cell mediated activation of macrophages and cytotoxic T cells</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The patient&#39;s skin rash following contact with poison ivy is a classic example of <strong>contact dermatitis</strong>, which is caused by a <strong>Type IV hypersensitivity</strong> reaction. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Type IV hypersensitivity is mediated by <strong>T cells</strong> rather than antibodies. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In this case, <strong>TH1 cells</strong> secrete cytokines, which activate <strong>macrophages and cytotoxic T cells</strong>, leading to an inflammatory response in the skin.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Type I - IgE-mediated mast cell degranulation:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Type I hypersensitivity involves allergens binding to <strong>IgE</strong> bound to mast cells, which leads to degranulation. This type of hypersensitivity is responsible for conditions like <strong>anaphylaxis</strong> and <strong>allergic rhinitis</strong>, not contact dermatitis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Type II - Antibody-dependent cell lysis:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Type II hypersensitivity involves <strong>IgG or IgM</strong> binding to <strong>cell-bound antigens</strong>, leading to cell destruction via complement or <strong>ADCC</strong> (antibody-dependent cell-mediated cytotoxicity). Examples include <strong>hemolytic disease of the newborn</strong> and <strong>transfusion reactions</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Type III - Immune complex deposition:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Type III hypersensitivity involves <strong>antigen-antibody complexes</strong> that deposit in tissues and trigger an inflammatory response. Examples include <strong>systemic lupus erythematosus</strong> and <strong>post-streptococcal glomerulonephritis</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-135801.jpg\" style=\"height:811px; width:966px\" /></span></strong></span></span></p>",
      "correct_choice_id": 247896,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62140,
      "choices": [
        {
          "id": 247821,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Anti-nuclear antibody (ANA)</span></span></span></p>"
        },
        {
          "id": 247822,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Anti-Ro/SSA antibody</span></span></span></p>"
        },
        {
          "id": 247823,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Anti-double-stranded DNA (anti-dsDNA) antibody</span></span></span></p>"
        },
        {
          "id": 247824,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Anti-histone antibody</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 27-year-old woman with a history of systemic lupus erythematosus (SLE) presents with new-onset headaches, blurred vision, and hypertension. Fundoscopic examination shows flame-shaped hemorrhages and cotton-wool spots consistent with hypertensive retinopathy. She has previously been treated with corticosteroids for lupus nephritis, but her renal function has worsened. A renal biopsy shows wire-loop lesions and extensive immune complex deposition in the glomeruli. Which of the following autoantibodies is most specific for this<strong> </strong>patient&rsquo;s lupus-related renal pathology?</span></span></p>",
      "unique_key": "Q1948300",
      "difficulty_level": "intermediate",
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans. C) Anti-double-stranded DNA (anti-dsDNA) antibody </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This patient has severe lupus nephritis, a complication of SLE characterized by immune complex deposition in the kidneys. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The presence of wire-loop lesions on renal biopsy indicates diffuse proliferative glomerulonephritis, a severe form of lupus nephritis. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Anti-double-stranded DNA (anti-dsDNA)</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> antibodies are highly specific for SLE and are closely associated with lupus nephritis, correlating with disease activity.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Anti-nuclear antibody (ANA):&nbsp;</span></strong><span style=\"font-size:14.0pt\">Incorrect. ANA is sensitive but not specific for SLE, and while it is commonly positive in lupus, it is not specific for lupus nephritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Anti-Ro/SSA antibody:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Incorrect. Anti-Ro/SSA antibodies are seen in some patients with SLE but are more commonly associated with <strong>subacute cutaneous lupus erythematosus</strong> and <strong>Sj&ouml;gren&#39;s syndrome</strong>. They are not specific for lupus nephritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Anti-histone antibody:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Incorrect. Anti-histone antibodies are commonly associated with <strong>drug-induced lupus</strong>, not lupus nephritis or severe SLE.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Anti-double-stranded DNA (anti-dsDNA) antibodies&nbsp;</span></strong><span style=\"font-size:14.0pt\">are highly specific for <strong>systemic lupus erythematosus (SLE)</strong> and are strongly associated with <strong>lupus nephritis</strong>, making them a key marker for renal involvement in SLE.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247823,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62235,
      "choices": [
        {
          "id": 248197,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">MRCP</span></span></span></p>"
        },
        {
          "id": 248198,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">ERCP (Endoscopic Retrograde Cholangiopancreatography)</span></span></span></p>"
        },
        {
          "id": 248199,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Endoscopic ultrasound</span></span></span></p>"
        },
        {
          "id": 248200,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Laparoscopic cholecystectomy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old lady presents to the emergency department with severe abdominal pain. An abdominal ultrasound reveals the presence of multiple gallstones with no evidence of wall thickening. The bile duct (BD) diameter is measured at 12 mm, and serum bilirubin levels are elevated at 2.8. The patient&#39;s alkaline phosphatase levels are significantly elevated at 380. What is the next best step in the management of this patient? </span></span></p>",
      "unique_key": "Q8053835",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) MRCP </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Given the patient&#39;s presentation of multiple gallstones, an enlarged bile duct diameter, and elevated liver enzymes, there is a high suspicion of choledocholithiasis (stones in the common bile duct). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">An MRCP is the most appropriate initial investigation to visualize and confirm the presence of common bile duct stones without subjecting the patient to an invasive procedure.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>ERCP (Endoscopic Retrograde Cholangiopancreatography)</strong>: ERCP is an invasive procedure that allows both the visualization and treatment of biliary and pancreatic duct abnormalities. While it can be used to diagnose and treat choledocholithiasis, it is generally reserved for therapeutic interventions after the diagnosis has been established, given the risks associated with the procedure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Endoscopic ultrasound</strong>: This technique can be very sensitive for detecting common bile duct stones and other biliary pathologies. However, in the context of a patient with an enlarged bile duct and elevated liver enzymes suggestive of choledocholithiasis, MRCP would be the preferred initial diagnostic tool.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D</span></strong><span style=\"font-size:14.0pt\">. <strong>Laparoscopic cholecystectomy</strong>: While the patient may ultimately require a cholecystectomy, especially if the gallstones are the cause of her symptoms, it&#39;s crucial to first assess and manage any potential common bile duct stones. Directly proceeding to cholecystectomy without addressing potential common bile duct stones could lead to complications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In summary, given the patient&#39;s clinical presentation and laboratory findings suggesting the presence of common bile duct stones, an MRCP is the most appropriate initial step to visualize the biliary system and confirm the diagnosis.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248197,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62215,
      "choices": [
        {
          "id": 248117,
          "text": "<p><span style=\"font-size:18px;\">Tracheo-esophageal fistula</span></p>"
        },
        {
          "id": 248118,
          "text": "<p><span style=\"font-size:18px;\">Fetal posterior urethral valve</span></p>"
        },
        {
          "id": 248119,
          "text": "<p><span style=\"font-size:18px;\">Diaphragmatic hernia</span></p>"
        },
        {
          "id": 248120,
          "text": "<p><span style=\"font-size:18px;\">Congenital heart disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">A 32-year-old pregnant woman at 28 weeks gestation presents for a routine prenatal visit. On physical examination, the fundal height is measured at 24 cm. An ultrasound reveals oligohydramnios with absent amniotic fluid. The fetus is noted to have normal cardiac activity. Which of the following is the most likely cause of this patient's oligohydramnios?</span></p>",
      "unique_key": "Q7295242",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. B) Fetal posterior urethral valve</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>Fetal posterior urethral valves&nbsp;</strong>are a common cause of <strong>oligohydramnios</strong> in male fetuses.</span></li><li><span style=\"font-size:18px;\">This condition occurs due to a <strong>congenital obstruction of the urethra</strong>, preventing the fetus from properly emptying its bladder.</span></li><li><span style=\"font-size:18px;\">Since fetal urine is a major component of amniotic fluid, this obstruction leads to a <strong>reduction or absence of amniotic fluid (oligohydramnios)</strong>.</span></li><li><span style=\"font-size:18px;\">In this case, the ultrasound findings of absent liquor (amniotic fluid) and a discrepancy between gestational age and uterine size strongly suggest oligohydramnios caused by a lower urinary tract obstruction such as posterior urethral valves.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Tracheo-esophageal fistula:&nbsp;</strong>Incorrect. Tracheo-esophageal fistula is associated with <strong>polyhydramnios</strong> (excess amniotic fluid) because the fetus cannot swallow amniotic fluid properly. It does not cause oligohydramnios.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Diaphragmatic hernia:</strong> Incorrect. A diaphragmatic hernia can lead to pulmonary hypoplasia and respiratory issues at birth but is not a direct cause of oligohydramnios.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Congenital heart disease:</strong> Incorrect. Congenital heart disease generally does not affect the production or regulation of amniotic fluid, making it an unlikely cause of oligohydramnios.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>Posterior urethral valves&nbsp;</strong>cause <strong>oligohydramnios</strong> due to obstruction of fetal urine outflow.</span></li><li><span style=\"font-size:18px;\">Fetal urine production is essential for maintaining normal amniotic fluid levels, and obstruction leads to low or absent amniotic fluid, contributing to complications like pulmonary hypoplasia and other fetal abnormalities.</span></li></ul>",
      "correct_choice_id": 248118,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62164,
      "choices": [
        {
          "id": 247917,
          "text": "<p><span style=\"font-size:14.0pt;\">MRI of the pituitary</span></p>"
        },
        {
          "id": 247918,
          "text": "<p><span style=\"font-size:14.0pt;\">CECT Head</span></p>"
        },
        {
          "id": 247919,
          "text": "<p><span style=\"font-size:14.0pt;\">Dexamethasone</span></p>"
        },
        {
          "id": 247920,
          "text": "<p><span style=\"font-size:14.0pt;\">Urgent surgery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old woman presents to the emergency department with sudden onset of severe headache, nausea, and visual disturbances. She has a known history of a pituitary adenoma. On examination, she has reduced visual acuity and bitemporal hemianopsia. A CT scan of the head reveals a hemorrhagic mass in the sella turcica. Her blood pressure is 80/60 mm Hg, and laboratory tests reveal hyponatremia. Which of the following is the next best step in the management of this patient?</span></p>",
      "unique_key": "Q3475426",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;C) Dexamethasone</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Dexamethasone</strong> or another high-dose corticosteroid is the <strong>most important first step</strong> to address adrenal insufficiency caused by ACTH deficiency, which leads to hypotension and potential shock. This is a life-threatening situation that requires prompt intervention.</span></li><li><span style=\"font-size:14.0pt;\">After corticosteroid administration, <strong>urgent surgery</strong> will likely be required to decompress the optic chiasm and relieve the mass effect causing visual disturbances, but surgery should be delayed until the patient is hemodynamically stable.</span></li></ul><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option A. MRI of the pituitary</strong>: While MRI provides better soft tissue detail and will confirm the diagnosis, it is not the <strong>immediate next step</strong>. Stabilization with steroids comes first.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option B. CECT Head</strong>: A CT scan has already shown a hemorrhagic mass. An MRI could follow after stabilization, but CT imaging is not the priority at this point.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Urgent surgery</strong>: Surgery is essential, but <strong>after stabilizing the patient</strong> with corticosteroids to prevent further adrenal crisis.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>pituitary apoplexy</strong>, the immediate treatment with <strong>dexamethasone</strong> (or other steroids) is the priority to correct adrenal insufficiency, followed by further imaging and surgical intervention.&nbsp;</span></li></ul>",
      "correct_choice_id": 247919,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62159,
      "choices": [
        {
          "id": 247897,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Timolol</span></span></p>"
        },
        {
          "id": 247898,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Netarsudil</span></span></p>"
        },
        {
          "id": 247899,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Brimonidine</span></span></p>"
        },
        {
          "id": 247900,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetazolamide</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 62-year-old woman with a history of open-angle glaucoma visits her ophthalmologist for follow-up. She is being treated with various medications to lower her intraocular pressure (IOP). The physician wants to add a drug that specifically increases trabecular outflow to help manage her condition. Which of the following medications has this mechanism of action? </span></span></p>",
      "unique_key": "Q1016992",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Netarsudil</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Netarsudil&nbsp;</span></strong><span style=\"font-size:14.0pt\">is a <strong>Rho-kinase inhibitor</strong> used in the treatment of <strong>glaucoma</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It works by <strong>increasing trabecular outflow</strong>, thereby reducing intraocular pressure (IOP). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Rho-kinase inhibition leads to changes in the cytoskeleton of the trabecular meshwork, which enhances the outflow of aqueous humor through this pathway.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Timolol</span></strong><span style=\"font-size:14.0pt\">: Timolol is a <strong>beta-blocker</strong> that reduces intraocular pressure by <strong>decreasing the production of aqueous humor</strong> from the ciliary body. It does not increase trabecular outflow.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Brimonidine</span></strong><span style=\"font-size:14.0pt\">: Brimonidine is an <strong>alpha-2 adrenergic agonist</strong> that <strong>reduces aqueous humor production</strong> and also <strong>increases uveoscleral outflow</strong>, but it does not specifically increase <strong>trabecular outflow</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Acetazolamide</span></strong><span style=\"font-size:14.0pt\">: Acetazolamide is a <strong>carbonic anhydrase inhibitor</strong> that <strong>reduces the production of aqueous humor</strong> by the ciliary body, leading to decreased intraocular pressure. It does not affect trabecular outflow.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Netarsudil&nbsp;</span></strong><span style=\"font-size:14.0pt\">increases <strong>trabecular outflow</strong> by inhibiting <strong>Rho-kinase</strong>, making it effective in lowering <strong>intraocular pressure</strong> in <strong>glaucoma</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Timolol&nbsp;</span></strong><span style=\"font-size:14.0pt\">and <strong>acetazolamide</strong> decrease <strong>aqueous humor production</strong>, while <strong>brimonidine</strong> affects <strong>uveoscleral outflow</strong>.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247898,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62420,
      "choices": [
        {
          "id": 248929,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 3</span></p>"
        },
        {
          "id": 248930,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 5</span></p>"
        },
        {
          "id": 248931,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 4</span></p>"
        },
        {
          "id": 248932,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3 and 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old male is admitted to the ICU after a traumatic head injury. The clinician wants to assess the oculocephalic reflex, as part of the neurological evaluation. The test is performed by rapidly rotating the patient's head from side to side while observing eye movements. Which of the following cranial nerves are involved in the oculocephalic reflex?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">III</span></li><li><span style=\"font-size:14.0pt;\">IV</span></li><li><span style=\"font-size:14.0pt;\">VI</span></li><li><span style=\"font-size:14.0pt;\">VIII</span></li><li><span style=\"font-size:14.0pt;\">VII</span></li></ol>",
      "unique_key": "Q3862285",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>D) 1, 3 and 4</strong></span><br>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The <strong>oculocephalic reflex</strong>, also known as the <strong>doll’s eye reflex</strong>, assesses the integrity of several cranial nerves to determine <strong>brainstem function</strong>. The cranial nerves involved include:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Cranial Nerve III (Oculomotor Nerve)</strong>: This nerve controls the <strong>medial rectus</strong> and other muscles, allowing the eyes to move.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Cranial Nerve VI (Abducens Nerve)</strong>: The <strong>lateral rectus muscle</strong> is controlled by this nerve, which abducts the eye.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Cranial Nerve VIII (Vestibulocochlear Nerve)</strong>: This nerve is involved in sensing head position and relaying this information to the brainstem to adjust eye movements appropriately.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">When the examiner moves the patient's head rapidly from side to side, the eyes should move in the opposite direction to maintain visual fixation—this is a positive doll's eye reflex, indicating intact brainstem function involving cranial nerves <strong>III, VI, and VIII</strong>.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/22/screenshot-2024-10-22-132234_ZdvNBeS.png\" alt=\"\" width=\"702\" height=\"467\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2. Cranial Nerve IV (Trochlear Nerve)</strong> - This nerve controls the <strong>superior oblique</strong> muscle, which is involved in some eye movements, but it does not play a significant role in the doll’s eye reflex.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>5. Cranial Nerve VII (Facial Nerve)</strong> - This nerve is responsible for facial expression and is not involved in the oculocephalic reflex.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The <strong>oculocephalic reflex</strong> tests the integrity of cranial nerves <strong>III (Oculomotor)</strong>, <strong>VI (Abducens)</strong>, and <strong>VIII (Vestibulocochlear)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is used to assess brainstem function, especially in unconscious patients.</span></li><li><span style=\"font-size:14.0pt;\">A positive reflex indicates that the brainstem pathways are intact and capable of coordinating eye movements in response to head movement.</span></li></ul>",
      "correct_choice_id": 248932,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62397,
      "choices": [
        {
          "id": 248837,
          "text": "<p><span style=\"font-size:14.0pt;\">Androgen insensitivity syndrome</span></p>"
        },
        {
          "id": 248838,
          "text": "<p><span style=\"font-size:14.0pt;\">Congenital adrenal hyperplasia</span></p>"
        },
        {
          "id": 248839,
          "text": "<p><span style=\"font-size:14.0pt;\">Primary ovarian insufficiency</span></p>"
        },
        {
          "id": 248840,
          "text": "<p><span style=\"font-size:14.0pt;\">Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 16-year-old girl presents to the clinic with her mother due to concerns about primary amenorrhea. On examination, she has normal secondary sexual characteristics, including breast development and normal pubic and axillary hair. Her LH and FSH levels are normal, and a pelvic ultrasound reveals an absent uterus. What is the most likely diagnosis?</span></p>",
      "unique_key": "Q6265929",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome</strong> is characterized by the congenital absence of the uterus and part or all of the vaginal canal in women with a normal 46,XX karyotype.</span></li><li><span style=\"font-size:14.0pt;\">These patients typically present with <strong>primary amenorrhea</strong> but have normal secondary sexual development, such as breast and pubic/axillary hair development, because their ovaries are functional and produce normal hormone levels.</span></li><li><span style=\"font-size:14.0pt;\">Ultrasound typically shows an absent or rudimentary uterus.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Androgen insensitivity syndrome (AIS): </strong>Incorrect. Individuals with <strong>AIS</strong> have a 46,XY karyotype and are genetically male but are resistant to androgens, leading to female external genitalia. However, these patients typically lack pubic and axillary hair and have elevated LH and FSH levels, which is inconsistent with this patient’s normal hormone levels and secondary sexual characteristics.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Congenital adrenal hyperplasia (CAH): </strong>Incorrect. <strong>CAH</strong> is a group of disorders that result from enzyme deficiencies in the adrenal steroid synthesis pathway, leading to excess androgen production. Although CAH can cause amenorrhea, it is typically associated with ambiguous genitalia and elevated androgen levels, which are not seen in this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Primary ovarian insufficiency: </strong>Incorrect. <strong>Primary ovarian insufficiency</strong> is characterized by ovarian failure before the age of 40, leading to low estrogen levels and elevated FSH and LH levels. Patients with this condition usually do not have normal secondary sexual development, which makes this diagnosis unlikely.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome</strong> is a congenital disorder characterized by the absence of the uterus and upper vaginal canal, leading to primary amenorrhea in women with normal secondary sexual development.</span></li><li><span style=\"font-size:14.0pt;\">These patients have normal ovarian function and normal hormone levels, with a 46,XX karyotype.</span></li></ul>",
      "correct_choice_id": 248840,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62237,
      "choices": [
        {
          "id": 248205,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Left hepatic artery </span></span></span></p>"
        },
        {
          "id": 248206,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cystic artery</span></span></span></p>"
        },
        {
          "id": 248207,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Right hepatic artery</span></span></span></p>"
        },
        {
          "id": 248208,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Portal vein</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Moynihan&rsquo;s hump is an anatomical variation usually associated with which of the below structures? </span></span></p>",
      "unique_key": "Q4847634",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Right hepatic artery</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The right hepatic artery can be tortuous (caterpillar turn/ Moynihan&rsquo;s hump) and may lie very close to the gallbladder and the cystic duct before giving off a short cystic artery.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-161009.jpg\" style=\"height:325px; width:700px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">(b) Tortuous CHA and (c) Tortuous RHA are examples of the &lsquo;caterpillar turn&rsquo; or &lsquo;Moynihan&rsquo;s hump&rsquo;, which can lead to inadvertent arterial injury or bleeding during cholecystectomy. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Moynihan&rsquo;s hump is an abnormally located Right/common hepatic artery on to the Calot&rsquo;s triangle.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248207,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62391,
      "choices": [
        {
          "id": 248813,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calculating the ratio of maternal deaths to the number of married women alive during the study period.</span></span></p>"
        },
        {
          "id": 248814,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Expressing maternal deaths per 100,000 live births, including deaths up to 14 days after pregnancy termination.</span></span></p>"
        },
        {
          "id": 248815,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dividing the annual number of maternal deaths by the total number of women aged 15-49 years during the study period.</span></span></p>"
        },
        {
          "id": 248816,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Expressing maternal deaths per 100,000 live births, including deaths up to 42 days after pregnancy termination.</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A researcher is analyzing maternal health outcomes in a developing country. To measure the risk of maternal death relative to the number of live births in the area, the researcher needs to calculate a key indicator. Which of the following best describes this indicator? </span></span></p>",
      "unique_key": "Q4665332",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Expressing maternal deaths per 100,000 live births, including deaths up to 42 days after pregnancy termination.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The indicator described is the Maternal Mortality Ratio (MMR). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It measures the number of maternal deaths per 100,000 live births, where a maternal death is defined as a death that occurs during pregnancy, delivery, or within 42 days after the end of pregnancy, due to complications related to the pregnancy or its management. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This indicator helps assess the safety of maternal health services and is crucial for monitoring progress in maternal care.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The Maternal Mortality Ratio (MMR) reflects the risk of maternal death in relation to live births, considering deaths occurring during pregnancy or within 42 days post-pregnancy.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is a critical measure of the quality of maternal healthcare and is used for tracking improvements in maternal health services.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248816,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62126,
      "choices": [
        {
          "id": 247765,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Increased leptin sensitivity</span></span></span></p>"
        },
        {
          "id": 247766,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Decreased food intake via stimulation of the anorexigenic pathway</span></span></span></p>"
        },
        {
          "id": 247767,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Inhibition of melanocortin receptors, leading to increased appetite</span></span></span></p>"
        },
        {
          "id": 247768,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Activation of the satiety center in the hypothalamus</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old woman with recent weight gain and increased appetite is found to have elevated Agouti-related peptide (AgRP) levels in the hypothalamus. Which of the following best explains the physiological effect of increased AgRP activity? </span></span></p>",
      "unique_key": "Q2007706",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Inhibition of melanocortin receptors, leading to increased appetite</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Agouti-related peptide (AgRP) is a neuropeptide produced in the hypothalamus that plays a crucial role in regulating appetite and energy balance. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It functions primarily by inhibiting melanocortin-4 receptors (MC4R), which are part of the pathway responsible for suppressing appetite. By blocking these receptors, AgRP counteracts their anorexigenic (appetite-suppressing) effect, thus promoting increased appetite and food intake. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This mechanism is associated with the patient&rsquo;s increased appetite and recent weight gain. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">AgRP is an important regulator of feeding behavior and energy conservation, particularly during periods of energy deficit.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Increased leptin sensitivity</span></strong><span style=\"font-size:14.0pt\">: <strong>Incorrect.</strong> AgRP acts as an antagonist to the melanocortin receptors and promotes feeding behavior, but it does not directly increase leptin sensitivity. Leptin is a hormone that inhibits appetite, and increased AgRP would oppose this action, promoting hunger instead.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Decreased food intake via stimulation of the anorexigenic pathway</span></strong><span style=\"font-size:14.0pt\">: <strong>Incorrect. </strong>AgRP actually inhibits the anorexigenic pathway (the pathway that reduces appetite), leading to increased food intake. It promotes feeding behavior rather than suppressing it.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Activation of the satiety center in the hypothalamus</span></strong><span style=\"font-size:14.0pt\">: <strong>Incorrect.</strong> AgRP promotes hunger by inhibiting the melanocortin system, which reduces the activity of the satiety center rather than activating it. AgRP increases food-seeking behavior, not satiety.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Agouti-related peptide (AgRP) <strong>inhibits melanocortin receptors</strong> in the hypothalamus, leading to <strong>increased appetite</strong> and <strong>reduced energy expenditure</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This pathway is essential in the regulation of <strong>feeding behavior</strong> and <strong>energy balance</strong>.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247767,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62224,
      "choices": [
        {
          "id": 248153,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lymphatic filariasis caused by Brugia malayi</span></span></p>"
        },
        {
          "id": 248154,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chagas disease caused by Trypanosoma cruzi</span></span></p>"
        },
        {
          "id": 248155,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">African trypanosomiasis caused by Trypanosoma brucei</span></span></p>"
        },
        {
          "id": 248156,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Leishmaniasis caused by Leishmania donovani</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A Transmission Assessment Survey (TAS) is planned in a region that has recently undergone mass drug administration (MDA) to prevent the spread of a specific parasitic disease. For which of the following parasitic diseases is this survey method primarily used?</span></span></p>",
      "unique_key": "Q2637343",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Lymphatic filariasis caused by Brugia malayi</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The Transmission Assessment Survey (TAS) is specifically designed to assess whether mass drug administration (MDA) has successfully reduced lymphatic filariasis transmission to levels where further MDA is no longer required. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is used to monitor the prevalence of microfilariae in the population to ensure that the disease is no longer being transmitted at a level that could sustain new infections. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This applies to lymphatic filariasis caused by both Wuchereria bancrofti and Brugia malayi.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Chagas disease caused by Trypanosoma cruzi</span></strong><span style=\"font-size:14.0pt\">: Incorrect. Chagas disease is not addressed through mass drug administration (MDA) and therefore does not use TAS. It is typically controlled through vector control measures (targeting the kissing bug) and screening of blood transfusions. TAS is irrelevant for evaluating transmission in Chagas disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. African trypanosomiasis caused by Trypanosoma brucei</span></strong><span style=\"font-size:14.0pt\">: Incorrect. African trypanosomiasis (sleeping sickness) is controlled through active case detection, treatment, and vector control (such as reducing the tsetse fly population). Mass drug administration is not a strategy used in its elimination, making TAS an inappropriate tool for this disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Leishmaniasis caused by Leishmania donovani</span></strong><span style=\"font-size:14.0pt\">: Incorrect. Leishmaniasis is typically managed through vector control (targeting sandflies), early diagnosis, and prompt treatment. Mass drug administration is not part of the standard approach for leishmaniasis control, so TAS is not applicable for monitoring its transmission.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Transmission assessment survey (TAS) for Filariasis</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Importance: Helps us evaluate if transmission is not sustainable (at a quite low level) enough guiding us to stop MDA, to check for recrudescence</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Criteria: Mf prevalence &lt;1% even after 5th MDA, &gt;65% in coverage in each MDA</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">TAS carried out at: Schools 1st/2nd year primary children (If enrolment is &gt;75%), Community 6&ndash;7 years old children (If enrolment is &lt;75%)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Methods used: Cluster survey, Systematic sampling</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Major diagnostic tools: Immunochromatographic test (ICT), Brugia rapid (and Blood films, PCR)</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248153,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62203,
      "choices": [
        {
          "id": 248069,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase the rate of positive pressure ventilation</span></span></p>"
        },
        {
          "id": 248070,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Administer intravenous epinephrine</span></span></p>"
        },
        {
          "id": 248071,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reposition the head and continue ventilations</span></span></p>"
        },
        {
          "id": 248072,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Administer a second dose of surfactant</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 2-minute-old newborn has a heart rate of 50 beats/min despite receiving effective positive pressure ventilation (PPV) with a bag and mask. The healthcare team initiates chest compressions and continues ventilation, but the heart rate remains below 60 beats/min after 30 seconds of effective compressions and ventilation. What is the next best step in the management of this newborn? </span></span></p>",
      "unique_key": "Q4233352",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Administer intravenous epinephrine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">If a newborn&#39;s heart rate remains below 60 beats per minute after 30 seconds of effective chest compressions and ventilation, the administration of epinephrine is indicated as the next step. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Epinephrine is administered to improve cardiac output when compressions and ventilations alone are insufficient. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The preferred route is intravenous through the umbilical vein, and it can also be given via endotracheal tube if IV access is not immediately available.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Increase the rate of positive pressure ventilation:</span></strong><span style=\"font-size:14.0pt\"> This is incorrect as increasing the rate of PPV is not indicated when compressions are already being performed.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C.</span></strong><span style=\"font-size:14.0pt\"> <strong>Reposition the head and continue ventilations:</strong> This is incorrect as repositioning the head is part of the initial steps of resuscitation to ensure adequate airway and ventilation before starting compressions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D.</span></strong><span style=\"font-size:14.0pt\"> <strong>Administer a second dose of surfactant:</strong> This is incorrect as surfactant therapy is used for respiratory distress syndrome but is not part of the acute steps in neonatal resuscitation when the heart rate is below 60 beats per minute.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In neonatal resuscitation, if a newborn&#39;s heart rate remains below 60 beats per minute despite 30 seconds of effective chest compressions and ventilation, epinephrine should be administered immediately.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248070,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62244,
      "choices": [
        {
          "id": 248233,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neonatal pulmonary alveolar proteinosis</span></span></p>"
        },
        {
          "id": 248234,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Meconium aspiration syndrome</span></span></p>"
        },
        {
          "id": 248235,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyaline membrane disease</span></span></p>"
        },
        {
          "id": 248236,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transient tachypnea of the newborn</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A term male infant is born via cesarean section to a 27-year-old G1P1 mother after an uncomplicated pregnancy. The baby develops tachypnea, grunting, and mild chest retractions within an hour of birth. Oxygen saturation is 92% on room air. A chest x-ray reveals hyperinflation with fluid in the interlobar fissures and no mediastinal shift. Which of the following is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q6576625",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Transient tachypnea of the newborn</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Transient tachypnea of the newborn (TTN) is a common cause of respiratory distress in full-term infants, especially those born by cesarean section without labor. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It results from delayed clearance of lung fluid, leading to tachypnea shortly after birth. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Chest x-ray typically shows hyperinflation, perihilar streaking, and fluid in the fissures without mediastinal shift. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Symptoms often improve within 24 to 72 hours with supportive care, such as oxygen.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Neonatal pulmonary alveolar proteinosis:</span></strong><span style=\"font-size:14.0pt\"> This condition presents with progressive respiratory distress and diffuse ground-glass opacities on chest x-ray. It is rare in neonates and associated with mutations affecting surfactant metabolism or macrophage function. The clinical course is more severe and does not resolve quickly as in TTN.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Meconium aspiration syndrome:</span></strong><span style=\"font-size:14.0pt\"> Typically occurs in term or post-term infants who experience fetal distress or hypoxia during delivery, leading to meconium-stained amniotic fluid and aspiration. Chest x-ray shows patchy infiltrates and areas of consolidation. It is often associated with hyperinflation and air trapping but usually not isolated fluid in the fissures.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Hyaline membrane disease:&nbsp;</span></strong><span style=\"font-size:14.0pt\">This is a condition of preterm infants due to surfactant deficiency, resulting in respiratory distress within minutes to hours of birth. Chest x-ray shows diffuse ground-glass opacities and air bronchograms. It is less common in full-term infants and presents earlier than TTN.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Transient tachypnea of the newborn is characterized by delayed resorption of lung fluid, leading to respiratory distress soon after birth in term infants, especially following cesarean delivery without labor. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The chest x-ray findings include hyperinflation and fluid in the interlobar fissures. Symptoms resolve with supportive care within 24 to 72 hours.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248236,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62204,
      "choices": [
        {
          "id": 248073,
          "text": "<p><span style=\"font-size:14.0pt;\">Absent cerebral metabolism</span></p>"
        },
        {
          "id": 248074,
          "text": "<p><span style=\"font-size:14.0pt;\">Normal cerebral metabolism</span></p>"
        },
        {
          "id": 248075,
          "text": "<p><span style=\"font-size:14.0pt;\">Reduced cerebral metabolism</span></p>"
        },
        {
          "id": 248076,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased cerebral metabolism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 76-year-old man is brought to the emergency department unconscious. He exhibits no spontaneous movement of his extremities and does not respond to voice or painful stimuli. However, he is able to blink and move his eyes in the vertical plane. Based on these physical exam findings, which of the following would be revealed in FDG PET?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5096603",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Normal cerebral metabolism</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In patients with locked-in syndrome, despite the lack of movement or verbal response, the cerebral metabolism remains relatively intact, especially in areas responsible for cognitive function.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This is reflected in FDG PET scans, which typically show normal metabolic activity in these patients, as they are conscious and aware.</span></li></ul><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Absent cerebral metabolism:</strong> This would indicate complete lack of brain activity, which is not the case here since the patient retains consciousness.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Reduced cerebral metabolism:</strong> While motor pathways may show reduced activity due to paralysis, overall cerebral metabolism related to awareness and cognition remains normal.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Increased cerebral metabolism:</strong> This option would imply heightened brain activity, which does not apply in the context of a patient who cannot respond or move.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\">In locked-in syndrome, although motor functions are severely compromised, cognitive functions are preserved, leading to normal cerebral metabolism as observed on FDG PET scans.</span></p>",
      "correct_choice_id": 248074,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62365,
      "choices": [
        {
          "id": 248709,
          "text": "<p><span style=\"font-size:14.0pt;\">Bradycardia with AV block</span></p>"
        },
        {
          "id": 248710,
          "text": "<p><span style=\"font-size:14.0pt;\">Torsades de pointes</span></p>"
        },
        {
          "id": 248711,
          "text": "<p><span style=\"font-size:14.0pt;\">Tachycardia</span></p>"
        },
        {
          "id": 248712,
          "text": "<p><span style=\"font-size:14.0pt;\">Ventricular fibrillation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old man with hypertension and angina has been on metoprolol for several months, but his blood pressure remains inadequately controlled. His physician adds verapamil to his regimen. Which of the following adverse effects is most likely to occur due to this combination?</span></p>",
      "unique_key": "Q5955856",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Bradycardia with AV block</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The combination of <strong>metoprolol</strong>, a <strong>beta-blocker</strong>, and <strong>verapamil</strong>, a <strong>calcium channel blocker</strong>, can significantly impact the <strong>heart rate</strong> and <strong>AV nodal conduction</strong> due to their overlapping effects on the <strong>cardiac conduction system</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Metoprolol </strong>slows the <strong>heart rate</strong> and decreases <strong>myocardial contractility</strong> by blocking <strong>beta-adrenergic receptors</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Verapamil </strong>is a <strong>non-dihydropyridine calcium channel blocker</strong> that also slows <strong>heart rate</strong> and <strong>AV nodal conduction</strong> by inhibiting <strong>calcium influx</strong> in cardiac cells.</span></li><li><span style=\"font-size:14.0pt;\">When used together, they can have <strong>additive effects</strong> on the <strong>AV node</strong>, leading to <strong>bradycardia</strong> and <strong>AV block</strong>, which is a delay or complete block of electrical conduction through the AV node.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Torsades de pointes</strong>: This is typically associated with drugs that <strong>prolong the QT interval</strong>, such as <strong>certain antiarrhythmics</strong> (e.g., sotalol) or <strong>macrolide antibiotics</strong>. <strong>Metoprolol</strong> and <strong>verapamil</strong> are not known to cause <strong>QT prolongation</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Tachycardia</strong>: This is incorrect. <strong>Both metoprolol</strong> and <strong>verapamil</strong> slow the heart rate, and their combination is more likely to cause <strong>bradycardia</strong>, not <strong>tachycardia</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Ventricular fibrillation</strong>: This is incorrect. <strong>Ventricular fibrillation</strong> is a <strong>life-threatening arrhythmia</strong> that is not directly caused by the combination of <strong>metoprolol</strong> and <strong>verapamil</strong>. The primary risk with this combination is a <strong>slowed heart rate</strong> or <strong>AV block</strong>, rather than ventricular arrhythmias.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Metoprolol </strong>and <strong>verapamil</strong> have <strong>additive effects</strong> on <strong>slowing heart rate</strong> and <strong>AV nodal conduction</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Combining a <strong>beta-blocker</strong> with a <strong>non-dihydropyridine calcium channel blocker</strong> like <strong>verapamil</strong> increases the risk of <strong>bradycardia</strong> and <strong>AV block</strong>.</span></li></ul>",
      "correct_choice_id": 248709,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62075,
      "choices": [
        {
          "id": 247561,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Dys </span><span style=\"font-size:14.0pt\">&beta;</span><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">-lipoproteinemia</span></span></span></p>"
        },
        {
          "id": 247562,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Familial hypercholesterolemia</span></span></span></p>"
        },
        {
          "id": 247563,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Hypertriglyceridemia</span></span></span></p>"
        },
        {
          "id": 247564,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Abetalipoproteinemia</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old man presents with xanthomas on his palms and premature coronary artery disease. Laboratory tests reveal elevated total cholesterol and triglyceride levels. Further lipid panel analysis shows high levels of chylomicron remnants and intermediate-density lipoproteins (IDLs). Genetic testing confirms a mutation in the ApoE gene. Which of the following is the most likely diagnosis? </span></span></p>",
      "unique_key": "Q9849244",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Dys &beta;-lipoproteinemia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Dys &beta;-lipoproteinemia</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">, also known as <strong>Type III hyperlipoproteinemia</strong>, is characterized by a mutation in the <strong>ApoE</strong> gene, which impairs the clearance of <strong>chylomicron remnants</strong> and <strong>intermediate-density lipoproteins (IDLs)</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This condition leads to <strong>elevated levels of total cholesterol</strong> and <strong>triglycerides</strong>, resulting in the accumulation of these lipoproteins in the blood. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Clinically, patients present with <strong>palmar xanthomas</strong> (yellowish deposits on the palms) and <strong>premature atherosclerosis</strong>, leading to <strong>coronary artery disease</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The defective <strong>ApoE</strong> impairs the ability of the liver to uptake these lipoproteins, causing their buildup in the bloodstream.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Familial hypercholesterolemia</span></strong><span style=\"font-size:14.0pt\">: Incorrect. Familial hypercholesterolemia is due to a mutation in the <strong>LDL receptor</strong> or <strong>ApoB</strong> gene, leading to high levels of <strong>low-density lipoprotein (LDL)</strong>. It is characterized by <strong>elevated LDL cholesterol</strong>, <strong>tendon xanthomas</strong>, and <strong>premature coronary artery disease</strong>, but it does not typically involve <strong>elevated triglycerides</strong> or <strong>chylomicron remnants</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Hypertriglyceridemia</span></strong><span style=\"font-size:14.0pt\">: Incorrect. <strong>Hypertriglyceridemia</strong> refers to elevated levels of <strong>triglycerides</strong> without a significant increase in <strong>cholesterol</strong> levels or <strong>chylomicron remnants</strong>. It is often related to increased <strong>very-low-density lipoprotein (VLDL)</strong> production and is associated with <strong>pancreatitis</strong> rather than <strong>premature coronary artery disease</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option D. Abetalipoproteinemia</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">: It is caused by mutations in the <strong>MTTP</strong> gene, which encodes the microsomal triglyceride transfer protein. This protein is essential for the assembly and secretion of apolipoprotein B-containing lipoproteins (chylomicrons, VLDL, LDL) from the liver and intestines.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Key Features:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Fat malabsorption, Neurological problems, Retinal degeneration, Acanthocytosis, Diarrhea and steatorrhea</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Dys &beta;-lipoproteinemia (Type III hyperlipoproteinemia)&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">is characterized by <strong>elevated chylomicron remnants</strong> and <strong>IDLs</strong> due to a mutation in the <strong>ApoE</strong> gene. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This condition leads to <strong>elevated total cholesterol and triglycerides</strong>, <strong>palmar xanthomas</strong>, and <strong>premature atherosclerosis</strong>, making early diagnosis and management crucial to prevent cardiovascular complications.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247561,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62161,
      "choices": [
        {
          "id": 247905,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phase 4</span></span></p>"
        },
        {
          "id": 247906,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phase 3</span></span></p>"
        },
        {
          "id": 247907,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phase 2</span></span></p>"
        },
        {
          "id": 247908,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phase 1</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A pharmaceutical company has developed a new medication and has successfully completed several stages of clinical trials. They are now ready to submit a New Drug Application (NDA) to the FDA for approval to market the drug. This application is typically filed after completing which phase of clinical trials?</span></span></p>",
      "unique_key": "Q6397236",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Phase 3</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A <strong>New Drug Application (NDA)</strong> is submitted to the <strong>FDA</strong> (or equivalent regulatory body) after the completion of <strong>Phase 3 clinical trials</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Phase 3 trials involve <strong>large-scale testing</strong> in patients to evaluate the drug&rsquo;s <strong>efficacy and safety</strong> compared to the current standard of care. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">If the drug demonstrates a favorable balance of <strong>efficacy</strong> and <strong>safety</strong> during Phase 3 trials, the company submits an <strong>NDA</strong> to seek approval for marketing the drug to the public.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Phase 4</span></strong><span style=\"font-size:14.0pt\">: Phase 4 trials occur <strong>after the drug is approved</strong> and released on the market. These involve <strong>post-marketing surveillance</strong> to monitor <strong>long-term safety</strong> and <strong>rare adverse effects</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Phase 2</span></strong><span style=\"font-size:14.0pt\">: Phase 2 trials are <strong>initial efficacy studies</strong> conducted in a small group of patients with the disease of interest to assess whether the drug works and to further assess safety. Filing for an NDA does not occur after this phase.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Phase 1</span></strong><span style=\"font-size:14.0pt\">: Phase 1 trials focus on <strong>safety</strong>, <strong>dosage</strong>, and <strong>pharmacokinetics</strong> in <strong>healthy volunteers</strong> or patients and are not sufficient for an NDA filing.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Phase 1 trials&nbsp;</span></strong><span style=\"font-size:14.0pt\">assess <strong>safety and dosing </strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Phase 2 trials&nbsp;</span></strong><span style=\"font-size:14.0pt\">are smaller studies aimed at determining the <strong>efficacy</strong> of a drug.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">New Drug Application (NDA)&nbsp;</span></strong><span style=\"font-size:14.0pt\">is submitted after <strong>Phase 3 trials</strong>, which assess the drug&rsquo;s <strong>efficacy and safety</strong> in a large patient population.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Phase 4 trials&nbsp;</span></strong><span style=\"font-size:14.0pt\">involve <strong>post-marketing surveillance</strong> to monitor <strong>long-term side effects</strong>.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247906,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62120,
      "choices": [
        {
          "id": 247741,
          "text": "<p><span style=\"font-size:14.0pt;\">Plantaris</span></p>"
        },
        {
          "id": 247742,
          "text": "<p><span style=\"font-size:14.0pt;\">Gracilis</span></p>"
        },
        {
          "id": 247743,
          "text": "<p><span style=\"font-size:14.0pt;\">Tibialis posterior</span></p>"
        },
        {
          "id": 247744,
          "text": "<p><span style=\"font-size:14.0pt;\">Palmaris longus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old athlete sustains an injury to his Achilles tendon and requires surgical repair using a tendon graft. The surgeon selects a tendon that is commonly harvested for grafting procedures in the lower limb due to its small size and minimal impact on function. Which of the following tendons is most likely used for grafting in this scenario?</span></p>",
      "unique_key": "Q3592521",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Plantaris</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The <strong>plantaris</strong> tendon is often used in <strong>tendon grafting procedures</strong>, particularly for lower limb reconstructions like <strong>Achilles tendon repairs</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>plantaris</strong> is a small, thin muscle with a long tendon that runs alongside the Achilles tendon. It is easily harvested and can be used as a graft due to its length and strength.</span></li><li><span style=\"font-size:14.0pt;\">Its removal typically has minimal impact on the function of the lower limb because the <strong>plantaris muscle</strong> is considered vestigial and contributes little to overall movement.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-135437.jpg\" alt=\"\" width=\"400\" height=\"654\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Gracilis</strong>: Incorrect. The <strong>gracilis</strong> tendon, located in the medial thigh, is sometimes used as a graft, particularly in conjunction with the <strong>semitendinosus</strong> tendon for procedures like <strong>ACL reconstruction</strong>. However, it is not the preferred choice for smaller grafting needs, such as those involving the Achilles tendon, where the <strong>plantaris</strong> tendon is more suitable.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Tibialis posterior</strong>: Incorrect. The <strong>tibialis posterior</strong> is a major muscle of the lower leg that plays a critical role in supporting the arch of the foot and in plantarflexion. Its tendon is not typically harvested for grafting due to its essential role in foot stability and movement.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Palmaris longus</strong>: Incorrect. The <strong>palmaris longus</strong> is a tendon located in the forearm and is often used for grafting in <strong>upper limb</strong> procedures, such as <strong>hand</strong> and <strong>wrist</strong> reconstructions. It is not typically used in <strong>lower limb</strong> grafting procedures like those involving the Achilles tendon.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The <strong>plantaris</strong> tendon is commonly used for <strong>tendon grafting</strong> in <strong>lower limb</strong> surgical procedures, such as <strong>Achilles tendon repair</strong>, due to its accessibility and minimal impact on function.</span></li><li><span style=\"font-size:14.0pt;\">Its role as a vestigial muscle makes it a good choice for small grafting needs without compromising lower limb movement.</span></li></ul>",
      "correct_choice_id": 247741,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62056,
      "choices": [
        {
          "id": 247485,
          "text": "<p><span style=\"font-size:14.0pt;\">Left anterior descending artery (LAD)</span></p>"
        },
        {
          "id": 247486,
          "text": "<p><span style=\"font-size:14.0pt;\">Left circumflex artery (LCX)</span></p>"
        },
        {
          "id": 247487,
          "text": "<p><span style=\"font-size:14.0pt;\">Right coronary artery (RCA)</span></p>"
        },
        {
          "id": 247488,
          "text": "<p><span style=\"font-size:14.0pt;\">Posterior descending artery (PDA)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 61-year-old man with a history of coronary artery disease and hypertension presents with sudden onset of chest pain, dyspnea, and diaphoresis. He is found to have an acute myocardial infarction affecting the posterior wall of the left ventricle. Angiography reveals that the artery supplying the posterior interventricular septum and posterior wall of the heart is occluded. Given this information, which of the following arteries is most likely responsible for the blood supply to this region?</span></p>",
      "unique_key": "Q6289159",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Posterior descending artery (PDA)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The <strong>posterior descending artery (PDA) </strong>is the primary vessel responsible for supplying the posterior third of the interventricular septum and parts of the posterior wall of the left ventricle.</span></li><li><span style=\"font-size:14.0pt;\">The PDA typically arises from the <strong>right coronary artery (RCA)</strong> in about 85% of individuals with right-dominant circulation.</span></li><li><span style=\"font-size:14.0pt;\">In these individuals, occlusion of the RCA will affect the PDA, leading to ischemia in the posterior wall of the left ventricle and posterior septum, resulting in a posterior myocardial infarction.</span></li><li><span style=\"font-size:14.0pt;\">In the remaining 15% of individuals with left-dominant circulation, the PDA arises from the <strong>left circumflex artery (LCX)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">However, since the question specifies that the artery supplying the posterior wall and septum is occluded, it points to the PDA as the direct vessel involved.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-134128.png\" alt=\"\" width=\"694\" height=\"609\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Left anterior descending artery (LAD)</strong>: The LAD supplies the anterior wall of the left ventricle, the anterior two-thirds of the interventricular septum, and part of the apex of the heart. Occlusion of the LAD would result in an anterior or anteroseptal myocardial infarction, not a posterior infarction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Left circumflex artery (LCX)</strong>: The LCX primarily supplies the lateral and posterior aspects of the left ventricle in left-dominant circulation. However, unless the PDA arises from the LCX in left-dominant circulation, the LCX alone does not directly supply the posterior interventricular septum and posterior left ventricle. Since the PDA is mentioned as supplying the posterior septum and wall, LCX is not the best choice in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Right coronary artery (RCA)</strong>: While the RCA often gives rise to the PDA in right-dominant circulation, it is not the RCA itself that directly supplies the posterior wall of the left ventricle. The PDA, which arises from the RCA in right-dominant circulation, is the more precise answer to the question.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The <strong>posterior descending artery (PDA)</strong> is responsible for supplying the posterior interventricular septum and the posterior wall of the left ventricle.</span></li><li><span style=\"font-size:14.0pt;\">In the majority of individuals with right-dominant circulation, the PDA arises from the <strong>right coronary artery (RCA)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Occlusion of the PDA leads to ischemia in the posterior aspects of the heart.</span></li></ul>",
      "correct_choice_id": 247488,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62216,
      "choices": [
        {
          "id": 248121,
          "text": "<p><span style=\"font-size:18px;\">Type 4 hysterectomy</span></p>"
        },
        {
          "id": 248122,
          "text": "<p><span style=\"font-size:18px;\">Type 3 hysterectomy</span></p>"
        },
        {
          "id": 248123,
          "text": "<p><span style=\"font-size:18px;\">Type 1 hysterectomy</span></p>"
        },
        {
          "id": 248124,
          "text": "<p><span style=\"font-size:18px;\">Type 2 hysterectomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">A 60-year-old woman is diagnosed with stage IB1 cervical cancer after a biopsy reveals a 2 cm lesion confined to the cervix. She is otherwise healthy and is considering surgical options for treatment. Which of the following is the most appropriate surgical management for this patient?</span></p>",
      "unique_key": "Q5517309",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. B) Type 3 hysterectomy</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">For a patient with <strong>stage IB1 cervical cancer</strong> (a lesion confined to the cervix that is ≤4 cm), the most appropriate surgical management is a <strong>Type 3 hysterectomy</strong>, also known as a <strong>radical hysterectomy</strong>.</span></li><li><span style=\"font-size:18px;\">This procedure involves removing the uterus, cervix, the upper part of the vagina, and surrounding parametrial tissue.</span></li><li><span style=\"font-size:18px;\">It also typically includes pelvic lymph node dissection.</span></li><li><span style=\"font-size:18px;\">This approach is essential for achieving local control of the tumor and ensuring that any potential spread to surrounding tissues is addressed.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Type 4 hysterectomy:&nbsp;</strong>Incorrect. A <strong>Type 4 hysterectomy</strong> is a more extensive procedure, used for more advanced cervical cancer, which involves the removal of even more surrounding tissue, including portions of the ureters and bladder, beyond what is necessary for a stage IB1 tumor.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Type 1 hysterectomy:&nbsp;</strong>Incorrect. A <strong>Type 1 hysterectomy</strong> (simple hysterectomy) involves only the removal of the uterus and cervix without the removal of parametrial tissue or vaginal tissue. This is not sufficient for the treatment of stage IB1 cervical cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Type 2 hysterectomy:&nbsp;</strong>Incorrect. A <strong>Type 2 hysterectomy</strong> (modified radical hysterectomy) removes less parametrial tissue than a Type 3 hysterectomy, making it less suitable for stage IB1 cervical cancer, which requires a more extensive resection.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">For patients with <strong>stage IB1 cervical cancer</strong>, the most appropriate surgical management is a <strong>Type 3 (radical) hysterectomy</strong>, which includes the removal of the uterus, cervix, upper vagina, parametrial tissue, and often a pelvic lymph node dissection to ensure complete removal of cancerous tissue.</span></li></ul>",
      "correct_choice_id": 248122,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62343,
      "choices": [
        {
          "id": 248625,
          "text": "<p><span style=\"font-size:14.0pt;\">Aortic regurgitation</span></p>"
        },
        {
          "id": 248626,
          "text": "<p><span style=\"font-size:14.0pt;\">Mitral regurgitation</span></p>"
        },
        {
          "id": 248627,
          "text": "<p><span style=\"font-size:14.0pt;\">Aortic stenosis</span></p>"
        },
        {
          "id": 248628,
          "text": "<p><span style=\"font-size:14.0pt;\">Congestive cardiac failure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following conditions is most likely associated with the leftward shift of the pressure-volume loop?</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/22/screenshot-2024-10-22-113929.png\" alt=\"\" width=\"300\" height=\"286\"> &nbsp;</span></p>",
      "unique_key": "Q8333596",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Aortic stenosis</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul><li><span style=\"font-size:14.0pt;\">A <strong>leftward shift</strong> of the pressure-volume loop indicates that the heart is working at a <strong>lower end-diastolic volume</strong> and higher pressures, consistent with <strong>aortic stenosis</strong>.</span></li><li><span style=\"font-size:14.0pt;\">In aortic stenosis, the left ventricle must generate significantly higher pressures to overcome the narrowed aortic valve, resulting in a taller and narrower loop.</span></li><li><span style=\"font-size:14.0pt;\">The ventricle's ability to fill may also be reduced, leading to a smaller end-diastolic volume, causing the loop to shift leftward.</span></li><li><span style=\"font-size:14.0pt;\">The narrowed aortic valve increases afterload, which is the hallmark of aortic stenosis.</span></li></ul><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Aortic regurgitation</strong>: Incorrect. Aortic regurgitation results in an increase in left ventricular volume due to the backflow of blood into the ventricle during diastole, leading to a <strong>rightward</strong> and <strong>widened</strong> loop, not a leftward shift. The loop also shows increased stroke volume due to the extra volume regurgitated back into the ventricle.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Mitral regurgitation</strong>: Incorrect. Mitral regurgitation is characterized by an increase in left ventricular volume due to backflow of blood from the ventricle into the left atrium during systole, causing a <strong>rightward shift</strong> in the loop. The loop becomes wider due to the increased volume in the ventricle, but there is no leftward shift.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Congestive cardiac failure</strong>: Incorrect. Congestive cardiac failure typically leads to a <strong>downward and rightward shift</strong> of the loop due to reduced contractility and higher end-diastolic volumes, not a leftward shift. The loop reflects impaired systolic function and reduced ejection fraction.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul><li><span style=\"font-size:14.0pt;\">A <strong>leftward shift</strong> of the pressure-volume loop is indicative of <strong>aortic stenosis</strong>, where the heart generates higher pressures at lower volumes due to increased afterload from the stenotic aortic valve.</span></li><li><span style=\"font-size:14.0pt;\">The ventricle must work harder to pump blood through the narrowed valve, leading to this characteristic change in the loop.</span></li></ul>",
      "correct_choice_id": 248627,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62375,
      "choices": [
        {
          "id": 248749,
          "text": "<p><span style=\"font-size:14.0pt;\">Mannitol infusion</span></p>"
        },
        {
          "id": 248750,
          "text": "<p><span style=\"font-size:14.0pt;\">Mechanical hyperventilation</span></p>"
        },
        {
          "id": 248751,
          "text": "<p><span style=\"font-size:14.0pt;\">Head of bed elevation</span></p>"
        },
        {
          "id": 248752,
          "text": "<p><span style=\"font-size:14.0pt;\">Glucocorticoids</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">An 84-year-old woman presented with weakness and altered sensorium. Her CT is shown. Which of the following interventions would not be effective?</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/22/screenshot-2024-10-22-122340.png\" alt=\"\" width=\"300\" height=\"347\"></span></p>",
      "unique_key": "Q3689965",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;D) Glucocorticoids</strong>&nbsp;<br><br>&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Glucocorticoids are typically not effective in managing elevated intracranial pressure (ICP) in cases of non-tumor-related causes, such as traumatic brain injury, stroke, or cerebral hemorrhage.</span></li><li><span style=\"font-size:14.0pt;\">Their use is reserved for vasogenic edema due to brain tumors or certain types of inflammatory brain diseases, such as meningitis or autoimmune encephalitis.</span></li><li><span style=\"font-size:14.0pt;\">In this scenario, the CT likely suggests an acute cause of intracranial hypertension, such as hemorrhage or stroke, where glucocorticoids would not help.</span></li></ul><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;A. Mannitol infusion:</strong> Mannitol is an osmotic diuretic that reduces intracranial pressure by drawing water out of the brain tissue and into the bloodstream, reducing cerebral edema and decreasing pressure on the brain.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;B.</strong> <strong>Mechanical hyperventilation:</strong> Hyperventilation can lower intracranial pressure by reducing carbon dioxide levels, which causes cerebral vasoconstriction and reduces cerebral blood flow and volume, lowering ICP.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;C.</strong> <strong>Head of bed elevation:</strong> Raising the head of the bed to 30 degrees is a non-invasive method to enhance venous drainage from the brain, reducing intracranial pressure without additional medication.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong><br><br>&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Glucocorticoids are not effective in managing elevated intracranial pressure in acute conditions like traumatic brain injury or stroke but are more useful in reducing vasogenic edema from brain tumors.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Effective interventions for reducing ICP in acute settings include mannitol, hyperventilation, and elevating the head of the bed.</span></li></ul>",
      "correct_choice_id": 248752,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62132,
      "choices": [
        {
          "id": 247789,
          "text": "<p><span style=\"font-size:14.0pt;\">Nucleotide excision repair</span></p>"
        },
        {
          "id": 247790,
          "text": "<p><span style=\"font-size:14.0pt;\">Mismatch repair</span></p>"
        },
        {
          "id": 247791,
          "text": "<p><span style=\"font-size:14.0pt;\">Non-homologous end joining</span></p>"
        },
        {
          "id": 247792,
          "text": "<p><span style=\"font-size:14.0pt;\">Base excision repair</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following repair mechanisms is most likely involved in the repair of double-stranded DNA breaks created by CRISPR-Cas9?</span></p>",
      "unique_key": "Q3708965",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Non-homologous end joining</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>CRISPR-Cas9 </strong>is a gene-editing technology that introduces <strong>double-stranded DNA breaks</strong> at specific locations within the genome.</span></li><li><span style=\"font-size:14.0pt;\">The repair of these breaks is most commonly achieved through <strong>non-homologous end joining (NHEJ)</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>NHEJ</strong> is a DNA repair mechanism that directly joins the ends of double-stranded breaks without the need for a homologous template.</span></li><li><span style=\"font-size:14.0pt;\">This process is often error-prone and can result in <strong>small insertions or deletions</strong> at the site of the break, potentially disrupting the target gene.</span></li><li><span style=\"font-size:14.0pt;\">This characteristic makes <strong>NHEJ</strong> a valuable mechanism in gene-editing techniques where the goal is to <strong>knock out</strong> a gene or create mutations.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Nucleotide excision repair</strong>: Incorrect. <strong>Nucleotide excision repair (NER)</strong> is involved in the repair of bulky DNA lesions, such as those caused by <strong>UV light</strong> and chemical damage. It is not the primary mechanism for repairing double-stranded breaks caused by <strong>CRISPR-Cas9</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Mismatch repair</strong>: Incorrect. <strong>Mismatch repair (MMR)</strong> is responsible for correcting <strong>base mismatches</strong> and <strong>small insertion-deletion loops</strong> that occur during DNA replication. It does not play a significant role in the repair of <strong>double-stranded DNA breaks</strong> created by gene-editing technologies like <strong>CRISPR-Cas9</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Base excision repair</strong>: Incorrect. <strong>Base excision repair (BER)</strong> is involved in repairing <strong>single-base lesions</strong> or <strong>small non-bulky damage</strong> to DNA, such as those caused by oxidative damage. It is not involved in repairing <strong>double-stranded DNA breaks</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>CRISPR-Cas9&nbsp;</strong>introduces <strong>double-stranded DNA breaks</strong> at specific genomic sites, which are most commonly repaired through <strong>non-homologous end joining (NHEJ)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This repair mechanism can introduce small insertions or deletions at the target site, making it a crucial aspect of gene-editing techniques.</span></li></ul>",
      "correct_choice_id": 247791,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62222,
      "choices": [
        {
          "id": 248145,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To correct fetal presentation from breech to cephalic</span></span></p>"
        },
        {
          "id": 248146,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To relieve aortocaval compression</span></span></p>"
        },
        {
          "id": 248147,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To assess fetal position</span></span></p>"
        },
        {
          "id": 248148,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">To correct uterine dextroversion</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 34-year-old pregnant woman at 32 weeks gestation is brought to the emergency department after collapsing at home. Upon arrival, she is unconscious. The medical team performs uterine displacement during the initial resuscitation efforts. What is the significance of this procedure? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-181151.jpg\" style=\"height:304px; width:350px\" /></span></span></p>",
      "unique_key": "Q6693881",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) To relieve aortocaval compression</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In late pregnancy, the large gravid uterus can compress the <strong>inferior vena cava</strong> and <strong>aorta</strong> when the patient is lying on her back, causing decreased venous return and hypotension, known as <strong>aortocaval compression syndrome</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This can lead to reduced cardiac output and may worsen the condition of an unconscious or critically ill pregnant woman.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Uterine displacement</span></strong><span style=\"font-size:14.0pt\"> involves manually shifting the uterus or tilting the patient to the left side, which helps relieve the pressure on these major blood vessels, improving venous return and stabilizing maternal blood flow. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This maneuver is crucial in the resuscitation of unconscious pregnant patients to prevent hemodynamic instability due to compression.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. To correct fetal presentation from breech to cephalic:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Incorrect. Correcting fetal presentation from breech to cephalic requires a different procedure, known as <strong>external cephalic version</strong>, which is typically performed later in pregnancy but is unrelated to uterine displacement.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. To assess fetal position:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Incorrect. Uterine displacement is not used to assess fetal position. Fetal position is determined through palpation (Leopold maneuvers) or ultrasound.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. To correct uterine dextroversion:</span></strong><span style=\"font-size:14.0pt\"> Incorrect. Uterine dextroversion is a natural rightward displacement of the uterus during pregnancy and does not require correction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Uterine displacement&nbsp;</span></strong><span style=\"font-size:14.0pt\">is performed to relieve <strong>aortocaval compression</strong> during resuscitation in pregnant women. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">By reducing pressure on the inferior vena cava and aorta, it improves maternal venous return and stabilizes circulation, which is critical in the management of unconscious or trauma patients in late pregnancy.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248146,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62227,
      "choices": [
        {
          "id": 248165,
          "text": "<p><span style=\"font-size:14.0pt;\">Perform a vaginal examination to determine fetal presentation</span></p>"
        },
        {
          "id": 248166,
          "text": "<p><span style=\"font-size:14.0pt;\">Manually elevate the presenting fetal part and prepare for urgent cesarean delivery</span></p>"
        },
        {
          "id": 248167,
          "text": "<p><span style=\"font-size:14.0pt;\">Place the patient in the Trendelenburg position and observe</span></p>"
        },
        {
          "id": 248168,
          "text": "<p><span style=\"font-size:14.0pt;\">Gently attempt to replace the umbilical cord back inside the vagina</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 29-year-old woman in active labor is being examined, and the midwife notes a visible umbilical cord prolapse. The fetal heart rate shows decelerations. What is the next immediate step in management?</span></p>",
      "unique_key": "Q4168901",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Manually elevate the presenting fetal part and prepare for urgent cesarean delivery</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Umbilical cord prolapse</strong> is an obstetric emergency where the umbilical cord descends through the cervix alongside or past the presenting fetal part, leading to the risk of cord compression and compromised fetal oxygenation.</span></li><li><span style=\"font-size:14.0pt;\">The immediate goal is to <strong>relieve pressure on the umbilical cord</strong> and ensure adequate fetal perfusion until delivery.</span></li><li><span style=\"font-size:14.0pt;\">The most effective immediate action is to <strong>manually elevate the presenting fetal part</strong> to relieve pressure on the cord while preparing for an <strong>urgent cesarean delivery</strong>, as this is the definitive treatment.</span></li><li><span style=\"font-size:14.0pt;\">The patient should also be positioned to maximize relief of cord compression, such as in <strong>Trendelenburg</strong> or <strong>knee-chest</strong> position, but the most critical intervention is manual elevation of the presenting part.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Perform a vaginal examination to determine fetal presentation:&nbsp;</strong>Incorrect. While determining fetal presentation is important in labor, once a cord prolapse is diagnosed, the priority is to <strong>relieve cord compression</strong> and expedite delivery. Vaginal examination can exacerbate cord compression and delay necessary intervention.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Place the patient in the Trendelenburg position and observe:&nbsp;</strong>Incorrect. While the <strong>Trendelenburg position</strong> can help reduce pressure on the umbilical cord, it is not sufficient on its own. Immediate intervention is needed to relieve pressure on the cord, and observation alone is not appropriate.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Gently attempt to replace the umbilical cord back inside the vagina:&nbsp;</strong>Incorrect. Attempting to replace the cord can further compromise blood flow through the cord and risk injury to the fetus. The focus should be on relieving compression, not replacing the cord.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">In cases of <strong>umbilical cord prolapse</strong>, immediate management involves <strong>manually elevating the presenting fetal part</strong> to relieve pressure on the umbilical cord and preparing for <strong>urgent cesarean delivery</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Cord prolapse can result in fetal hypoxia, and timely intervention is critical for fetal survival.</span></li></ul>",
      "correct_choice_id": 248166,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62351,
      "choices": [
        {
          "id": 248657,
          "text": "<p><span style=\"font-size:14.0pt;\">NPHS1 (nephrin) gene mutation</span></p>"
        },
        {
          "id": 248658,
          "text": "<p><span style=\"font-size:14.0pt;\">COL4A5 (type IV collagen) gene mutation</span></p>"
        },
        {
          "id": 248659,
          "text": "<p><span style=\"font-size:14.0pt;\">PKD1 (polycystin) gene mutation</span></p>"
        },
        {
          "id": 248660,
          "text": "<p><span style=\"font-size:14.0pt;\">PAX2 gene mutation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 7-year-old boy presents with generalized swelling and frothy urine. He was diagnosed with nephrotic syndrome three months ago and started on corticosteroids, but his proteinuria has not improved. His urine protein excretion is 5 g/day, and a renal biopsy shows effacement of podocyte foot processes on electron microscopy, with no immune deposits. The patient is negative for hepatitis and HIV infections. Which of the following mutations is most likely responsible for this patient’s steroid-resistant condition?</span></p>",
      "unique_key": "Q4792581",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. A) NPHS1 (nephrin) gene mutation</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Mutation causes defects in nephrin, leading to disruption of the podocyte slit diaphragm, resulting in proteinuria and steroid-resistant nephrotic syndrome.</span></li><li><span style=\"font-size:18px;\">Mutations in NPHS1 → congenital nephrotic syndrome of the Finnish type but also associated with steroid-resistant nephrotic syndrome in children.</span></li><li><span style=\"font-size:18px;\">It causes:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:18px;\">Massive proteinuria</span></li><li><span style=\"font-size:18px;\">Foot process effacement</span></li><li><span style=\"font-size:18px;\">Steroid non-responsiveness</span></li><li><span style=\"font-size:18px;\">No immune complex deposition</span></li><li><span style=\"font-size:18px;\">Electron microscopy shows diffuse foot process effacement, without immune deposits.</span></li></ul></li></ul><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. COL4A5 (type IV collagen) gene mutation: </strong>Incorrect. Mutations in <strong>COL4A5</strong> are associated with <strong>Alport syndrome</strong>, which involves defects in the basement membrane leading to hematuria, progressive renal failure, and hearing loss, not the nephrotic syndrome with podocyte effacement described in this case.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>Option C. PKD1 (polycystin) gene mutation: </strong>Incorrect. Mutations in <strong>PKD1</strong> are associated with <strong>autosomal dominant polycystic kidney disease (ADPKD)</strong>, which typically presents with cyst formation in the kidneys, hypertension, and kidney failure, not nephrotic syndrome.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>Option D. PAX2 gene mutation: </strong>Incorrect. Mutations in <strong>PAX2</strong> are linked to <strong>renal-coloboma syndrome</strong>, which causes renal hypoplasia and eye abnormalities, not nephrotic syndrome or podocyte effacement.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>Steroid-resistant nephrotic syndrome </strong>with podocyte effacement is often linked to mutations in genes responsible for the structural integrity of the glomerular filtration barrier, such as the <strong>NPHS1 (nephrin) gene</strong>, which plays a key role in maintaining the slit diaphragm between podocytes.</span></p></li></ul>",
      "correct_choice_id": 248657,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62198,
      "choices": [
        {
          "id": 248049,
          "text": "<p><span style=\"font-size:14.0pt;\">Greater than 3 times the upper limit of AST or ALT.</span></p>"
        },
        {
          "id": 248050,
          "text": "<p><span style=\"font-size:14.0pt;\">Greater than 2 times the upper limit of bilirubin.</span></p>"
        },
        {
          "id": 248051,
          "text": "<p><span style=\"font-size:14.0pt;\">Jaundice to liver failure ratio of 3:1.</span></p>"
        },
        {
          "id": 248052,
          "text": "<p><span style=\"font-size:14.0pt;\">No other alternative cause of liver injury.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old man is enrolled in a clinical trial for a new medication to manage hyperlipidemia. After 8 weeks of treatment, he developed jaundice. The patient has no history of liver disease, and his liver function tests were normal prior to starting the medication. Which of the following statements is false regarding Hy's Law?</span></p>",
      "unique_key": "Q9290547",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;C) Jaundice to liver failure ratio of 3:1.</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Hy's Law suggests that significant liver injury is indicated if there is an elevation of liver enzymes (AST or ALT) greater than three times the upper limit of normal and bilirubin greater than two times the upper limit of normal, with no other identified cause for liver injury.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">However, the jaundice to liver failure ratio does not typically apply as a specific ratio of 3:1; rather, it indicates the presence of liver injury, which can lead to liver failure without a defined ratio.</span></li></ul><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Greater than 3 times the upper limit of AST or ALT:</strong> This is a correct statement; Hy's Law specifies that AST or ALT must exceed three times the upper limit of normal.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Greater than 2 times the upper limit of bilirubin:</strong> This is also a correct statement, as Hy's Law requires that bilirubin levels be more than twice the upper limit of normal.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option D. No other alternative cause of liver injury:</strong> This statement is correct, as Hy's Law requires ruling out other potential causes of liver injury.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Hy's Law is important in identifying drug-induced liver injury and involves criteria regarding the elevation of liver enzymes and bilirubin levels, along with the exclusion of other causes of liver injury, but does not specifically define a ratio of jaundice to liver failure.</span></li></ul>",
      "correct_choice_id": 248051,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62226,
      "choices": [
        {
          "id": 248161,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Administer tocolytics and deliver at 37 weeks</span></span></p>"
        },
        {
          "id": 248162,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Conservative management and continue observation</span></span></p>"
        },
        {
          "id": 248163,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Administer antihypertensive, magnesium sulfate, and proceed with delivery</span></span></p>"
        },
        {
          "id": 248164,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Give steroid cover and delay delivery until steroid cover is complete</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old woman at 35 weeks and 5 days gestation presents to the labor and delivery unit with severe epigastric pain, headache, and blurred vision. Her blood pressure is 170/110 mmHg. She is having regular contractions, and on examination, her cervix is 3 cm dilated with intact membranes. What is the most appropriate next step in the management of this patient?</span></span></p>",
      "unique_key": "Q8852102",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Administer antihypertensive, magnesium sulfate, and proceed with delivery</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This patient presents with <strong>severe preeclampsia</strong> at 35 weeks of gestation, which is characterized by hypertension (BP &ge;160/110 mmHg), signs of end-organ damage (epigastric pain, headache, blurred vision), and labor. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The immediate goals of management are to control her blood pressure with <strong>antihypertensives</strong> to prevent complications such as stroke, prevent seizures with <strong>magnesium sulfate</strong>, and proceed with <strong>delivery</strong> due to the severity of preeclampsia and the patient being at term or near-term (&ge;34 weeks).</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Given that she is already in labor and near term, the most appropriate action is to <strong>proceed with delivery</strong>, as this is the definitive treatment for preeclampsia. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Delaying delivery or administering tocolytics is contraindicated in this scenario.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Administer tocolytics and deliver at 37 weeks:</span></strong><span style=\"font-size:14.0pt\"> Incorrect. Tocolytics are used to delay labor, but they are contraindicated in cases of severe preeclampsia due to the risk of worsening maternal and fetal outcomes. Delivery should not be delayed in this situation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Conservative management and continue observation:</span></strong><span style=\"font-size:14.0pt\"> Incorrect. Conservative management is inappropriate in cases of severe preeclampsia, especially with the patient already in labor. Immediate treatment and delivery are necessary.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Give steroid cover and delay delivery until steroid cover is complete:</span></strong><span style=\"font-size:14.0pt\"> Incorrect. Corticosteroids are typically given to enhance fetal lung maturity in cases of preterm labor &lt;34 weeks. In this case, the patient is already past 34 weeks, and delaying delivery for steroid cover is not appropriate.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In a patient with <strong>severe preeclampsia</strong> at &ge;34 weeks gestation, immediate management involves <strong>controlling blood pressure, preventing seizures with magnesium sulfate, and proceeding with delivery</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This is necessary to prevent maternal and fetal complications.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248163,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62196,
      "choices": [
        {
          "id": 248041,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Stimulating osteoclast activity</span></span></span></p>"
        },
        {
          "id": 248042,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Inhibiting osteoblast function</span></span></span></p>"
        },
        {
          "id": 248043,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Promoting osteoclast apoptosis</span></span></span></p>"
        },
        {
          "id": 248044,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Enhancing calcium absorption</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the mechanism of action of bisphosphonates in the treatment of osteoporosis? </span></span></p>",
      "unique_key": "Q4145037",
      "difficulty_level": "beginner",
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">C) Promoting osteoclast apoptosis</span></strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Bisphosphonates work primarily by inducing apoptosis (programmed cell death) in osteoclasts. </span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">When bisphosphonates are ingested, they are absorbed into the bone matrix. </span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">When osteoclasts attach to the bone surface to resorb it, they take up bisphosphonates, which then disrupt their metabolic activity. </span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This disruption leads to an increase in osteoclast apoptosis, thereby reducing the number of osteoclasts available to resorb bone and ultimately slowing down the bone loss that occurs in osteoporosis.</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Stimulating osteoclast activity:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Bisphosphonates do not stimulate osteoclast activity; in fact, they inhibit it. Osteoclasts are responsible for bone resorption (the process of breaking down bone tissue), and stimulating their activity would lead to increased bone loss, which is contrary to the goal of treating osteoporosis. In osteoporosis, there is an imbalance where bone resorption outpaces bone formation, and bisphosphonates aim to correct this imbalance.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Inhibiting osteoblast function:&nbsp;</span></strong><span style=\"font-size:14.0pt\">While bisphosphonates primarily target osteoclasts to reduce bone resorption, they do not directly inhibit osteoblast function. Osteoblasts are the cells responsible for bone formation, and preserving their function is crucial for maintaining bone density. Bisphosphonates do not have a significant negative impact on osteoblasts; rather, they work to stabilize bone remodeling by preventing excessive resorption.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Enhancing calcium absorption:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Bisphosphonates do not enhance calcium absorption from the gastrointestinal tract. Instead, they work by decreasing bone resorption and, consequently, reducing the release of calcium from bones into the bloodstream. They may be used alongside calcium and vitamin D supplements to ensure adequate mineralization of bone, but their primary action is not to enhance calcium absorption.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:&nbsp; </span></strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Bisphosphonates<strong> </strong>promote osteoclast apoptosis, reducing bone resorption and helping to maintain or improve bone density in osteoporosis.</span></span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248043,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62185,
      "choices": [
        {
          "id": 248001,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">FSH in the follicular phase</span></span></span></p>"
        },
        {
          "id": 248002,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Luteal phase LH</span></span></span></p>"
        },
        {
          "id": 248003,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Post-luteal phase LH</span></span></span></p>"
        },
        {
          "id": 248004,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Anti-Mullerian hormone (AMH)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 36-year-old woman presents to your clinic with concerns about her fertility. She is trying to conceive and would like to understand her ovarian reserve, as she is aware that age may impact her chances of becoming pregnant. You are considering various tests to assess her ovarian reserve. Which of the following is the most accurate measure of ovarian reserve? </span></span></p>",
      "unique_key": "Q7266525",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Anti-Mullerian hormone (AMH)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Anti-Mullerian hormone (AMH)&nbsp;</span></strong><span style=\"font-size:14.0pt\">is considered the best and most accurate marker for <strong>ovarian reserve</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">AMH is produced by granulosa cells of small growing follicles in the ovaries and reflects the quantity of remaining ovarian follicles. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The level of AMH correlates with the number of antral and pre-antral follicles, providing a reliable estimate of ovarian reserve. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">AMH levels remain relatively stable throughout the menstrual cycle and decrease as a woman ages, making it a highly valuable tool for assessing fertility potential.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. FSH in the follicular phase:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Incorrect. <strong>Follicle-stimulating hormone (FSH)</strong> levels in the early follicular phase (day 3) are commonly used to assess ovarian reserve, but FSH levels can fluctuate and are less reliable than AMH for predicting ovarian reserve.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Luteal phase LH:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Incorrect. <strong>Luteinizing hormone (LH)</strong> levels in the luteal phase are not useful for assessing ovarian reserve. LH is primarily involved in ovulation and does not provide information about the remaining ovarian follicle pool.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Post-luteal phase LH:</span></strong><span style=\"font-size:14.0pt\"> Incorrect. LH levels after the luteal phase do not reflect ovarian reserve and are not used for this purpose.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Anti-Mullerian hormone (AMH)&nbsp;</span></strong><span style=\"font-size:14.0pt\">is the most accurate and reliable marker for assessing <strong>ovarian reserve</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It reflects the number of small growing follicles in the ovaries and remains stable throughout the menstrual cycle, providing valuable insight into fertility potential.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248004,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62199,
      "choices": [
        {
          "id": 248053,
          "text": "<p><span style=\"font-size:14.0pt;\">Guillain-Barré syndrome</span></p>"
        },
        {
          "id": 248054,
          "text": "<p><span style=\"font-size:14.0pt;\">Amyotrophic lateral sclerosis (ALS)</span></p>"
        },
        {
          "id": 248055,
          "text": "<p><span style=\"font-size:14.0pt;\">Chronic inflammatory demyelinating polyneuropathy (CIDP)</span></p>"
        },
        {
          "id": 248056,
          "text": "<p><span style=\"font-size:14.0pt;\">Multifocal motor neuropathy (MMN)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old man presents with progressive weakness in his legs and arms over the past 6 months. He reports difficulty walking and frequent falls. On examination, he has reduced deep tendon reflexes in all extremities, and sensation to vibration and proprioception is diminished in his feet. Nerve conduction studies show evidence of demyelination. A lumbar puncture reveals elevated cerebrospinal fluid (CSF) protein with normal cell count. Which of the following conditions is the most likely diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9410389",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Chronic inflammatory demyelinating polyneuropathy (CIDP)</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient's progressive weakness, reduced deep tendon reflexes, diminished sensation to vibration and proprioception, along with the nerve conduction studies showing demyelination, suggest a chronic condition affecting the peripheral nerves.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The elevated CSF protein with a normal cell count (albuminocytologic dissociation) is characteristic of CIDP, which is a chronic inflammatory demyelinating polyneuropathy.</span></li></ul><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Guillain-Barré syndrome:</strong> While this condition also presents with demyelination, it typically presents acutely and often follows a viral infection. It usually features a rapid onset of weakness and areflexia rather than the progressive weakness over 6 months seen in this patient.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Amyotrophic lateral sclerosis (ALS):</strong> ALS primarily affects motor neurons leading to weakness and atrophy but typically does not show sensory loss or elevated CSF protein with a normal cell count.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Multifocal motor neuropathy (MMN):</strong> This condition usually presents with asymmetric motor weakness and typically does not involve sensory deficits or elevated CSF protein levels.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Chronic inflammatory demyelinating polyneuropathy (CIDP) is characterized by progressive weakness, sensory loss, reduced reflexes, and a distinctive CSF profile of elevated protein with normal cell count, distinguishing it from other neuropathies.</span></li></ul>",
      "correct_choice_id": 248055,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62144,
      "choices": [
        {
          "id": 247837,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Epidermal growth factor (EGF)</span></span></p>"
        },
        {
          "id": 247838,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Platelet-derived growth factor (PDGF)</span></span></p>"
        },
        {
          "id": 247839,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fibroblast growth factor (FGF)</span></span></p>"
        },
        {
          "id": 247840,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transforming growth factor-beta (TGF-&beta;)</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old woman presents to the dermatology clinic with a raised, thick scar on her ear that developed after a piercing 2 years ago. The scar is firm, extends beyond the boundaries of the original wound, and continues to grow. She has a family history of similar scars in her mother and sister. Histologic examination of the lesion shows dense collagen bundles. Which of the following growth factors is most involved in the pathogenesis of this patient&rsquo;s condition?</span></span></p>",
      "unique_key": "Q2210787",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans. D) Transforming growth factor-beta (TGF-&beta;)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This patient has a <strong>keloid</strong>, characterized by excessive collagen deposition that extends beyond the borders of the original wound. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">TGF-&beta;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> plays a central role in promoting fibrosis and collagen production, which contributes to keloid formation.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Epidermal growth factor (EGF):&nbsp;</span></strong><span style=\"font-size:14.0pt\">Incorrect. EGF primarily stimulates <strong>keratinocyte</strong> and <strong>epithelial cell</strong> proliferation and is not primarily involved in excessive collagen deposition seen in keloids.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Platelet-derived growth factor (PDGF):&nbsp;</span></strong><span style=\"font-size:14.0pt\">Incorrect. PDGF stimulates <strong>fibroblast</strong> and <strong>smooth muscle cell</strong> proliferation but is less involved in the excessive collagen deposition seen in keloids compared to TGF-&beta;.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Fibroblast growth factor (FGF):&nbsp;</span></strong><span style=\"font-size:14.0pt\">Incorrect. FGF is important for <strong>angiogenesis</strong> and <strong>wound healing</strong>, but its role is less central than TGF-&beta; in the pathogenesis of keloids.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Transforming growth factor-beta (TGF-&beta;)&nbsp;</span></strong><span style=\"font-size:14.0pt\">plays a major role in the pathogenesis of <strong>keloids</strong> by promoting fibroblast activity and excessive <strong>collagen deposition</strong>, leading to abnormal scar formation.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247840,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62245,
      "choices": [
        {
          "id": 248237,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pontine Paramedian Reticular Formation</span></span></p>"
        },
        {
          "id": 248238,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Raphe Nucleus</span></span></p>"
        },
        {
          "id": 248239,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rostral Interstitial Nucleus of Cajal</span></span></p>"
        },
        {
          "id": 248240,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nucleus of Perlia</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 58-year-old patient presents with difficulty in controlling upward and downward eye movements. A lesion is suspected in a structure associated with the control of vertical gaze. Which of the following is the center for vertical gaze? </span></span></p>",
      "unique_key": "Q2814431",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>C) Rostral Interstitial Nucleus of Cajal</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The <strong>Rostral Interstitial Nucleus of Cajal (riMLF)</strong> is responsible for controlling <strong>vertical gaze</strong>, including both upward and downward movements, as well as torsional movements of the eyes. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is located in the pretectal region of the <strong>midbrain</strong> and works in conjunction with other structures like the <strong>interstitial nucleus of Cajal</strong> and fibers of the posterior commissure to coordinate vertical eye movements.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-161117.jpg\" style=\"height:458px; width:900px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Pontine Paramedian Reticular Formation (PPRF)</strong>: This area is primarily responsible for <strong>horizontal gaze movements</strong>, especially conjugate movements toward the ipsilateral side.</span></span></span></p>\r\n\r\n<p><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Raphe Nucleus</strong>: This nucleus plays a role in <strong>serotonin production</strong> and is involved in regulating mood and sleep rather than gaze control.</span></span></span></p>\r\n\r\n<p><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Nucleus of Perlia</strong>: This nucleus is thought to be involved in <strong>convergence</strong>, and its exact function is still controversial and less understood compared to well-established structures like the rostral interstitial nucleus of Cajal.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The <strong>Rostral Interstitial Nucleus of Cajal</strong> is the primary center for controlling <strong>vertical gaze</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It works together with other midbrain nuclei to enable coordinated upward and downward eye movements. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In contrast, <strong>horizontal gaze</strong> is primarily controlled by the <strong>Pontine Paramedian Reticular Formation (PPRF)</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Understanding these gaze centers is critical for localizing lesions in patients presenting with gaze palsies.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248239,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62146,
      "choices": [
        {
          "id": 247845,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Erythroxylum coca</span></span></p>"
        },
        {
          "id": 247846,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Datura</span></span></p>"
        },
        {
          "id": 247847,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Digitalis Purpura</span></span></p>"
        },
        {
          "id": 247848,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cannabis</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A forensic expert is analyzing plant residues found at a crime scene in a rural area known for illicit drug activity. Among several samples, the expert finds leaf suspected to contain a substance with significant abuse potential, which is frequently trafficked and abused globally. Identify the plant, which is known for being the primary source of this substance?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-163916.jpg\" style=\"height:468px; width:350px\" /></span></span></p>",
      "unique_key": "Q9433634",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>A) Erythroxylum coca</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Erythroxylum coca</span></strong><span style=\"font-size:14.0pt\"> is the correct choice as it is known for being the primary source of cocaine, a substance with significant abuse potential. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cocaine is derived from the leafs of this plant and has major implications in both forensic toxicology and criminal investigations due to its psychoactive effects and high potential for dependency and abuse.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><strong>Option</strong>&nbsp;<strong>B</strong>. <strong>Datura</strong>: While it contains toxic compounds such as scopolamine and atropine and is occasionally abused for its hallucinogenic effects, it is less commonly associated with global trafficking compared to cocaine.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C</span></strong><span style=\"font-size:14.0pt\">. <strong>Digitalis Purpura</strong>: Known as Digitalis purpurea, this plant is used medically for its cardiotonic glycosides like digoxin and digitoxin, and is not abused due to severe toxic effects and lack of psychoactive properties.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option&nbsp;</span></strong><span style=\"font-size:14.0pt\"><strong>D</strong>. <strong>Cannabis</strong>: Although cannabis (marijuana) is widely abused for its psychoactive effects from THC, the context of global trafficking and powerful psychoactive substance fits better with cocaine derived from Erythroxylum coca.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Cocaine is obtained from Erythroxylum coca, which can be identified by following features:</span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"color:#202122\">Leaf</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"color:#202122\">: Characteristic of the leaf is an areolated portion bounded by two longitudinal curved lines, one line on each side of the midrib.</span></span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"color:#202122\">Flowers&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"color:#202122\">are small, and disposed in little clusters on short stalks. </span></span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"color:#202122\">Red Berries:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"color:#202122\">The flowers mature into red&nbsp;berries.</span></span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>",
      "correct_choice_id": 247845,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        10
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62353,
      "choices": [
        {
          "id": 248665,
          "text": "<p><span style=\"font-size:14.0pt;\">Hypothyroidism</span></p>"
        },
        {
          "id": 248666,
          "text": "<p><span style=\"font-size:14.0pt;\">Hypoparathyroidism</span></p>"
        },
        {
          "id": 248667,
          "text": "<p><span style=\"font-size:14.0pt;\">Hyperparathyroidism</span></p>"
        },
        {
          "id": 248668,
          "text": "<p><span style=\"font-size:14.0pt;\">Hyperthyroidism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old woman presents with bone pain and a history of recurrent kidney stones. X-rays of the bones reveal lytic lesions in the long bones. A bone biopsy of the lesion shows fibrous tissue with osteoclast-like giant cells, consistent with a brown tumor. Which of the following conditions is most likely associated with this bone lesion?</span></p>",
      "unique_key": "Q3256867",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Hyperparathyroidism</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul><li><span style=\"font-size:14.0pt;\"><p style=\"text-align:justify;\"><strong>Brown tumors </strong>are a hallmark finding in <strong>hyperparathyroidism</strong>, particularly <strong>severe or untreated cases</strong>.</span></p></span></li><li><span style=\"font-size:14.0pt;\"><p style=\"text-align:justify;\"><strong>Hyperparathyroidism </strong>leads to <strong>increased levels of PTH</strong>, which causes <strong>osteoclast activation</strong> and <strong>bone resorption</strong>.</span></p></span></li><li><span style=\"font-size:14.0pt;\"><p style=\"text-align:justify;\">This results in the formation of <strong>cystic bone lesions</strong> known as <strong>brown tumors</strong>.</span></p></span></li><li><span style=\"font-size:14.0pt;\"><p style=\"text-align:justify;\">These lesions contain <strong>fibrous tissue</strong>, <strong>osteoclasts</strong>, and <strong>hemosiderin</strong>, which gives them their characteristic <strong>brown color</strong> on histological examination.</span></p></span></li><li><span style=\"font-size:14.0pt;\"><p style=\"text-align:justify;\"><strong>Brown tumors </strong>are seen in conditions like <strong>primary hyperparathyroidism</strong>, usually due to a <strong>parathyroid adenoma</strong>, or in <strong>secondary hyperparathyroidism</strong> related to <strong>chronic renal failure</strong>.</span></p></span></li></ul><p style=\"text-align:justify;\">&nbsp;</span></p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/22/screenshot-2024-10-22-115520.png\" alt=\"\" width=\"500\" height=\"185\"></span></p><p style=\"text-align:justify;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Hypothyroidism</strong>: Incorrect. <strong>Hypothyroidism</strong> does not cause <strong>osteoclastic activity</strong> or the formation of <strong>brown tumors</strong>. It is more commonly associated with <strong>myopathy</strong>, <strong>weight gain</strong>, and <strong>bradycardia</strong>, rather than <strong>bone lesions</strong>.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Hypoparathyroidism</strong>: Incorrect. <strong>Hypoparathyroidism</strong> is characterized by <strong>low PTH levels</strong> and <strong>hypocalcemia</strong>, leading to symptoms like <strong>muscle cramps</strong>, <strong>tetany</strong>, and <strong>seizures</strong>. It does not cause the <strong>excessive bone resorption</strong> required for <strong>brown tumor</strong> formation.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Hyperthyroidism</strong>: Incorrect. <strong>Hyperthyroidism</strong> may cause <strong>increased bone turnover</strong> but does not specifically lead to <strong>brown tumors</strong>. The bone changes seen in <strong>hyperthyroidism</strong> are related to <strong>osteoporosis</strong> rather than <strong>osteoclastic resorption</strong> as seen in <strong>hyperparathyroidism</strong>.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul><li><span style=\"font-size:14.0pt;\"><strong>Brown tumors </strong>are cystic bone lesions seen in <strong>severe hyperparathyroidism</strong>, resulting from excessive <strong>osteoclastic activity</strong> and <strong>bone resorption</strong> due to <strong>elevated PTH levels</strong>.</span></li></ul>",
      "correct_choice_id": 248667,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62288,
      "choices": [
        {
          "id": 248409,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mild non-proliferative diabetic retinopathy</span></span></p>"
        },
        {
          "id": 248410,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Severe non-proliferative diabetic retinopathy</span></span></p>"
        },
        {
          "id": 248411,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Birdshot choroidopathy</span></span></p>"
        },
        {
          "id": 248412,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Proliferative diabetic retinopathy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 58-year-old diabetic male presents with progressive worsening of vision. On examination, fundus findings suggest neovascularization. Fluorescein angiography findings is shown in the image. What is the most likely diagnosis? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/22/screenshot-2024-10-22-093415.jpg\" style=\"height:410px; width:300px\" /></span></span></p>",
      "unique_key": "Q7726739",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>D) Proliferative diabetic retinopathy</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The image demonstrates the features of <strong>proliferative diabetic retinopathy (PDR)</strong>, characterized by <strong>neovascularization</strong> arising from the <strong>optic nerve head (neovascularization of the disc, NVD)</strong>, as well as neovascularization along larger retinal vessels and elsewhere (NVE). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">These new, fragile blood vessels develop in response to retinal ischemia and can lead to severe complications like vitreous hemorrhage or retinal detachment if untreated. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The presence of neovascularization is a key distinguishing feature of PDR.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Mild non-proliferative diabetic retinopathy (NPDR)</strong>: In mild NPDR, microaneurysms and intraretinal hemorrhages are present, but there is <strong>no neovascularization</strong>, which is the hallmark of proliferative disease.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Severe non-proliferative diabetic retinopathy</strong>: Severe NPDR is characterized by increased microaneurysms, venous beading, and intraretinal microvascular abnormalities (IRMA) but still lacks the neovascularization seen in PDR.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Birdshot choroidopathy</strong>: Birdshot choroidopathy presents with characteristic yellow-white lesions scattered across the fundus and is not typically associated with neovascularization. It is a type of posterior uveitis that affects the choroid and retina bilaterally.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Proliferative diabetic retinopathy is the advanced stage of diabetic eye disease, marked by neovascularization, which requires aggressive treatment like laser photocoagulation to prevent severe visual loss. </span></span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is crucial for diabetics, particularly those with a long history or poorly controlled diabetes, to undergo regular eye examinations for early detection and management of diabetic retinopathy.</span></span></li>\r\n</ul>",
      "correct_choice_id": 248412,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        8
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62248,
      "choices": [
        {
          "id": 248249,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hematoma compressing the trachea</span></span></span></p>"
        },
        {
          "id": 248250,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Bilateral vocal cord paralysis</span></span></span></p>"
        },
        {
          "id": 248251,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Unilateral recurrent laryngeal nerve injury</span></span></span></p>"
        },
        {
          "id": 248252,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Laryngospasm</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman underwent a total thyroidectomy for a large goiter. Two hours postoperatively, she develops acute onset stridor and difficulty breathing while in the recovery room. Her voice is normal, but she has inspiratory stridor and increased work of breathing. The surgical site shows no signs of swelling or hematoma. Which of the following is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q3923888",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans</span></strong><span style=\"font-size:14.0pt\">. <strong>B) Bilateral vocal cord paralysis</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The clinical presentation of acute onset stridor with a normal voice shortly after thyroid surgery is highly suggestive of <strong>bilateral recurrent laryngeal nerve injury</strong> leading to <strong>bilateral vocal cord paralysis</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">When both recurrent laryngeal nerves are injured, the vocal cords remain in a paramedian position, leading to airway narrowing, stridor, and respiratory distress while preserving normal phonation. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This condition requires prompt recognition and airway management, often necessitating <strong>reintubation and tracheostomy</strong> for securing the airway.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A</span></strong><span style=\"font-size:14.0pt\">. <strong>Hematoma compressing the trachea:</strong> A hematoma would typically present with swelling at the surgical site and would cause external compression of the trachea, not vocal cord paralysis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C</span></strong><span style=\"font-size:14.0pt\">. <strong>Unilateral recurrent laryngeal nerve injury:</strong> Unilateral recurrent laryngeal nerve injury usually presents with hoarseness rather than stridor and is less likely to cause acute airway compromise.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D</span></strong><span style=\"font-size:14.0pt\">. <strong>Laryngospasm:</strong> Laryngospasm is a sudden spasm of the vocal cords, often transient and usually related to irritation, anesthesia, or hypocalcemia. It is less likely in a patient with normal calcium levels and no history of laryngeal stimulation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective</span></strong><span style=\"font-size:14.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In patients presenting with postoperative stridor after thyroid surgery, bilateral vocal cord paralysis should be considered, especially if the voice remains normal. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Immediate airway management is crucial, as the condition can progress rapidly to airway obstruction.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248250,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62417,
      "choices": [
        {
          "id": 248917,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Mouth then nose</span></span></span></p>"
        },
        {
          "id": 248918,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Nose then mouth</span></span></span></p>"
        },
        {
          "id": 248919,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Mouth then nose then esophagus</span></span></span></p>"
        },
        {
          "id": 248920,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Trachea then nose then mouth</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A term neonate is delivered via emergency cesarean section due to fetal distress. At birth, the baby is not crying and appears limp with poor muscle tone. The delivery team initiates neonatal resuscitation, including suctioning to clear the airway. What is the correct order of suctioning during neonatal resuscitation to reduce the risk of aspiration? </span></span></p>",
      "unique_key": "Q6680236",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Mouth then nose</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">During neonatal resuscitation, the mouth is suctioned first followed by the nose. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This order is important to reduce the risk of aspiration. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Suctioning the nose first can stimulate the infant to gasp and potentially inhale secretions into the lungs.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Nose then mouth:</span></strong><span style=\"font-size:14.0pt\"> Suctioning the nose first increases the risk of aspiration, as it can cause the neonate to gasp before clearing secretions from the mouth.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Mouth then nose then esophagus:</span></strong><span style=\"font-size:14.0pt\"> Routine suctioning of the esophagus is not recommended in neonatal resuscitation unless there is a specific indication, as it can cause a vagal response and bradycardia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Trachea then nose then mouth:</span></strong><span style=\"font-size:14.0pt\"> Routine tracheal suctioning is not indicated unless there is evidence of meconium aspiration and the infant is not vigorous (e.g., poor tone, respiratory effort).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In neonatal resuscitation, suctioning should follow the order of mouth first, then nose, to reduce the risk of aspiration. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The suction pressure should be kept between 80-100 mm Hg using a 12 or 14 French suction catheter to prevent injury to the delicate neonatal tissues.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248917,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62121,
      "choices": [
        {
          "id": 247745,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Portal vein &amp; hepatic artery</span></span></p>"
        },
        {
          "id": 247746,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hepatic vein &amp; hepatic artery</span></span></p>"
        },
        {
          "id": 247747,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Common bile duct &amp; hepatic vein</span></span></p>"
        },
        {
          "id": 247748,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Common bile duct &amp; portal vein</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old man is undergoing emergency laparotomy due to severe blunt abdominal trauma resulting in liver injury and significant bleeding. During the surgery, the surgeon applies a clamp to a structure within the hepatoduodenal ligament to temporarily control the bleeding and allow time to assess the liver damage. Which of the following structures is primarily compressed during this procedure?</span></span></p>",
      "unique_key": "Q1101027",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Portal vein &amp; hepatic artery</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Pringle&rsquo;s maneuver&nbsp;</span></strong><span style=\"font-size:14.0pt\">is a surgical technique used to control bleeding from the liver, particularly in cases of trauma or during liver surgeries. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It involves clamping or compressing the <strong>hepatoduodenal ligament</strong>, which contains the <strong>portal vein</strong>, <strong>hepatic artery</strong>, and <strong>common bile duct</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">By compressing the hepatoduodenal ligament, the surgeon temporarily occludes blood flow through the <strong>portal vein</strong> and <strong>hepatic artery</strong>, which are the main blood vessels supplying the liver. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This maneuver helps to control bleeding until more definitive surgical measures can be taken.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-135456.jpg\" style=\"height:628px; width:594px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Hepatic vein &amp; hepatic artery</span></strong><span style=\"font-size:14.0pt\">: Incorrect. The <strong>hepatic veins</strong> drain blood from the liver into the <strong>inferior vena cava</strong> and are not located within the <strong>hepatoduodenal ligament</strong>. Pringle&rsquo;s maneuver targets vessels that supply blood to the liver, not those that drain it.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Common bile duct &amp; hepatic vein</span></strong><span style=\"font-size:14.0pt\">: Incorrect. While the <strong>common bile duct</strong> is located within the <strong>hepatoduodenal ligament</strong>, the <strong>hepatic veins</strong> are not. The <strong>hepatic veins</strong> are located posteriorly in the liver and drain into the <strong>inferior vena cava</strong>, so they are not involved in Pringle&rsquo;s maneuver.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Common bile duct &amp; portal vein</span></strong><span style=\"font-size:14.0pt\">: Incorrect. The <strong>portal vein</strong> is one of the structures compressed during Pringle&rsquo;s maneuver, but the focus is on controlling blood flow through the <strong>portal vein</strong> and <strong>hepatic artery</strong>, not the <strong>common bile duct</strong>. The bile duct is not a major target for controlling hemorrhage in this procedure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Pringle&rsquo;s maneuver&nbsp;</span></strong><span style=\"font-size:14.0pt\">is used to temporarily control liver bleeding by compressing the <strong>hepatoduodenal ligament</strong>, which occludes the <strong>portal vein</strong> and <strong>hepatic artery</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This maneuver helps to reduce blood flow to the liver during traumatic injuries or liver surgeries, providing time for further surgical intervention.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247745,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62345,
      "choices": [
        {
          "id": 248633,
          "text": "<p><span style=\"font-size:14.0pt;\">Pyruvate carboxylase</span></p>"
        },
        {
          "id": 248634,
          "text": "<p><span style=\"font-size:14.0pt;\">Glycogen phosphorylase</span></p>"
        },
        {
          "id": 248635,
          "text": "<p><span style=\"font-size:14.0pt;\">Hormone-sensitive lipase</span></p>"
        },
        {
          "id": 248636,
          "text": "<p><span style=\"font-size:14.0pt;\">Phosphofructokinase 1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old woman has been on a prolonged fast for two days, consuming only water. During this period, her body has shifted its metabolism to maintain blood glucose levels and provide energy. Which of the following enzymes would have decreased activity during this fasting state?</span></p>",
      "unique_key": "Q3953962",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Phosphofructokinase 1</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul><li><span style=\"font-size:14.0pt;\"><strong>Phosphofructokinase 1 (PFK-1) </strong>is a key enzyme in <strong>glycolysis</strong>, responsible for the conversion of <strong>fructose-6-phosphate</strong> to <strong>fructose-1,6-bisphosphate</strong>.</span></li><li><span style=\"font-size:14.0pt;\">During <strong>fasting</strong>, the body aims to conserve glucose and instead increases <strong>gluconeogenesis</strong> and <strong>fatty acid oxidation</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>PFK-1 activity decreases</strong> as glycolysis is downregulated in favor of gluconeogenesis.</span></li><li><span style=\"font-size:14.0pt;\">The reduction in <strong>insulin</strong> and the increase in <strong>glucagon</strong> during fasting inhibit <strong>PFK-1</strong>, leading to decreased glycolytic flux.</span></li></ul><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Pyruvate carboxylase</strong>: Incorrect. <strong>Pyruvate carboxylase</strong> is an enzyme involved in <strong>gluconeogenesis</strong>, converting <strong>pyruvate</strong> to <strong>oxaloacetate</strong>. During <strong>fasting</strong>, gluconeogenesis is upregulated to maintain blood glucose levels, so <strong>pyruvate carboxylase activity increases</strong>, not decreases.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>B. Glycogen phosphorylase</strong>: Incorrect. <strong>Glycogen phosphorylase</strong> is responsible for <strong>glycogenolysis</strong>, breaking down <strong>glycogen</strong> into <strong>glucose-1-phosphate</strong>. During <strong>fasting</strong>, glycogen stores are mobilized to maintain blood glucose levels, so <strong>glycogen phosphorylase activity</strong> increases during this time.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Hormone-sensitive lipase</strong>: Incorrect. <strong>Hormone-sensitive lipase (HSL)</strong> is involved in the <strong>breakdown of stored triglycerides</strong> into <strong>free fatty acids</strong> in adipose tissue. During <strong>fasting</strong>, HSL is activated by <strong>glucagon</strong> and <strong>epinephrine</strong>, leading to increased <strong>lipolysis</strong> for energy production. Thus, its activity increases, not decreases.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul><li><span style=\"font-size:14.0pt;\">During <strong>fasting</strong>, the body prioritizes <strong>gluconeogenesis</strong> and <strong>fatty acid oxidation</strong> over <strong>glycolysis</strong> to maintain blood glucose levels.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Phosphofructokinase 1 (PFK-1) </strong>activity decreases as glycolysis is downregulated, while enzymes involved in <strong>gluconeogenesis</strong> and <strong>lipolysis</strong> are upregulated.</span></li></ul>",
      "correct_choice_id": 248636,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62205,
      "choices": [
        {
          "id": 248077,
          "text": "<p><span style=\"font-size:14.0pt;\">Midshaft of the humerus</span></p>"
        },
        {
          "id": 248078,
          "text": "<p><span style=\"font-size:14.0pt;\">Proximal tibia, anteromedial from the tibial tuberosity</span></p>"
        },
        {
          "id": 248079,
          "text": "<p><span style=\"font-size:14.0pt;\">Distal femur, lateral condyle</span></p>"
        },
        {
          "id": 248080,
          "text": "<p><span style=\"font-size:14.0pt;\">Distal radius, near the wrist joint</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 6-year-old child presents to the emergency department in hypovolemic shock following a motor vehicle accident. Despite multiple attempts, intravenous access could not be obtained within 90 seconds. The decision is made to establish intraosseous (IO) access. Which of the following is the most appropriate site for intraosseous cannulation in this child?</span></p>",
      "unique_key": "Q5041848",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Proximal tibia, anteromedial from the tibial tuberosity</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The proximal tibia is the most common and preferred site for intraosseous cannulation in children due to its accessibility and the presence of a rich vascular network.</span></li><li><span style=\"font-size:14.0pt;\">Insertion is typically 1-2 cm anteromedial from the tibial tuberosity, which allows for rapid infusion of fluids and medications in emergency situations when IV access is not feasible.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-174407.png\" alt=\"\" width=\"300\" height=\"520\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt;\"><strong>Midshaft of the humerus:</strong> The midshaft of the humerus is not a recommended site for initial IO access, especially in pediatric patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:14pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:14.0pt;\"><strong>Distal femur, lateral condyle:</strong> The distal femur can be used as an alternative site in infants and young children but is not as commonly used as the proximal tibia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:14.0pt;\"><strong>Distal radius, near the wrist joint:</strong> The distal radius is not a typical site for intraosseous access in emergency situations.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Intraosseous (IO) access is an effective alternative for rapid fluid and medication administration in emergency situations when intravenous access cannot be established.</span></li><li><span style=\"font-size:14.0pt;\">Common sites for IO cannulation include the proximal tibia (1-2 cm anteromedial from the tibial tuberosity), distal femur, and distal tibia near the medial malleolus.</span></li></ul>",
      "correct_choice_id": 248078,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62192,
      "choices": [
        {
          "id": 248025,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recurrence can occur due to neovascularisation</span></span></p>"
        },
        {
          "id": 248026,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Saphenous nerve injury causes loss of sensation in the medial aspect of the leg</span></span></p>"
        },
        {
          "id": 248027,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The sural nerve is in danger during stripping of the great saphenous vein</span></span></p>"
        },
        {
          "id": 248028,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deep vein thrombosis can occur postoperatively</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old male undergoes surgery for varicose veins. During the procedure, the surgeon strips the great saphenous vein. Which of the following statements regarding complications of varicose vein surgery is false? </span></span></p>",
      "unique_key": "Q9550877",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) The sural nerve is in danger during stripping of the great saphenous vein</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The sural nerve runs laterally alongside the short saphenous vein, not the great saphenous vein. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Therefore, the sural nerve is more likely to be injured during stripping of the short saphenous vein, not the great saphenous vein.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A.</span></strong><span style=\"font-size:14.0pt\"> <strong>Recurrence can occur due to neovascularisation:</strong> Some surgeons have argued that surgical trauma and subsequent inflammation in the groin are associated with neovascularisation, which in turn may lead to recurrence</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B.</span></strong><span style=\"font-size:14.0pt\"> <strong>Saphenous nerve injury causes loss of sensation in the medial aspect of the leg:</strong> The saphenous nerve accompanies the great saphenous vein medially, and injury to it during surgery can result in sensory loss in the medial aspect of the leg.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D.</span></strong><span style=\"font-size:14.0pt\"> <strong>Deep vein thrombosis can occur postoperatively:</strong> Surgery involving the veins can lead to venous stasis and predispose patients to deep vein thrombosis, especially in the postoperative period.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In varicose vein surgery, injury to the <strong>saphenous nerve</strong> is a common complication due to its close proximity to the great saphenous vein. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">However, the <strong>sural nerve</strong> is at risk during stripping of the short saphenous vein, not the great saphenous vein. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Postoperative complications include lymphedema and deep vein thrombosis.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248027,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62194,
      "choices": [
        {
          "id": 248033,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lichen planopilaris </span></span></p>"
        },
        {
          "id": 248034,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tinea capitis</span></span></p>"
        },
        {
          "id": 248035,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alopecia areata</span></span></p>"
        },
        {
          "id": 248036,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Discoid lupus erythematosus</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 43-year-old woman presents with asymptomatic patchy hair loss that she noticed over the past several months. She reports that the areas of hair loss are smooth and shiny with adherent scaling noted in few areas. Physical examination reveals atrophic patches with evidence of scarring on the scalp. Carpet tack sign was positive on removal of scales. There are no associated lesions elsewhere on her skin or nails. Which of the following conditions is most likely responsible for this patient&#39;s presentation? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-173014.jpg\" style=\"height:239px; width:350px\" /></p>",
      "unique_key": "Q5252445",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Discoid lupus erythematosus</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This patient presents with <strong>cicatricial (scarring) alopecia</strong>, characterized by <strong>patchy hair loss</strong> in areas that are <strong>smooth, shiny, and atrophic</strong>, with evidence of scarring and few areas of adherent scaling. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">One of the most common causes of scarring alopecia is <strong>discoid lupus erythematosus (DLE)</strong>, a chronic autoimmune condition that affects the skin. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In DLE, inflammatory processes lead to permanent destruction of hair follicles and result in scarring. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The hallmark of DLE is <strong>scarring</strong> and <strong>atrophic plaques</strong>, which can occur on the scalp, causing irreversible hair loss. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Carpet tack sign positivity</span></strong><span style=\"font-size:14.0pt\"> also points to the diagnosis of DLE. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The presence of these smooth, shiny areas of scarring strongly points toward DLE in this case.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Lichen planopilaris:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Lichen planopilaris is a variant of lichen planus that affects hair follicles and can cause scarring alopecia. However, the presentation is usually accompanied by pruritus and associated skin lesions and nail involvement, which were not noted in this case. Also Carpet tack sign is not associated with LPP.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Tinea capitis:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Tinea capitis is a fungal infection of the scalp, commonly seen in children. It often presents with itchy lesions over scalp, and inflammatory variants, kerion &amp; favus present with boggy swelling or scutula respectively, both of which are not mentioned in the question.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Alopecia areata:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Alopecia areata is an autoimmune condition that causes <strong>non-scarring hair loss</strong> with smooth, round patches of hair loss. However, there is no scarring or atrophy in alopecia areata, and hair can often regrow in the affected areas.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Discoid lupus erythematosus (DLE)&nbsp;</span></strong><span style=\"font-size:14.0pt\">is a chronic autoimmune condition that can cause <strong>cicatricial (scarring) alopecia</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Patients with DLE often present with <strong>smooth, shiny, atrophic patches</strong> of hair loss with adherent scaling showing Carpet tack sign positivity, which is a key feature that distinguishes DLE from other causes of hair loss.</span></span></li>\r\n</ul>",
      "correct_choice_id": 248036,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        18
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62153,
      "choices": [
        {
          "id": 247873,
          "text": "<p><span style=\"font-size:14.0pt;\">Doxycycline</span></p>"
        },
        {
          "id": 247874,
          "text": "<p><span style=\"font-size:14.0pt;\">Chloramphenicol</span></p>"
        },
        {
          "id": 247875,
          "text": "<p><span style=\"font-size:14.0pt;\">Azithromycin</span></p>"
        },
        {
          "id": 247876,
          "text": "<p><span style=\"font-size:14.0pt;\">Penicillin G</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following drugs corresponds to Drug A?</span></p><p>&nbsp;</p><figure class=\"image\"><img style=\"aspect-ratio:944/275;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Sg1D9ZN.png\" width=\"944\" height=\"275\"></figure>",
      "unique_key": "Q9788066",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Doxycycline</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Doxycycline&nbsp;</strong>is a <strong>tetracycline antibiotic</strong> that binds to the <strong>30S ribosomal subunit</strong> of bacterial ribosomes.</span></li><li><span style=\"font-size:14.0pt;\">It prevents the attachment of <strong>aminoacyl-tRNA</strong> to the <strong>A site</strong> on the ribosome, thereby inhibiting the <strong>addition of new amino acids</strong> to the growing polypeptide chain.</span></li><li><span style=\"font-size:14.0pt;\">This action effectively halts <strong>bacterial protein synthesis</strong>, making it bacteriostatic.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Chloramphenicol</strong>: This drug binds to the <strong>50S ribosomal subunit</strong> and inhibits <strong>peptidyl transferase</strong>, preventing the formation of peptide bonds between amino acids during protein elongation. It does not act at the A site or involve the 30S subunit.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Azithromycin</strong>: <strong>Azithromycin</strong> is a <strong>macrolide</strong> that binds to the <strong>50S ribosomal subunit</strong>, blocking <strong>translocation</strong> during protein synthesis. It does not inhibit the binding of aminoacyl-tRNA at the 30S subunit.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Penicillin G</strong>: <strong>Penicillin G</strong> is a <strong>beta-lactam antibiotic</strong> that inhibits <strong>cell wall synthesis</strong> by blocking <strong>transpeptidase enzymes</strong> involved in peptidoglycan cross-linking. It does not act on the ribosome or protein synthesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Doxycycline&nbsp;</strong>inhibits bacterial protein synthesis by targeting the <strong>30S ribosomal subunit</strong> and preventing the binding of <strong>aminoacyl-tRNA</strong> to the <strong>A site</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Chloramphenicol&nbsp;</strong>and <strong>azithromycin</strong> act on the <strong>50S subunit</strong>, but with different mechanisms.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Penicillin G&nbsp;</strong>acts on <strong>bacterial cell wall synthesis</strong>, not on the ribosomal machinery.</span></li></ul>",
      "correct_choice_id": 247873,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62220,
      "choices": [
        {
          "id": 248137,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1 only </span></span></span></p>"
        },
        {
          "id": 248138,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">2 and 3</span></span></span></p>"
        },
        {
          "id": 248139,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">3 only </span></span></span></p>"
        },
        {
          "id": 248140,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">3 and 4</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 32-year-old woman is bitten by a stray dog and presents to the clinic for post-exposure prophylaxis (PEP) for rabies. Which of the following statements is correct regarding rabies PEP?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Category I exposure requires both vaccine and immunoglobulin.</span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Immunoglobulin is not needed if the patient has received prior full rabies vaccination.</span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Local wound cleaning is essential in all cases of dog bites.</span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vaccination is stopped if the dog dies within 3 days of the bite.</span></span></li>\r\n</ol>",
      "unique_key": "Q2696654",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) 2 and 3</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Statement 2</span></strong><span style=\"font-size:14.0pt\">: Correct. If a patient has previously received a full rabies vaccination series, rabies immunoglobulin (RIG) is not required. In such cases, booster doses of the rabies vaccine are administered after exposure.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Statement 3</span></strong><span style=\"font-size:14.0pt\">: Correct. Local wound cleaning is a critical step in rabies PEP and should be performed in all cases of animal bites. It helps reduce the viral load at the wound site, decreasing the chance of infection.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options</span></strong><span style=\"font-size:14.0pt\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Statement 1</span></strong><span style=\"font-size:14.0pt\">: Incorrect. Category I exposure involves minor contact with animals, such as touching or feeding, with no skin breach. This does not require PEP unless there is a high suspicion of rabies. Category II and III exposures are the ones that require vaccine and possibly immunoglobulin.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Statement 4:</span></strong><span style=\"font-size:14.0pt\"> Incorrect. Vaccination should not be stopped even if the dog dies within 3 days of the bite, as rabies can remain asymptomatic in the animal for some time. PEP should be continued based on the exposure risk and clinical judgment.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Post Exposure Prophylaxis of Rabies Guidelines</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Category-wise PEP measures:</span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Category I wound: None</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Category II wound: Local treatment of wound +Immediate vaccination</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Category III wound: Local treatment of wound +Immediate vaccination + Immediate immunoglobulin</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">PEP is discontinued if:</span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Suspected animal proved free of rabies by an appropriate laboratory</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In case of domestic animal, latter remains healthy throughout 10-day observation period from day of bite</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Rabies Immunoglobulin is NOT indicated in previously vaccinated individuals</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248138,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62234,
      "choices": [
        {
          "id": 248193,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Amoebic liver abscess</span></span></span></p>"
        },
        {
          "id": 248194,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hydatid cyst</span></span></span></p>"
        },
        {
          "id": 248195,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hepatic adenoma</span></span></span></p>"
        },
        {
          "id": 248196,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pyogenic liver abscess</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old man presents with a history of progressive abdominal discomfort and early satiety. Physical examination reveals hepatomegaly, with the liver palpable 10 cm below the costal margin. A CT scan of the abdomen is shown below. Which of the following is the most likely diagnosis?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-160916.jpg\" style=\"height:331px; width:400px\" /></span></span></p>",
      "unique_key": "Q3142752",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Hydatid cyst</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The CT scan findings of multilocular cysts with calcifications, septations, and daughter cysts, along with the characteristic cartwheel or spoke-wheel appearance, are highly suggestive of <strong>hydatid cyst</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This condition is caused by infection with the parasite Echinococcus, and it commonly involves the liver.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Amoebic liver abscess:</span></strong><span style=\"font-size:14.0pt\"> This would present with a solitary lesion, often without the characteristic daughter cysts or calcifications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Hepatic adenoma:</span></strong><span style=\"font-size:14.0pt\"> It is usually a solitary, well-defined, non-cystic lesion that does not have the septations or calcifications seen in hydatid disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Pyogenic liver abscess:</span></strong><span style=\"font-size:14.0pt\"> This typically presents as a solitary or multiple abscess with fluid levels and may show air-fluid levels, but without the classic cartwheel or daughter cyst appearance.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hydatid cysts, caused by Echinococcus species, present with multiloculated cystic lesions on imaging, often with calcifications, septations, and daughter cysts. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">They are a parasitic infection commonly transmitted via contact with dogs or sheep. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Treatment involves anti-parasitic drugs and possibly surgical intervention.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248194,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62173,
      "choices": [
        {
          "id": 247953,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Smothering</span></span></p>"
        },
        {
          "id": 247954,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Choking</span></span></p>"
        },
        {
          "id": 247955,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Throttling</span></span></p>"
        },
        {
          "id": 247956,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gagging</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A forensic expert is investigating a case of suspected suffocation. The cause of death involves various types of mechanical asphyxia, but one listed method is not classified under suffocation. Which of the following is not typically considered a type of suffocation?</span></span></p>",
      "unique_key": "Q8208049",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>C) Throttling</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Throttling</span></strong><span style=\"font-size:14.0pt\"> refers to manual strangulation, which involves external compression of the neck using the hands or another object to obstruct blood vessels and the airway, ultimately causing asphyxia. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It does not fall under the category of suffocation, which involves blockage of airflow rather than compression of the neck.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Smothering</strong>: Involves obstructing the external air passages (e.g., nose and mouth) with an external object, thereby preventing breathing and leading to suffocation.</span></span></span></p>\r\n\r\n<p><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B</span></strong><span style=\"font-size:14.0pt\">. <strong>Choking</strong>: Involves blockage of the internal airway (e.g., by a foreign body in the throat or trachea) that prevents the individual from breathing properly.</span></span></span></p>\r\n\r\n<p><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D</span></strong><span style=\"font-size:14.0pt\">. <strong>Gagging</strong>: Gagging is a type of suffocation where an obstruction is placed in or around the mouth to prevent the individual from breathing adequately, resulting in asphyxia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Suffocation refers to a condition where the airway is obstructed, either internally or externally, leading to hypoxia. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Throttling</span></strong><span style=\"font-size:14.0pt\"> is a form of manual strangulation involving direct pressure on the neck, which makes it distinct from other types of suffocation, such as smothering, choking, and gagging. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Recognizing these differences is essential in forensic medicine for accurately determining the mechanism of death in asphyxia cases.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247955,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62354,
      "choices": [
        {
          "id": 248669,
          "text": "<p><span style=\"font-size:14.0pt;\">Mannoproteins</span></p>"
        },
        {
          "id": 248670,
          "text": "<p><span style=\"font-size:14.0pt;\">Beta 1, 3, glucan</span></p>"
        },
        {
          "id": 248671,
          "text": "<p><span style=\"font-size:14.0pt;\">Chitin</span></p>"
        },
        {
          "id": 248672,
          "text": "<p><span style=\"font-size:14.0pt;\">Ergosterol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old man presents with fever, facial swelling, and nasal congestion. He is immunocompromised due to poorly controlled diabetes mellitus and is diagnosed with mucormycosis. Which of the following cell wall components is notably absent or minimally present in the fungal pathogen causing mucormycosis?</span></p>",
      "unique_key": "Q7251489",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B)</strong> <strong>Beta 1, 3, glucan</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul><li><span style=\"font-size:14.0pt;\">Mucormycosis is caused by fungi of the order <strong>Mucorales</strong> such as <i>Mucor</i> and <i>Rhizopus</i>.</span></li><li><span style=\"font-size:14.0pt;\">The cell walls of these fungi lack significant amounts of <strong>Beta 1, 3 glucan</strong>, which is otherwise a common polysaccharide present in the cell walls of most other fungi.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Beta 1, 3 glucan</strong> serves as a major structural component in most fungi and is important in diagnostic tests like the Beta-D-Glucan (BDG) test, which is positive for infections like candidiasis and aspergillosis but is typically negative in <strong>mucormycosis</strong>.</span></li></ul><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Mannoproteins:</strong> These are present in most fungal cell walls, including those of mucor species. They play roles in adherence and immune evasion.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Chitin:</strong> Chitin provides structural strength to the fungal cell wall and is a common component found across various fungal species, including mucor.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Ergosterol:</strong> <strong>Ergosterol</strong> is a component of the fungal cell membrane, not the cell wall, and is found in nearly all fungal species, including those causing mucormycosis.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul><li><span style=\"font-size:14.0pt;\"><strong>Beta 1, 3 glucan </strong>is notably absent or present at very low levels in fungi causing mucormycosis, unlike in other fungi like <i>Candida</i> or <i>Aspergillus</i>.</span></li><li><span style=\"font-size:14.0pt;\">This absence is clinically significant since diagnostic tests for Beta-D-Glucan are negative in mucormycosis.</span></li></ul>",
      "correct_choice_id": 248670,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62124,
      "choices": [
        {
          "id": 247757,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase in left atrial pressure</span></span></p>"
        },
        {
          "id": 247758,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase in left ventricular volume</span></span></p>"
        },
        {
          "id": 247759,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase in intrathoracic pressure adding to aortic pressure</span></span></p>"
        },
        {
          "id": 247760,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase in intrathoracic pressure adding to left ventricular pressure</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following best explains the rise in blood pressure during the early phase of the Valsalva maneuver?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-135519.jpg\" style=\"height:327px; width:400px\" /></span></span></p>",
      "unique_key": "Q7292769",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Increase in intrathoracic pressure adding to aortic pressure</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The Valsalva maneuver consists of forced expiration against a closed glottis, which increases <strong>intrathoracic pressure</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">During <strong>Phase I</strong> of the maneuver, the rise in intrathoracic pressure is transmitted to the <strong>aorta</strong>, resulting in a transient increase in blood pressure. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This occurs because the elevated pressure in the thoracic cavity temporarily compresses the aorta, leading to an increase in aortic pressure before the blood flow begins to decrease due to reduced venous return.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Increase in left atrial pressure</span></strong><span style=\"font-size:14.0pt\">: Incorrect. While intrathoracic pressure increases left atrial pressure during the Valsalva maneuver, this does not directly cause the rise in blood pressure observed during <strong>Phase I</strong>. The pressure rise is primarily due to increased aortic pressure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Increase in left ventricular volume</span></strong><span style=\"font-size:14.0pt\">: Incorrect. Left ventricular volume does not increase during the initial phase of the Valsalva maneuver. In fact, as intrathoracic pressure increases, venous return to the heart decreases, leading to a subsequent decrease in left ventricular filling during later phases.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Increase in intrathoracic pressure adding to left ventricular pressure</span></strong><span style=\"font-size:14.0pt\">: Incorrect. Although intrathoracic pressure increases during the Valsalva maneuver, the immediate rise in blood pressure is due to the increase in <strong>aortic pressure</strong> rather than left ventricular pressure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">During <strong>Phase I</strong> of the Valsalva maneuver, the <strong>increase in intrathoracic pressure</strong> is transmitted to the <strong>aorta</strong>, resulting in a transient rise in <strong>aortic pressure</strong> and blood pressure. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This precedes the drop in venous return that characterizes later phases of the maneuver.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247759,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62162,
      "choices": [
        {
          "id": 247909,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-1, B-3, C-2, D-4</span></span></p>"
        },
        {
          "id": 247910,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-3, B-4, C-1, D-2</span></span></p>"
        },
        {
          "id": 247911,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-3, B-2, C-1, D-4</span></span></p>"
        },
        {
          "id": 247912,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-2, B-3, C-4, D-1</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following types of teeth with their typical ages of eruption in children and adolescents. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-165203.png\" style=\"height:308px; width:1000px\" /></span></span></p>",
      "unique_key": "Q5904083",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.</span></strong><span style=\"font-size:14.0pt\"> <strong>C) A-3, B-2, C-1, D-4</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The chronology of eruption of secondary dentition or permanent teeth is as follows:</span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Canine:</span></strong><span style=\"font-size:14.0pt\"> Erupts at 11-12 years (A-3)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Lateral incisor:</span></strong><span style=\"font-size:14.0pt\"> Erupts at 8-9 years (B-2)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">First molar:</span></strong><span style=\"font-size:14.0pt\"> The first molars are among the earliest permanent teeth to erupt, usually appearing at 6-7 years of age. (C-1)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Third molar:</span></strong><span style=\"font-size:14.0pt\"> Third molars, or &quot;wisdom teeth,&quot; are the last to erupt and typically appear between 17-25 years of age. (D-4)</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronology of eruption of secondary dentition or permanent teeth:</span></span></strong><br />\r\n&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-165244.png\" style=\"height:980px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Mnemonic: <strong>M</strong>other <strong>I</strong>s <strong>I</strong>n <strong>P</strong>ain <strong>P</strong>apa <strong>C</strong>an <strong>M</strong>ake <strong>M</strong>edicine</span></span></span></p>",
      "correct_choice_id": 247911,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62128,
      "choices": [
        {
          "id": 247773,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pacinian corpuscles</span></span></span></p>"
        },
        {
          "id": 247774,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Meissner corpuscles</span></span></span></p>"
        },
        {
          "id": 247775,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ruffini corpuscles</span></span></span></p>"
        },
        {
          "id": 247776,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Merkel cells</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old man visits the clinic for a routine checkup. During the neurological examination, you assess his sensory perception. The patient is able to sense skin stretching and responds appropriately to joint position changes. These sensory modalities are primarily mediated by mechanoreceptors located in the skin and joints. Which of the following mechanoreceptors is most likely responsible for detecting skin stretch and contributing to joint position sense in this patient? </span></span></p>",
      "unique_key": "Q1046039",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Ruffini corpuscles</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ruffini corpuscles are slowly adapting mechanoreceptors found in the skin and joints. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">They are specialized for detecting <strong>skin stretch</strong> and are involved in providing information related to <strong>joint position</strong> and <strong>movement</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ruffini corpuscles play a critical role in proprioception, helping the body understand limb positioning and the movement of joints, as well as the stretching of skin during movement. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This allows the patient to accurately perceive changes in skin tension and the position of their joints, as described in this clinical case.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Pacinian corpuscles</span></strong><span style=\"font-size:14.0pt\">: Incorrect. Pacinian corpuscles are mechanoreceptors that detect <strong>deep pressure</strong> and <strong>vibration</strong>, not skin stretch or joint position sense. They are rapidly adapting and respond to transient mechanical changes rather than continuous skin stretch or proprioceptive input.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Meissner corpuscles</span></strong><span style=\"font-size:14.0pt\">: Incorrect. Meissner corpuscles are rapidly adapting mechanoreceptors responsible for detecting <strong>light touch</strong> and <strong>fine tactile discrimination</strong>, especially in areas like the fingertips. They do not detect skin stretch or provide information about joint position.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Merkel cells</span></strong><span style=\"font-size:14.0pt\">: Incorrect. Merkel cells are mechanoreceptors that detect <strong>sustained pressure</strong> and texture, helping in fine tactile sensing such as detecting textures and shapes. However, they are not involved in sensing skin stretch or joint position.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ruffini corpuscles&nbsp;</span></strong><span style=\"font-size:14.0pt\">are mechanoreceptors responsible for detecting <strong>skin stretch</strong> and providing information about <strong>joint position</strong> and <strong>movement</strong>, playing an essential role in <strong>proprioception</strong>.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247775,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62152,
      "choices": [
        {
          "id": 247869,
          "text": "<p><span style=\"font-size:14.0pt;\">Layer A</span></p>"
        },
        {
          "id": 247870,
          "text": "<p><span style=\"font-size:14.0pt;\">Layer B</span></p>"
        },
        {
          "id": 247871,
          "text": "<p><span style=\"font-size:14.0pt;\">Layer C</span></p>"
        },
        {
          "id": 247872,
          "text": "<p><span style=\"font-size:14.0pt;\">Layer D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old patient presents with symptoms of chronic diarrhea. A stool sample is collected and processed using the formal-ether concentration technique to examine for the presence of parasites. The specimen is labelled with four different layers (A, B, C, D) after centrifugation. At which layer are parasitic ova most likely to be found under the microscope?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-135632.jpg\" alt=\"\" width=\"400\" height=\"464\"></span></p>",
      "unique_key": "Q8389443",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt;\"><strong>D) Layer D</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-135643.jpg\" alt=\"\" width=\"400\" height=\"384\"></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The formal-ether concentration technique is a sedimentation method used to isolate parasitic ova, cysts, and larvae from stool samples.</span></li><li><span style=\"font-size:14.0pt;\">It relies on the differential densities of fecal debris and parasitic organisms.</span></li><li><span style=\"font-size:14.0pt;\">The heavier parasitic elements, including ova and cysts, settle at the bottom of the tube and are concentrated in the sediment, which is referred to as Layer D in this scenario.</span></li><li><span style=\"font-size:14.0pt;\">Thus, parasitic ova are most likely found at the bottom sediment layer (Layer D).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Layer A</strong>: This level contains ether, which is used to extract fecal debris.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Layer B</strong>: This level is where the plug of debris is found after centrifugation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14pt;\"><strong>Option C. Layer</strong>&nbsp;</span><span style=\"font-size:14.0pt;\"><strong>C</strong>: This level contains formalin, which fixes and preserves the morphology of the parasitic elements.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The formal-ether concentration technique for stool samples is a sedimentation method where parasitic ova, cysts, and larvae settle at the bottom of the tube after centrifugation.</span></li><li><span style=\"font-size:14.0pt;\">The bottom layer (Layer D) contains the concentrated parasitic elements.</span></li></ul>",
      "correct_choice_id": 247872,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62184,
      "choices": [
        {
          "id": 247997,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer magnesium sulfate</span></p>"
        },
        {
          "id": 247998,
          "text": "<p><span style=\"font-size:14.0pt;\">Induction of labor</span></p>"
        },
        {
          "id": 247999,
          "text": "<p><span style=\"font-size:14.0pt;\">Perform fetal scalp pH monitoring</span></p>"
        },
        {
          "id": 248000,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer antibiotics</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 34-year-old pregnant woman at 36 weeks gestation presents to the emergency department with continuous vaginal bleeding and abdominal pain. She has a history of chronic hypertension. On examination, her vitals are stable, and the uterus is tense and tender. Ultrasound confirms placental abruption. The fetal heart rate is normal. What is the most appropriate next step in the management of this patient?</span></p>",
      "unique_key": "Q4124499",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Induction of labor</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">In cases of <strong>placental abruption</strong> where maternal vitals are stable, the fetal heart rate is normal, and the gestational age is <strong>36 weeks</strong>, the preferred management is <strong>induction of labor</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Placental abruption refers to the premature detachment of the placenta from the uterine wall, which can lead to serious complications for both the mother and fetus.</span></li><li><span style=\"font-size:14.0pt;\">Since the fetus is near term and both the mother and fetus are stable, inducing labor is the safest option to expedite delivery and prevent further complications.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Administer magnesium sulfate:</strong> Incorrect. Magnesium sulfate is typically used for <strong>seizure prophylaxis</strong> in patients with preeclampsia or eclampsia, which is not relevant in this case of stable placental abruption.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Perform fetal scalp pH monitoring:</strong> Incorrect. Fetal scalp pH monitoring is used to assess fetal well-being during labor, particularly if there is concern for fetal distress. In this case, there is no evidence of fetal distress, and it is not indicated.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Administer antibiotics:</strong> Incorrect. Antibiotics would be necessary if there was a concern for infection, such as <strong>chorioamnionitis</strong>, which is not present in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">In cases of <strong>placental abruption</strong> at or near term (≥36 weeks), with stable maternal and fetal conditions, <strong>induction of labor</strong> is the preferred management.</span></li><li><span style=\"font-size:14.0pt;\">Immediate cesarean section is reserved for cases with signs of fetal distress or maternal instability.</span></li></ul>",
      "correct_choice_id": 247998,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62428,
      "choices": [
        {
          "id": 248961,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ascending pharyngeal artery</span></span></span></p>"
        },
        {
          "id": 248962,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Dorsal lingual branches of the lingual artery</span></span></span></p>"
        },
        {
          "id": 248963,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tonsillar branch of the facial artery</span></span></span></p>"
        },
        {
          "id": 248964,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Descending palatine branch of the maxillary artery</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 7-year-old child presents to the emergency department with a sore throat, difficulty swallowing, and a fever of 39.2&deg;C (102.5&deg;F). Physical examination reveals swollen and erythematous tonsils with exudates bilaterally. The child is diagnosed with acute tonsillitis. During a routine tonsillectomy, there is significant bleeding from the tonsillar bed. Which of the following arteries is most likely the primary source of the hemorrhage? </span></span></p>",
      "unique_key": "Q8676456",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans</span></strong><span style=\"font-size:14.0pt\">. <strong>C) Tonsillar branch of the facial artery</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The tonsillar branch of the <strong>facial artery</strong> is the primary source of blood supply to the palatine tonsils. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">During a tonsillectomy, this vessel is the most likely source of significant bleeding. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Other arteries that contribute to the blood supply of the tonsil include the ascending palatine branch of the facial artery, the ascending pharyngeal artery (branch of the external carotid), dorsal lingual branches of the lingual artery, and descending palatine branches of the maxillary artery. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">However, the tonsillar branch of the facial artery is typically the dominant vessel and thus most often implicated in hemorrhage during tonsillectomy.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective</span></strong><span style=\"font-size:14.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The <strong>tonsillar branch of the facial artery</strong> is the main arterial supply to the palatine tonsils, and it is the most common source of hemorrhage during tonsillectomy. </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248963,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62134,
      "choices": [
        {
          "id": 247797,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Abnormal synthesis of collagen leading to lung and liver fibrosis</span></span></span></p>"
        },
        {
          "id": 247798,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Deposition of misfolded &alpha;1-antitrypsin proteins in the lungs</span></span></span></p>"
        },
        {
          "id": 247799,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Destruction of alveolar walls due to neutrophil elastase activity</span></span></span></p>"
        },
        {
          "id": 247800,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Autoimmune attack on hepatocytes and alveoli</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old man with a history of chronic cough and progressive shortness of breath presents with worsening dyspnea. He has a 10 pack-year smoking history but quit 10 years ago. Physical examination reveals decreased breath sounds bilaterally and hyperresonance to percussion. Spirometry shows a FEV1/FVC ratio of 55% and a reduced diffusing capacity for carbon monoxide (DLCO). A liver biopsy performed for abnormal liver enzymes reveals periodic Acid-Schiff (PAS)-positive, diastase-resistant inclusions within hepatocytes.<strong> </strong>Which of the following mechanisms is most likely responsible for this patient&rsquo;s lung and liver findings? </span></span></p>",
      "unique_key": "Q7150950",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans. C) Destruction of alveolar walls due to neutrophil elastase activity</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This patient has alpha-1 antitrypsin (AAT) deficiency, a condition that leads to unregulated neutrophil elastase activity due to lack of functional AAT, resulting in destruction of alveolar walls and panacinar emphysema. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The PAS-positive, diastase-resistant inclusions in hepatocytes represent accumulated misfolded AAT proteins, leading to liver disease.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Abnormal synthesis of collagen leading to lung and liver fibrosis:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Incorrect. This describes conditions like <strong>pulmonary fibrosis</strong> and <strong>cirrhosis</strong>, but this patient&rsquo;s lung findings (emphysema) are due to elastase activity, not fibrosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Deposition of misfolded &alpha;1-antitrypsin proteins in the lungs:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Incorrect. The misfolded AAT accumulates in the <strong>liver</strong>, not the lungs. The lung damage is due to <strong>elastase activity</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Autoimmune attack on hepatocytes and alveoli:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Incorrect. This describes conditions like <strong>autoimmune hepatitis</strong> or <strong>Goodpasture syndrome</strong>, but the lung and liver findings here are due to AAT deficiency.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">&alpha;1-antitrypsin deficiency&nbsp;</span></strong><span style=\"font-size:14.0pt\">leads to <strong>uncontrolled neutrophil elastase activity</strong>, causing <strong>alveolar wall destruction</strong> (emphysema) and <strong>misfolded protein accumulation in the liver</strong>, manifesting as <strong>PAS-positive, diastase-resistant inclusions</strong>.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247799,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62149,
      "choices": [
        {
          "id": 247857,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Methimazole</span></span></span></p>"
        },
        {
          "id": 247858,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ibuprofen</span></span></span></p>"
        },
        {
          "id": 247859,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Prednisone</span></span></span></p>"
        },
        {
          "id": 247860,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hydroxychloroquine</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old woman presents with fever, sore throat, and generalized fatigue. Laboratory studies reveal an absolute neutrophil count (ANC) of 400/mm&sup3;, consistent with agranulocytosis. Which of the following drugs is most likely to cause agranulocytosis in this patient? </span></span></p>",
      "unique_key": "Q8091362",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Methimazole</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Methimazole&nbsp;</span></strong><span style=\"font-size:14.0pt\">is an antithyroid medication that can cause <strong>agranulocytosis</strong> as a rare but serious side effect. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is used to treat <strong>hyperthyroidism</strong>, such as <strong>Graves&#39; disease</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Agranulocytosis can present with symptoms like <strong>fever</strong>, <strong>sore throat</strong>, and signs of infection. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Patients on <strong>methimazole</strong> should be advised to seek immediate medical attention if they develop such symptoms, as <strong>agranulocytosis</strong> can be life-threatening.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Ibuprofen</span></strong><span style=\"font-size:14.0pt\">: While <strong>ibuprofen</strong> (a nonsteroidal anti-inflammatory drug, or NSAID) can cause gastrointestinal and renal side effects, it is not typically associated with causing <strong>agranulocytosis</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Prednisone</span></strong><span style=\"font-size:14.0pt\">: <strong>Prednisone</strong>, a <strong>corticosteroid</strong>, can cause <strong>leukocytosis</strong> (an increase in white blood cell count) rather than <strong>agranulocytosis</strong>. It can suppress the immune system but is not directly associated with severe reductions in neutrophil counts.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Hydroxychloroquine</span></strong><span style=\"font-size:14.0pt\">: <strong>Hydroxychloroquine</strong> is an immunomodulatory drug used in the treatment of <strong>rheumatoid arthritis</strong> and <strong>lupus</strong>. It can cause <strong>rare hematological side effects</strong>, such as <strong>aplastic anemia</strong>, but <strong>agranulocytosis</strong> is far more commonly linked to <strong>methimazole</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Methimazole&nbsp;</span></strong><span style=\"font-size:14.0pt\">can cause <strong>agranulocytosis</strong>, a serious side effect that requires patients to be vigilant about symptoms like <strong>fever</strong> and <strong>sore throat</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">NSAIDs&nbsp;</span></strong><span style=\"font-size:14.0pt\">like <strong>ibuprofen</strong> and <strong>corticosteroids</strong> like <strong>prednisone</strong> are not typically associated with <strong>agranulocytosis</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Hydroxychloroquine&nbsp;</span></strong><span style=\"font-size:14.0pt\">has rare hematologic side effects but is less commonly linked to <strong>agranulocytosis</strong> compared to <strong>methimazole</strong>.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247857,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62210,
      "choices": [
        {
          "id": 248097,
          "text": "<p><span style=\"font-size:14.0pt;\">Endolymphatic hydrops</span></p>"
        },
        {
          "id": 248098,
          "text": "<p><span style=\"font-size:14.0pt;\">Otosclerosis</span></p>"
        },
        {
          "id": 248099,
          "text": "<p><span style=\"font-size:14.0pt;\">Acoustic neuroma</span></p>"
        },
        {
          "id": 248100,
          "text": "<p><span style=\"font-size:14.0pt;\">Eustachian tube dysfunction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old woman presents with progressive hearing loss that started during her second pregnancy. She has a family history of hearing loss in her mother. On examination, Rinne test is negative bilaterally, and Weber test localizes to the left ear. Tympanic membranes appear normal. What is the most likely underlying pathology?</span></p>",
      "unique_key": "Q2086821",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt;\"><strong>B) Otosclerosis</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">This patient's presentation is consistent with <strong>otosclerosis</strong>, which is characterized by progressive conductive hearing loss, often noted during or after pregnancy due to hormonal influences that can exacerbate the condition.</span></li><li><span style=\"font-size:14.0pt;\">The family history of hearing loss supports a hereditary predisposition, and the negative Rinne test (indicative of conductive hearing loss) further suggests otosclerosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Endolymphatic hydrops: </strong>Endolymphatic hydrops (Meniere's disease) is characterized by episodic vertigo, fluctuating hearing loss, tinnitus, and aural fullness, which are not described in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Acoustic neuroma:&nbsp;</strong>Acoustic neuroma typically presents with asymmetric sensorineural hearing loss and may involve tinnitus or imbalance but not conductive hearing loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Eustachian tube dysfunction:&nbsp;</strong>Eustachian tube dysfunction can cause conductive hearing loss, but it usually presents with symptoms like ear fullness or a history of recurrent upper respiratory infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Otosclerosis is a common cause of progressive conductive hearing loss, often presenting in young adults, particularly women, and may be exacerbated by hormonal changes such as pregnancy.</span></li><li><span style=\"font-size:14.0pt;\">Diagnosis is supported by family history, clinical testing (e.g., negative Rinne test), and can be confirmed with <strong>impedance audiometry</strong>.</span></li></ul>",
      "correct_choice_id": 248098,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62412,
      "choices": [
        {
          "id": 248897,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tc 99m DMSA</span></span></span></p>"
        },
        {
          "id": 248898,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tc 99m DTPA</span></span></span></p>"
        },
        {
          "id": 248899,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Captopril DTPA</span></span></span></p>"
        },
        {
          "id": 248900,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tc 99m MAG3</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 48-year-old female with a history of renal transplantation 4 months prior is being evaluated for renal function. Which imaging modality should be utilized for functional assessment of her transplanted kidney? </span></span></p>",
      "unique_key": "Q2844003",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Tc 99m MAG3 </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tc 99m MAG3 is ideal for renal function evaluation in transplant recipients because it provides information on both glomerular filtration and tubular excretion</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Tc 99m DMSA:</span></strong><span style=\"font-size:14.0pt\"> Incorrect. Tc 99m DMSA primarily assesses the renal cortex and is used for evaluating renal scarring and pyelonephritis, not routinely for post-transplant function.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Tc 99m DTPA:</span></strong><span style=\"font-size:14.0pt\"> Incorrect. Tc 99m DTPA measures the glomerular filtration rate but does not provide information on tubular function, which is significant in the evaluation of a transplanted kidney.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Captopril DTPA:</span></strong><span style=\"font-size:14.0pt\"> Incorrect. Captopril DTPA is used for the detection of renovascular hypertension, not routine post-transplant renal function assessment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective</span></strong><span style=\"font-size:14.0pt\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The most appropriate nuclear medicine imaging test to assess renal function in a patient who has undergone renal transplantation is Tc 99m MAG3 scan because it measures renal perfusion, function, and urinary excretion effectively in the post-transplant setting.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248900,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62118,
      "choices": [
        {
          "id": 247733,
          "text": "<p><span style=\"font-size:14.0pt;\">Clozapine</span></p>"
        },
        {
          "id": 247734,
          "text": "<p><span style=\"font-size:14.0pt;\">Pimozide</span></p>"
        },
        {
          "id": 247735,
          "text": "<p><span style=\"font-size:14.0pt;\">Fluphenazine</span></p>"
        },
        {
          "id": 247736,
          "text": "<p><span style=\"font-size:14.0pt;\">Haloperidol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old patient with schizophrenia is being treated with an antipsychotic drug. The patient has a history of developing extrapyramidal symptoms (EPS) with previous medications and prefers a drug that will not cause these side effects. Which of the following drugs is known to cause sedation but not extrapyramidal side effects?</span></p>",
      "unique_key": "Q9928490",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Clozapine</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Clozapine&nbsp;</strong>is an <strong>atypical antipsychotic</strong> that has a lower affinity for <strong>D2 receptors</strong> compared to <strong>5HT2A receptors</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This receptor profile significantly reduces the risk of <strong>extrapyramidal symptoms (EPS)</strong>, such as <strong>tremors</strong>, <strong>rigidity</strong>, and <strong>dystonia</strong>, which are common with many other antipsychotics that strongly block <strong>D2 receptors</strong>.</span></li><li><span style=\"font-size:14.0pt;\">However, clozapine is associated with <strong>sedation</strong> due to its antagonism of <strong>histamine H1 receptors</strong>.</span></li><li><span style=\"font-size:14.0pt;\">While it is effective for treatment-resistant schizophrenia, it requires close monitoring for potential side effects like <strong>agranulocytosis</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Pimozide</strong>: Pimozide is a <strong>typical antipsychotic</strong> that has a higher risk of causing <strong>extrapyramidal symptoms (EPS)</strong> due to its strong blockade of <strong>D2 receptors</strong> in the nigrostriatal pathway.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Fluphenazine</strong>: Fluphenazine is a <strong>high-potency typical antipsychotic</strong> that is well-known for its ability to cause <strong>EPS</strong> because of strong <strong>D2 receptor antagonism</strong>. It is less likely to cause sedation but more likely to cause motor side effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Haloperidol</strong>: Haloperidol is another <strong>high-potency typical antipsychotic</strong> with a high risk of <strong>EPS</strong> due to potent <strong>D2 receptor blockade</strong>. It is less sedating compared to low-potency antipsychotics.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Clozapine&nbsp;</strong>is an <strong>atypical antipsychotic</strong> that causes <strong>sedation</strong> but has a <strong>low risk of extrapyramidal symptoms (EPS)</strong> due to its lower affinity for <strong>D2 receptors</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Typical antipsychotics&nbsp;</strong>like <strong>pimozide</strong>, <strong>fluphenazine</strong>, and <strong>haloperidol</strong> have a higher risk of <strong>EPS</strong> because they strongly block <strong>D2 receptors</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Clozapine&nbsp;</strong>requires close monitoring for <strong>agranulocytosis</strong> but is particularly useful for patients who cannot tolerate <strong>EPS</strong>.</span></li></ul>",
      "correct_choice_id": 247733,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62367,
      "choices": [
        {
          "id": 248717,
          "text": "<p><span style=\"font-size:14.0pt;\">Amphotericin B</span></p>"
        },
        {
          "id": 248718,
          "text": "<p><span style=\"font-size:14.0pt;\">Potassium-sparing diuretic</span></p>"
        },
        {
          "id": 248719,
          "text": "<p><span style=\"font-size:14.0pt;\">Renin-angiotensin system blockers</span></p>"
        },
        {
          "id": 248720,
          "text": "<p><span style=\"font-size:14.0pt;\">Cyclosporine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following medications is least likely to cause hyperkalemia?</span></p>",
      "unique_key": "Q1798203",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Amphotericin B</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Amphotericin B </strong>is an <strong>antifungal agent</strong> that can cause <strong>hypokalemia</strong> rather than <strong>hyperkalemia</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It disrupts fungal cell membranes by binding to <strong>ergosterol</strong>, and a common side effect is <strong>renal tubular dysfunction</strong>, leading to the <strong>loss of potassium</strong> through the kidneys.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, it is least likely to cause <strong>hyperkalemia</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Potassium-sparing diuretic</strong>: <strong>Potassium-sparing diuretics</strong> like <strong>spironolactone</strong> or <strong>amiloride</strong> can cause <strong>hyperkalemia</strong> by <strong>inhibiting potassium excretion</strong> in the kidneys. They are commonly associated with elevated potassium levels, especially when combined with other drugs that affect <strong>potassium balance</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Renin-angiotensin system blockers</strong>: <strong>ACE inhibitors</strong> (e.g., <strong>lisinopril</strong>) and <strong>ARBs</strong> inhibit the <strong>renin-angiotensin-aldosterone system (RAAS)</strong>, reducing <strong>aldosterone</strong> secretion and <strong>potassium excretion</strong>, which can lead to <strong>hyperkalemia</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Cyclosporine</strong>: <strong>Cyclosporine</strong> is an <strong>immunosuppressant</strong> that can cause <strong>hyperkalemia</strong> by reducing <strong>aldosterone secretion</strong> and impairing <strong>potassium excretion</strong> in the kidneys. This makes it a common culprit in transplant patients experiencing elevated <strong>potassium</strong> levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Amphotericin B </strong>is associated with <strong>hypokalemia</strong>, not <strong>hyperkalemia</strong>, due to its effects on the kidneys.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Potassium-sparing diuretics</strong>, <strong>renin-angiotensin system blockers</strong>, and <strong>cyclosporine</strong> can all cause <strong>hyperkalemia</strong> by impairing <strong>renal potassium excretion</strong>.</span></li><li><span style=\"font-size:14.0pt;\">When using medications that affect potassium levels, monitoring serum <strong>potassium</strong> is crucial, particularly when combining drugs that can <strong>increase potassium</strong> levels.</span></li></ul>",
      "correct_choice_id": 248717,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62073,
      "choices": [
        {
          "id": 247553,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hers disease</span></span></span></p>"
        },
        {
          "id": 247554,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">McArdle disease</span></span></span></p>"
        },
        {
          "id": 247555,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Von Gierke&#39;s disease</span></span></span></p>"
        },
        {
          "id": 247556,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Anderson disease</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 4-year-old girl is brought to the emergency department due to progressive weakness in her limbs and an enlarging abdomen. Her parents report that she has become more tired and less active over the past few months. Physical examination reveals hepatomegaly and decreased muscle tone. A skeletal muscle biopsy shows abnormal glycogen accumulation with very long outer branches. Which of the following conditions is the most likely diagnosis? </span></span></p>",
      "unique_key": "Q7825235",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Anderson disease</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Anderson disease</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">, also known as <strong>glycogen storage disease type IV (GSD IV)</strong>, is caused by a deficiency in the <strong>branching enzyme</strong> (amylo-1,4 to 1,6-glucosyltransferase). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This enzyme is critical for forming the branched structure of glycogen. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">In its absence, glycogen accumulates with <strong>very long outer branches</strong>, leading to a structure that is less soluble and more resistant to breakdown. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The accumulation of abnormal glycogen primarily affects the <strong>liver</strong> and <strong>muscle</strong>, causing symptoms such as <strong>hepatomegaly</strong>, <strong>progressive muscle weakness</strong>, and <strong>myopathy</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Over time, the buildup of abnormal glycogen can result in <strong>liver fibrosis</strong> and <strong>cirrhosis</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Hers disease</span></strong><span style=\"font-size:14.0pt\">: Incorrect. <strong>Hers disease</strong> (GSD VI) results from a deficiency in <strong>liver glycogen phosphorylase</strong>, which affects the liver&rsquo;s ability to break down glycogen. It is associated with <strong>mild hypoglycemia</strong>, <strong>hepatomegaly</strong>, and <strong>growth retardation</strong>, but it does not involve abnormal glycogen branching with very long outer chains as seen in <strong>Anderson disease</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. McArdle disease</span></strong><span style=\"font-size:14.0pt\">: Incorrect. <strong>McArdle disease</strong> (GSD V) is due to a deficiency in <strong>muscle glycogen phosphorylase</strong>, leading to <strong>exercise intolerance</strong>, <strong>muscle cramps</strong>, and <strong>myoglobinuria</strong> after exertion. It does not result in abnormal glycogen with long outer branches and does not typically cause <strong>hepatomegaly</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Von Gierke&#39;s disease</span></strong><span style=\"font-size:14.0pt\">: Incorrect. <strong>Von Gierke&#39;s disease</strong> (GSD I) is caused by a deficiency in <strong>glucose-6-phosphatase</strong>, leading to <strong>severe hypoglycemia</strong>, <strong>lactic acidosis</strong>, <strong>hyperuricemia</strong>, and <strong>hyperlipidemia</strong>. The glycogen structure in this condition is normal, but the liver cannot release glucose into the blood, leading to <strong>hepatomegaly</strong>. It does not present with abnormal branching of glycogen as seen in <strong>Anderson disease</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Anderson disease (GSD IV)&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">is caused by a deficiency in the <strong>branching enzyme</strong>, leading to the accumulation of <strong>abnormal glycogen with very long outer branches</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This glycogen accumulates in the <strong>liver</strong> and <strong>muscle</strong>, causing <strong>hepatomegaly</strong>, <strong>muscle weakness</strong>, and <strong>myopathy</strong>. </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247556,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62413,
      "choices": [
        {
          "id": 248901,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">12 months</span></span></span></p>"
        },
        {
          "id": 248902,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">18 months</span></span></span></p>"
        },
        {
          "id": 248903,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">2 years</span></span></span></p>"
        },
        {
          "id": 248904,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">4 years</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 2-year-old child is brought to the pediatric clinic by his parents for a routine check-up. The parents mention that they are beginning to encourage their child to use the toilet, but they are unsure if it is the right time. The child has recently shown some interest in using the toilet but has not yet consistently communicated the need to go. At what age is toilet training typically started in a developmentally normal child? </span></span></p>",
      "unique_key": "Q8223935",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) 2 years</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Toilet training is usually started around 2 years of age in a developmentally normal child. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">At this age, the child may begin to show interest in using the toilet and may have enough physical and cognitive maturity to participate in the process.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. 12 months:</span></strong><span style=\"font-size:14.0pt\"> At 12 months, most children are not yet developmentally ready for toilet training. They lack the necessary motor skills and bladder control.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. 18 months:</span></strong><span style=\"font-size:14.0pt\"> While some children may start showing interest in the toilet around 18 months, most are not yet ready for consistent training.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. 4 years:</span></strong><span style=\"font-size:14.0pt\"> By 4 years of age, most children are expected to have mastered toilet training. Starting at this age would be considered delayed for most children.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Toilet training generally begins around the age of 2 years, when the child has developed the physical readiness and cognitive skills needed to participate in the process.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248903,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62145,
      "choices": [
        {
          "id": 247841,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Anaplasma phagocytophilum</span></span></span></p>"
        },
        {
          "id": 247842,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ehrlichia chaffeensis</span></span></span></p>"
        },
        {
          "id": 247843,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Bartonella henselae</span></span></span></p>"
        },
        {
          "id": 247844,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Coxiella burnetii</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 32-year-old male presents to the clinic with fever, fatigue, and a recent history of a tick bite. Laboratory results reveal a peripheral blood smear stained with Giemsa, as shown below. Which of the following organisms is most likely responsible for the patient&rsquo;s symptoms? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-164001.png\" style=\"height:438px; width:300px\" /></p>",
      "unique_key": "Q8872631",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>B) Ehrlichia chaffeensis</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ehrlichia chaffeensis causes human monocytic ehrlichiosis, a tick-borne disease. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">On a Giemsa-stained peripheral blood smear, it is characterized by the presence of &ldquo;morulae,&rdquo; which are clusters of bacteria observed within monocytes. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The presence of these characteristic clusters helps in the diagnosis of ehrlichiosis.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Anaplasma phagocytophilum</span></strong><span style=\"font-size:14.0pt\">: Anaplasma phagocytophilum causes human granulocytic anaplasmosis, which involves neutrophils rather than monocytes. Morulae are seen in neutrophils, not monocytes, distinguishing it from Ehrlichia chaffeensis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Bartonella henselae</span></strong><span style=\"font-size:14.0pt\">: Bartonella henselae is the causative agent of cat scratch disease. Although it can be visualized with specialized stains like Warthin-Starry, it does not typically present with morulae in peripheral blood smears.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Coxiella burnetii</span></strong><span style=\"font-size:14.0pt\">: Coxiella burnetii, responsible for Q fever, cannot be diagnosed via Giemsa stain of peripheral blood smears, as it is an intracellular pathogen that requires serologic testing or PCR.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ehrlichia chaffeensis can be identified by the presence of morulae within monocytes on a Giemsa-stained peripheral smear. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Distinguishing between intracellular infections often involves noting which type of white blood cells are affected and recognizing specific intracellular patterns.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247842,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62229,
      "choices": [
        {
          "id": 248173,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Babcock&#39;s forceps</span></span></span></p>"
        },
        {
          "id": 248174,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Lane&#39;s tissue holding forceps</span></span></span></p>"
        },
        {
          "id": 248175,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Kocher&#39;s hemostatic forceps</span></span></span></p>"
        },
        {
          "id": 248176,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Allis tissue forceps</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the instrument<strong>: </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-181518.jpg\" style=\"height:229px; width:350px\" /></p>",
      "unique_key": "Q6064235",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>D) Allis tissue forceps</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Allis tissue forceps</span></strong><span style=\"font-size:14.0pt\"> have distal blades that are not opposing each other. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The tip has teeth in each blade that are opposing. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">There is a lock in the proximal part.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Babcock&#39;s forceps:</strong> In <strong>Babcock&rsquo;s forceps</strong>, the distal part of the blade is curved with a triangular fenestra, which allows soft tissues to bulge out. The tip is non-traumatic with transverse serrations. It has a lock in the proximal part. It is used to hold tubular structures, such as parts of the bowel, fallopian tube, appendix, ureter, etc.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-181644.jpg\" style=\"height:518px; width:612px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Lane&rsquo;s tissue holding forceps:</strong> They are stout with thick distal blades and oval fenestrae. It has an opposing tooth on the tip and a lock in the proximal part. It is used to hold bulky and tough structures and lymph nodes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-181706.jpg\" style=\"height:339px; width:603px\" /></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Kocher&rsquo;s hemostatic forceps:</strong> They are identified by the opposing tooth on the tip and serrations in the distal blades. It is used to hold pedicles, tough structures, and cut ends of muscles. It can also hold ribs during rib dissection and be used for blunt dissection or resected bowel.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-181728.jpg\" style=\"height:549px; width:537px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Babcock&rsquo;s forceps</span></strong><span style=\"font-size:14.0pt\"> are non-traumatic and primarily used for holding tubular structures like the bowel or fallopian tubes, making them ideal for atraumatic manipulation in surgeries involving delicate tissues. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Allis forceps&nbsp;</span></strong><span style=\"font-size:14.0pt\">have toothed jaws and are better suited for holding tougher structures like fascia, while <strong>Kocher&rsquo;s forceps</strong> are designed for holding firm structures like pedicles and muscles.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248176,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62230,
      "choices": [
        {
          "id": 248177,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Evacuation under ultrasound guidance is preferable</span></span></p>"
        },
        {
          "id": 248178,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Baseline hemogram, TSH, and chest X-ray are essential</span></span></p>"
        },
        {
          "id": 248179,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-D immunoglobulin is not required for Rh-negative women</span></span></p>"
        },
        {
          "id": 248180,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment is typically by suction evacuation</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements is incorrect regarding the management of molar pregnancy? </span></span></p>",
      "unique_key": "Q2649118",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Anti-D immunoglobulin is not required for Rh-negative women</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In the management of molar pregnancy, <strong>Anti-D immunoglobulin</strong> is required for <strong>Rh-negative women</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Even though a molar pregnancy is abnormal, the presence of trophoblastic tissue still carries the Rh antigen, which can lead to maternal sensitization in Rh-negative women. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">To prevent this, <strong>Anti-D immunoglobulin</strong> should be administered after the evacuation of a molar pregnancy if the woman is Rh-negative.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Evacuation under ultrasound guidance is preferable:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Correct. <strong>Suction evacuation</strong> under ultrasound guidance ensures complete removal of the molar tissue and reduces the risk of complications like perforation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Baseline hemogram, TSH, and chest X-ray are essential:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Correct. <strong>Baseline investigations</strong>, including a hemogram, <strong>TSH</strong>, and <strong>chest X-ray</strong>, are important to assess for complications like anemia, hyperthyroidism, and metastatic spread to the lungs, which can occur in cases of molar pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Treatment is typically by suction evacuation:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Correct. <strong>Suction evacuation</strong> is the standard treatment for molar pregnancy. It effectively removes the abnormal trophoblastic tissue and allows for histopathological examination to confirm the diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In the management of <strong>molar pregnancy</strong>, <strong>Anti-D immunoglobulin</strong> is required for <strong>Rh-negative women</strong> to prevent Rh sensitization, even in abnormal pregnancies like a molar pregnancy. </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248179,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62217,
      "choices": [
        {
          "id": 248125,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Packet 1 for 12 months</span></span></span></p>"
        },
        {
          "id": 248126,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Packet 2 for 12 months</span></span></span></p>"
        },
        {
          "id": 248127,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Packet 1 for 6 months</span></span></span></p>"
        },
        {
          "id": 248128,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Packet 2 for 6 months</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient visits the outpatient department with a satellite skin lesion. During examination, one hypopigmented lesion and one thickened nerve are observed. Images of two blister packs are provided below. Which treatment would be most appropriate for this patient according to NLEP Guidelines?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-160448.jpg\" style=\"height:286px; width:400px\" /></span></span></p>",
      "unique_key": "Q1167618",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Ans. C) Packet 1 for 6 months.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">The treatment best suited for this patient, would be packet 1 for 6 months. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">One thickened nerve&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">and <strong>one hypopigmented satellite skin lesion</strong> in a clinical setting point to <strong>paucibacillary (PB leprosy</strong>) according to <strong>NLEP Guidelines.</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">NLEP guidelines&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">mention a <strong>2 drug MDT</strong> for <strong>PB</strong> leprosy.</span></span></span></li>\r\n\t<li><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">According to NLEP Guidelines, Paucibacillary leprosy&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is treated with <strong>rifampicin and dapsone</strong>, over the course of <strong>six months.</strong></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-160505.jpg\" style=\"height:295px; width:900px\" /></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-160517.jpg\" style=\"height:525px; width:997px\" /></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-160533.jpg\" style=\"height:603px; width:1000px\" /></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-160603.jpg\" style=\"height:541px; width:1000px\" /></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-160620.jpg\" style=\"height:540px; width:1000px\" /></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">FUTURE OF NLEP Guidelines in India</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-160645.jpg\" style=\"height:761px; width:902px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-160705_z3HDJvr.jpg\" style=\"height:473px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-160735_B8WOaQf.jpg\" style=\"height:668px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">MoHFW, GoI wants to implement the above-mentioned changes in Hansen&rsquo;s disease classification and treatment from 1<sup>st</sup> April 2025.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">According to <strong>NLEP Guidelines</strong>, for a patient with <strong>Paucibacillary leprosy</strong>, characterized by <strong>1-5 skin lesions and / or No nerve thickening or One thickened nerve,</strong> the appropriate treatment is with a regimen containing <strong>Rifampicin and Dapsone (Packet 1)</strong> for a duration of <strong>6 months.</strong></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248127,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        18
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62393,
      "choices": [
        {
          "id": 248821,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1, 2 and 4</span></span></span></p>"
        },
        {
          "id": 248822,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">2, 3 and 4</span></span></span></p>"
        },
        {
          "id": 248823,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1, 3 and 5</span></span></span></p>"
        },
        {
          "id": 248824,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">2, 4 and 5</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 22-year-old marathon runner is looking to optimize his nutrition for endurance performance. He regularly consumes bananas as part of his diet and is curious about their nutritional profile. His primary concerns are calories, calcium, and micronutrient intake. Which of the following statements accurately describes the<strong> </strong>nutritional content of bananas per 100 grams?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Iron: 10 mg</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Calcium: 10 mg</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Beta-carotene: 124 micrograms</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Calories: 104 kcal</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Vitamin C: 27 mg</span></span></span></li>\r\n</ol>",
      "unique_key": "Q8283498",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) 2, 3 and 4</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ripe banana - </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Calories:</span></strong><span style=\"font-size:14.0pt\"> Bananas contain <strong>104 kcal</strong>, making them an excellent source of quick energy, particularly beneficial for athletes like marathon runners.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Calcium:</span></strong><span style=\"font-size:14.0pt\"> Each 100 grams of banana provides <strong>10 mg of calcium</strong>, contributing to daily calcium intake, though not as a significant source.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Beta-carotene:</span></strong><span style=\"font-size:14.0pt\"> Bananas provide <strong>124 micrograms</strong> of beta-carotene, a precursor to vitamin A, important for vision and immune function.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">1. Iron</span></strong><span style=\"font-size:14.0pt\">: Bananas typically contain only a small amount of iron, 0.5 mg per 100 gm.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">5. Vitamin C</span></strong><span style=\"font-size:14.0pt\">: The vitamin C content of bananas is 7<strong> </strong>mg per 100 grams. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Banana is a good source of:</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Vitamins A, B6, C</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Carbohydrates, Energy</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Fibre</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Potassium, Phosphorus</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;Banana is NOT a good source of:</span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Calcium, Iron (Due to presence of phytates)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Zinc</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Additional Information </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Nutritive value of some fruits &amp; dry fruits (per 100 gm)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/22/screenshot-2024-10-22-125638.png\" style=\"height:646px; width:1000px\" /></span></strong></span></span></p>",
      "correct_choice_id": 248822,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62410,
      "choices": [
        {
          "id": 248889,
          "text": "<p><span style=\"font-size:14.0pt;\">CO<sub>2 </sub>pressure in inhaled air</span></p>"
        },
        {
          "id": 248890,
          "text": "<p><span style=\"font-size:14.0pt;\">CO<sub>2</sub> pressure in exhaled air</span></p>"
        },
        {
          "id": 248891,
          "text": "<p><span style=\"font-size:14.0pt;\">O<sub>2</sub> pressure in inhaled air</span></p>"
        },
        {
          "id": 248892,
          "text": "<p><span style=\"font-size:14.0pt;\">O<sub>2</sub> pressure in exhaled air</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">You are in the operating room and notice the tracing in gray color waveform on this device. What does it indicate?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/22/screenshot-2024-10-22-131256.png\" alt=\"\" width=\"300\" height=\"226\"></span></p>",
      "unique_key": "Q1121370",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"background-color:hsl(0, 0%, 100%);font-size:14.0pt;\"><strong>Ans. B) CO<sub>2 </sub>pressure in exhaled air</strong></span></p><p>&nbsp;</p><ul><li><span style=\"background-color:hsl(0, 0%, 100%);font-size:14.0pt;\"><strong>Function:</strong> Capnography measures the concentration of CO2 in exhaled air over time, producing a waveform called a capnogram.</span></li><li><span style=\"background-color:hsl(0, 0%, 100%);font-size:14.0pt;\"><strong>Components:</strong> Capnography equipment typically comprises a CO2 sensor, which can be placed in the circuit of a mechanically ventilated patient or near the patient's airway for non-intubated individuals (e.g., during procedural sedation). The CO2 concentration is then plotted over time to produce a waveform.</span></li><li><span style=\"background-color:hsl(0, 0%, 100%);font-size:14.0pt;\"><strong>Waveform Analysis:</strong> The capnogram is typically divided into four phases:</span><ul><li><span style=\"background-color:hsl(0, 0%, 100%);font-size:14.0pt;\"><strong>Phase I:</strong> Baseline, representing inspired gas, which is ideally CO2-free.</span></li><li><span style=\"background-color:hsl(0, 0%, 100%);font-size:14.0pt;\"><strong>Phase II:</strong> The expiratory upstroke, representing the beginning of expiration with a mix of dead space and alveolar gas.</span></li><li><span style=\"background-color:hsl(0, 0%, 100%);font-size:14.0pt;\"><strong>Phase III:</strong> Alveolar plateau, where the CO2 concentration stabilizes, reflecting primarily alveolar gas.</span></li><li><span style=\"background-color:hsl(0, 0%, 100%);font-size:14.0pt;\"><strong>Phase 0:</strong> Inspiratory downstroke, as the patient begins to inhale again.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"background-color:hsl(0, 0%, 100%);\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/22/screenshot-2024-10-22-131334.png\" alt=\"\" width=\"300\" height=\"230\"></span></p><p>&nbsp;</p><ul><li><span style=\"background-color:hsl(0, 0%, 100%);font-size:14.0pt;\"><strong>End-Tidal CO2 (EtCO2):</strong> This is the maximum value of CO2 at the end of expiration, and it provides an estimation of the arterial CO2 concentration, although they may not always be identical due to various physiological and pathological factors.</span></li></ul><p>&nbsp;</p><p><span style=\"background-color:hsl(0, 0%, 100%);font-size:14.0pt;\"><strong>Clinical Applications:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"background-color:hsl(0, 0%, 100%);font-size:14.0pt;\"><strong>Confirming correct endotracheal tube placement.</strong></span></li><li><span style=\"background-color:hsl(0, 0%, 100%);font-size:14.0pt;\"><strong>Monitoring the quality of cardiopulmonary resuscitation (CPR).</strong> A sudden rise in EtCO2 can indicate return of spontaneous circulation (ROSC).</span></li><li><span style=\"background-color:hsl(0, 0%, 100%);font-size:14.0pt;\"><strong>Evaluating a patient's ventilatory status.</strong></span></li><li><span style=\"background-color:hsl(0, 0%, 100%);font-size:14.0pt;\"><strong>Monitoring patients during procedural sedation.</strong></span></li><li><span style=\"background-color:hsl(0, 0%, 100%);font-size:14.0pt;\"><strong>Detecting conditions like pulmonary embolism, bronchospasm, and hypoventilation, among others.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"background-color:hsl(0, 0%, 100%);font-size:14.0pt;\"><strong>Limitations:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"background-color:hsl(0, 0%, 100%);font-size:14.0pt;\">Factors like changes in cardiac output, changes in alveolar ventilation, and equipment issues can influence the accuracy of capnography.</span></li></ul><p>&nbsp;</p><p><span style=\"background-color:hsl(0, 0%, 100%);font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"background-color:hsl(0, 0%, 100%);font-size:14.0pt;\"><strong>Option A. CO2 pressure in inhaled air: </strong>Airway pressure monitoring involves measuring the pressure within the airways, typically during mechanical ventilation, but it does not produce a CO2 waveform.</span></p><p>&nbsp;</p><p><span style=\"background-color:hsl(0, 0%, 100%);font-size:14.0pt;\"><strong>Option C. O2 pressure in inhaled air:</strong> Measuring the pressure of oxygen in inhaled air is not typically displayed as a capnography waveform.</span></p><p>&nbsp;</p><p><span style=\"background-color:hsl(0, 0%, 100%);font-size:14.0pt;\"><strong>Option D. O2 pressure in exhaled air: </strong>Measuring the pressure of oxygen in exhaled air is not typically displayed as a capnography waveform.</span></p><p>&nbsp;</p><p><span style=\"background-color:hsl(0, 0%, 100%);font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"background-color:hsl(0, 0%, 100%);font-size:14.0pt;\">Capnography is a crucial monitoring tool in the operating room and other clinical settings, used to measure and display the concentration of CO2 in exhaled air over time, helping to assess ventilation, confirm endotracheal tube placement, and monitor the effectiveness of resuscitation</span></li></ul><p>&nbsp;</p>",
      "correct_choice_id": 248890,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        19
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62077,
      "choices": [
        {
          "id": 247569,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prevention of bacterial dissemination</span></span></p>"
        },
        {
          "id": 247570,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stimulation of fibroblast proliferation</span></span></p>"
        },
        {
          "id": 247571,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Activation of complement and autoantibody production</span></span></p>"
        },
        {
          "id": 247572,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibition of T cell-mediated immunity</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old woman presents with fever, fatigue, and joint pain. She is diagnosed with a systemic autoimmune disease, and laboratory tests show positive anti-double-stranded DNA (anti-dsDNA) and anti-Smith (anti-Sm) antibodies. She is started on immunosuppressive<strong> </strong></span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">therapy, and her symptoms improve. Studies suggest that neutrophils in this condition form extracellular networks of chromatin and antimicrobial proteins that contribute to the propagation of autoimmune responses. Which of the following is the most likely role of these extracellular networks in this patient&rsquo;s condition? </span></span></p>",
      "unique_key": "Q5963261",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans. C)&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Activation of complement and autoantibody production</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Neutrophil extracellular traps (NETs) are webs of chromatin released by neutrophils to trap and kill pathogens, but in autoimmune diseases like SLE, they can abnormally expose nuclear antigens, leading to autoantibody production and activation of the complement system. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This process contributes to the pathogenesis of SLE.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Prevention of bacterial dissemination:</span></strong><span style=\"font-size:14.0pt\"> Incorrect. While NETs help trap and kill pathogens in normal immune responses, their role in this context is related to autoimmune activation, not bacterial containment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Stimulation of fibroblast proliferation:</span></strong><span style=\"font-size:14.0pt\"> Incorrect. Fibroblast proliferation is more related to tissue repair and fibrosis, not a direct effect of NETs in autoimmune conditions like SLE.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Inhibition of T cell-mediated immunity:</span></strong><span style=\"font-size:14.0pt\"> Incorrect. NETs do not inhibit T cell responses; rather, they promote the activation of the immune system, including complement and autoantibody production.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In systemic lupus erythematosus (SLE), neutrophil extracellular traps (NETs) contribute to the propagation of autoimmune responses by promoting complement activation and autoantibody production.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247571,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62074,
      "choices": [
        {
          "id": 247557,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hypoxanthine</span></span></span></p>"
        },
        {
          "id": 247558,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Uridine</span></span></span></p>"
        },
        {
          "id": 247559,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cytidine</span></span></span></p>"
        },
        {
          "id": 247560,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Guanine</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 11-year-old boy presents with symptoms of chronic anemia, weakness, and poor growth, with a low weight-to-height ratio. Laboratory tests reveal elevated levels of orotic acid in the urine. Which of the following is the most appropriate treatment for this patient? </span></span></p>",
      "unique_key": "Q1878606",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Uridine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The presentation is consistent with <strong>orotic aciduria</strong>, a disorder caused by a deficiency in <strong>uridine monophosphate (UMP) synthase</strong>, which is an enzyme involved in the <strong>de novo pyrimidine synthesis pathway</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This deficiency results in the accumulation of <strong>orotic acid</strong> due to an inability to convert it into <strong>UMP</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The elevated orotic acid can lead to <strong>megaloblastic anemia</strong>, <strong>growth retardation</strong>, and <strong>weakness</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Uridine&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">supplementation is the treatment of choice because it bypasses the enzymatic defect in <strong>UMP synthase</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Supplementing with uridine provides a source of <strong>pyrimidine</strong> that can be converted into <strong>UMP</strong>, which then supports normal pyrimidine synthesis and metabolism. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This helps to reduce the accumulation of <strong>orotic acid</strong> and corrects the associated symptoms like <strong>anemia</strong> and <strong>growth retardation</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Hypoxanthine</span></strong><span style=\"font-size:14.0pt\">: Incorrect. <strong>Hypoxanthine</strong> is a precursor in the <strong>purine synthesis</strong> pathway, not the <strong>pyrimidine synthesis</strong> pathway. It has no role in correcting <strong>UMP synthase deficiency</strong> or reducing <strong>orotic aciduria</strong>. It would not address the patient&#39;s symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Cytidine</span></strong><span style=\"font-size:14.0pt\">: Incorrect. While <strong>cytidine</strong> is a pyrimidine nucleoside, it is not the treatment of choice for <strong>orotic aciduria</strong>. <strong>Uridine</strong> directly bypasses the <strong>UMP synthase deficiency</strong> and helps reduce orotic acid accumulation more effectively.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Guanine</span></strong><span style=\"font-size:14.0pt\">: Incorrect. <strong>Guanine</strong> is a purine base and is not involved in the <strong>pyrimidine synthesis</strong> pathway. It does not address the underlying <strong>UMP synthase deficiency</strong> or the symptoms associated with <strong>orotic aciduria</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Orotic aciduria&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">results from a <strong>deficiency in UMP synthase</strong>, leading to <strong>elevated orotic acid levels</strong>, <strong>megaloblastic anemia</strong>, and <strong>growth retardation</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The most effective treatment is <strong>uridine supplementation</strong>, which bypasses the enzyme defect, allowing the body to produce <strong>UMP</strong> and normalize pyrimidine levels.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247558,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62209,
      "choices": [
        {
          "id": 248093,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Keratoconus</span></span></p>"
        },
        {
          "id": 248094,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Keratomalacia</span></span></p>"
        },
        {
          "id": 248095,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Staphyloma</span></span></p>"
        },
        {
          "id": 248096,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Granular dystrophy</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old patient presents with progressive vision loss in the left eye. Examination findings shown in the image. What is the most likely diagnosis? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-174649.png\" style=\"height:163px; width:300px\" /></p>",
      "unique_key": "Q5185518",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.</span></strong><span style=\"font-size:14.0pt\"> <strong>C) Staphyloma</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Staphyloma&nbsp;</span></strong><span style=\"font-size:14.0pt\">is characterized by the outward bulging of the <strong>uveal tissue</strong> through a weakened area of the <strong>cornea or sclera</strong>, resulting in a bluish, opaque appearance of the affected area. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It often arises due to trauma, infection, or inflammatory disease that leads to the loss of structural integrity in the eye&#39;s wall, leading to the prolapse of underlying tissue.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Keratoconus</strong>: Involves progressive thinning and conical protrusion of the cornea without uveal prolapse. The typical presentation is a cone-shaped corneal deformation, and it usually does not involve a bluish discoloration as seen in staphyloma.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Keratomalacia</strong>: Associated with severe <strong>vitamin A deficiency</strong>, leading to corneal ulceration and softening. While it can cause significant corneal damage, it does not present with uveal tissue prolapse or the marked protrusion seen in staphyloma.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Granular dystrophy</strong>: This condition is characterized by small, discrete, white opacities in the corneal stroma. It does not cause corneal thinning, bulging, or exposure of the uveal tissue.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Staphyloma&nbsp;</span></strong><span style=\"font-size:14.0pt\">involves the thinning of the corneal or scleral layers of the eye, with a characteristic protrusion involving the <strong>uveal tissue</strong>, which gives it a bluish hue. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This condition is usually secondary to injury, infection, or inflammatory processes that compromise the eye&#39;s structural integrity, leading to potential vision loss if untreated.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Types of Staphylomas -</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-174718.png\" style=\"height:571px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Note:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The most common cause for anterior staphyloma is sloughing corneal ulcer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The most common cause for posterior staphyloma is degenerative high axial myopia.</span></span></span></p>",
      "correct_choice_id": 248095,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        8
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62101,
      "choices": [
        {
          "id": 247665,
          "text": "<p><span style=\"font-size:14.0pt;\">Treponema pallidum</span></p>"
        },
        {
          "id": 247666,
          "text": "<p><span style=\"font-size:14.0pt;\">Chlamydia trachomatis</span></p>"
        },
        {
          "id": 247667,
          "text": "<p><span style=\"font-size:14.0pt;\">Haemophilus ducreyi</span></p>"
        },
        {
          "id": 247668,
          "text": "<p><span style=\"font-size:14.0pt;\">Herpes simplex</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old male presents to the clinic with complaints of painful genital ulcers that have been present for several days. Which of the following pathogens is most likely causing these symptoms?</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-154343.jpg\" alt=\"\" width=\"300\" height=\"194\"></p>",
      "unique_key": "Q1306146",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"background-color:hsl(0,0%,100%);font-size:14pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"background-color:hsl(0,0%,100%);font-size:14.0pt;\"><strong>C) Haemophilus ducreyi</strong></span></p><p>&nbsp;</p><ul><li><span style=\"background-color:hsl(0,0%,100%);font-size:14.0pt;\"><strong>Haemophilus ducreyi&nbsp;</strong>is the causative organism of <strong>chancroid</strong>, which typically presents with <strong>painful genital ulcers</strong> and <strong>tender inguinal lymphadenopathy</strong>.</span></li><li><span style=\"background-color:hsl(0,0%,100%);font-size:14.0pt;\">The ulcers caused by chancroid are characteristically <strong>soft</strong>, have an <strong>irregular margin</strong>, and are often associated with <strong>pain</strong>—making it distinct from other sexually transmitted infections that present with genital ulcers.</span></li><li><span style=\"background-color:hsl(0,0%,100%);font-size:14.0pt;\">This condition is also accompanied by <strong>painful unilateral lymphadenopathy</strong> that may progress to <strong>suppurative inguinal buboes</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"background-color:hsl(0,0%,100%);font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"background-color:hsl(0,0%,100%);font-size:14.0pt;\"><strong>Option A. Treponema pallidum</strong>: This is the causative organism of <strong>syphilis</strong>. Primary syphilis presents with a <strong>painless, firm, and well-demarcated chancre</strong>. Unlike chancroid, syphilis does not cause painful ulcers.</span></p><p>&nbsp;</p><p><span style=\"background-color:hsl(0,0%,100%);font-size:14.0pt;\"><strong>Option B. Chlamydia trachomatis</strong>: Specifically, the <strong>L1-L3 serovars</strong> of Chlamydia trachomatis cause <strong>lymphogranuloma venereum (LGV)</strong>, which can present with a <strong>painless genital ulcer</strong> followed by <strong>painful lymphadenopathy</strong> (buboes). The ulcer itself is not painful.</span></p><p>&nbsp;</p><p><span style=\"background-color:hsl(0,0%,100%);font-size:14.0pt;\"><strong>Option D. Herpes simplex</strong>: Herpes simplex virus (HSV) infection can also cause painful genital ulcers. However, HSV ulcers typically present as multiple vesicles that rupture to form shallow ulcers, usually accompanied by systemic symptoms such as fever and malaise. The ulcers in HSV are not usually as irregular and deep as those seen in chancroid.</span></p><p>&nbsp;</p><p><span style=\"background-color:hsl(0,0%,100%);font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"background-color:hsl(0,0%,100%);font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-154247.jpg\" alt=\"\" width=\"750\" height=\"390\"></strong></span></p>",
      "correct_choice_id": 247667,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62105,
      "choices": [
        {
          "id": 247681,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Anencephaly</span></span></span></p>"
        },
        {
          "id": 247682,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Microcephaly</span></span></span></p>"
        },
        {
          "id": 247683,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Spina Bifida</span></span></span></p>"
        },
        {
          "id": 247684,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hydrocephalus</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old pregnant woman presents to the clinic with fever, rash, and conjunctivitis. She recently travelled to a tropical region known for mosquito-borne illnesses. The life cycle of infective agent is shown in the diagram. Which of the following congenital abnormalities is a major concern if the infection is transmitted transplacentally? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/22/screenshot-2024-10-22-122549.jpg\" style=\"height:383px; width:700px\" /></p>",
      "unique_key": "Q2474875",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.</span></strong><span style=\"font-size:14.0pt\"> <strong>B) Microcephaly</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Zika Virus&nbsp;</span></strong><span style=\"font-size:14.0pt\">is the agent shown in the lifecycle diagram, involving transmission between <strong>non-human primates</strong> and <strong>humans</strong> via <strong>Aedes spp. mosquitoes</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It has an <strong>enzootic cycle</strong> in primates and an <strong>urban cycle</strong> in humans. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">When a pregnant woman contracts the Zika virus, the infection can be transmitted transplacentally, potentially leading to <strong>microcephaly</strong> in the fetus. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Microcephaly</span></strong><span style=\"font-size:14.0pt\"> is characterized by an abnormally small head, resulting from impaired brain development, and may cause significant neurological deficits.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Anencephaly</span></strong><span style=\"font-size:14.0pt\">: This congenital abnormality involves the absence of major portions of the brain and skull but is not associated with Zika virus infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Spina Bifida</span></strong><span style=\"font-size:14.0pt\">: This neural tube defect involves incomplete closure of the spine and is related to folic acid deficiency during pregnancy, not Zika virus infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Hydrocephalus</span></strong><span style=\"font-size:14.0pt\">: This condition is characterized by an accumulation of cerebrospinal fluid in the brain but is not the primary concern in Zika infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Zika Virus</span></strong><span style=\"font-size:14.0pt\">, transmitted by <strong>Aedes mosquitoes</strong>, can cause <strong>microcephaly</strong> when transmitted to the fetus during pregnancy. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pregnant women should take precautions to avoid mosquito exposure in endemic areas to prevent this serious congenital complication.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247682,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62157,
      "choices": [
        {
          "id": 247889,
          "text": "<p><span style=\"font-size:14.0pt;\">Campylobacter jejuni</span></p>"
        },
        {
          "id": 247890,
          "text": "<p><span style=\"font-size:14.0pt;\">Salmonella enterica</span></p>"
        },
        {
          "id": 247891,
          "text": "<p><span style=\"font-size:14.0pt;\">Vibrio cholerae</span></p>"
        },
        {
          "id": 247892,
          "text": "<p><span style=\"font-size:14.0pt;\">Shigella flexneri</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 40-year-old farmer presents with gastroenteritis characterized by severe abdominal pain and diarrhea. Stool culture reveals a Gram-negative bacillus that does not ferment lactose, produces a streak of hydrogen sulphide (H₂S), and is oxidase negative. Which of the following organisms is the most likely cause of this infection?</span></p>",
      "unique_key": "Q5840299",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt;\"><strong>B)</strong> <strong>Salmonella enterica</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Based on the patient's presentation and stool culture findings, the most likely causative agent is Salmonella enterica.</span></li><li><span style=\"font-size:14.0pt;\">This organism is a Gram-negative bacillus that is known to cause gastroenteritis, often associated with poultry or animal exposure.</span></li><li><span style=\"font-size:14.0pt;\">It does not ferment lactose, produces H₂S, and is oxidase negative—characteristics that match Salmonella.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Campylobacter jejuni:&nbsp;</strong>This Gram-negative bacillus grows in a microaerophilic environment and prefers 42°C, but it is oxidase positive and comma-shaped, which does not match the characteristics provided.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Vibrio cholerae:&nbsp;</strong>Vibrio cholerae is a Gram-negative, comma-shaped, oxidase-positive organism that grows in alkaline media, primarily causing watery diarrhea (cholera), not typically bloody diarrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Shigella flexneri:&nbsp;</strong>Shigella is a Gram-negative bacillus that causes bloody diarrhea but is a non-lactose fermenter and does not produce H₂S, unlike Salmonella. Therefore, it does not match the complete description given.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-135738.jpg\" alt=\"\" width=\"992\" height=\"752\"></strong></span></p>",
      "correct_choice_id": 247890,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62359,
      "choices": [
        {
          "id": 248689,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A-4, B-3, C-1, D-2</span></span></span></p>"
        },
        {
          "id": 248690,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A-3, B-4, C-2, D-1</span></span></span></p>"
        },
        {
          "id": 248691,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A-1, B-3, C-4, D-2</span></span></span></p>"
        },
        {
          "id": 248692,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A-2, B-1, C-3, D-4</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following organisms with their appropriate transport media: </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/22/screenshot-2024-10-22-120850.png\" style=\"height:217px; width:1000px\" /></p>",
      "unique_key": "Q6233257",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.</span></strong><span style=\"font-size:14.0pt\"> <strong>A) A-4, B-3, C-1, D-2</strong></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Streptococcus</span></strong><span style=\"font-size:14.0pt\">: The appropriate transport medium is <strong>Pike&rsquo;s Medium</strong> (A-4). This medium is used for Streptococci to keep the sample viable until further testing.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Neisseria</span></strong><span style=\"font-size:14.0pt\">: <strong>Amies Medium</strong> or <strong>Stuart&#39;s Medium</strong> is used to transport <strong>Neisseria</strong> (B-3), especially because these organisms are highly susceptible to changes in temperature and must be kept viable for accurate culture.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Vibrio cholerae</span></strong><span style=\"font-size:14.0pt\">: <strong>VR Medium (Venkatraman-Ramakrishnan)</strong> and <strong>Cary Blair Medium</strong> are used to transport <strong>Vibrio cholerae</strong> (C-1). These media maintain the viability of Vibrio species, which are sensitive to environmental changes.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Shigella</span></strong><span style=\"font-size:14.0pt\">: <strong>Buffered glycerol saline</strong> or <strong>Cary Blair Medium</strong> are used to transport <strong>Shigella</strong> and <strong>Salmonella</strong> (D-2). These bacteria need to be kept in conditions that prevent overgrowth of other bacteria.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/22/screenshot-2024-10-22-120941.png\" style=\"height:273px; width:1000px\" /></p>",
      "correct_choice_id": 248689,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62366,
      "choices": [
        {
          "id": 248713,
          "text": "<p><span style=\"font-size:14.0pt;\">Imipenem</span></p>"
        },
        {
          "id": 248714,
          "text": "<p><span style=\"font-size:14.0pt;\">Meropenem</span></p>"
        },
        {
          "id": 248715,
          "text": "<p><span style=\"font-size:14.0pt;\">Ertapenem</span></p>"
        },
        {
          "id": 248716,
          "text": "<p><span style=\"font-size:14.0pt;\">Doripenem</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old male with a history of chronic renal insufficiency is admitted to the hospital with severe bacterial pneumonia. He is started on a carbapenem due to suspected multidrug-resistant organisms. Which of the following carbapenems carries the highest risk of seizures, particularly in patients with renal impairment?</span></p>",
      "unique_key": "Q1494998",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Imipenem</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Imipenem </strong>is a <strong>carbapenem</strong> that is associated with a <strong>higher risk of seizures</strong>, especially in patients with <strong>renal insufficiency</strong> or <strong>central nervous system (CNS) disorders</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The risk of seizures with imipenem is thought to be due to its ability to cross the <strong>blood-brain barrier</strong> and interact with <strong>GABA receptors</strong> in the CNS.</span></li><li><span style=\"font-size:14.0pt;\">This effect can be particularly pronounced in patients with <strong>impaired renal function</strong>, where <strong>drug accumulation</strong> can increase CNS exposure.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Meropenem</strong>: <strong>Meropenem</strong> has a lower risk of seizures compared to <strong>imipenem</strong>, making it a preferred option in patients with a history of <strong>seizures</strong> or <strong>CNS disorders</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Ertapenem</strong>: <strong>Ertapenem</strong> is less likely to cause seizures compared to <strong>imipenem</strong> and is generally well-tolerated, though it is less broad-spectrum in activity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Doripenem</strong>: <strong>Doripenem</strong> has a lower seizure risk compared to <strong>imipenem</strong>, with a safety profile similar to <strong>meropenem</strong> in terms of CNS effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Imipenem </strong>is associated with the <strong>highest risk of seizures</strong> among the <strong>carbapenems</strong>, particularly in patients with <strong>renal impairment</strong> or <strong>CNS disorders</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Meropenem </strong>and <strong>doripenem</strong> are preferred alternatives when there is concern about seizure risk.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Adjusting the dose </strong>in <strong>renal impairment</strong> is crucial when using <strong>imipenem</strong> to minimize the risk of <strong>CNS toxicity</strong>.</span></li></ul>",
      "correct_choice_id": 248713,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62076,
      "choices": [
        {
          "id": 247565,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">Collagen degradation exceeds synthesis</span></p>"
        },
        {
          "id": 247566,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">Granulation tissue is still present</span></p>"
        },
        {
          "id": 247567,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">Wound strength is 80% of normal tissue&nbsp;</span></p>"
        },
        {
          "id": 247568,
          "text": "<p><span style=\"font-size:14.0pt;\">Type IV collagen predominates</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old woman undergoes cesarean section to deliver a term infant, and the lower abdominal incision is sutured. The sutures are removed 1 week later. Which of the following statements best describes the wound site at the time of suture removal?</span></p>",
      "unique_key": "Q2420209",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Granulation tissue is still present</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">At 1 week, wound healing is incomplete, and granulation tissue is still present.</span></li><li><span style=\"font-size:14.0pt;\">More collagen is synthesized in the following weeks.</span></li><li><span style=\"font-size:14.0pt;\">Wound strength peaks at about 80% by 3 months.</span></li><li><span style=\"font-size:14.0pt;\">Type IV collagen is found in basement membranes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Collagen degradation exceeds synthesis:</strong> Incorrect. Collagen synthesis predominates at this stage, not degradation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Wound strength is 80% of normal tissue:</strong> Incorrect. At 1 week, wound strength is only around 10%, not 80%.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Type IV collagen predominates:</strong> Incorrect. Type III collagen, not type IV, predominates in the early stages of wound healing.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Granulation tissue is present in the proliferative phase of wound healing, typically seen around 1 week after injury.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Summary Timeline of Wound Healing:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_IPQwZb9.png\" width=\"1339\" height=\"397\"></span></p>",
      "correct_choice_id": 247566,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62404,
      "choices": [
        {
          "id": 248865,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Glasgow Coma Scale (GCS)</span></span></span></p>"
        },
        {
          "id": 248866,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Respiratory rate</span></span></span></p>"
        },
        {
          "id": 248867,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Systolic blood pressure</span></span></span></p>"
        },
        {
          "id": 248868,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pulse rate</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following components is not part of the Revised Trauma Score (RTS)? </span></span></p>",
      "unique_key": "Q2342242",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Pulse rate</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Pulse rate</span></strong><span style=\"font-size:14.0pt\"> is <em>not</em> part of the Revised Trauma Score.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Glasgow Coma Scale (GCS)</span></strong><span style=\"font-size:14.0pt\">: The GCS assesses eye-opening, verbal, and motor responses and is part of the RTS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Respiratory rate</span></strong><span style=\"font-size:14.0pt\">: This is another component of the RTS and contributes to the assessment of respiratory function.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Systolic blood pressure</span></strong><span style=\"font-size:14.0pt\">: This is included in the RTS to assess circulatory status.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The Revised Trauma Score (RTS) is a clinical tool used to assess trauma severity, incorporating the Glasgow Coma Scale, respiratory rate, and systolic blood pressure. </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248868,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62341,
      "choices": [
        {
          "id": 248617,
          "text": "<p><span style=\"font-size:14.0pt;\">Duodenum</span></p>"
        },
        {
          "id": 248618,
          "text": "<p><span style=\"font-size:14.0pt;\">Esophagus</span></p>"
        },
        {
          "id": 248619,
          "text": "<p><span style=\"font-size:14.0pt;\">Vagina</span></p>"
        },
        {
          "id": 248620,
          "text": "<p><span style=\"font-size:14.0pt;\">Urinary bladder</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In which of the following organs is the type of epithelium shown in the image found?</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/22/screenshot-2024-10-22-113817.png\" alt=\"\" width=\"300\" height=\"346\"></span></p>",
      "unique_key": "Q1623349",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Urinary bladder</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul><li><span style=\"font-size:14.0pt;\">The image shows <strong>transitional epithelium</strong> (also known as <strong>urothelium</strong>), which is characteristic of the <strong>urinary bladder</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Transitional epithelium</strong> is a specialized type of epithelium that can stretch and expand to accommodate fluctuating volumes of fluid, such as urine in the bladder.</span></li><li><span style=\"font-size:14.0pt;\">This epithelium has a distinctive appearance with multiple layers of cells.</span></li><li><span style=\"font-size:14.0pt;\">When the bladder is relaxed, the <strong>surface cells</strong> (dome-shaped or umbrella cells) appear rounded.</span></li><li><span style=\"font-size:14.0pt;\">When the bladder is distended with urine, these surface cells flatten out, allowing the bladder to stretch without tearing.</span></li></ul><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Duodenum</strong>: Incorrect. The <strong>duodenum</strong> is lined with <strong>simple columnar epithelium</strong> with numerous <strong>goblet cells</strong> for absorption and secretion. It does not exhibit the multilayered and dome-shaped surface cells seen in <strong>transitional epithelium</strong>.</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Esophagus</strong>: Incorrect. The <strong>esophagus</strong> is lined with <strong>stratified squamous non-keratinized epithelium</strong> to protect against mechanical stress during swallowing. It does not have the distensible properties of <strong>transitional epithelium</strong>.</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Vagina: </strong>Incorrect. The vagina is lined with <strong>stratified squamous non-keratinized epithelium,</strong> which is designed to withstand friction and mechanical stress during intercourse and childbirth. It does not have the elastic properties seen in transitional epithelium, which are essential for the urinary bladder.</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul><li><span style=\"font-size:14.0pt;\"><strong>Transitional epithelium </strong>(urothelium) is found in the <strong>urinary bladder</strong> and other parts of the <strong>urinary tract</strong>, such as the <strong>ureters</strong> and the <strong>proximal urethra</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is uniquely adapted to <strong>stretch</strong> and <strong>expand</strong> in response to varying volumes of urine, allowing the bladder to fill and empty without damage.</span></li></ul>",
      "correct_choice_id": 248620,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62135,
      "choices": [
        {
          "id": 247801,
          "text": "<p><span style=\"font-size:14.0pt;\">Naloxone should be used for long-term maintenance to prevent opioid relapse.</span></p>"
        },
        {
          "id": 247802,
          "text": "<p><span style=\"font-size:14.0pt;\">Naltrexone can decrease opioid cravings during the maintenance phase of recovery.</span></p>"
        },
        {
          "id": 247803,
          "text": "<p><span style=\"font-size:14.0pt;\">Naltrexone is effective in reducing alcohol cravings and preventing opioid relapse.</span></p>"
        },
        {
          "id": 247804,
          "text": "<p><span style=\"font-size:14.0pt;\">Naloxone is effective without the need for repeated dosing in acute opioid toxicity.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements is true regarding the use of naloxone and naltrexone in opioid management?</span></p>",
      "unique_key": "Q8088191",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Naltrexone is effective in reducing alcohol cravings and preventing opioid relapse.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Naltrexone</strong> is used as a <strong>maintenance therapy</strong> after acute opioid detoxification to <strong>prevent relapse</strong> by blocking the euphoric effects of opioids.</span></li><li><span style=\"font-size:14.0pt;\">It is also effective in <strong>reducing cravings in chronic alcohol use disorder</strong>, making it useful in the management of <strong>alcohol dependence</strong>.</span></li><li><span style=\"font-size:14.0pt;\">However, it does <strong>not decrease cravings for opioids</strong> themselves, which differentiates it from medications like <strong>buprenorphine</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Naloxone should be used for long-term maintenance to prevent opioid relapse</strong>: This is incorrect. <strong>Naloxone</strong> is used for <strong>acute opioid overdose</strong> due to its rapid onset of action. It has a <strong>short half-life</strong>, requiring repeated administration in cases of severe toxicity, making it unsuitable for long-term maintenance.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Naltrexone can decrease opioid cravings during the maintenance phase of recovery</strong>: This is incorrect. While <strong>naltrexone</strong> prevents the euphoric effects of opioids and thus helps to <strong>prevent relapse</strong>, it does <strong>not decrease the cravings for opioids</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Naloxone is effective without the need for repeated dosing in acute opioid toxicity</strong>: This is incorrect. Due to its <strong>short duration of action</strong>, <strong>naloxone</strong> often requires <strong>repeated dosing</strong> or a <strong>continuous infusion</strong> in cases of severe opioid toxicity, as the effects of the opioid may outlast those of naloxone.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Naloxone </strong>is used for <strong>acute opioid overdose</strong> but has a <strong>short half-life</strong>, necessitating <strong>frequent dosing</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Naltrexone </strong>is used for <strong>maintenance therapy</strong> to <strong>prevent opioid relapse</strong> and <strong>reduce cravings for alcohol</strong>, but <strong>it does not decrease opioid cravings</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Naltrexone </strong>blocks the euphoric effects of opioids, helping to <strong>prevent relapse</strong> in patients undergoing recovery.</span></li></ul>",
      "correct_choice_id": 247803,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62339,
      "choices": [
        {
          "id": 248609,
          "text": "<p><span style=\"font-size:14.0pt;\">Left common carotid artery</span></p>"
        },
        {
          "id": 248610,
          "text": "<p><span style=\"font-size:14.0pt;\">Intercostal vessels</span></p>"
        },
        {
          "id": 248611,
          "text": "<p><span style=\"font-size:14.0pt;\">Subclavian artery</span></p>"
        },
        {
          "id": 248612,
          "text": "<p><span style=\"font-size:14.0pt;\">Thoracic duct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 11-year-old boy is brought to the emergency department after falling from a height. He complains of severe pain on the right side of his chest. Examination reveals tenderness at the midaxillary line, and imaging shows a rib fracture with accumulation of blood in the pleural space, causing a hemothorax and atelectasis. Which of the following is the most likely source of bleeding in this patient?</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/22/screenshot-2024-10-22-113644.png\" alt=\"\" width=\"300\" height=\"252\"></span></p>",
      "unique_key": "Q1741720",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Intercostal vessels</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul><li><span style=\"font-size:14.0pt;\">The <strong>intercostal vessels </strong>run along the <strong>inferior margin</strong> of each rib in the <strong>intercostal spaces</strong>, making them vulnerable to injury when there is a <strong>rib fracture</strong>.</span></li><li><span style=\"font-size:14.0pt;\">In this case, the <strong>rib fracture at the midaxillary line</strong> likely caused damage to the intercostal arteries and veins, leading to bleeding into the pleural space and subsequent <strong>hemothorax</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>intercostal arteries</strong> branch off the <strong>thoracic aorta</strong>, while the intercostal veins drain into the <strong>azygos system</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Injury to these vessels can cause significant bleeding, particularly in the context of trauma such as a fall, leading to complications like <strong>hemothorax</strong> and <strong>atelectasis</strong>.</span></li></ul><p style=\"margin-left:48px;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Left common carotid artery</strong>: Incorrect. The <strong>left common carotid artery</strong> supplies the head and neck, originating from the <strong>aortic arch</strong>. It is not located near the ribs or pleural space and would not be affected by a rib fracture. Injury to this vessel would lead to neck or upper chest bleeding, not a <strong>hemothorax</strong> from rib trauma.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Subclavian artery</strong>: Incorrect. The <strong>subclavian artery</strong> is located above the first rib and beneath the clavicle. It supplies blood to the upper limbs and parts of the chest. While it can be injured in severe trauma, it is not directly related to rib fractures at the <strong>midaxillary line</strong>. Damage to the subclavian artery would cause bleeding in the upper chest or shoulder region rather than a hemothorax from a rib injury.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Thoracic duct</strong>: Incorrect. The <strong>thoracic duct</strong> is the main lymphatic channel in the body, draining lymph into the <strong>left subclavian vein</strong>. Injury to the thoracic duct can result in a <strong>chylothorax</strong> (accumulation of lymph in the pleural space), but it would not cause a <strong>hemothorax</strong>. It is also less likely to be injured from a rib fracture compared to the <strong>intercostal vessels</strong>.</span></p><p style=\"margin-left:48px;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul><li><span style=\"font-size:14.0pt;\"><strong>Intercostal vessels </strong>are a common source of bleeding in cases of <strong>rib fractures</strong>, as they run along the <strong>inferior margin of each rib</strong> and can be damaged by fractures.</span></li><li><span style=\"font-size:14.0pt;\">Injury to these vessels can lead to a <strong>hemothorax</strong>, which is the accumulation of blood in the <strong>pleural space</strong>, potentially causing <strong>atelectasis</strong> and difficulty breathing.</span></li></ul>",
      "correct_choice_id": 248610,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62155,
      "choices": [
        {
          "id": 247881,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BSL-1</span></span></p>"
        },
        {
          "id": 247882,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BSL-2</span></span></p>"
        },
        {
          "id": 247883,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BSL-3</span></span></p>"
        },
        {
          "id": 247884,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BSL-4</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A laboratory technician is working with a pathogen that poses a high risk of aerosol transmission and has the potential to cause serious or lethal disease. The laboratory must use a containment level with stringent safety measures, including a pass-through autoclave with bioseal in the laboratory room. Which Biosafety Level (BSL) is most appropriate for handling this pathogen?</span></span></p>",
      "unique_key": "Q8828307",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>C) BSL-3</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">BSL-3 is designated for working with pathogens that are either indigenous or exotic and that pose a potential for aerosol transmission. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">These agents can cause serious or potentially lethal diseases. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Safety measures at BSL-3 include high containment procedures, including a pass-through autoclave with a bioseal required in the laboratory room.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. BSL-1:</span></strong><span style=\"font-size:14.0pt\"> This level is used for working with agents that pose minimal potential hazards to personnel and the environment, typically involving no containment. Pathogens at this level are unlikely to cause disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. BSL-2:</span></strong><span style=\"font-size:14.0pt\"> BSL-2 is for agents that pose moderate hazards to personnel and the environment, such as Influenza or HIV. Containment at this level includes moderate-risk procedures but does not include the high containment measures necessary for aerosol-transmitted pathogens.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. BSL-4:</span></strong><span style=\"font-size:14.0pt\"> BSL-4 is the highest biosafety level, used for dangerous and exotic agents that pose a high risk of aerosol-transmitted infections and life-threatening diseases (e.g., Ebola virus). This level also requires stringent safety measures, including a pass-through autoclave, but it is meant for higher-risk pathogens than those handled at BSL-3.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-135707.jpg\" style=\"height:630px; width:1000px\" /></span></strong></span></span></p>",
      "correct_choice_id": 247883,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62395,
      "choices": [
        {
          "id": 248829,
          "text": "<p><span style=\"font-size:14.0pt;\">Amniocentesis for evaluation of fetal chromosomal anomalies</span></p>"
        },
        {
          "id": 248830,
          "text": "<p><span style=\"font-size:14.0pt;\">Pre-conceptional gene testing of an ova</span></p>"
        },
        {
          "id": 248831,
          "text": "<p><span style=\"font-size:14.0pt;\">Maternal serum for evaluation of fetal chromosomal abnormalities</span></p>"
        },
        {
          "id": 248832,
          "text": "<p><span style=\"font-size:14.0pt;\">Testing of maternal tissue</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following best describes Non-Invasive Prenatal Testing (NIPT)?</span></p>",
      "unique_key": "Q3438529",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Maternal serum for evaluation of fetal chromosomal abnormalities</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Non-Invasive Prenatal Testing (NIPT) </strong>involves analyzing <strong>cell-free fetal DNA (cffDNA)</strong> that circulates in the maternal bloodstream.</span></li><li><span style=\"font-size:14.0pt;\">This test can detect common <strong>chromosomal abnormalities</strong> such as <strong>Down syndrome (trisomy 21)</strong>, trisomy 18, trisomy 13, and sex chromosome anomalies.</span></li><li><span style=\"font-size:14.0pt;\">NIPT is performed by collecting a <strong>maternal blood sample</strong> and is non-invasive, posing no risk to the fetus.</span></li><li><span style=\"font-size:14.0pt;\">It can be offered as early as 10 weeks of pregnancy and is a highly accurate screening tool for detecting fetal chromosomal abnormalities.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Amniocentesis for evaluation of fetal chromosomal anomalies: </strong>Incorrect. <strong>Amniocentesis</strong> is an <strong>invasive</strong> procedure that involves extracting amniotic fluid for genetic testing. While it provides definitive information, it carries a risk of complications such as miscarriage and is not part of NIPT.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Pre-conceptional gene testing of an ova: </strong>Incorrect. <strong>Pre-conceptional gene testing</strong> refers to <strong>preimplantation genetic testing</strong> during in-vitro fertilization (IVF) cycles, not to prenatal testing like NIPT, which evaluates the fetus during pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Testing of maternal tissue: </strong>Incorrect. NIPT tests the <strong>cell-free fetal DNA (cffDNA)</strong> in the maternal bloodstream, not maternal tissue.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Non-Invasive Prenatal Testing (NIPT) </strong>is a highly accurate screening test for detecting <strong>fetal chromosomal abnormalities</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It analyzes cell-free fetal DNA from maternal blood and can screen for conditions like <strong>trisomy 21 (Down syndrome)</strong>, trisomy 18, and trisomy 13.</span></li><li><span style=\"font-size:14.0pt;\">It is a non-invasive method that poses no risk to the fetus and can be done as early as 10 weeks gestation.</span></li></ul>",
      "correct_choice_id": 248831,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62247,
      "choices": [
        {
          "id": 248245,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amitriptyline</span></span></p>"
        },
        {
          "id": 248246,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sertraline</span></span></p>"
        },
        {
          "id": 248247,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mirtazapine</span></span></p>"
        },
        {
          "id": 248248,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fluvoxamine</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 62-year-old patient with a history of angle-closure glaucoma presents with symptoms consistent with major depressive disorder. The clinician is considering starting the patient on antidepressant therapy. Which of the following drugs should be avoided in this patient?</span></span></p>",
      "unique_key": "Q4276730",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>A) Amitriptyline</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Amitriptyline&nbsp;</span></strong><span style=\"font-size:14.0pt\">is a <strong>tricyclic antidepressant (TCA)</strong> that has strong <strong>anticholinergic</strong> properties. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">TCAs have a high affinity for <strong>muscarinic receptors</strong>, leading to their blockade, which can impair the outflow of <strong>aqueous humor</strong> and <strong>increase intraocular pressure</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This effect can worsen <strong>angle-closure glaucoma</strong>, a condition characterized by reduced drainage of aqueous humor due to the angle between the cornea and iris being too narrow or blocked. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Therefore, amitriptyline should be avoided in patients with angle-closure glaucoma to prevent exacerbation of the condition.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Sertraline</strong>: Sertraline is a <strong>selective serotonin reuptake inhibitor (SSRI)</strong> that does not have significant anticholinergic activity and is generally safe for patients with glaucoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Mirtazapine</strong>: Mirtazapine is a tetracyclic antidepressant that has minimal anticholinergic effects, making it a safer choice for patients with angle-closure glaucoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Fluvoxamine</strong>: Fluvoxamine is another <strong>SSRI</strong> with negligible anticholinergic activity and can be used safely in patients with glaucoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Amitriptyline</span></strong><span style=\"font-size:14.0pt\">, a <strong>tricyclic antidepressant (TCA)</strong>, should be avoided in patients with <strong>angle-closure glaucoma</strong> due to its <strong>anticholinergic</strong> effects, which can further impede the outflow of aqueous humor and raise intraocular pressure. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">When treating depression in patients with glaucoma, medications with minimal or no anticholinergic effects, such as <strong>SSRIs</strong>, are generally preferred to avoid worsening of glaucoma.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248245,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62398,
      "choices": [
        {
          "id": 248841,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute pyelonephritis</span></p>"
        },
        {
          "id": 248842,
          "text": "<p><span style=\"font-size:14.0pt;\">Glomerulonephritis</span></p>"
        },
        {
          "id": 248843,
          "text": "<p><span style=\"font-size:14.0pt;\">Renal calculus</span></p>"
        },
        {
          "id": 248844,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute cystitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old pregnant woman in her second trimester presents with sudden onset of severe left flank pain and visible blood in her urine. She has no prior history of renal disease or urinary tract infections. On examination, she appears uncomfortable but afebrile, and her vital signs are stable. What is the most likely diagnosis?</span></p>",
      "unique_key": "Q2361021",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Renal calculus</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Renal calculi (kidney stones)</strong> are more likely during pregnancy due to physiological changes such as increased urinary calcium excretion and urinary stasis.</span></li><li><span style=\"font-size:14.0pt;\">The classic presentation includes <strong>sudden-onset flank pain</strong>, hematuria, and possibly nausea or vomiting.</span></li><li><span style=\"font-size:14.0pt;\">The absence of fever and normal vital signs rule out conditions like pyelonephritis.</span></li><li><span style=\"font-size:14.0pt;\">The second trimester is a common time for kidney stones to present due to the dilation of the renal pelvis and ureters, which predisposes to stone formation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Acute pyelonephritis: </strong>Incorrect. <strong>Acute pyelonephritis</strong> typically presents with <strong>fever, chills, and flank pain</strong> along with signs of systemic infection, which are absent in this case. Hematuria is less common in pyelonephritis than in renal calculi.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Glomerulonephritis: </strong>Incorrect. <strong>Glomerulonephritis</strong> typically presents with hematuria but is usually associated with <strong>hypertension, proteinuria, and edema</strong>, none of which are present in this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Acute cystitis: </strong>Incorrect. <strong>Acute cystitis</strong> usually presents with <strong>dysuria, urgency, and frequency</strong>, without the severe flank pain described here. Hematuria can be present, but the key distinguishing feature is the flank pain, which suggests involvement of the upper urinary tract (e.g., renal calculi).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">In a pregnant woman presenting with <strong>sudden-onset flank pain and hematuria</strong>, <strong>renal calculi</strong> (kidney stones) should be highly suspected, particularly in the second trimester.</span></li><li><span style=\"font-size:14.0pt;\">Hematuria, along with severe flank pain, is a classic presentation of nephrolithiasis, and pregnancy predisposes to stone formation due to urinary stasis and increased calcium excretion.</span></li></ul>",
      "correct_choice_id": 248843,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62236,
      "choices": [
        {
          "id": 248201,
          "text": "<p><span style=\"font-size:14.0pt;\">Benign enlargement of the&nbsp;prostate</span></p>"
        },
        {
          "id": 248202,
          "text": "<p><span style=\"font-size:14.0pt;\">Rectal cancer</span></p>"
        },
        {
          "id": 248203,
          "text": "<p><span style=\"font-size:14.0pt;\">Meningomyelocele</span></p>"
        },
        {
          "id": 248204,
          "text": "<p><span style=\"font-size:14.0pt;\">Uterine prolapse</span></p>"
        }
      ],
      "text": "<p><span style=\"background-color:hsl(0,0%,100%);font-size:14.0pt;\">The procedure shown in the image is done for which of the below mentioned condition.&nbsp;</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-160935.jpg\" alt=\"\" width=\"400\" height=\"302\"></p>",
      "unique_key": "Q9723378",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Rectal cancer</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Image shows trans-anal local excision that is typically reserved for early-stage rectal cancers, specifically for tumors that are:</span><ul><li><span style=\"font-size:14.0pt;\">Small (&lt;3 cm)</span></li><li><span style=\"font-size:14.0pt;\">Well- to moderately-differentiated</span></li><li><span style=\"font-size:14.0pt;\">Within 8 cm of the anal verge</span></li><li><span style=\"font-size:14.0pt;\">Limited to &lt;30% of the rectal circumference</span></li><li><span style=\"font-size:14.0pt;\">Without lymph node involvement</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt;\"><strong>Benign enlargement of the&nbsp;prostate: </strong>TURP is done for enlargement of the&nbsp;prostate</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Meningomyelocele:&nbsp;</strong>Meningomyelocele requires open surgical repair</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Uterine prolapse:&nbsp;</strong>Uterine prolapse repair is done vaginally/transabdominally.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Transanal local excision is suitable for small, early-stage rectal tumors (T1, N0) that are well-differentiated and confined without lymph node involvement.</span></li><li><span style=\"font-size:14.0pt;\">More advanced tumors (T2 with lymph node involvement) require more extensive surgical approaches, such as transabdominal resection.</span></li></ul>",
      "correct_choice_id": 248202,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62211,
      "choices": [
        {
          "id": 248101,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Strengthen community action</span></span></p>"
        },
        {
          "id": 248102,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Develop personal skills</span></span></p>"
        },
        {
          "id": 248103,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ensure equitable healthcare financing</span></span></p>"
        },
        {
          "id": 248104,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Create supportive environments</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Ottawa Charter for Health Promotion outlines key strategies to improve global health. Which of the following is not the action areas identified in the Ottawa Charter? </span></span></p>",
      "unique_key": "Q6208093",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Ensure equitable healthcare financing</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ensure equitable healthcare financing is not explicitly listed as one of the five action areas in the Ottawa Charter, although equitable financing is an important aspect of overall health system reforms. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The Ottawa Charter focuses more on community action, skills development, supportive environments, and policy reorientation.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The Ottawa Charter for Health Promotion was established in 1986 and outlines five key action areas for health promotion:</span></span></span></li>\r\n</ul>\r\n\r\n<ol style=\"margin-left:40px\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Strengthen community action</span></strong><span style=\"font-size:14.0pt\">: Empowering communities to take control over their health by supporting community-based initiatives.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Develop personal skills</span></strong><span style=\"font-size:14.0pt\">: Providing individuals with information and education to make healthy choices and improve their well-being.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Create supportive environments</span></strong><span style=\"font-size:14.0pt\">: Promoting physical and social environments that support health.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Build healthy public policy</span></strong><span style=\"font-size:14.0pt\">: Integrating health considerations into public policies across sectors.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Reorient health services</span></strong><span style=\"font-size:14.0pt\">: Shifting healthcare focus from treatment to prevention and promoting equity in health.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-174845.jpg\" style=\"height:521px; width:571px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The Ottawa Charter for Health Promotion emphasizes community involvement, individual empowerment, and supportive environments as key strategies to enhance global health. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">While equitable healthcare financing is important, it is not one of the core action areas specifically defined by the charter.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248103,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62179,
      "choices": [
        {
          "id": 247977,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 4</span></p>"
        },
        {
          "id": 247978,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 4</span></p>"
        },
        {
          "id": 247979,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3 and 4</span></p>"
        },
        {
          "id": 247980,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3 and 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 3-year-old child with autoimmune disease is about to begin long-term steroid therapy. The pediatrician reviews the child's vaccination status and makes recommendations regarding which vaccines should be administered or avoided. Which of the following statements is/are accurate in this situation?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Continue routine vaccinations as per the immunization schedule.</span></li><li><span style=\"font-size:14.0pt;\">Administer the pneumococcal vaccine according to the standard schedule.</span></li><li><span style=\"font-size:14.0pt;\">Only inactivated vaccines should be used during steroid therapy.</span></li><li><span style=\"font-size:14.0pt;\">Oral polio vaccine (OPV) should not be given to the child’s siblings.</span></li></ol>",
      "unique_key": "Q4870225",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;C) 2, 3, 4</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">In the case of a child with an autoimmune disease who will receive steroid therapy, certain vaccination guidelines need to be followed:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2. Pneumococcal Vaccine</strong>: This vaccine is particularly important for immunocompromised children to protect against pneumococcal infections, which they are at a higher risk for.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3. Inactivated Vaccines</strong>: During steroid therapy, live vaccines (like MMR and OPV) are generally avoided due to the weakened immune response. Only killed or inactivated vaccines should be used.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4. Avoiding OPV for Siblings</strong>: OPV is a live attenuated vaccine, which poses a risk of vaccine-derived transmission to immunocompromised individuals. Therefore, it is recommended to avoid OPV for siblings when a child in the household is immunocompromised.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option</strong>:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>Continue routine vaccinations as per the immunization schedule:&nbsp;</strong>Routine vaccination schedules cannot be continued without modification for children on long-term steroids because <strong>live vaccines</strong> are contraindicated.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Children on long-term steroid therapy should receive inactivated vaccines only, such as the pneumococcal vaccine.</span></li><li><span style=\"font-size:14.0pt;\">Live vaccines like the oral polio vaccine (OPV) should be avoided in both the patient and close contacts (e.g., siblings) due to the risk of transmission.</span></li></ul>",
      "correct_choice_id": 247979,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62181,
      "choices": [
        {
          "id": 247985,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is a screening test for cervical cancer.</span></span></span></p>"
        },
        {
          "id": 247986,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is a diagnostic test for cervical cancer.</span></span></span></p>"
        },
        {
          "id": 247987,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is a screening tool for all types of genital tract cancers.</span></span></span></p>"
        },
        {
          "id": 247988,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is a diagnostic test for vaginal infections.</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old woman presents to the clinic with a history of abnormal vaginal discharge. During the visit, the physician recommends a Pap smear as part of her routine care. The patient is curious and asks about the purpose of this test. Which of the following is the most accurate description of the Pap smear? </span></span></p>",
      "unique_key": "Q1543270",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans</span></strong><span style=\"font-size:14.0pt\">. <strong>A) It is a screening test for cervical cancer.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A Pap smear (Papanicolaou test) is used primarily as a screening tool to detect precancerous changes and early-stage cervical cancer. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It involves collecting cells from the cervix to check for abnormal cells that could indicate cervical dysplasia or cervical cancer. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">While it can sometimes incidentally detect infections like Trichomoniasis, its primary purpose is cervical cancer screening.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options</span></strong><span style=\"font-size:14.0pt\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. It is a diagnostic test for cervical cancer</span></strong><span style=\"font-size:14.0pt\">: Incorrect. A Pap smear is a screening test, not a diagnostic one. If abnormalities are found, further diagnostic procedures like colposcopy and biopsy are needed to confirm cervical cancer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. It is a screening tool for all types of genital tract cancers</span></strong><span style=\"font-size:14.0pt\">: Incorrect. The Pap smear specifically screens for cervical cancer and precancerous changes in the cervix, not other types of genital tract cancers like ovarian or endometrial cancer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. It is a diagnostic test for vaginal infections</span></strong><span style=\"font-size:14.0pt\">: Incorrect. While the Pap smear may incidentally detect vaginal infections like Trichomoniasis, it is not designed as a diagnostic test for infections. It is primarily used for cervical cancer screening.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective</span></strong><span style=\"font-size:14.0pt\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A Pap smear is primarily a screening test for cervical cancer. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It helps detect precancerous changes and early-stage cervical cancer. It is not a diagnostic test for infections or for other gynecological cancers.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247985,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62378,
      "choices": [
        {
          "id": 248761,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Disulfiram</span></span></span></p>"
        },
        {
          "id": 248762,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Naltrexone</span></span></span></p>"
        },
        {
          "id": 248763,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Acamprosate</span></span></span></p>"
        },
        {
          "id": 248764,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Topiramate</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman with a history of alcohol use disorder wants to stop drinking. She has had multiple failed attempts in the past. What is the most appropriate pharmacological treatment to prevent relapse? </span></span></p>",
      "unique_key": "Q7511018",
      "difficulty_level": "intermediate",
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Ans. B) Naltrexone</span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Naltrexone</span></strong><span style=\"font-size:14.0pt\"> is an opioid receptor antagonist that helps reduce cravings and the rewarding effects of alcohol, making it a suitable choice for preventing relapse in individuals with alcohol use disorder. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is particularly helpful for patients who continue to experience cravings.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Disulfiram:</span></strong><span style=\"font-size:14.0pt\"> Disulfiram works by inhibiting aldehyde dehydrogenase, leading to unpleasant symptoms (e.g., nausea, flushing) when alcohol is consumed. It is best suited for patients who are highly motivated to abstain because it relies on the patient&rsquo;s willingness to adhere to the treatment and avoid alcohol. It is less effective in preventing relapse in those with a history of multiple failed attempts.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Acamprosate:</span></strong><span style=\"font-size:14.0pt\"> Acamprosate helps with maintaining abstinence by modulating glutamatergic neurotransmission, reducing post-acute withdrawal symptoms like anxiety and insomnia. It is most effective when started after achieving abstinence but is less effective than naltrexone in reducing cravings during the initial period of recovery.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Topiramate:</span></strong><span style=\"font-size:14.0pt\"> Topiramate is sometimes used off-label for alcohol use disorder to reduce cravings, but it is not as well established as naltrexone or acamprosate. It is not considered a first-line pharmacological option for preventing relapse.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Naltrexone is the preferred pharmacological treatment for preventing relapse in alcohol use disorder due to its ability to reduce cravings and the rewarding effects of alcohol.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248762,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62206,
      "choices": [
        {
          "id": 248081,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Continue lithium at the current dose</span></span></p>"
        },
        {
          "id": 248082,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase lithium dose preoperatively</span></span></p>"
        },
        {
          "id": 248083,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Discontinue lithium 48-72 hours before surgery</span></span></p>"
        },
        {
          "id": 248084,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Switch to valproic acid before surgery</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 40-year-old man with bipolar disorder is stable on lithium. He is scheduled for surgery next week. What is the most appropriate recommendation regarding his lithium?</span></span></p>",
      "unique_key": "Q9378379",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Discontinue lithium 48-72 hours before surgery</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Lithium should typically be <strong>stopped 48-72 hours before major surgery</strong> due to the <strong>risk of lithium toxicity</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">During surgery, there is a potential for fluctuations in fluid and electrolyte levels, which can affect lithium clearance and increase the risk of toxicity. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Additionally, anesthesia can impair renal function, further complicating lithium management. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Discontinuing lithium temporarily and restarting it after surgery is usually the safest approach.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Continue lithium at the current dose:</span></strong><span style=\"font-size:14.0pt\"> Continuing lithium during surgery is not advisable due to the risk of renal impairment, dehydration, and potential lithium toxicity caused by altered kidney function and fluid shifts during and after the procedure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Increase lithium dose preoperatively:</span></strong><span style=\"font-size:14.0pt\"> Increasing the lithium dose would increase the risk of toxicity, especially given the renal and fluid challenges during surgery. This approach is not recommended.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Switch to valproic acid before surgery:</span></strong><span style=\"font-size:14.0pt\"> Switching to another mood stabilizer like valproic acid is not typically necessary just for the surgical period. Temporary discontinuation of lithium is a simpler and safer option.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Lithium should be temporarily discontinued 48-72 hours before major surgery to reduce the risk of toxicity due to changes in renal function and fluid balance.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248083,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62243,
      "choices": [
        {
          "id": 248229,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Galactosidase deficiency</span></span></span></p>"
        },
        {
          "id": 248230,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Urea cycle defect</span></span></span></p>"
        },
        {
          "id": 248231,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Galactose-1-phosphate uridyltransferase deficiency</span></span></span></p>"
        },
        {
          "id": 248232,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Glucose-6-phosphatase deficiency</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 10-day-old newborn is brought to the emergency department by his parents due to persistent jaundice, lethargy, and poor feeding &amp; hypoglycemia. The parents report that the infant&#39;s stool has become pale, and they have noticed dark yellow urine stains on his diaper. Opthalmology reference was done which revealed the formation of cataract. The infant was started on antibiotics for presumed sepsis 2 days ago but has not improved. Laboratory tests reveal conjugated hyperbilirubinemia, elevated liver enzymes, and a positive reducing substances test in the urine. Which of the following is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q6935686",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Galactose-1-phosphate uridyltransferase deficiency</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The presentation of conjugated hyperbilirubinemia with a history of sepsis in a newborn, along with pale stools, jaundice, and dark urine, suggests a diagnosis of galactosemia. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The most common type is due to a deficiency in the enzyme galactose-1-phosphate uridyltransferase. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This enzyme deficiency prevents the proper metabolism of galactose, leading to toxic accumulation of galactose-1-phosphate in various organs.</span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Galactosemia&nbsp;</span></strong><span style=\"font-size:14.0pt\">is an autosomal recessive disorder characterized by an inability to convert galactose into glucose. Symptoms often present early in life when infants are exposed to milk, which contains lactose (comprising glucose and galactose).</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Without this enzyme, the infant accumulates galactose-1-phosphate, leading to liver damage, kidney dysfunction, and brain involvement.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">These infants are also at high risk for E. coli sepsis.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Treatment involves the immediate elimination of lactose from the diet and the use of soy-based or lactose-free formulas.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Galactosidase deficiency:</span></strong><span style=\"font-size:14.0pt\"> It is not a specific term. The enzyme deficiency in classical galactosemia is galactose-1-phosphate uridyltransferase, not a general galactosidase.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Urea cycle defect:</span></strong><span style=\"font-size:14.0pt\"> This would more likely present with hyperammonemia, vomiting, and neurologic symptoms (such as seizures), but not conjugated hyperbilirubinemia or jaundice.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Glucose-6-phosphatase deficiency:</span></strong><span style=\"font-size:14.0pt\"> This (von Gierke disease) presents with hypoglycemia, lactic acidosis, hyperuricemia, and hepatomegaly, but it is not associated with jaundice or sepsis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Galactosemia, caused by a deficiency in galactose-1-phosphate uridyltransferase, presents in neonates with jaundice, hepatomegaly, and sepsis, particularly with E. coli. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Early recognition and dietary management with lactose-free formula are essential to prevent long-term complications and improve outcomes.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248231,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62154,
      "choices": [
        {
          "id": 247877,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Aromatase inhibitor</span></span></span></p>"
        },
        {
          "id": 247878,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">5 alpha reductase inhibitor</span></span></span></p>"
        },
        {
          "id": 247879,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Phosphodiesterase 5 inhibitor</span></span></span></p>"
        },
        {
          "id": 247880,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Selective Estrogen Receptor Modulator (SERM)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old male with a history of hypertension presents to the clinic with complaints of erectile dysfunction. His physician prescribes a medication that works by enhancing the effect of nitric oxide through the inhibition of a specific enzyme, leading to increased levels of cyclic GMP and smooth muscle relaxation in the corpus cavernosum. Which of the following is the mechanism of action of this drug? </span></span></p>",
      "unique_key": "Q2807501",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Phosphodiesterase 5 inhibitor</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Sildenafil&nbsp;</span></strong><span style=\"font-size:14.0pt\">is a <strong>phosphodiesterase 5 (PDE5) inhibitor</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It works by <strong>inhibiting the enzyme PDE5</strong>, which normally breaks down <strong>cyclic GMP (cGMP)</strong> in the corpus cavernosum. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">By inhibiting PDE5, sildenafil allows for <strong>increased levels of cGMP</strong>, leading to <strong>smooth muscle relaxation</strong> and <strong>enhanced blood flow</strong> to the penis, thereby facilitating <strong>erection</strong> during sexual stimulation.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Aromatase inhibitor</span></strong><span style=\"font-size:14.0pt\">: This class of drugs inhibits the enzyme <strong>aromatase</strong>, which converts androgens into estrogens. Aromatase inhibitors are typically used in the treatment of <strong>hormone receptor-positive breast cancer</strong> in <strong>postmenopausal women</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. 5 alpha reductase inhibitor</span></strong><span style=\"font-size:14.0pt\">: These drugs, such as <strong>finasteride</strong> and <strong>dutasteride</strong>, inhibit <strong>5 alpha reductase</strong>, an enzyme that converts <strong>testosterone</strong> to <strong>dihydrotestosterone (DHT)</strong>. They are used in the management of <strong>benign prostatic hyperplasia (BPH)</strong> and <strong>androgenic alopecia</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Selective Estrogen Receptor Modulator (SERM)</span></strong><span style=\"font-size:14.0pt\">: <strong>SERMs</strong> (e.g., tamoxifen) are compounds that act as <strong>estrogen receptor agonists</strong> or <strong>antagonists</strong> depending on the tissue. They are primarily used in <strong>breast cancer treatment</strong> and <strong>osteoporosis prevention</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Sildenafil&nbsp;</span></strong><span style=\"font-size:14.0pt\">is a <strong>PDE5 inhibitor</strong> that enhances <strong>cGMP</strong> levels, leading to <strong>smooth muscle relaxation</strong> and <strong>improved blood flow</strong> in the treatment of <strong>erectile dysfunction</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Aromatase inhibitors&nbsp;</span></strong><span style=\"font-size:14.0pt\">and <strong>5 alpha reductase inhibitors</strong> are used in <strong>hormone-related conditions</strong>, but they do not directly affect <strong>cGMP levels</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">SERMs&nbsp;</span></strong><span style=\"font-size:14.0pt\">act on <strong>estrogen receptors</strong> and are unrelated to the mechanism of action of <strong>sildenafil</strong>.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247879,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62188,
      "choices": [
        {
          "id": 248013,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dilatation and curettage</span></span></p>"
        },
        {
          "id": 248014,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Extra-amniotic instillation of ethacridine lactate</span></span></p>"
        },
        {
          "id": 248015,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mifepristone + misoprostol</span></span></p>"
        },
        {
          "id": 248016,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Manual vacuum aspiration</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 24-year-old woman at 8 weeks gestation presents to the clinic seeking medical termination of pregnancy. You review the options for first-trimester abortion with her. Which of the following methods is not used for medical termination in the first trimester? </span></span></p>",
      "unique_key": "Q9490478",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Extra-amniotic instillation of ethacridine lactate</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Extra-amniotic instillation of ethacridine lactate</span></strong><span style=\"font-size:14.0pt\"> is used for second-trimester abortions, typically beyond 12-14 weeks gestation. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is not used for <strong>first-trimester</strong> medical terminations. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ethacridine lactate works by inducing labor, but because the amniotic cavity is too small to allow for this method in the first trimester, it is not appropriate for early pregnancy termination.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Dilatation and curettage:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Incorrect. <strong>Dilatation and curettage (D&amp;C)</strong> is a surgical method that can be used for pregnancy termination in the <strong>first trimester</strong>, particularly before 13 weeks.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Mifepristone + misoprostol:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Incorrect. This combination is the standard regimen for <strong>medical termination of pregnancy</strong> in the <strong>first trimester</strong>. <strong>Mifepristone</strong> blocks progesterone receptors, and <strong>misoprostol</strong> induces uterine contractions to expel the pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Manual vacuum aspiration:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Incorrect. <strong>Manual vacuum aspiration (MVA)</strong> is a safe and effective method for <strong>first-trimester abortion</strong>, commonly performed up to 12-14 weeks gestation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Extra-amniotic instillation of ethacridine lactate&nbsp;</span></strong><span style=\"font-size:14.0pt\">is not used for <strong>first-trimester medical termination of pregnancy</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is primarily used for second-trimester abortions, while first-trimester options include <strong>mifepristone + misoprostol</strong>, <strong>manual vacuum aspiration</strong>, and <strong>dilatation and curettage</strong>.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248014,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62348,
      "choices": [
        {
          "id": 248645,
          "text": "<p><span style=\"font-size:14.0pt;\">Competitive</span></p>"
        },
        {
          "id": 248646,
          "text": "<p><span style=\"font-size:14.0pt;\">Feedback</span></p>"
        },
        {
          "id": 248647,
          "text": "<p><span style=\"font-size:14.0pt;\">Irreversible</span></p>"
        },
        {
          "id": 248648,
          "text": "<p><span style=\"font-size:14.0pt;\">Noncompetitive</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In cases of ethylene glycol poisoning and its characteristic metabolic acidosis, treatment involves correction of the acidosis, removal of any remaining ethylene glycol, and administration of an inhibitor of alcohol dehydrogenase (ADH), the enzyme that oxidizes ethylene glycol to the organic acids that cause the acidosis. Ethanol frequently is the inhibitor given to treat ethylene glycol poisoning. Results of experiments using ADH with and without ethanol are shown to the right. Based on these data, what type of inhibition is caused by the ethanol?</span></p><p>&nbsp;</p><figure class=\"image\"><img style=\"aspect-ratio:1422/457;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_I2krhmr.png\" width=\"1422\" height=\"457\"></figure>",
      "unique_key": "Q4781117",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Competitive</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">A competitive inhibitor increases the apparent Km for a given substrate.</span></li><li><span style=\"font-size:14.0pt;\">This means that, in the presence of a competitive inhibitor, more substrate is needed to achieve one half Vmax.</span></li><li><span style=\"font-size:14.0pt;\">The effect of a competitive inhibitor is reversed by increasing substrate concentration ([S]).</span></li><li><span style=\"font-size:14.0pt;\">At a sufficiently high [S], the reaction velocity reaches the Vmax observed in the absence of inhibitor.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Feedback:</strong> Feedback inhibition occurs when the product of a reaction inhibits the enzyme that helped produce it, usually as part of a regulatory pathway. Ethanol is not a product of the reaction catalyzed by alcohol dehydrogenase; instead, it acts as a competitive inhibitor. Therefore, feedback inhibition does not apply in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Irreversible:</strong> Irreversible inhibition occurs when an inhibitor forms a permanent bond with the enzyme, completely inactivating it. In this case, the data shows that increasing the substrate concentration increases the reaction rate, indicating that the inhibition by ethanol can be overcome. This suggests that the inhibition is reversible, not irreversible.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Noncompetitive:</strong> Noncompetitive inhibition occurs when an inhibitor binds to an enzyme at a site other than the active site, reducing the enzyme's activity regardless of substrate concentration. If ethanol were acting as a noncompetitive inhibitor, the reaction rate would not increase significantly with increasing substrate concentration, as the inhibition would not depend on substrate competition. However, in the data provided, increasing the substrate concentration increases the reaction rate, which is inconsistent with noncompetitive inhibition.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Ethanol acts as a <i>competitive inhibitor</i> of alcohol dehydrogenase, competing with the substrate (such as ethylene glycol) for the enzyme's active site.</span></li><li><span style=\"font-size:14.0pt;\">Competitive inhibition can be overcome by increasing the substrate concentration, which increases the rate of the enzymatic reaction.</span></li></ul>",
      "correct_choice_id": 248645,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62374,
      "choices": [
        {
          "id": 248745,
          "text": "<p><span style=\"font-size:14.0pt;\">Defective bicarbonate reabsorption in the proximal tubule</span></p>"
        },
        {
          "id": 248746,
          "text": "<p><span style=\"font-size:14.0pt;\">Impaired hydrogen ion secretion in the distal tubule</span></p>"
        },
        {
          "id": 248747,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased chloride reabsorption in the collecting duct</span></p>"
        },
        {
          "id": 248748,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased ammonium excretion in the proximal tubule</span></p>"
        }
      ],
      "text": "<p><span style=\"background-color:hsl(0,0%,100%);font-size:14.0pt;\">A 52-year-old woman with a known history of Sjogren’s syndrome presents with fatigue, muscle weakness and recurrent loin pain;</span><span style=\"background-color:hsl(0,0%,100%);font-size:11.0pt;\">&nbsp;</span><span style=\"background-color:hsl(0,0%,100%);font-size:14.0pt;\">lab finding shows: S. Na – 136 mEq/L, S. K&nbsp; - 3.2 mEq/L, S. HCO3 16 mEq/L, S. Cl – 112 mEq/L. Her X-ray of the abdomen is shown below. Which of the following is the likely mechanism responsible for this presentation?</span></p><p><span style=\"background-color:hsl(0,0%,100%);font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"background-color:hsl(0,0%,100%);font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/22/screenshot-2024-10-22-122209.png\" alt=\"\" width=\"300\" height=\"359\"></span></p>",
      "unique_key": "Q3891757",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Impaired hydrogen ion secretion in the distal tubule</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient presents with <strong>Renal Tubular Acidosis (RTA) Type 1</strong>, which is also known as <strong>distal RTA</strong>. Type 1 RTA is characterized by an inability of the <strong>distal tubules</strong> to secrete hydrogen ions effectively, resulting in a persistently high urine pH (&gt;5.5) and a <strong>non-anion gap metabolic acidosis</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Sjogren’s syndrome is an autoimmune condition frequently associated with distal RTA due to autoimmune destruction of the intercalated cells in the distal tubules, leading to impaired hydrogen ion excretion.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This causes systemic acidosis, hypokalemia, and an increased risk of calcium phosphate kidney stones due to the alkaline urine.</span></li></ul><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Defective bicarbonate reabsorption in the proximal tubule:</strong> This describes <strong>RTA Type 2</strong> (proximal RTA), which results from impaired bicarbonate reabsorption. However, in RTA Type 2, urine pH can become low (&lt;5.5) after significant bicarbonate loss, unlike the persistently alkaline urine seen in distal RTA.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Increased chloride reabsorption in the collecting duct:</strong> This mechanism is not involved in RTA. Increased chloride reabsorption may be relevant to conditions like hyperchloremic metabolic acidosis but does not explain the underlying issue in this case.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Increased ammonium excretion in the proximal tubule:</strong> Ammonium excretion is not impaired in distal RTA, and increased ammonium excretion would actually help compensate for acidosis, which is not the mechanism at play here.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>RTA Type 1 (distal RTA)</strong> is commonly associated with <strong>Sjogren’s syndrome</strong> and involves impaired hydrogen ion secretion in the distal tubules, leading to metabolic acidosis with a persistently high urine pH, hypokalemia, and an increased risk of kidney stones.</span></li></ul>",
      "correct_choice_id": 248746,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62221,
      "choices": [
        {
          "id": 248141,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Student&rsquo;s paired &lsquo;t&rsquo; test</span></span></p>"
        },
        {
          "id": 248142,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Student&rsquo;s unpaired &lsquo;t&rsquo; test</span></span></p>"
        },
        {
          "id": 248143,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chi-square test</span></span></p>"
        },
        {
          "id": 248144,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wilcoxon&rsquo;s signed rank test</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A research team is investigating whether obesity is a significant risk factor for breast cancer. They want to determine if there is an association between categorical variables: obesity (present or absent) and breast cancer occurrence (present or absent). Which of the following statistical tests would be the most appropriate for this analysis?</span></span></p>",
      "unique_key": "Q9840625",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Chi-square test</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The <strong>Chi-square test</strong> is the most appropriate test in this scenario. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This test is used to examine the association between two <strong>categorical variables</strong>&mdash;in this case, <strong>obesity</strong> (present/absent) and <strong>breast cancer occurrence</strong> (present/absent). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It helps determine whether there is a statistically significant relationship between obesity and breast cancer.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Student&rsquo;s paired &#39;t&#39; test:</span></strong><span style=\"font-size:14.0pt\"> This test compares the means of two related groups (e.g., pre-treatment and post-treatment in the same group of patients). It is not applicable when comparing categorical variables like obesity and breast cancer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Student&rsquo;s unpaired &#39;t&#39; test:</span></strong><span style=\"font-size:14.0pt\"> This test compares the means of two independent groups (e.g., mean weight in obese vs. non-obese individuals). It is used for <strong>continuous data</strong> and not for categorical variables.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Wilcoxon&rsquo;s signed rank test:</span></strong><span style=\"font-size:14.0pt\"> This is a non-parametric test used to compare two related groups when the data is not normally distributed. It is more suited for ordinal or continuous data, not categorical comparisons like obesity and breast cancer occurrence.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The <strong>Chi-square test</strong> is used to assess associations between two categorical variables, making it ideal for determining whether <strong>obesity</strong> is a significant risk factor for <strong>breast cancer</strong>.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248143,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62167,
      "choices": [
        {
          "id": 247929,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aspirin</span></span></p>"
        },
        {
          "id": 247930,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clopidogrel</span></span></p>"
        },
        {
          "id": 247931,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Abciximab</span></span></p>"
        },
        {
          "id": 247932,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of these</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Based on the mechanism shown in the below image, which of the following drugs most likely corresponds to Drug C? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-135824.jpg\" style=\"height:320px; width:400px\" /></p>",
      "unique_key": "Q7672304",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">B) Clopidogrel</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Clopidogrel&nbsp;</span></strong><span style=\"font-size:14.0pt\">is an <strong>ADP receptor inhibitor</strong> that specifically targets the <strong>P2Y12 receptor</strong> on platelets. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">By blocking this receptor, clopidogrel prevents <strong>ADP-mediated platelet activation</strong>, thereby reducing <strong>platelet aggregation</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This mechanism is especially useful in the prevention of <strong>arterial thrombosis</strong> in conditions like <strong>acute coronary syndrome</strong> and after <strong>stent placement</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Aspirin</span></strong><span style=\"font-size:14.0pt\">: Aspirin inhibits <strong>cyclooxygenase (COX)</strong>, reducing the synthesis of <strong>thromboxane A2 (TxA2)</strong>, which is involved in platelet aggregation. It does not act directly on the <strong>ADP receptors</strong> like P2Y12.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Abciximab</span></strong><span style=\"font-size:14.0pt\">: Abciximab is a <strong>GPIIb/IIIa receptor antagonist</strong>, which blocks the <strong>final common pathway</strong> of platelet aggregation by preventing fibrinogen binding to the <strong>GPIIb/IIIa receptors</strong> on the platelet surface.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. All of these</span></strong><span style=\"font-size:14.0pt\">: This option is incorrect because only <strong>Clopidogrel</strong> specifically acts on the <strong>P2Y12 ADP receptor</strong>. Aspirin and Abciximab act on different pathways involved in platelet aggregation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Mechanism of action of anti-platelet drugs</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-135915.jpg\" style=\"height:523px; width:1000px\" /></span></strong></span></span></p>",
      "correct_choice_id": 247930,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62208,
      "choices": [
        {
          "id": 248089,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-c, 2-b, 3-a</span></span></p>"
        },
        {
          "id": 248090,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-b, 2-c, 3-a</span></span></p>"
        },
        {
          "id": 248091,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-a, 2-c, 3-b</span></span></p>"
        },
        {
          "id": 248092,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1-c, 2-a, 3-b</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following countries with their achievements:</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-174454.jpg\" style=\"height:197px; width:1000px\" /></span></span></p>",
      "unique_key": "Q8450453",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) 1-c, 2-b, 3-a</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Russia (1-c)</span></strong><span style=\"font-size:14.0pt\">: It was the first country to socialize medicine completely, creating a state-run health system that provided healthcare services to all citizens.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Germany (2-b)</span></strong><span style=\"font-size:14.0pt\">: It was the first country to introduce compulsory sickness insurance under Otto von Bismarck&#39;s leadership, laying the foundation for modern social health insurance systems.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">India (3-a)</span></strong><span style=\"font-size:14.0pt\">: It was the first country to establish a fingerprinting bureau, which helped in advancing the field of forensic science.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">First Country Honours</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">First country to socialize medicine completely: Russia</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">First country to introduce compulsory sickness insurance: Germany</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">First country to start family planning programme: India</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">First country to start blindness control programme: India</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">First country to establish finger printing bureau: India (Calcutta, 1897)</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248089,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62169,
      "choices": [
        {
          "id": 247937,
          "text": "<p><span style=\"font-size:14.0pt;\">Metformin</span></p>"
        },
        {
          "id": 247938,
          "text": "<p><span style=\"font-size:14.0pt;\">Pioglitazone</span></p>"
        },
        {
          "id": 247939,
          "text": "<p><span style=\"font-size:14.0pt;\">Semaglutide</span></p>"
        },
        {
          "id": 247940,
          "text": "<p><span style=\"font-size:14.0pt;\">Resmetirom</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 52-year-old woman with a BMI 34 kg/m² presents for evaluation of her liver function tests, which reveal elevated levels of AST and ALT. She has no history of alcohol use, viral hepatitis, or significant liver disease. After lifestyle modifications and weight loss attempts, her healthcare provider discusses pharmacotherapy options for her condition. Which of the following medications is FDA-approved for the management of her condition?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4964558",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;D) Resmetirom</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Resmetirom is an FDA-approved medication specifically indicated for the treatment of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) in adults with liver fibrosis.</span></li><li><span style=\"font-size:14.0pt;\">&nbsp;It works as a selective thyroid hormone receptor beta agonist, which helps improve liver fat content and liver function tests.</span></li></ul><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Metformin:</strong> Metformin is primarily used for managing type 2 diabetes and is not specifically FDA-approved for the treatment of NAFLD or NASH, though it may be used off-label.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Pioglitazone:</strong> While pioglitazone has shown benefits in improving liver histology in patients with NASH, it is not specifically FDA-approved for this indication and is primarily used for diabetes management.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Semaglutide:</strong> Semaglutide is used for the management of type 2 diabetes and obesity, but it does not have FDA approval specifically for the treatment of NAFLD or NASH.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Resmetirom is the only FDA-approved medication specifically targeting the treatment of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis, making it an essential option for managing liver function abnormalities associated with obesity and metabolic syndrome.</span></li></ul>",
      "correct_choice_id": 247940,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62122,
      "choices": [
        {
          "id": 247749,
          "text": "<p><span style=\"font-size:14.0pt;\">Gastric fundus</span></p>"
        },
        {
          "id": 247750,
          "text": "<p><span style=\"font-size:14.0pt;\">Duodenum</span></p>"
        },
        {
          "id": 247751,
          "text": "<p><span style=\"font-size:14.0pt;\">Transverse colon</span></p>"
        },
        {
          "id": 247752,
          "text": "<p><span style=\"font-size:14.0pt;\">Pancreatic tail</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 52-year-old woman presents with a history of heartburn, regurgitation, and a sensation of fullness in her chest, especially after eating large meals. She reports that the symptoms worsen when lying down. A barium swallow study is performed, revealing part of the stomach protruding through the esophageal hiatus into the chest cavity. Which of the following structures is most likely herniated through the diaphragm in this condition?</span></p>",
      "unique_key": "Q6109781",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Gastric fundus</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">In a <strong>hiatal hernia</strong>, the <strong>gastric fundus</strong> or other parts of the stomach protrude through the <strong>esophageal hiatus</strong> of the <strong>diaphragm</strong> into the <strong>thoracic cavity</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>esophageal hiatus</strong> is an opening in the diaphragm that normally allows the <strong>esophagus</strong> to pass through to connect with the <strong>stomach</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Hiatal hernias are classified into <strong>sliding hiatal hernias</strong> and <strong>paraesophageal hiatal hernias</strong>:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Sliding hiatal hernia</strong> is the most common type and occurs when the gastroesophageal junction and part of the stomach move above the diaphragm.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Paraesophageal hiatal hernia </strong>occurs when a portion of the <strong>gastric fundus</strong> herniates through the hiatus alongside the esophagus, while the gastroesophageal junction remains below the diaphragm.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Patients with hiatal hernias often experience <strong>gastroesophageal reflux disease (GERD)</strong> symptoms, such as <strong>heartburn</strong> and <strong>regurgitation</strong>, due to the displacement of the stomach into the thoracic cavity, altering the pressure gradient.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-161530.png\" alt=\"\" width=\"400\" height=\"480\"></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-161541.png\" alt=\"\" width=\"400\" height=\"196\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Duodenum</strong>: Incorrect. The <strong>duodenum</strong> is fixed retro-peritoneally and is not typically involved in hiatal hernias. Its location and attachments make it unlikely to herniate through the esophageal hiatus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Transverse colon</strong>: Incorrect. The <strong>transverse colon</strong> is more likely to be involved in hernias through the <strong>diaphragmatic crura</strong> or <strong>foramen of Morgagni</strong>, but not through the esophageal hiatus. Hiatal hernias involve structures adjacent to the gastroesophageal junction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Pancreatic tail</strong>: Incorrect. The <strong>pancreatic tail</strong> is positioned deep within the abdomen and would not be involved in a hiatal hernia through the esophageal hiatus. It is fixed near the splenic hilum and is not near the diaphragm’s esophageal opening.</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">A <strong>hiatal hernia</strong> involves the herniation of the <strong>gastric fundus</strong> or other parts of the stomach through the <strong>esophageal hiatus</strong> of the <strong>diaphragm</strong> into the <strong>thoracic cavity</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is commonly associated with <strong>gastroesophageal reflux disease (GERD)</strong> due to altered pressure dynamics at the gastroesophageal junction.</span></li></ul>",
      "correct_choice_id": 247749,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62411,
      "choices": [
        {
          "id": 248893,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">Radial Dislocation</span></p>"
        },
        {
          "id": 248894,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">Congenital radial head dysplasia</span></p>"
        },
        {
          "id": 248895,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">Radio-ulnar synostosis</span></p>"
        },
        {
          "id": 248896,
          "text": "<p><span style=\"font-size:14.0pt;\">Elbow dislocation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A child is unable to carry out movements of pronation-supination since childhood due to:</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/22/screenshot-2024-10-22-131520.png\" alt=\"\" width=\"300\" height=\"342\"></p>",
      "unique_key": "Q1184467",
      "difficulty_level": "beginner",
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><strong>Ans. C) Radio-ulnar synostosis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><strong>Radio-ulnar synostosis</strong> is a congenital condition where the radius and ulna are fused together at the elbow.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">This fusion prevents the normal rotation of the radius around the ulna, leading to a complete inability to perform pronation and supination.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">Children with this condition typically have a characteristic limitation in forearm movements from an early age.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">They may have a functional limitation but may adapt to certain activities.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">This condition is lifelong and profoundly affects the ability to perform these rotational movements, making it the most fitting option for the scenario described.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><strong>Option A. Radial Dislocation: </strong>Radial dislocation, particularly of the radial head, occurs when the head of the radius is displaced from its normal position. This condition can be due to trauma, such as a fall, or can occur in specific scenarios like \"nursemaid's elbow,\" where the radius slips out of its normal position due to sudden pulling. A child with a radial dislocation may have pain, limited movement, and visible deformity. However, this is usually an acute condition and, if treated, can allow for full recovery of movement. While it can limit these movements temporarily, it is generally not a lifelong issue unless there are recurrent dislocations or complications.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><strong>Option B. Congenital Radial Head Dysplasia: </strong>Congenital radial head dysplasia refers to a developmental abnormality of the radial head that can lead to dysfunction in the forearm. This condition often results in a poorly formed radial head, which can cause instability or misalignment at the elbow joint. Children may experience restricted motion or discomfort, particularly in pronation and supination. However, this is less common than some other causes. It can affect function but may not completely prevent pronation and supination; the degree of limitation can vary widely.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><strong>Option D. Elbow Dislocation: </strong>Elbow dislocation occurs when the bones of the elbow joint are displaced. Commonly results from trauma, such as falls or sports injuries, leading to the displacement of the ulna and/or radius from the humerus. Acute pain, swelling, and visible deformity are typical. Movement is usually severely restricted immediately after dislocation. After reduction, most children can regain normal function, including pronation and supination, with appropriate rehabilitation. Chronic issues arise only if there are complications or recurrent dislocations, but it generally does not cause lifelong inability to perform these movements.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">Radio-ulnar synostosis directly leads to an inability to perform pronation and supination due to the fusion of the radius and ulna.</span></p></li></ul>",
      "correct_choice_id": 248895,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        15
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62093,
      "choices": [
        {
          "id": 247633,
          "text": "<p><span style=\"font-size:14.0pt;\">Hyperthyroidism</span></p>"
        },
        {
          "id": 247634,
          "text": "<p><span style=\"font-size:14.0pt;\">Histamine secretion by the tumor</span></p>"
        },
        {
          "id": 247635,
          "text": "<p><span style=\"font-size:14.0pt;\">Paraneoplastic production of serotonin</span></p>"
        },
        {
          "id": 247636,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased parathyroid hormone-related protein (PTHrP) secretion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old man presents with a painless thyroid nodule and diarrhea. A thyroid biopsy reveals the presence of amyloid deposits within the tumor. He is also found to have a strong family history of thyroid cancer and so his genetic testing was done which reveals a RET proto<strong>-</strong>oncogene mutation. Which of the following is the most likely underlying cause of this patient's diarrhea?</span></p>",
      "unique_key": "Q6832571",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Paraneoplastic production of serotonin</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">This patient has <strong>medullary thyroid cancer (MTC)</strong>, which is derived from <strong>parafollicular C cells</strong> that produce <strong>calcitonin</strong>. Other hormones like Serotonin, VIP and ACTH can also be secreted by tumor cells.</span></li><li><span style=\"font-size:14.0pt;\">These hormones<strong> </strong>can cause <strong>secretory diarrhea</strong> by increasing intestinal secretion.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>RET proto-oncogene mutation</strong> further supports the diagnosis of familial <strong>medullary thyroid carcinoma</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Hyperthyroidism:</strong> Incorrect. The patient’s presentation lacks the classic symptoms of hyperthyroidism (such as weight loss, tremors, and palpitations). MTC does not typically result in hyperthyroidism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Histamine secretion by the tumor:&nbsp;</strong>Incorrect. Histamine does not cause diarrhea</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Increased parathyroid hormone-related protein (PTHrP) secretion:&nbsp;</strong>Incorrect. PTHrP causes <strong>hypercalcemia of malignancy</strong>, often associated with squamous cell carcinomas or renal cell carcinoma, not medullary thyroid carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">In <strong>medullary thyroid carcinoma</strong>, excessive <strong>calcitonin</strong> production by tumor cells can cause <strong>diarrhea</strong> as a paraneoplastic symptom. This cancer is associated with <strong>RET proto-oncogene mutations</strong> and amyloid deposits in the thyroid.</span></li><li><span style=\"font-size:14.0pt;\">Medullary thyroid carcinoma → Calcitonin producing tumor</span></li><li><span style=\"font-size:14.0pt;\">Calcitonin and other hormones like serotonin, VIP and ACTH increases intestinal fluid secretion → Secretory diarrhea</span></li><li><span style=\"font-size:14.0pt;\">Amyloid deposits = calcitonin aggregates</span></li><li><span style=\"font-size:14.0pt;\">RET mutation → Diagnostic hallmark of familial MTC (MEN 2 syndromes)</span></li><li><span style=\"font-size:14.0pt;\">MEN 2A: Medullary thyroid carcinoma + pheochromocytoma + parathyroid hyperplasia</span></li><li><span style=\"font-size:14.0pt;\">MEN 2B: Medullary thyroid carcinoma + pheochromocytoma + mucosal neuromas + marfanoid habitus</span></li></ul>",
      "correct_choice_id": 247635,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62119,
      "choices": [
        {
          "id": 247737,
          "text": "<p><span style=\"font-size:14.0pt;\">Foramen ovale</span></p>"
        },
        {
          "id": 247738,
          "text": "<p><span style=\"font-size:14.0pt;\">Internal acoustic meatus</span></p>"
        },
        {
          "id": 247739,
          "text": "<p><span style=\"font-size:14.0pt;\">Jugular foramen</span></p>"
        },
        {
          "id": 247740,
          "text": "<p><span style=\"font-size:14.0pt;\">Hypoglossal canal</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 50-year-old woman presents with sudden onset of right-sided facial paralysis, inability to close her right eye, and loss of taste sensation on the anterior two-thirds of her tongue. Physical examination reveals drooping of the right side of her face and absence of the corneal reflex on the right. Imaging reveals a lesion at the base of the skull affecting the cranial nerve as it exits through its respective foramen. Which foramen is most likely involved in this patient?</span></p>",
      "unique_key": "Q6597314",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Internal acoustic meatus</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">This patient's presentation of sudden right-sided facial paralysis, inability to close the eye, and loss of taste sensation on the anterior two-thirds of the tongue is consistent with a lesion of the <strong>facial nerve (cranial nerve VII)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The facial nerve is responsible for motor control of the muscles of facial expression, taste sensation from the anterior two-thirds of the tongue, and innervation to the lacrimal and salivary glands.</span></li><li><span style=\"font-size:14.0pt;\">It also contributes to the afferent limb of the corneal reflex.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>facial nerve (CN VII)</strong> exits the skull through the <strong>internal acoustic meatus</strong>, along with the vestibulocochlear nerve (CN VIII).</span></li><li><span style=\"font-size:14.0pt;\">A lesion at this location, such as from a tumor or other compressive pathology, can result in facial paralysis and loss of taste sensation as seen in this patient.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-161248.png\" alt=\"\" width=\"500\" height=\"383\">&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Foramen ovale</strong>: The foramen ovale transmits the <strong>mandibular branch of the trigeminal nerve (cranial nerve V3)</strong>. This nerve is responsible for sensory innervation to the lower face and motor innervation to the muscles of mastication. A lesion affecting the foramen ovale would present with loss of sensation in the mandibular distribution and difficulty with mastication, not facial paralysis or loss of taste sensation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Jugular foramen</strong>: The jugular foramen transmits cranial nerves <strong>IX (glossopharyngeal)</strong>, <strong>X (vagus)</strong>, and <strong>XI (accessory)</strong>. A lesion here would cause deficits such as dysphagia (difficulty swallowing), hoarseness (vocal cord paralysis), and shoulder weakness (due to accessory nerve involvement), but not facial paralysis or loss of taste on the anterior tongue.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Hypoglossal canal</strong>: The hypoglossal canal transmits the <strong>hypoglossal nerve (cranial nerve XII)</strong>, which controls the muscles of the tongue. Lesions here cause weakness or atrophy of the tongue muscles, typically with deviation of the tongue to the side of the lesion when protruded, but this would not cause facial paralysis or taste disturbances.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The <strong>facial nerve (cranial nerve VII) </strong>exits the skull via the <strong>internal acoustic meatus</strong> and is responsible for motor innervation to the muscles of facial expression, taste sensation on the anterior two-thirds of the tongue, and innervation to the lacrimal and salivary glands.</span></li><li><span style=\"font-size:14.0pt;\">A lesion affecting the internal acoustic meatus can result in <strong>facial paralysis</strong> and <strong>loss of taste sensation</strong> on the anterior two-thirds of the tongue.</span></li></ul>",
      "correct_choice_id": 247738,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62142,
      "choices": [
        {
          "id": 247829,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RET proto-oncogene mutation</span></span></p>"
        },
        {
          "id": 247830,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BRAF mutation</span></span></p>"
        },
        {
          "id": 247831,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TP53 mutation</span></span></p>"
        },
        {
          "id": 247832,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RAS mutation</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 38-year-old woman presents with a painless nodule in her neck that she noticed two months ago. She has no history of radiation exposure and her family history is unremarkable. Fine-needle aspiration biopsy of the thyroid nodule reveals cells as are given in the image. There are also psammoma bodies present. Ultrasound shows a solitary, well-defined nodule in the right thyroid lobe. Which of the following genetic mutations is most commonly associated with this patient&#39;s condition?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-135606.jpg\" style=\"height:220px; width:400px\" /></span></span></p>",
      "unique_key": "Q2890487",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans. B) BRAF mutation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This patient has features consistent with <strong>papillary thyroid cancer</strong>, the most common type of thyroid malignancy. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Orphan Annie-eye nuclei&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">and <strong>psammoma bodies&nbsp;</strong>are characteristic histologic findings. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">BRAF mutations</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> are commonly associated with papillary thyroid cancer and are often predictive of a more aggressive course.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">BRAF mutations can be seen with Malignant melanoma, Hairy cell leukemia, LCH, Papillary thyroid cancer&nbsp; </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. RET proto-oncogene mutation:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Incorrect. <strong>RET mutations</strong> are associated with <strong>medullary thyroid carcinoma</strong>, not papillary thyroid carcinoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. TP53 mutation:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Incorrect. <strong>TP53 mutations</strong> are typically associated with <strong>anaplastic thyroid carcinoma</strong>, a much more aggressive and rare type of thyroid cancer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. RAS mutation:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Incorrect. <strong>RAS mutations</strong> can be associated with <strong>follicular thyroid carcinoma</strong> and <strong>follicular variant of papillary thyroid carcinoma</strong>, but they are less common in classic papillary thyroid carcinoma than BRAF mutations.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Papillary thyroid carcinoma (PTC)&nbsp;</span></strong><span style=\"font-size:14.0pt\">is often associated with <strong>BRAF mutations</strong> and is characterized by <strong>papillary structures</strong>, <strong>orphan Annie eye nuclei</strong>, and <strong>psammoma bodies</strong>.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247830,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62401,
      "choices": [
        {
          "id": 248853,
          "text": "<p><span style=\"font-size:14.0pt;\">Order an ultrasound</span></p>"
        },
        {
          "id": 248854,
          "text": "<p><span style=\"font-size:14.0pt;\">Prescribe ulipristal acetate</span></p>"
        },
        {
          "id": 248855,
          "text": "<p><span style=\"font-size:14.0pt;\">Give the Yuzpe regimen</span></p>"
        },
        {
          "id": 248856,
          "text": "<p><span style=\"font-size:14.0pt;\">Prescribe levonorgestrel</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 24-year-old woman presents to the clinic with her husband, both expressing concern after having unprotected intercourse 4 days ago. They do not want to conceive at this time, and she is very anxious. What is the most appropriate next step in management?</span></p>",
      "unique_key": "Q7719973",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Prescribe ulipristal acetate</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Ulipristal acetate </strong>is an effective form of <strong>emergency contraception</strong> that can be used up to <strong>5 days (120 hours)</strong> after unprotected intercourse.</span></li><li><span style=\"font-size:14.0pt;\">It is a selective progesterone receptor modulator that works by inhibiting or delaying ovulation.</span></li><li><span style=\"font-size:14.0pt;\">Given that this patient had unprotected intercourse 4 days ago, ulipristal acetate is the best option for preventing pregnancy.</span></li><li><span style=\"font-size:14.0pt;\">Ulipristal is more effective than levonorgestrel when used in the later part of the 5-day window, and it does not lose efficacy as rapidly over time.</span></li><li><span style=\"font-size:14.0pt;\">It is appropriate for patients who seek emergency contraception more than 72 hours after intercourse.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Order an ultrasound: </strong>Incorrect. An <strong>ultrasound</strong> is not necessary for emergency contraception. Ultrasound is used to confirm an established pregnancy or evaluate other gynecologic concerns, but it is not relevant at this early stage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Give the Yuzpe regimen: </strong>Incorrect. The <strong>Yuzpe regimen</strong> involves high-dose combined oral contraceptives (estrogen and progestin) as emergency contraception. While effective, it is less effective and associated with more side effects (nausea and vomiting) compared to ulipristal acetate.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Prescribe levonorgestrel : </strong>Incorrect. <strong>Levonorgestrel</strong> is another form of emergency contraception but is most effective when used within <strong>72 hours</strong> of intercourse. Given that the patient is 4 days (96 hours) post-intercourse, <strong>ulipristal acetate</strong> is the preferred option.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Ulipristal acetate </strong>is the most effective form of <strong>emergency contraception</strong> when used within <strong>5 days (120 hours)</strong> after unprotected intercourse.</span></li><li><span style=\"font-size:14.0pt;\">It is particularly useful when more than 72 hours have passed, as its efficacy remains higher than that of levonorgestrel.</span></li><li><span style=\"font-size:14.0pt;\">Emergency contraception works by inhibiting or delaying ovulation and should be given as soon as possible after unprotected intercourse.</span></li></ul>",
      "correct_choice_id": 248854,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62225,
      "choices": [
        {
          "id": 248157,
          "text": "<p><span style=\"font-size:14.0pt;\">Succenturiate lobe</span></p>"
        },
        {
          "id": 248158,
          "text": "<p><span style=\"font-size:14.0pt;\">Normal placenta</span></p>"
        },
        {
          "id": 248159,
          "text": "<p><span style=\"font-size:14.0pt;\">Both succenturiate lobe and velamentous insertion</span></p>"
        },
        {
          "id": 248160,
          "text": "<p><span style=\"font-size:14.0pt;\">Marginal insertion of the cord</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old woman is undergoing a routine ultrasound at 28 weeks gestation. The ultrasound reveals the placental structure as shown in the image . What is the most likely diagnosis based on these findings?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-160829.jpg\" alt=\"\" width=\"400\" height=\"386\"></span></p>",
      "unique_key": "Q1096867",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Both succenturiate lobe and velamentous insertion</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The image and clinical description suggest the presence of both a <strong>succenturiate lobe</strong> and <strong>velamentous cord insertion</strong>.</span></li><li><span style=\"font-size:14.0pt;\">A succenturiate lobe is an accessory placental lobe that is separate from the main placental body and connected by blood vessels.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Velamentous insertion</strong> occurs when the umbilical cord inserts into the fetal membranes rather than the placental mass.</span></li><li><span style=\"font-size:14.0pt;\">This configuration makes the vessels vulnerable to injury, especially during labor.</span></li><li><span style=\"font-size:14.0pt;\">This combination can lead to complications like <strong>vasa previa</strong> or hemorrhage if the vessels are damaged during labor or delivery.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Succenturiate lobe:</strong> Incorrect. While the succenturiate lobe is present in this case, this option does not explain the velamentous cord insertion, which is a significant finding in the ultrasound and the image.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Normal placenta:</strong> Incorrect. A normal placenta has a single placental mass with the umbilical cord inserting directly into it. The findings described are abnormal, specifically involving an accessory lobe and velamentous insertion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Marginal insertion of the cord:</strong> Incorrect. In marginal insertion, the umbilical cord inserts at the edge of the placental mass, but still directly into the placenta, not into the membranes as seen with velamentous insertion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Both succenturiate lobe and velamentous insertion</strong> are placental abnormalities.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>succenturiate lobe</strong> is an accessory placental lobe, and <strong>velamentous cord insertion</strong> is when the umbilical cord inserts into the membranes, making the vessels vulnerable to injury.</span></li><li><span style=\"font-size:14.0pt;\">These conditions increase the risk of complications such as <strong>vasa previa</strong> and fetal hemorrhage.</span></li></ul>",
      "correct_choice_id": 248159,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62219,
      "choices": [
        {
          "id": 248133,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Artemether plus lumefantrine</span></span></p>"
        },
        {
          "id": 248134,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Artesunate plus sulfadoxine-pyrimethamine</span></span></p>"
        },
        {
          "id": 248135,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chloroquine</span></span></p>"
        },
        {
          "id": 248136,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Quinine</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old man recently returned from a rural area in northeastern India, where he experienced several episodes of fever, chills, and fatigue over the past week. He presents to a district hospital, and laboratory testing confirms a diagnosis of Plasmodium falciparum malaria. What is the most appropriate first-line treatment for his condition in this region?</span></span></p>",
      "unique_key": "Q6277090",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Artemether plus lumefantrine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The Drug of choice treatment for Plasmodium falciparum infection in North Eastern states is artemether + lumefantrine</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">ARTEMISINS - ARTESUNATE AND ARTEMETHER</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Fastest acting anti-malarial</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Effective against MDR parasites</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Short acting</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">C/I in 1st trimester</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">&nbsp;Artemisinin Combination Therapy [ACT]</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Artemisin + Long acting drug</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">DOC for chloroquine resistant malaria Combinations</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Artemether + Lumefantrine: DOC in North Eastern States</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Artesunate + Sulfadoxine-Pyrimethamine: DOC for rest of India</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The dose of artesunate is 200 mg OD for 3 days whereas sulfadoxine (1500 mg) and pyrimethamine (75 mg) should be taken on day 1 only)</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">For P. falciparum malaria in regions with known drug resistance, artemether plus lumefantrine is the most effective first-line treatment, ensuring rapid and sustained clearance of the malaria parasite.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248133,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62291,
      "choices": [
        {
          "id": 248421,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Otitis externa</span></span></p>"
        },
        {
          "id": 248422,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Perichondritis</span></span></p>"
        },
        {
          "id": 248423,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chondrodermatitis helicis</span></span></p>"
        },
        {
          "id": 248424,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Auricular cellulitis</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 40-year-old man presents to the emergency department with pain and swelling in his left ear, which developed over the past 2 days. He mentions a history of repeated trauma to the ear from his job as a boxing coach. On physical examination, the left ear shows erythema, tenderness, and a swollen, indurated pinna with no visible discharge. The tympanic membrane appears normal. What is the most likely diagnosis? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/22/screenshot-2024-10-22-093842.jpg\" style=\"height:467px; width:350px\" /></p>",
      "unique_key": "Q9600873",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>B) Perichondritis</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The clinical presentation of painful, erythematous swelling over the auricle in a patient with a history of trauma suggests <strong>perichondritis</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Perichondritis is an infection of the perichondrium, typically occurring after trauma, lacerations, or surgical incisions to the ear. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The most common causative organism is <strong>Pseudomonas aeruginosa</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">If left untreated, it can lead to cartilage necrosis, resulting in a &quot;cauliflower ear&quot; deformity, which is often seen in individuals exposed to repeated ear trauma, such as boxers and wrestlers.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Otitis externa: Otitis externa</span></strong><span style=\"font-size:14.0pt\"> typically presents with pain, itching, and discharge from the ear canal, but it does not involve the pinna itself.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Chondrodermatitis helicis: Chondrodermatitis helicis</span></strong><span style=\"font-size:14.0pt\"> presents as a painful nodule on the helix or antihelix, caused by chronic pressure and not by infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Auricular cellulitis: Auricular cellulitis</strong> can present with erythema and swelling, but it involves the soft tissue of the auricle and not specifically the cartilage, and it is not associated with a history of trauma as prominently.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Perichondritis of the ear commonly results from trauma or surgery and can progress to cartilage necrosis if untreated. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It typically requires antibiotic therapy targeting <strong>Pseudomonas aeruginosa</strong> and may present as a painful, erythematous swelling of the auricle without tympanic membrane involvement.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248422,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        9
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62147,
      "choices": [
        {
          "id": 247849,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Administer a booster dose of Hepatitis B vaccine</span></span></span></p>"
        },
        {
          "id": 247850,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Administer Hepatitis B immunoglobulin (HBIG) with a full vaccination course</span></span></span></p>"
        },
        {
          "id": 247851,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Repeat the full course of Hepatitis B vaccine</span></span></span></p>"
        },
        {
          "id": 247852,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">No treatment required</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old healthcare worker accidentally sustains a needle stick injury while handling a patient who is known to be Hepatitis B positive. The healthcare worker&rsquo;s serology report shows HBsAg negative and Anti-HBs level of 105 mIU/ml. What is the most appropriate next step in management? </span></span></p>",
      "unique_key": "Q5260547",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>D) No treatment required</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The healthcare worker&rsquo;s serology indicates that he is HBsAg negative, which confirms the absence of active infection, and the Anti-HBs level of 105 mIU/ml demonstrates sufficient immunity to Hepatitis B from prior vaccination. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">An Anti-HBs titre greater than 10 mIU/ml is considered protective. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Therefore, no further treatment is necessary as the healthcare worker already has adequate antibody titres.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Administer a booster dose of Hepatitis B vaccine</span></strong><span style=\"font-size:14.0pt\">: A booster is not needed when an individual has a protective antibody titre (&gt;10 mIU/ml). In this case, a level of 105 mIU/ml is well above the protective threshold.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Administer Hepatitis B immunoglobulin (HBIG) with a full vaccination course</span></strong><span style=\"font-size:14.0pt\">: HBIG is recommended for post-exposure prophylaxis in individuals who are not vaccinated or do not have sufficient antibody titres. Given that the healthcare worker has adequate immunity, this option is not necessary.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Repeat the full course of Hepatitis B vaccine</span></strong><span style=\"font-size:14.0pt\">: Repeating the full vaccination course is indicated for individuals who are non-responders to the initial vaccination series or who have very low or absent antibody titres. Since the healthcare worker has a sufficient level of antibodies, repeating the course is not warranted.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In individuals with prior Hepatitis B vaccination, an Anti-HBs titre greater than 10 mIU/ml indicates sufficient immunity. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">If this threshold is met after a needle stick exposure, no additional prophylactic treatment is required.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247852,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62355,
      "choices": [
        {
          "id": 248673,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1 and 3</span></span></span></p>"
        },
        {
          "id": 248674,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1 and 2</span></span></span></p>"
        },
        {
          "id": 248675,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">3 and 5</span></span></span></p>"
        },
        {
          "id": 248676,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1, 2, 3 and 5</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Which of the following organisms also share the characteristic known as &ldquo;viable but not cultivable&rdquo;? </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1. M. leprae </span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">2. M. tuberculosis </span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">3. Treponema pallidum </span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">4. Salmonella </span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">5. Staphylococcus</span></span></span></p>",
      "unique_key": "Q3258832",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) 1 and 3</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">1. Mycobacterium leprae</span></strong><span style=\"font-size:14.0pt\"> is the causative agent of leprosy and is termed &quot;viable but not cultivable&quot; because it cannot be grown in artificial media in laboratory conditions. Instead, it is grown in armadillo models or mouse footpads. This limitation makes diagnosis largely dependent on clinical findings and histopathology.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">3. Treponema pallidum</span></strong><span style=\"font-size:14.0pt\">, the causative agent of syphilis, is another example of a microorganism that cannot be cultured in artificial laboratory media. Its unique requirements for growth in human tissues make it extremely difficult to cultivate outside a living host, thereby classifying it as viable but non-cultivable in traditional lab settings.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">2. Mycobacterium tuberculosis</span></strong><span style=\"font-size:14.0pt\">: Unlike M. leprae, M. tuberculosis can be cultured in standard laboratory media, such as Lowenstein-Jensen medium, and therefore does not fit the description of viable but not cultivable.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">4. Salmonella</span></strong><span style=\"font-size:14.0pt\">: Salmonella species can be easily cultivated in standard nutrient media and are commonly grown for laboratory identification purposes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">5. Staphylococcus</span></strong><span style=\"font-size:14.0pt\">: Staphylococcus species, including Staphylococcus aureus, can be readily grown in nutrient-rich media like blood agar, making them cultivable in standard laboratory conditions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Certain pathogens such as <strong>Mycobacterium leprae</strong> and <strong>Treponema pallidum</strong> are described as &quot;viable but not cultivable&quot; because they cannot be grown in artificial laboratory media. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Diagnostic approaches for such pathogens rely heavily on alternative techniques like animal models, clinical symptoms, or serology.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248673,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62186,
      "choices": [
        {
          "id": 248005,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These symptoms are associated with hyperdopaminergic activity in the mesocortical pathway</span></span></p>"
        },
        {
          "id": 248006,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Second-generation antipsychotics are significantly more effective than first-generation antipsychotics in treating these symptoms</span></span></span></p>"
        },
        {
          "id": 248007,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">These symptoms are typically more resistant to treatment than positive symptoms and are associated with poorer functional outcomes</span></span></span></p>"
        },
        {
          "id": 248008,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cognitive remediation therapy has shown consistent, large effect sizes in improving these symptoms across multiple studies</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old man suffering from schizophrenia presents with social withdrawal, lack of motivation, and reduced emotional expression. His family reports that these symptoms have been present for the past year. Which of the following statements about his condition is true?&nbsp; </span></span></p>",
      "unique_key": "Q9975511",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) These symptoms are typically more resistant to treatment than positive symptoms and are associated with poorer functional outcomes</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The symptoms described (social withdrawal, lack of motivation, reduced emotional expression) are <strong>negative symptoms of schizophrenia</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Negative symptoms are generally <strong>more difficult to treat</strong> with antipsychotic medication compared to positive symptoms like hallucinations and delusions. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">They are associated with <strong>greater functional impairment</strong> and <strong>poorer overall prognosis</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. These symptoms are associated with hyperdopaminergic activity in the mesocortical pathway (False):&nbsp;</span></strong><span style=\"font-size:14.0pt\">Negative symptoms are associated with <strong>hypodopaminergic</strong> activity (reduced dopamine activity) in the mesocortical pathway, not hyperdopaminergic activity. Hyperdopaminergic activity (in the mesolimbic pathway) is more associated with positive symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Second-generation antipsychotics are significantly more effective than first-generation antipsychotics in treating these symptoms (False):&nbsp;</span></strong><span style=\"font-size:14.0pt\">While second-generation antipsychotics may have some benefits over first-generation antipsychotics in terms of side effects and possibly better tolerability, their effectiveness in treating negative symptoms is <strong>only modestly better</strong>, and overall, the impact on negative symptoms remains limited.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Cognitive remediation therapy has shown consistent, large effect sizes in improving these symptoms across multiple studies (False):&nbsp;</span></strong><span style=\"font-size:14.0pt\">Cognitive remediation therapy is <strong>more effective for improving cognitive deficits</strong> rather than negative symptoms. The impact on negative symptoms tends to be smaller and less consistent.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><u><span style=\"font-size:14.0pt\">Negative Symptoms of Schizophrenia:</span></u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Negative symptoms are defined by the absence of normal behaviors.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">They are sometimes also called deficit symptoms.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">They are:</span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Avolition - Loss of drive for goal-directed activities</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Apathy - Lack of concern</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Anhedonia -Lack of pleasure in previously pleasurable activities </span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Asociality -Lack of social interaction</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Affective flattening (Or emotional blunting) - Lack of emotional response</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Alogia - Decreased verbal communication</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">They are more resistant to treatment than positive symptoms and are linked to greater functional impairment.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248007,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62072,
      "choices": [
        {
          "id": 247549,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hypersensitivity of the peripheral chemoreceptors to hypoxia</span></span></span></p>"
        },
        {
          "id": 247550,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Increased respiratory drive due to metabolic acidosis</span></span></span></p>"
        },
        {
          "id": 247551,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Delayed detection of changes in blood CO2 by central chemoreceptors</span></span></span></p>"
        },
        {
          "id": 247552,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Increased lung stiffness leading to decreased tidal volume</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 68-year-old man with a history of chronic heart failure is brought to the emergency department due to increasing shortness of breath, fatigue, and periods of rapid breathing followed by pauses in breathing during sleep. His wife reports that she has noticed these episodes of irregular breathing during the night, where his breathing pattern alternates between deep, rapid breaths and periods of no breathing. Physical examination reveals an elevated jugular venous pressure and bilateral crackles on lung auscultation. Which of the following best explains the underlying mechanism of this patient&#39;s breathing pattern? </span></span></p>",
      "unique_key": "Q1668113",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Delayed detection of changes in blood CO2 by central chemoreceptors</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cheyne-Stokes breathing is a cyclic pattern of breathing characterized by periods of hyperventilation followed by apnea. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This abnormal respiratory pattern occurs due to a <strong>delayed response</strong> of the central chemoreceptors in detecting changes in arterial carbon dioxide (CO2) levels. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In patients with chronic heart failure, as seen in this case, reduced cardiac output leads to poor blood circulation, which in turn delays the transport of CO2 to the brain&rsquo;s respiratory centers. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The central chemoreceptors, responsible for detecting CO2 levels, respond with a delay, causing alternating phases of hyperventilation (when CO2 is elevated) and apnea (when CO2 levels drop too low due to overcompensation). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The respiratory centers overshoot in response to these delayed signals, resulting in the waxing and waning pattern of breathing characteristic of Cheyne-Stokes respiration.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-144504.jpg\" style=\"height:305px; width:550px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Hypersensitivity of the peripheral chemoreceptors to hypoxia</span></strong><span style=\"font-size:14.0pt\">: Incorrect. While peripheral chemoreceptors respond to hypoxia, they are not primarily responsible for the cyclic breathing pattern seen in Cheyne-Stokes breathing. The main issue in Cheyne-Stokes is the delayed feedback in response to changes in blood CO2 levels, which does not involve hypoxia sensitivity as the primary cause.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Increased respiratory drive due to metabolic acidosis</span></strong><span style=\"font-size:14.0pt\">: Incorrect. Metabolic acidosis increases the respiratory drive and can lead to rapid, deep breathing (Kussmaul breathing), not the cyclical waxing and waning pattern characteristic of Cheyne-Stokes breathing.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Increased lung stiffness leading to decreased tidal volume</span></strong><span style=\"font-size:14.0pt\">: Incorrect. Increased lung stiffness (as seen in conditions like pulmonary fibrosis) may result in shallow, rapid breathing, but it does not lead to the cyclical breathing pattern of hyperventilation followed by apnea that defines Cheyne-Stokes breathing.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Cheyne-Stokes breathing</span></strong><span style=\"font-size:14.0pt\"> is characterized by alternating periods of hyperventilation and apnea. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It occurs due to <strong>delayed detection of blood CO2 changes by central chemoreceptors</strong>, often seen in patients with <strong>heart failure</strong> or <strong>neurological damage</strong>.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247551,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62200,
      "choices": [
        {
          "id": 248057,
          "text": "<p><span style=\"font-size:14.0pt;\">Drug-resistant tuberculosis</span></p>"
        },
        {
          "id": 248058,
          "text": "<p><span style=\"font-size:14.0pt;\">HIV-associated pneumonia</span></p>"
        },
        {
          "id": 248059,
          "text": "<p><span style=\"font-size:14.0pt;\">Immune Reconstitution Inflammatory Syndrome</span></p>"
        },
        {
          "id": 248060,
          "text": "<p><span style=\"font-size:14.0pt;\">Antiretroviral drug toxicity</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old man with advanced HIV (CD4 count of 50 cells/µL) presents with a 3-week history of cough, night sweats, weight loss, and fatigue. Sputum testing is positive for acid-fast bacilli, leading to a diagnosis of pulmonary tuberculosis (TB). After starting anti-TB therapy, he begins antiretroviral therapy (ART) 2 weeks later. Six weeks after initiating ART, he returns with worsening cough, fever, and new lymphadenopathy. His repeat chest X-ray shows worsening infiltrates. What is the most likely cause of his clinical deterioration?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7099567",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;C) Immune Reconstitution Inflammatory Syndrome</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Immune Reconstitution Inflammatory Syndrome (IRIS) occurs when there is a paradoxical worsening of an underlying infection after the initiation of antiretroviral therapy in immunocompromised individuals, such as those with advanced HIV.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">As the immune system starts to recover due to ART, it may mount an exaggerated inflammatory response to existing infections, leading to clinical deterioration, such as worsening pulmonary symptoms and new lymphadenopathy in this patient.</span></li></ul><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Drug-resistant tuberculosis:</strong> While drug-resistant TB is a possibility, the timing of the deterioration shortly after starting ART is more characteristic of IRIS than of resistance, especially since he was started on appropriate anti-TB therapy.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option B. HIV-associated pneumonia:</strong> While patients with low CD4 counts are at risk for various opportunistic infections, the specific symptoms and timeline in this case are more suggestive of IRIS.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Antiretroviral drug toxicity:</strong> Although ART can have side effects, the clinical picture and timing of the deterioration are not typical of direct toxicity, especially since the worsening symptoms correlate with the initiation of ART rather than with adverse effects.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Immune Reconstitution Inflammatory Syndrome (IRIS) is a common phenomenon in patients with advanced HIV starting antiretroviral therapy, leading to a paradoxical worsening of previously existing infections due to an inflammatory response as the immune system begins to recover.</span></li></ul>",
      "correct_choice_id": 248059,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62385,
      "choices": [
        {
          "id": 248789,
          "text": "<p><span style=\"font-size:14.0pt;\">Chrysophyllum</span></p>"
        },
        {
          "id": 248790,
          "text": "<p><span style=\"font-size:14.0pt;\">Calotropis</span></p>"
        },
        {
          "id": 248791,
          "text": "<p><span style=\"font-size:14.0pt;\">Parthenium</span></p>"
        },
        {
          "id": 248792,
          "text": "<p><span style=\"font-size:14.0pt;\">Rothrangal</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old man presents to the dermatology clinic with recurrent skin rashes, primarily affecting his face and hands. He notes that the rashes often worsen after spending time outdoors, particularly when he visits rural areas. Physical examination reveals erythematous patches with scaling. The dermatologist suspects a contact dermatitis triggered by an airborne allergen. Which of the following is the most common cause of airborne dermatitis in this region?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/22/screenshot-2024-10-22-124440.png\" alt=\"\" width=\"300\" height=\"320\"></span></p>",
      "unique_key": "Q2997421",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Parthenium</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Parthenium hysterophorus</strong>, a common weed, is the most frequent cause of <strong>airborne contact dermatitis</strong> in India.</span></li><li><span style=\"font-size:14.0pt;\">The plant releases airborne allergens, particularly in rural areas, leading to dermatitis, especially on exposed areas like the face and hands .</span></li><li><span style=\"font-size:14.0pt;\"><strong>Parthenium </strong>is a known allergen that can trigger <strong>allergic contact dermatitis</strong>, often affecting individuals who spend significant time outdoors in regions where the weed is prevalent.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Chrysophyllum: Chrysophyllum </strong>is not a common cause of airborne contact dermatitis and is not widely associated with allergic skin reactions in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Calotropis: Calotropis</strong> is known for its latex, which can cause contact dermatitis through direct contact, but it is not a major cause of <strong>airborne</strong> dermatitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Rothrangal:</strong> This is not a recognized cause of airborne dermatitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Parthenium hysterophorus </strong>is the most common cause of <strong>airborne contact dermatitis</strong> in India, particularly in rural areas.</span></li><li><span style=\"font-size:14.0pt;\">It causes skin reactions through airborne allergens, affecting individuals who are exposed to it outdoors.</span></li></ul>",
      "correct_choice_id": 248791,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        18
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62180,
      "choices": [
        {
          "id": 247981,
          "text": "<p><span style=\"font-size:14.0pt;\">Contrast-induced AKI</span></p>"
        },
        {
          "id": 247982,
          "text": "<p><span style=\"font-size:14.0pt;\">Atheroembolic disease</span></p>"
        },
        {
          "id": 247983,
          "text": "<p><span style=\"font-size:14.0pt;\">Thrombotic thrombocytopenic purpura (TTP)</span></p>"
        },
        {
          "id": 247984,
          "text": "<p><span style=\"font-size:14.0pt;\">Antiphospholipid syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 68-year-old male presents with acute kidney injury (AKI) 7 days after undergoing coronary angiography (CAG). Laboratory tests reveal elevated creatinine levels and hypocomplementemia. A renal biopsy is done and shown below. Which of the following is the most likely underlying cause of his symptoms?</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-171401.jpg\" alt=\"\" width=\"350\" height=\"279\"></span></p>",
      "unique_key": "Q2267649",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Atheroembolic disease&nbsp;</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The most likely underlying cause of this patient's AKI is <strong>atheroembolic disease</strong> (cholesterol embolization).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This condition commonly occurs after procedures such as <strong>coronary angiography</strong> that involve the manipulation of atherosclerotic plaques. Cholesterol crystals can dislodge from atherosclerotic plaques in the aorta and renal arteries, causing <strong>small vessel occlusions</strong> and ischemic damage. The classic triad includes:</span></li><li><span style=\"font-size:14.0pt;\"><strong>AKI</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Hypocomplementemia</strong> (due to complement activation by emboli)</span></li><li><span style=\"font-size:14.0pt;\">Signs of cholesterol embolization, which may include <strong>livedo reticularis</strong> and <strong>blue toe syndrome</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Renal biopsy typically shows <strong>cholesterol clefts</strong> within small renal arteries.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>delayed onset</strong> of AKI (days after the procedure) and the presence of <strong>hypocomplementemia</strong> further support this diagnosis.</span></li></ul><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Contrast-induced AKI</strong>: Contrast nephropathy typically occurs <strong>within 48 hours</strong> of contrast administration and resolves over several days. It is usually characterized by a <strong>rise in creatinine</strong> without hypocomplementemia or embolic phenomena.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Thrombotic thrombocytopenic purpura (TTP)</strong>: TTP is a thrombotic microangiopathy that presents with <strong>thrombocytopenia, hemolytic anemia, AKI, fever, and neurologic symptoms</strong>. There is no mention of thrombocytopenia or other features of TTP in this patient.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Antiphospholipid syndrome</strong>: This syndrome is characterized by <strong>thrombosis</strong> and <strong>recurrent pregnancy loss</strong>, along with the presence of antiphospholipid antibodies. While it can cause AKI due to renal vascular thrombosis, the clinical presentation and hypocomplementemia are more consistent with atheroembolic disease.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Atheroembolic disease</strong> is a potential complication after vascular procedures, presenting with delayed AKI, hypocomplementemia, and cholesterol crystal embolization.</span></li></ul>",
      "correct_choice_id": 247982,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62133,
      "choices": [
        {
          "id": 247793,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Accumulation of iron within macrophages</span></span></span></p>"
        },
        {
          "id": 247794,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Products of free radical-induced lipid peroxidation</span></span></span></p>"
        },
        {
          "id": 247795,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Deposition of misfolded proteins</span></span></span></p>"
        },
        {
          "id": 247796,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Glycogen storage in excess</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 75-year-old man presents to his primary care physician for a routine physical examination. He reports no significant health issues but mentions mild fatigue. Physical examination is unremarkable.<strong> </strong></span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">He has a history of well-controlled hypertension. A liver biopsy, performed as part of a research study, shows granular, brownish-yellow intracytoplasmic deposits within hepatocytes. No signs of inflammation or fibrosis are noted. The patient&#39;s liver enzymes are within normal limits. Which of the following best describes the nature of the observed deposits in this patient&rsquo;s liver cells? </span></span></p>",
      "unique_key": "Q7237281",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans. B) Products of free radical-induced lipid peroxidation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Lipofuscin (</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">a <strong>wear-and-tear</strong> pigment) affects tissues such as the liver, heart, and brain. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Lipofuscin represents <strong>products of lipid peroxidation</strong> resulting from <strong>oxidative damage</strong> over time and is considered a marker of cellular aging.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Accumulation of iron within macrophages:</span></strong><span style=\"font-size:14.0pt\"> Incorrect. Iron (hemosiderin) stains with Prussian blue, unlike lipofuscin.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Deposition of misfolded proteins:</span></strong><span style=\"font-size:14.0pt\"> Incorrect. Misfolded proteins (e.g., amyloid) stain with Congo red, not typical of these deposits.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Glycogen storage in excess:</span></strong><span style=\"font-size:14.0pt\"> Incorrect. Glycogen appears clear in special stains (PAS), not brownish-yellow.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Lipofuscin&nbsp;</span></strong><span style=\"font-size:14.0pt\">is an age-related pigment resulting from <strong>lipid peroxidation</strong> and is harmless.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247794,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62242,
      "choices": [
        {
          "id": 248225,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Neurocysticercosis</span></span></span></p>"
        },
        {
          "id": 248226,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tuberculoma</span></span></span></p>"
        },
        {
          "id": 248227,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">PML</span></span></span></p>"
        },
        {
          "id": 248228,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cryptococcomas</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 20-year-old male patient presented with a headache and altered sensorium. MRI was performed which revealed multiple rings enhancing lesions. MR spectroscopy showed a prominent lipid-lactate peak. What is the likely diagnosis?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-161029.jpg\" style=\"height:218px; width:400px\" /></span></span></p>",
      "unique_key": "Q7231071",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Tuberculoma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Foci of infection <strong>which conglomerating ring enhancing lesions, common around brainstem</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tuberculoma is <strong>central nervous system tuberculosis</strong> characterized by <strong>intracranial granulomas</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">On <strong>MRI</strong>, these can <strong>appear as ring-enhancing lesions</strong>, particularly around the <strong>brainstem</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">MR spectroscopy&nbsp;</span></strong><span style=\"font-size:14.0pt\">reveals a <strong>lipid-lactate peak</strong> due to <strong>necrosis</strong> within the <strong>lesion</strong>, which is a distinguishing feature in comparison to other infections.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Neurocysticercosis:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Neurocysticercosis is a <strong>parasitic infection</strong> caused by the <strong>larval stage of Taenia solium</strong>, presenting with <strong>seizures</strong>, <strong>headaches</strong>, or other <strong>neurological symptoms</strong>. MRI findings often include cystic lesions with or without a scolex (the head of the larva), and ring-enhancing lesions when the cyst is dying. MR spectroscopy may show elevated choline and reduced N-acetyl aspartate (NAA), but a prominent lipid-lactate peak is not typical.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. PML (Progressive Multifocal Leukoencephalopathy):&nbsp;</span></strong><span style=\"font-size:14.0pt\">PML is a <strong>demyelinating disease</strong> caused by the <strong>JC virus</strong>, most commonly in <strong>immunocompromised patients</strong>. MRI shows non-enhancing white matter lesions without mass effect, typically in the parieto-occipital regions. MR spectroscopy in PML typically shows a reduction in NAA, reflecting neuronal loss or damage, without a prominent lipid-lactate peak.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Cryptococcomas:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Cryptococcomas are <strong>localized granulomatous lesions</strong> caused by <strong>Cryptococcus</strong>, seen in <strong>both immunocompetent</strong> and <strong>immunocompromised individuals</strong>. MRI may show multiple ring-enhancing lesions, similar to tuberculoma, but spectroscopy differs, usually without a significant lipid-lactate peak.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In a <strong>patient presenting with headaches</strong> and <strong>altered sensorium</strong>, <strong>multiple ring-enhancing lesions</strong> on <strong>MRI</strong>, accompanied by a <strong>prominent lipid-lactate peak</strong> on <strong>MR spectroscopy</strong>, are indicative of <strong>tuberculoma</strong>, where the lipid-lactate peak suggests necrosis within the lesions.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-161054.jpg\" style=\"height:222px; width:700px\" /></span></span></span></p>",
      "correct_choice_id": 248226,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        17
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62168,
      "choices": [
        {
          "id": 247933,
          "text": "<p><span style=\"font-size:18px;\">Reentrant atrial circuits; start anticoagulation therapy</span></p>"
        },
        {
          "id": 247934,
          "text": "<p><span style=\"font-size:18px;\">Multiple ectopic foci in the atria; correct underlying hypoxia</span></p>"
        },
        {
          "id": 247935,
          "text": "<p><span style=\"font-size:18px;\">Gradual shift of the pacemaker focus within the atria; observe without intervention</span></p>"
        },
        {
          "id": 247936,
          "text": "<p><span style=\"font-size:18px;\">Sinoatrial node dysfunction; initiate permanent pacemaker placement</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">A 72-year-old woman with a history of COPD presents with palpitations. She denies chest pain, shortness of breath, or palpitations. ECG was taken and shown below. Cardiac examination shows no murmurs, and her blood pressure is stable at 100/60 mmHg and her SpO2 is 91% with 4L of nasal O2. Serum electrolytes and thyroid function tests are normal. Considering the patient's ECG findings, which of the following mechanisms most likely explains the condition, and what would be the appropriate next step in management?<strong>&nbsp;</strong></span></p><p><span style=\"font-size:18px;\">&nbsp;</span></p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-165842.jpg\" alt=\"\" width=\"500\" height=\"100\"></span></p>",
      "unique_key": "Q6791174",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans.&nbsp;B) Multiple ectopic foci in the atria; correct underlying hypoxia</strong></span></p><p><span style=\"font-size:18px;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:18px;\">The patient’s history of COPD and the ECG findings (likely showing <strong>multifocal atrial tachycardia (MAT)</strong>) suggest a condition often caused by multiple ectopic foci in the atria.&nbsp;</span></li><li><span style=\"font-size:18px;\">MAT is associated with underlying pulmonary conditions, such as COPD, where <strong>hypoxia</strong> contributes to the arrhythmia.&nbsp;</span></li><li><span style=\"font-size:18px;\">The first step in management is to <strong>correct the underlying hypoxia</strong> to address the arrhythmia.</span></li></ul><p><span style=\"font-size:18px;\">&nbsp;</span></p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:18px;\">&nbsp;</span></p><p><span style=\"font-size:18px;\"><strong>Option A. Reentrant atrial circuits; start anticoagulation therapy:</strong> This describes <strong>atrial fibrillation</strong>, which usually requires anticoagulation. However, the ECG and history are more consistent with multifocal atrial tachycardia rather than atrial fibrillation.</span></p><p><span style=\"font-size:18px;\">&nbsp;</span></p><p><span style=\"font-size:18px;\"><strong>Option C. Gradual shift of the pacemaker focus within the atria; observe without intervention:</strong> This describes <strong>wandering atrial pacemaker</strong>, which is typically benign and does not require intervention. However, the patient's COPD history and the likely multifocal atrial tachycardia require correcting the hypoxia.</span></p><p><span style=\"font-size:18px;\">&nbsp;</span></p><p><span style=\"font-size:18px;\"><strong>Option D. Sinoatrial node dysfunction; initiate permanent pacemaker placement:</strong> This would apply in cases of <strong>sick sinus syndrome</strong>, which is not supported by the patient's presentation or ECG findings.</span></p><p><span style=\"font-size:18px;\">&nbsp;</span></p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:18px;\">&nbsp;</span></p><p><span style=\"font-size:18px;\">In patients with a history of COPD presenting with palpitations and ECG findings of <strong>multifocal atrial tachycardia (MAT)</strong>, the underlying cause is often <strong>hypoxia</strong> due to lung disease, and the primary management is to address the hypoxia, typically improving the arrhythmia.</span></p>",
      "correct_choice_id": 247934,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62369,
      "choices": [
        {
          "id": 248725,
          "text": "<p><span style=\"font-size:14.0pt;\">Entry wound is bevelled in the outer table of the skull</span></p>"
        },
        {
          "id": 248726,
          "text": "<p><span style=\"font-size:14.0pt;\">Abrasion collar is seen in entry wound</span></p>"
        },
        {
          "id": 248727,
          "text": "<p><span style=\"font-size:14.0pt;\">Harrison-Gilroy test can detect gunshot residue</span></p>"
        },
        {
          "id": 248728,
          "text": "<p><span style=\"font-size:14.0pt;\">Stellate shaped wound is seen in contact shot</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A forensic expert is describing the distinguishing features of gunshot wounds during an autopsy of a gunshot victim. Each type of gunshot wound has characteristic appearances, depending on the range and the point of entry. Which of the following is not a correct feature of a gunshot wound?</span></p>",
      "unique_key": "Q4854020",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) Entry wound is bevelled in the outer table of the skull</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The entry wound of a gunshot in the skull is characterized by beveling in the <strong>inner table</strong> of the skull, not the outer table.</span></li><li><span style=\"font-size:14.0pt;\">When a bullet penetrates the skull, it creates a clean round hole on the outer table, but as it passes through and exits, it causes beveling on the inner aspect, creating a characteristic internal cone-shaped defect.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Abrasion collar is seen in entry wound</strong>: The entry wound of a gunshot typically has an abrasion collar due to the friction between the bullet and the skin upon entry.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Harrison-Gilroy test can detect gunshot residue</strong>: The Harrison-Gilroy test is indeed used to detect gunshot residue, indicating a person fired or was close to a firearm when it was discharged.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D</strong>. <strong>Stellate shaped wound is seen in contact shot</strong>: A stellate (star-shaped) wound is often seen in contact gunshot wounds, particularly over bony areas, due to gases expanding beneath the skin, causing it to tear in a star-like pattern.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">When assessing gunshot wounds, understanding the anatomical features of entry and exit wounds is crucial.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Bevelling </strong>occurs in the <strong>inner table</strong> of the skull at the entry wound and in the <strong>outer table</strong> at the exit point.</span></li><li><span style=\"font-size:14.0pt;\">Recognizing these features helps forensic experts determine the direction of the bullet and understand the circumstances of the shooting.</span></li></ul>",
      "correct_choice_id": 248725,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62218,
      "choices": [
        {
          "id": 248129,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Isthmus</span></span></p>"
        },
        {
          "id": 248130,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infundibulum</span></span></p>"
        },
        {
          "id": 248131,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Interstitial portion</span></span></p>"
        },
        {
          "id": 248132,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ampulla</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 24-year-old woman presents to the emergency department with lower abdominal pain and spotting. She is confirmed to have an unruptured tubal ectopic pregnancy based on ultrasound findings. Which of the following is the most common site of implantation in this ectopic pregnancy? </span></span></p>",
      "unique_key": "Q5518693",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Ampulla</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The <strong>ampulla</strong> of the fallopian tube is the most common site for ectopic pregnancy, accounting for approximately 70-80% of cases. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This region is where fertilization typically occurs, and if there is a delay in the movement of the fertilized egg, it may implant in the ampulla rather than traveling to the uterus. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The fallopian tube is not designed to support a growing pregnancy, making ectopic pregnancies life-threatening if not managed promptly.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Isthmus:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Incorrect. The <strong>isthmus</strong> is a common site for ectopic pregnancy, but it is less common than the ampulla. Ectopic pregnancies in the isthmus account for about 12% of cases.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Infundibulum:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Incorrect. The <strong>infundibulum</strong>, which is closer to the ovary, is a rarer site for ectopic implantation compared to the ampulla and isthmus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Interstitial portion:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Incorrect. The <strong>interstitial portion</strong> (the part of the tube that traverses the uterine wall) is the least common site for ectopic pregnancy, accounting for 2-4% of cases.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The <strong>ampulla</strong> of the fallopian tube is the <strong>most common site</strong> of implantation in ectopic pregnancies, occurring in about 70-80% of cases.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248132,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62156,
      "choices": [
        {
          "id": 247885,
          "text": "<p><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Exenatide</span></span></p>"
        },
        {
          "id": 247886,
          "text": "<p><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sitagliptin</span></span></p>"
        },
        {
          "id": 247887,
          "text": "<p><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rosiglitazone</span></span></p>"
        },
        {
          "id": 247888,
          "text": "<p><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Repaglinide</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 58-year-old woman with type 2 diabetes mellitus is being evaluated for adjustments to her antidiabetic medication regimen. She has been experiencing issues with postprandial blood glucose control. Which of the following antidiabetic drugs does not enhance insulin secretion? </span></span></p>",
      "unique_key": "Q4206299",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Ans. C) Rosiglitazone</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Rosiglitazone&nbsp;</span></strong><span style=\"font-size:14.0pt\">is a <strong>thiazolidinedione (TZD)</strong> that works by <strong>increasing insulin sensitivity</strong> in peripheral tissues such as muscle and adipose tissue. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It acts as an <strong>agonist of the PPAR-&gamma; (peroxisome proliferator-activated receptor-gamma)</strong>, which improves the body&#39;s response to insulin, thereby reducing blood glucose levels. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Unlike other options, <strong>rosiglitazone does not directly stimulate insulin secretion</strong> from the pancreas.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Exenatide</span></strong><span style=\"font-size:14.0pt\">: Exenatide is a <strong>GLP-1 receptor agonist</strong> that <strong>enhances insulin secretion</strong> in response to food intake by mimicking the incretin hormone <strong>GLP-1</strong>. It stimulates <strong>glucose-dependent insulin release</strong> from the pancreas.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Sitagliptin</span></strong><span style=\"font-size:14.0pt\">: Sitagliptin is a <strong>DPP-4 inhibitor</strong> that works by <strong>increasing the levels of endogenous incretin hormones</strong> like <strong>GLP-1</strong> and <strong>GIP</strong>, which in turn <strong>enhance insulin secretion</strong> in a glucose-dependent manner.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Repaglinide</span></strong><span style=\"font-size:14.0pt\">: Repaglinide is a <strong>meglitinide</strong> that directly <strong>stimulates insulin release</strong> from the pancreatic <strong>beta cells</strong> by closing <strong>ATP-sensitive potassium channels</strong>, similar to sulfonylureas.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Rosiglitazone&nbsp;</span></strong><span style=\"font-size:14.0pt\">increases <strong>insulin sensitivity</strong> without directly stimulating <strong>insulin secretion</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Exenatide</span></strong><span style=\"font-size:14.0pt\">, <strong>sitagliptin</strong>, and <strong>repaglinide</strong> enhance <strong>insulin release</strong> from the pancreas through different mechanisms.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Thiazolidinediones (TZDs)&nbsp;</span></strong><span style=\"font-size:14.0pt\">like <strong>rosiglitazone</strong> target <strong>insulin resistance</strong>, making them unique among many antidiabetic therapies.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247887,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62175,
      "choices": [
        {
          "id": 247961,
          "text": "<p><span style=\"font-size:14.0pt;\">MYH7 mutation</span></p>"
        },
        {
          "id": 247962,
          "text": "<p><span style=\"font-size:14.0pt;\">LMNA mutation</span></p>"
        },
        {
          "id": 247963,
          "text": "<p><span style=\"font-size:14.0pt;\">BMPR2 mutation</span></p>"
        },
        {
          "id": 247964,
          "text": "<p><span style=\"font-size:14.0pt;\">KCNQ1 mutation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 40-year-old woman with recent episodes of syncope, shortness of breath, and palpitations presents with jugular venous distention, pitting edema, and a narrowly split S2. ECG shows atrial fibrillation with right axis deviation, and echocardiography reveals right ventricular hypertrophy. Which genetic mutation is most likely responsible for her condition?</span></p>",
      "unique_key": "Q7178774",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) BMPR2 mutation</strong>.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient's symptoms of <strong>syncope, shortness of breath, palpitations</strong>, and physical findings such as <strong>jugular venous distention, pitting edema, narrowly split S2</strong>, along with <strong>right ventricular hypertrophy</strong> seen on echocardiography, are suggestive of <strong>pulmonary arterial hypertension (PAH)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The ECG findings of <strong>atrial fibrillation with right axis deviation</strong> further support this diagnosis.</span></li><li><span style=\"font-size:14.0pt;\"><strong>BMPR2 (Bone Morphogenetic Protein Receptor Type 2) mutations</strong> are associated with <strong>heritable pulmonary arterial hypertension (PAH)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Mutations in this gene lead to abnormal vascular remodeling in the pulmonary arteries, causing elevated pulmonary pressures and right ventricular hypertrophy, which can eventually lead to right heart failure, as seen in this patient. BMPR2 mutations are the most common genetic cause of familial PAH.</span></li></ul><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option A. MYH7 mutation:</strong> This mutation is associated with <strong>hypertrophic cardiomyopathy</strong>, a condition characterized by left ventricular hypertrophy and typically does not cause right ventricular hypertrophy or pulmonary hypertension.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option B. LMNA mutation:</strong> Mutations in the <strong>LMNA</strong> gene are associated with various forms of <strong>cardiomyopathy</strong> and conduction system diseases but are not linked to pulmonary arterial hypertension or right ventricular hypertrophy.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option D. KCNQ1 mutation:</strong> This mutation is responsible for <strong>long QT syndrome</strong>, which leads to arrhythmias but does not cause pulmonary hypertension or right ventricular hypertrophy.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>BMPR2</strong> mutation is most commonly associated with <strong>heritable pulmonary arterial hypertension (PAH)</strong>, which presents with signs of right heart strain, including <strong>right ventricular hypertrophy</strong>, <strong>jugular venous distention</strong>, and <strong>narrowly split S2</strong>.</span></li></ul>",
      "correct_choice_id": 247963,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62285,
      "choices": [
        {
          "id": 248397,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">50 mL/kg</span></span></p>"
        },
        {
          "id": 248398,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">75 mL/kg</span></span></p>"
        },
        {
          "id": 248399,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">100 mL/kg</span></span></p>"
        },
        {
          "id": 248400,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">150 mL/kg</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 4-year-old child presents to the emergency department with a history of vomiting and diarrhea for 2 days. The child is irritable, has sunken eyes, and decreased skin turgor with a capillary refill time of about 2 seconds. The pediatrician diagnoses the child with moderate dehydration. What is the recommended amount of oral rehydration solution (ORS) to be given to this child?</span></span></p>",
      "unique_key": "Q1447034",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) 75 mL/kg</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">For a child with moderate dehydration, the recommended amount of ORS is 75 mL/kg of body weight. This helps to replace the fluid loss effectively and rehydrate the child.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. 50 mL/kg:</span></strong><span style=\"font-size:14.0pt\"> This amount is insufficient for moderate dehydration. It may be more appropriate for minimal dehydration.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. 100 mL/kg:</span></strong><span style=\"font-size:14.0pt\"> This amount is typically used in cases of severe dehydration when initial rehydration with IV fluids may also be considered.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. 150 mL/kg:</span></strong><span style=\"font-size:14.0pt\"> This exceeds the recommended amount and could lead to fluid overload in a child with moderate dehydration.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">For children with moderate dehydration, administer oral rehydration solution (ORS) at a dose of 75 mL/kg of body weight. </span></span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This amount helps to replenish lost fluids and electrolytes while ensuring gradual rehydration.</span></span></li>\r\n</ul>",
      "correct_choice_id": 248398,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62170,
      "choices": [
        {
          "id": 247941,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tolcapone</span></span></p>"
        },
        {
          "id": 247942,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Selegiline</span></span></p>"
        },
        {
          "id": 247943,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amantadine</span></span></p>"
        },
        {
          "id": 247944,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Biperiden</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 65-year-old man with a history of schizophrenia presents with tremors, bradykinesia, and rigidity that started after he was started on antipsychotic medication. His symptoms are consistent with drug-induced Parkinsonism. Which of the following is the most appropriate drug to manage this condition? </span></span></p>",
      "unique_key": "Q6541814",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Biperiden</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Biperiden&nbsp;</span></strong><span style=\"font-size:14.0pt\">is an <strong>anticholinergic agent</strong> that is effective in treating <strong>drug-induced Parkinsonism</strong>, particularly when caused by <strong>antipsychotic medications</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It works by <strong>blocking muscarinic receptors</strong> in the brain, which helps to <strong>restore the balance</strong> between <strong>dopaminergic</strong> and <strong>cholinergic activity</strong> that is often disrupted by medications like <strong>antipsychotics</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Anticholinergic agents are the <strong>first-line treatment</strong> for <strong>extrapyramidal symptoms (EPS)</strong>, including <strong>drug-induced Parkinsonism</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Tolcapone</span></strong><span style=\"font-size:14.0pt\">: <strong>Tolcapone</strong> is a <strong>COMT (Catechol-O-methyltransferase) inhibitor</strong> used in <strong>Parkinson&#39;s disease</strong> to enhance the effects of <strong>levodopa</strong>. It is not used for <strong>drug-induced Parkinsonism</strong> as it is more specific for treating the <strong>motor fluctuations</strong> in <strong>idiopathic Parkinson&#39;s disease</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Selegiline</span></strong><span style=\"font-size:14.0pt\">: <strong>Selegiline</strong> is a <strong>MAO-B (monoamine Oxidase-B) inhibitor</strong> used in the management of <strong>idiopathic Parkinson&#39;s disease</strong> by reducing the breakdown of <strong>dopamine</strong>. It is not effective in managing <strong>drug-induced Parkinsonism</strong> caused by <strong>antipsychotics</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Amantadine</span></strong><span style=\"font-size:14.0pt\">: <strong>Amantadine</strong> is an <strong>NMDA receptor antagonist</strong> with some <strong>dopaminergic</strong> activity and can be used in <strong>Parkinson&#39;s disease</strong> for managing <strong>mild symptoms</strong>. However, <strong>anticholinergics</strong> like <strong>biperiden</strong> are preferred for <strong>drug-induced Parkinsonism</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Biperiden&nbsp;</span></strong><span style=\"font-size:14.0pt\">and other <strong>anticholinergics</strong> are the <strong>drug of choice</strong> for <strong>drug-induced Parkinsonism</strong>, particularly due to <strong>antipsychotic medications</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Tolcapone&nbsp;</span></strong><span style=\"font-size:14.0pt\">and <strong>selegiline</strong> are used in <strong>idiopathic Parkinson&rsquo;s disease</strong> but are not effective for <strong>drug-induced Parkinsonism</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Amantadine&nbsp;</span></strong><span style=\"font-size:14.0pt\">has some role in <strong>Parkinson&rsquo;s disease</strong> but is not the first-line treatment for <strong>drug-induced extrapyramidal symptoms</strong>.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247944,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62344,
      "choices": [
        {
          "id": 248629,
          "text": "<p><span style=\"font-size:14.0pt;\">B, A, C, D</span></p>"
        },
        {
          "id": 248630,
          "text": "<p><span style=\"font-size:14.0pt;\">D, C, B, A</span></p>"
        },
        {
          "id": 248631,
          "text": "<p><span style=\"font-size:14.0pt;\">C, D, A, B</span></p>"
        },
        {
          "id": 248632,
          "text": "<p><span style=\"font-size:14.0pt;\">A, B, C, D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 58-year-old male presents to the emergency department with palpitations and dizziness. His ECG shows ventricular arrhythmia. The pathophysiology of ventricular action potentials is reviewed to understand the mechanism behind the abnormal electrical activity. Which of the following options correctly arranges the sequence of events in the ventricular action potential?</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\">A) Transient outward flow of potassium</span></p><p><span style=\"font-size:14.0pt;\">B) Repolarizing K⁺ currents</span></p><p><span style=\"font-size:14.0pt;\">C) Opening of voltage-gated sodium channels</span></p><p><span style=\"font-size:14.0pt;\">D) Opening of voltage-gated calcium channels&nbsp;</span></p>",
      "unique_key": "Q7657836",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) C, D, A, B</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Explanation:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\">The ventricular action potential consists of distinct phases that occur in the following sequence:</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>C. Opening of voltage-gated sodium channels</strong>: This occurs during <strong>Phase 0</strong>, where rapid sodium influx leads to depolarization of the ventricular membrane.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>D. Transient outward flow of potassium</strong>: During <strong>Phase 1</strong>, a brief outward potassium current causes a small drop in membrane potential, initiating partial repolarization.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>A. Opening of voltage-gated calcium channels</strong>: In <strong>Phase 2</strong>, calcium channels open, allowing calcium influx, which sustains the <strong>plateau phase</strong>, balancing the outward potassium flow.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>B. Repolarizing K⁺ currents</strong>: During <strong>Phase 3</strong>, calcium channels close, and potassium efflux dominates, causing repolarization of the membrane and the return to the resting membrane potential.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\">This correct sequence is essential for coordinated contraction of the ventricular myocardium and proper cardiac function.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/22/screenshot-2024-10-22-114213.png\" alt=\"\" width=\"500\" height=\"366\"></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul><li><span style=\"font-size:14.0pt;\">The <strong>ventricular action potential</strong> occurs in a specific order: <strong>sodium channel opening (depolarization)</strong>, followed by <strong>transient potassium outflow</strong>, then <strong>calcium channel activation</strong> (plateau phase), and finally, <strong>potassium-driven repolarization</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This sequence is critical for maintaining proper electrical and mechanical function of the heart.</span></li></ul>",
      "correct_choice_id": 248631,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62131,
      "choices": [
        {
          "id": 247785,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Vitamin B1</span></span></span></p>"
        },
        {
          "id": 247786,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Vitamin B6</span></span></span></p>"
        },
        {
          "id": 247787,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Vitamin B12</span></span></span></p>"
        },
        {
          "id": 247788,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Folic acid</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old man is brought to the emergency department after being found unconscious on the street. The history reveals chronic alcohol use. Upon arrival, he is confused and disoriented. His vitals are stable, and the physical exam shows no signs of trauma. Which of the following is the most appropriate initial treatment for this patient? </span></span></p>",
      "unique_key": "Q6903913",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Vitamin B1</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The most appropriate initial treatment in this scenario is <strong>Vitamin B1 (thiamine)</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Chronic alcohol use is strongly associated with <strong>thiamine deficiency</strong>, which can lead to <strong>Wernicke encephalopathy</strong>, a condition characterized by <strong>confusion</strong>, <strong>ataxia</strong>, and <strong>ophthalmoplegia</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Thiamine is a critical cofactor for enzymes involved in glucose metabolism, including <strong>pyruvate dehydrogenase</strong> and <strong>&alpha;-ketoglutarate dehydrogenase</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Administering <strong>thiamine</strong> before giving <strong>glucose</strong> is essential, as giving glucose alone can deplete the remaining thiamine stores, potentially worsening <strong>Wernicke encephalopathy</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Early treatment with thiamine can prevent progression to <strong>irreversible neurological damage</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Vitamin B6</span></strong><span style=\"font-size:14.0pt\">: Incorrect. <strong>Vitamin B6 (pyridoxine)</strong> is important in the management of certain conditions, such as <strong>isoniazid toxicity</strong> and <strong>some types of anemia</strong>, but it is not the first-line treatment for <strong>Wernicke encephalopathy</strong> caused by thiamine deficiency in chronic alcohol use.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Vitamin B12</span></strong><span style=\"font-size:14.0pt\">: Incorrect. <strong>Vitamin B12 (cobalamin)</strong> deficiency is associated with <strong>megaloblastic anemia</strong> and <strong>subacute combined degeneration</strong> of the spinal cord, but it is not the treatment for <strong>Wernicke encephalopathy</strong>. This patient&#39;s symptoms, combined with his history of chronic alcohol use, point to a thiamine deficiency rather than a B12 deficiency.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Folic acid</span></strong><span style=\"font-size:14.0pt\">: Incorrect. <strong>Folic acid</strong> is often used to treat <strong>megaloblastic anemia</strong> in chronic alcohol users, as alcohol can impair folate absorption. However, it does not address the risk of <strong>Wernicke encephalopathy</strong>. <strong>Thiamine</strong> is the priority in this scenario.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">In patients with chronic alcohol use at risk for <strong>Wernicke encephalopathy</strong>, <strong>Vitamin B1 (thiamine)</strong> should be administered before any <strong>glucose</strong> to prevent worsening of neurological symptoms. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Thiamine deficiency can cause serious complications if not addressed promptly, making early intervention crucial in preventing irreversible damage.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247785,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62201,
      "choices": [
        {
          "id": 248061,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There is a strong positive correlation between drug dosage and blood pressure reduction.</span></span></p>"
        },
        {
          "id": 248062,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There is a negative correlation between drug dosage and blood pressure reduction.</span></span></p>"
        },
        {
          "id": 248063,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The data shows no significant correlation between drug dosage and blood pressure reduction.</span></span></p>"
        },
        {
          "id": 248064,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The relationship between drug dosage and blood pressure reduction is non-linear.</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A researcher is analyzing the relationship between the dosage of a new drug (variable X) and the reduction in blood pressure (variable Y) in a group of hypertensive patients. The scatter plot below displays the data collected from this study. Based on the plot, what conclusion can be drawn about the relationship between the drug dosage and blood pressure reduction? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-173449.jpg\" style=\"height:218px; width:350px\" /></span></span></p>",
      "unique_key": "Q3626104",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) There is a strong positive correlation between drug dosage and blood pressure reduction.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The scatter plot shows that as X (drug dosage) increases, Y (blood pressure reduction) also increases, which is characteristic of a positive correlation. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The data points tend to form an upward trend, indicating that higher doses of the drug are associated with greater reductions in blood pressure. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This type of relationship is often seen when increasing a medication dose results in a stronger therapeutic effect.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options</span></strong><span style=\"font-size:14.0pt\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. There is a negative correlation between drug dosage and blood pressure reduction</span></strong><span style=\"font-size:14.0pt\">: Incorrect. A negative correlation would indicate that as the drug dosage increases, the reduction in blood pressure decreases. The plot shows the opposite trend, with both increasing together.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. The data shows no significant correlation between drug dosage and blood pressure reduction</span></strong><span style=\"font-size:14.0pt\">: Incorrect. The scatter plot clearly shows a pattern where higher X values (dosage) are associated with higher Y values (reduction), indicating a significant positive correlation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. The relationship between drug dosage and blood pressure reduction is non-linear</span></strong><span style=\"font-size:14.0pt\">: Incorrect. The scatter plot suggests a linear trend, where changes in X correspond consistently with changes in Y, forming an approximately straight-line pattern.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Scatter plots are valuable for visualizing relationships between two continuous variables. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-173628.jpg\" style=\"height:202px; width:750px\" /></span></span></p>",
      "correct_choice_id": 248061,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62172,
      "choices": [
        {
          "id": 247949,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">Thiamine administration should be given before glucose</span></p>"
        },
        {
          "id": 247950,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">The classic triad includes confusion, ataxia, and ophthalmoplegia</span></p>"
        },
        {
          "id": 247951,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">Korsakoff's syndrome always follows if left untreated</span></p>"
        },
        {
          "id": 247952,
          "text": "<p><span style=\"font-size:14.0pt;\">Prompt treatment can reverse symptoms in many cases</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 50-year-old man with a history of heavy alcohol use presents with confusion, ataxia, and ophthalmoplegia. Which of the following statements about his condition is false?</span></p>",
      "unique_key": "Q8355823",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Korsakoff's syndrome always follows if left untreated</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">While untreated Wernicke’s encephalopathy can progress to Korsakoff’s syndrome, it <strong>does not always do so</strong>. Korsakoff’s syndrome, characterized by severe memory impairment and confabulation, occurs in some cases but not all. Early recognition and treatment of Wernicke’s encephalopathy can prevent progression to Korsakoff's syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Thiamine administration should be given before glucose (True):</strong> Thiamine should be administered before glucose in patients with suspected Wernicke’s encephalopathy because giving glucose without thiamine can worsen the condition. Thiamine is a cofactor in carbohydrate metabolism, and administering glucose first can deplete the already low thiamine levels, exacerbating symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. The classic triad includes confusion, ataxia, and ophthalmoplegia (True):</strong> The classic triad of Wernicke’s encephalopathy includes confusion, ataxia, and ophthalmoplegia (paralysis or weakness of the eye muscles). However, not all patients present with the full triad, making early diagnosis sometimes challenging.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Prompt treatment can reverse symptoms in many cases (True):</strong> Early administration of thiamine can reverse the symptoms of Wernicke’s encephalopathy, especially if treatment is initiated quickly. However, if the condition progresses to Korsakoff’s syndrome, cognitive impairments may become permanent.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Wernicke’s encephalopathy is an acute complication due to thiamine (Vitamin B1) deficiency. It is characterized by a triad of global confusion, ophthalmoplegia (6th cranial nerve palsy &gt; 3rd nerve palsy), and ataxia in the context of chronic alcohol abuse. Wernicke encephalopathy may clear spontaneously in a few days or weeks or may progress to Korsakoff syndrome. Immediate treatment with thiamine is essential to prevent further progression to Korsakoff syndrome.&nbsp;&nbsp;</span></p>",
      "correct_choice_id": 247951,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62283,
      "choices": [
        {
          "id": 248389,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Use paladai for routine feeding as the primary method</span> </span></span></p>"
        },
        {
          "id": 248390,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Switch to nasogastric tube feeding due to gestational age</span></span></p>"
        },
        {
          "id": 248391,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Initiate breastfeeding directly with mother&rsquo;s milk</span></span></p>"
        },
        {
          "id": 248392,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Avoid using paladai until 36 weeks gestational age</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 2-day-old newborn is in the neonatal intensive care unit (NICU) because his mother is severely ill and unable to breastfeed. The child was born at 33 weeks of gestation and is stable. Which of the following is the most appropriate method for feeding for this newborn?</span></span></p>",
      "unique_key": "Q4234866",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Use paladai for routine feeding as the primary method</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A paladai, can be used for feeding neonates born at a gestational age of 32-34 weeks when coordination between swallowing and breathing starts to develop. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is suitable for stable preterm infants who can safely take feeds without the need for tube feeding.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Switch to nasogastric tube feeding due to gestational age:&nbsp;</strong></span><span style=\"font-size:14.0pt\">Nasogastric tube feeding is more appropriate for neonates born before 32 weeks of gestation or for those who cannot coordinate suck, swallow, and breathing. Since the newborn in the scenario is at 33 weeks and stable, paladai can be safely used.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Initiate breastfeeding directly with mother&rsquo;s milk:&nbsp;</strong></span><span style=\"font-size:14.0pt\">Direct breastfeeding may not be immediately feasible for mothers who are unable to breastfeed, and the baby might still be developing the suckling reflex. Hence, expressed milk through paladai is appropriate in this case.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Avoid using paladai until 36 weeks gestational age:&nbsp;</strong></span><span style=\"font-size:14.0pt\">Paladai can be used from 32 weeks gestational age; waiting until 36 weeks is unnecessary when the infant is otherwise stable and shows feeding readiness signs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The paladai is suitable for feeding stable preterm infants born between 32-34 weeks of gestation when coordination between sucking, swallowing, and breathing begins to develop. </span></span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a practical alternative when direct breastfeeding is not an option due to maternal health conditions.</span></span></li>\r\n</ul>",
      "correct_choice_id": 248389,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62240,
      "choices": [
        {
          "id": 248217,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Falling on an outstretched hand</span></span></span></p>"
        },
        {
          "id": 248218,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Direct blow to the shoulder</span></span></span></p>"
        },
        {
          "id": 248219,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Seizure or electric shock</span></span></span></p>"
        },
        {
          "id": 248220,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Rotational force applied to the arm</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the mechanism of injury most commonly associated with a posterior shoulder dislocation? </span></span></p>",
      "unique_key": "Q8062759",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">C) Seizure or electric shock</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This option accurately describes the most common mechanism associated with posterior shoulder dislocations. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">During a seizure or electric shock, the muscles can contract violently and uncontrollably. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This muscle spasm can pull the arm into an adducted and internally rotated position, leading to the humeral head dislocating posteriorly out of the glenoid cavity. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Posterior dislocations are relatively rare compared to anterior dislocations, but this mechanism is a classic cause.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Falling on an outstretched hand:&nbsp;</span></strong><span style=\"font-size:14.0pt\">This mechanism is typically associated with anterior shoulder dislocations, not posterior. When a person falls and attempts to catch themselves with an outstretched hand, the force is transmitted through the arm to the shoulder. This can cause the humeral head to dislocate forward (anteriorly) out of the glenoid cavity. Anterior dislocations are the most common type, accounting for the majority of shoulder dislocations.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Direct blow to the shoulder:&nbsp;</span></strong><span style=\"font-size:14.0pt\">A direct blow to the shoulder can cause a variety of shoulder injuries, including fractures or dislocations. However, it is more commonly associated with anterior dislocations. A significant impact can push the humeral head forward or downward but does not typically result in posterior dislocation unless the force is combined with other factors, such as rotation or specific positioning.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Rotational force applied to the arm:&nbsp;</span></strong><span style=\"font-size:14.0pt\">While rotational forces can lead to various shoulder injuries, including some types of dislocations, they are more commonly linked to specific types of traumatic injuries or certain sports-related incidents. This mechanism alone is not typically sufficient to cause a posterior dislocation unless it occurs in conjunction with other factors, such as the arm being in an abnormal position. It is more often involved in injuries like rotator cuff tears or other joint instability rather than a distinct posterior dislocation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Seizure or electric shock is the primary mechanism for posterior shoulder dislocations due to the violent contraction of muscles and subsequent positioning of the arm.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248219,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62163,
      "choices": [
        {
          "id": 247913,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Quinidine - Class Ib</span></span></p>"
        },
        {
          "id": 247914,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lignocaine - Class Ia</span></span></p>"
        },
        {
          "id": 247915,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amiodarone - Class IV</span></span></p>"
        },
        {
          "id": 247916,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&beta;-blockers - Class II</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the correct match of antiarrhythmic drugs with their respective class? </span></span></p>",
      "unique_key": "Q6759908",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) &beta;-blockers - Class II</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">&beta;-blockers&nbsp;</span></strong><span style=\"font-size:14.0pt\">are classified as <strong>Class II antiarrhythmics</strong>. They work by <strong>blocking beta-adrenergic receptors</strong>, reducing <strong>sympathetic activity</strong> in the heart, which results in a <strong>decrease in heart rate</strong> and <strong>myocardial contractility</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This class of drugs is particularly useful in treating <strong>tachyarrhythmias</strong> that are driven by <strong>excessive sympathetic stimulation</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Quinidine - Class Ib</span></strong><span style=\"font-size:14.0pt\">: This is incorrect. <strong>Quinidine</strong> is a <strong>Class Ia</strong> antiarrhythmic, not Class Ib. Class Ia drugs block <strong>sodium channels</strong> and also have some <strong>potassium channel blocking</strong> effects, which help <strong>prolong the action potential</strong> duration.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Lignocaine - Class Ia</span></strong><span style=\"font-size:14.0pt\">: This is incorrect. <strong>Lignocaine (lidocaine)</strong> is actually a <strong>Class Ib</strong> antiarrhythmic. Class Ib drugs primarily <strong>shorten the action potential duration</strong> and are effective in treating <strong>ventricular arrhythmias</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Amiodarone - Class IV</span></strong><span style=\"font-size:14.0pt\">: This is incorrect. <strong>Amiodarone</strong> is classified as a <strong>Class III antiarrhythmic</strong>, which blocks <strong>potassium channels</strong>, leading to <strong>prolongation of the action potential</strong> and <strong>refractory period</strong>. It also has actions across other classes but is primarily used as a Class III agent. <strong>Class IV drugs</strong> include <strong>calcium channel blockers</strong> like <strong>verapamil</strong> and <strong>diltiazem</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Class II antiarrhythmics&nbsp;</span></strong><span style=\"font-size:14.0pt\">are <strong>&beta;-blockers</strong>, which reduce <strong>sympathetic stimulation</strong> of the heart.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Quinidine&nbsp;</span></strong><span style=\"font-size:14.0pt\">is a <strong>Class Ia</strong> drug, while <strong>lidocaine</strong> is <strong>Class Ib</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Amiodarone&nbsp;</span></strong><span style=\"font-size:14.0pt\">is a <strong>Class III</strong> antiarrhythmic that affects <strong>potassium channels</strong>.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247916,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62065,
      "choices": [
        {
          "id": 247521,
          "text": "<p><span style=\"font-size:14.0pt;\">Vertebral artery</span></p>"
        },
        {
          "id": 247522,
          "text": "<p><span style=\"font-size:14.0pt;\">Anterior cerebral artery</span></p>"
        },
        {
          "id": 247523,
          "text": "<p><span style=\"font-size:14.0pt;\">Middle cerebral artery</span></p>"
        },
        {
          "id": 247524,
          "text": "<p><span style=\"font-size:14.0pt;\">Posterior cerebral artery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old woman visits the emergency department with sudden onset dizziness, nausea, and difficulty maintaining balance. She reports that the symptoms began while she was having her hair washed in a salon with her head extended backward over a sink. Physical examination reveals nystagmus, ataxia, and dysarthria. A neurological assessment suggests possible artery damage. Which of the following arteries is most likely damaged in this scenario?</span></p>",
      "unique_key": "Q3841359",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Vertebral artery</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The <strong>vertebral artery</strong> is susceptible to damage or dissection in situations involving <strong>sudden or prolonged neck extension</strong>, such as during a hair wash with the head extended backward over a sink.</span></li><li><span style=\"font-size:14.0pt;\">The vertebral artery supplies blood to the <strong>posterior circulation</strong> of the brain, including the <strong>cerebellum</strong> and <strong>brainstem</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Damage to this artery can result in <strong>vertebrobasilar insufficiency</strong>, leading to symptoms such as <strong>dizziness</strong>, <strong>nystagmus</strong>, <strong>ataxia</strong>, and <strong>dysarthria</strong>.</span></li><li><span style=\"font-size:14.0pt;\">These symptoms occur because of reduced blood flow to the brainstem and cerebellum, which are critical for balance and coordination.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-134542.jpg\" alt=\"\" width=\"450\" height=\"384\">&nbsp;</p><p>&nbsp;</p><figure class=\"image\"><img style=\"aspect-ratio:434/515;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Picture1_3FqD1mq.png\" width=\"434\" height=\"515\"></figure><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Anterior cerebral artery</strong>: Incorrect. The anterior cerebral artery supplies the medial portions of the frontal and parietal lobes, and damage to this artery typically presents with symptoms like <strong>contralateral leg weakness</strong> and <strong>personality changes</strong>, not with dizziness and ataxia.</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Middle cerebral artery</strong>: Incorrect. The middle cerebral artery supplies the lateral aspects of the frontal, parietal, and temporal lobes, and damage here is typically associated with <strong>contralateral hemiparesis</strong>, <strong>aphasia</strong>, or <strong>sensory deficits</strong>, rather than balance and coordination issues.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Posterior cerebral artery</strong>: Incorrect. While the posterior cerebral artery supplies parts of the <strong>occipital lobe</strong> and <strong>thalamus</strong>, its damage typically causes <strong>visual disturbances</strong> or <strong>sensory loss</strong> rather than the cerebellar symptoms (e.g., ataxia and nystagmus) seen with vertebral artery damage.</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Vertebral artery damage&nbsp;</strong>can occur due to <strong>sudden neck hyperextension</strong>, leading to <strong>vertebrobasilar insufficiency</strong> and symptoms such as <strong>dizziness</strong>, <strong>nystagmus</strong>, <strong>ataxia</strong>, and <strong>dysarthria</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Recognizing the relationship between neck positioning and vertebral artery vulnerability is crucial for diagnosis and management.</span></li></ul>",
      "correct_choice_id": 247521,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62389,
      "choices": [
        {
          "id": 248805,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Leg vein thrombosis</span></span></p>"
        },
        {
          "id": 248806,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Headache</span></span></p>"
        },
        {
          "id": 248807,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Breakthrough bleeding</span></span></p>"
        },
        {
          "id": 248808,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Breast tenderness</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old woman comes to the clinic for her annual check-up. She has been using oral contraceptive pills (OCPs) for contraception for the past couple of years, without any significant side effects. She asks about long term risks associated with OCPs. Which of the following is considered the most serious complication of oral contraceptive usage? </span></span></p>",
      "unique_key": "Q6637890",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Leg vein thrombosis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Leg vein thrombosis (deep vein thrombosis, or DVT) is a serious complication associated with oral contraceptive pills (OCPs). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The estrogen component of OCPs increases the risk of thromboembolic events, including DVT and pulmonary embolism. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A patient presenting with unilateral leg pain, swelling, and tenderness should be evaluated for DVT as this can lead to life-threatening complications such as pulmonary embolism if not treated promptly.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options</span></strong><span style=\"font-size:14.0pt\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Headache</span></strong><span style=\"font-size:14.0pt\">: Incorrect. Headaches can be a common side effect of oral contraceptives, especially in women prone to migraines. However, they are generally not considered a serious complication unless associated with neurological symptoms suggestive of stroke.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Breakthrough bleeding</span></strong><span style=\"font-size:14.0pt\">: Incorrect. Breakthrough bleeding is a common and mild side effect of OCPs, particularly during the first few months of use. It does not pose a significant risk to the patient&rsquo;s health.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Breast tenderness</span></strong><span style=\"font-size:14.0pt\">: Incorrect. Breast tenderness is a frequent side effect of hormonal contraceptives due to the estrogen and progesterone components. However, it is not dangerous and typically resolves with continued use.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective</span></strong><span style=\"font-size:14.0pt\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Oral contraceptives increase the risk of thromboembolic events, including deep vein thrombosis (DVT) and pulmonary embolism, which are among the most serious complications.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Unilateral leg swelling and pain in a woman on OCPs should raise suspicion for DVT, and prompt diagnosis and treatment are crucial to prevent life-threatening consequences.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Milder side effects like headache, breakthrough bleeding, and breast tenderness are common but do not carry the same level of risk as thrombosis.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248805,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62160,
      "choices": [
        {
          "id": 247901,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">a-3, b-1, c-2</span></span></span></p>"
        },
        {
          "id": 247902,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">a-1, b-2, c-3</span></span></span></p>"
        },
        {
          "id": 247903,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">a-2, b-1, c-3</span></span></span></p>"
        },
        {
          "id": 247904,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">a-3, b-2, c-1</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Match the following postmortem changes with the correct image provided.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Column A (Postmortem Changes):</span></strong></span></span></p>\r\n\r\n<ol style=\"list-style-type:lower-alpha\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Suggillation</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Putrefaction</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Adipocere</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Column B </span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-164743.jpg\" style=\"height:227px; width:350px\" /></span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-164840.jpg\" style=\"height:186px; width:350px\" /></span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-164928.jpg\" style=\"height:333px; width:350px\" /></span></span></strong></p>",
      "unique_key": "Q9345310",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;<strong>Ans. A) a-3, b-1, c-2</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">a. Suggillation (a3)</span></strong><span style=\"font-size:14.0pt\">: Suggillation is the settling of blood in dependent areas after death, creating a purple discoloration, which matches <strong>Image 3</strong>, where this characteristic feature is evident.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">b. Putrefaction (b1)</span></strong><span style=\"font-size:14.0pt\">: Putrefaction refers to the breakdown of tissues by bacterial activity, leading to liquefaction and characteristic green or black discoloration, as seen in <strong>Image 1</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">c. Adipocere (c2)</span></strong><span style=\"font-size:14.0pt\">: Adipocere, or &quot;grave wax,&quot; is formed by the transformation of body fat into a waxy substance, typically seen in bodies exposed to a moist environment. This is well-depicted in <strong>Image 2</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Suggillation&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">involves discoloration due to blood pooling, <strong>putrefaction</strong> is the decomposition of tissues due to bacterial activity, and <strong>adipocere</strong> results from chemical changes in fatty tissues, often under moist conditions. </span></span></p>",
      "correct_choice_id": 247901,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        10
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62388,
      "choices": [
        {
          "id": 248801,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 3</span></span></p>"
        },
        {
          "id": 248802,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2, 4</span></span></p>"
        },
        {
          "id": 248803,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 2, 3, 4</span></span></p>"
        },
        {
          "id": 248804,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 3, 4</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A public health researcher is compiling data on causes of death in India for a study on mortality trends. To ensure comprehensive data collection, the researcher utilizes various sources of mortality data available in the country. Which of the following sources are commonly used to gather causes of death data in India?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Sample Registration System (SRS)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Census</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Medical Certification of Cause of Death (MCCD)</span></span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Verbal autopsy through Lay information</span></span></li>\r\n</ol>",
      "unique_key": "Q4298584",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) 1, 3, 4</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The sources are commonly used for collecting causes of death data in India:</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">1.</span></strong><span style=\"font-size:14.0pt\"> <strong>Sample Registration System</strong> (SRS): This system provides continuous and reliable data on births, deaths, and causes of death through a dual recording system that includes a field investigator and local enumerators.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">3. Medical Certification of Cause of Death (MCCD)</span></strong><span style=\"font-size:14.0pt\">: This method involves the certification of death causes by medical professionals for deaths that occur in hospitals or healthcare facilities.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">4. Lay information and verbal autopsy</span></strong><span style=\"font-size:14.0pt\">: This method involves collecting information from family members or close contacts about the circumstances leading up to a person&#39;s death. It is particularly useful in rural and hard-to-reach areas where medical certification might not be available.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Option</span></strong><span style=\"font-size:14.0pt\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">2. Census:</span></strong><span style=\"font-size:14.0pt\"> Incorrect. Census does not collect specific causes of death data. The Census focuses on population counts and demographics rather than mortality causes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective</span></strong><span style=\"font-size:14.0pt\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Vital Statistics Data Sources: Census, Sample Registration System (SRS), Demographic Surveys (NSSO), Civil Registration System, Health Surveys (NFHS, DLHS) </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Sources for Causes of Death: SRS (IMR, NNMR, MMR, U5MR), Death declaration and Medical certification, Lay information (Through First line health workers)</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248804,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62223,
      "choices": [
        {
          "id": 248149,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">More than 10% of TB patients tested for HIV are HIV-positive.</span></span></p>"
        },
        {
          "id": 248150,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">More than 12% of TB patients tested for HIV are HIV-positive.</span></span></p>"
        },
        {
          "id": 248151,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">More than 15% of TB patients tested for HIV are HIV-positive.</span></span></p>"
        },
        {
          "id": 248152,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">More than 20% of TB patients tested for HIV are HIV-positive.</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A public health officer is evaluating tuberculosis (TB) and HIV co-infection rates in a district to determine if it should be classified as a high-priority TB-HIV district under the National Tuberculosis Elimination Program (NTEP) in India. According to NTEP guidelines, which of the following criteria defines a high-priority TB-HIV district?</span></span></p>",
      "unique_key": "Q6399546",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) More than 10% of TB patients tested for HIV are HIV-positive.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">According to the National Tuberculosis Elimination Program (NTEP), a district is classified as a high-priority TB-HIV district if more than 10% of TB patients tested for HIV in the district are found to be HIV-positive. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This classification helps in prioritizing integrated care and resource allocation for TB-HIV co-infection management.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Categorisation of Districts under NTEP (for HIV-TB Co-infection)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-160812.jpg\" style=\"height:510px; width:900px\" /></span></span></span></p>",
      "correct_choice_id": 248149,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62141,
      "choices": [
        {
          "id": 247825,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Eumycetoma</span></span></span></p>"
        },
        {
          "id": 247826,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Sporotrichosis</span></span></span></p>"
        },
        {
          "id": 247827,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Actinomycosis</span></span></span></p>"
        },
        {
          "id": 247828,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cutaneous Tuberculosis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old farmer from a rural region presents with a progressively enlarging, swollen hand with multiple nodules and discharging sinuses, as shown below. He reports that the condition has been present for several months and initially started with a small painless swelling after a minor trauma while working in the fields. The patient denies any systemic symptoms like fever or malaise. What is the most likely diagnosis? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-163534.png\" style=\"height:221px; width:300px\" /></span></span></p>",
      "unique_key": "Q8799334",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>A) Eumycetoma</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Eumycetoma is a chronic granulomatous fungal infection affecting the skin and subcutaneous tissues, often leading to the formation of tumefaction, multiple nodules, and sinuses discharging granules. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It typically occurs after trauma involving contaminated soil or organic matter, which explains the history of trauma while farming. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The grains seen in the discharging sinuses are characteristic of mycetoma, which differentiates it from other infections.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Sporotrichosis</span></strong><span style=\"font-size:14.0pt\">: This is a fungal infection caused by <em>Sporothrix schenckii</em>. It typically presents as nodular lesions along lymphatic vessels but does not usually present with multiple draining sinuses or characteristic granules.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Actinomycosis</span></strong><span style=\"font-size:14.0pt\">: Actinomycosis is a bacterial infection that can produce multiple draining sinuses, but it commonly affects the cervicofacial region, and the discharges typically contain sulfur granules.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Cutaneous Tuberculosis</span></strong><span style=\"font-size:14.0pt\">: Cutaneous TB presents with skin lesions but is rarely associated with discharging sinuses containing granules. It also involves systemic symptoms more frequently.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Eumycetoma is a chronic infection involving the skin and subcutaneous tissue that presents with swelling, nodules, and multiple discharging sinuses containing grains. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is often caused by fungi and primarily affects individuals working in rural environments.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247825,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62231,
      "choices": [
        {
          "id": 248181,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Transient hypocalcemia</span></span></span></p>"
        },
        {
          "id": 248182,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Horner&rsquo;s syndrome</span></span></span></p>"
        },
        {
          "id": 248183,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Recurrent laryngeal nerve injury</span></span></span></p>"
        },
        {
          "id": 248184,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Postoperative hematoma</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 52-year-old man undergoes a right-sided neck dissection for invasive neck cancer. Two days postoperatively, he developed partial ptosis, miosis, and decreased sweating on the right side of his face. Which of the following is the most likely diagnosis? </span></span></p>",
      "unique_key": "Q5947132",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Horner&rsquo;s syndrome</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Horner&rsquo;s syndrome</span></strong><span style=\"font-size:14.0pt\"> is characterized by a triad of ptosis, miosis, and anhidrosis (loss of sweating) on the affected side of the face. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It occurs due to disruption of the cervical sympathetic pathway. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In this patient, the cervical sympathetic trunk may have been damaged during neck dissection for thyroid cancer, which is a known risk factor for Horner&rsquo;s syndrome.</span></span></span></li>\r\n</ul>\r\n\r\n<ul style=\"list-style-type:circle; margin-left:40px\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ptosis</span></strong><span style=\"font-size:14.0pt\"> is caused by paralysis of M&uuml;ller&rsquo;s muscle.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Miosis</span></strong><span style=\"font-size:14.0pt\"> is due to loss of the dilator pupillae muscle function.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Anhidrosis</span></strong><span style=\"font-size:14.0pt\"> occurs because of loss of sympathetic innervation to the sweat glands.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Transient hypocalcemia:</strong> It is a common complication of thyroid or parathyroid surgery, but it presents with symptoms like perioral tingling, numbness, and muscle cramps rather than ptosis, miosis, or anhidrosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Recurrent laryngeal nerve injury:</strong> It often occurs in thyroid surgeries, leading to hoarseness or voice changes. It does not cause the ptosis, miosis, or anhidrosis seen in Horner&#39;s syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Postoperative hematoma:</strong> Following neck surgery can lead to airway obstruction, pain, and swelling. However, it is unlikely to cause the localized sympathetic nervous symptoms of Horner&rsquo;s syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Horner&rsquo;s syndrome is a result of disruption of the cervical sympathetic pathway, commonly due to surgical trauma in the neck region, particularly during thyroid or retro-esophageal surgeries. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Its classic triad includes ptosis, miosis, and anhidrosis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Recognizing these symptoms is crucial in postoperative evaluations, especially following surgeries involving the neck.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248182,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62096,
      "choices": [
        {
          "id": 247645,
          "text": "<p><span style=\"font-size:14.0pt;\">Hemophilia A</span></p>"
        },
        {
          "id": 247646,
          "text": "<p><span style=\"font-size:14.0pt;\">Disseminated intravascular coagulation (DIC)</span></p>"
        },
        {
          "id": 247647,
          "text": "<p><span style=\"font-size:14.0pt;\">Factor VIII inhibitor</span></p>"
        },
        {
          "id": 247648,
          "text": "<p><span style=\"font-size:14.0pt;\">Vitamin K deficiency</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old woman with no significant past medical history presents with new-onset bruising and joint pain. Laboratory workup shows a prolonged partial thromboplastin time (PTT), but her prothrombin time (PT) and bleeding time are normal. A mixing study is performed, where the patient's plasma is mixed with normal plasma. The PTT remains prolonged after mixing. Which of the following is the most likely diagnosis?</span></p>",
      "unique_key": "Q7692312",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Factor VIII inhibitor</strong></span></p><p>&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">This patient presents with a prolonged <strong>PTT</strong> and a mixing study that fails to correct the PTT.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">This suggests the presence of an <strong>inhibitor</strong>, rather than a deficiency in clotting factors.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">The decreased <strong>factor VIII activity</strong> and failure of the mixing study to normalize the PTT point toward a <strong>factor VIII inhibitor</strong> as the cause of the coagulopathy.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><strong>Option A. Hemophilia A: </strong>Incorrect. In hemophilia A, which involves a deficiency of Factor VIII, a mixing study would typically <strong>correct</strong> the prolonged PTT, as the normal plasma would provide the missing factor. Here, the mixing study did not correct the PTT, suggesting an inhibitor rather than a deficiency.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><strong>Option B. Disseminated intravascular coagulation (DIC):</strong> Incorrect. In DIC, both the PT and PTT would be prolonged, and the bleeding time might also be affected due to widespread consumption of clotting factors and platelets. This patient's PT and bleeding time are normal, making DIC unlikely.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><strong>Option D. Vitamin K deficiency:</strong> Incorrect. Vitamin K deficiency typically affects factors II, VII, IX, and X, leading to prolongation of both the PT and PTT. In this case, the PT is normal, ruling out vitamin K deficiency.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">A <strong>prolonged PTT</strong> that <strong>does not correct</strong> in a mixing study suggests the presence of an <strong>inhibitor</strong>, most commonly against <strong>Factor VIII</strong>, which can lead to bleeding symptoms similar to hemophilia.</span></p></li></ul>",
      "correct_choice_id": 247647,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62174,
      "choices": [
        {
          "id": 247957,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Psoralen + UV therapy (PUVA)</span></span></span></p>"
        },
        {
          "id": 247958,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Systemic steroid</span></span></span></p>"
        },
        {
          "id": 247959,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Acitretin</span></span></span></p>"
        },
        {
          "id": 247960,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Methotrexate</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 47-year-old woman presents to the emergency department with a sudden onset of painful, erythematous pustules covering her trunk and extremities. She feels febrile and has been experiencing chills for the past few days. Physical examination reveals widespread pustules on erythematous skin. Her vital signs show a fever of 38.5&deg;C (101.3&deg;F). A skin biopsy is performed, and she is diagnosed with pustular psoriasis. You are determining the best treatment to control her condition. Which of the following is the most appropriate treatment option for this patient? </span></span></p>",
      "unique_key": "Q6540246",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Acitretin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Pustular psoriasis</span></strong><span style=\"font-size:14.0pt\"> is a severe, rare form of psoriasis characterized by widespread erythematous plaques with sterile pustules. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Patients may experience systemic symptoms such as fever, chills, and malaise. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The treatment of choice for <strong>generalized pustular psoriasis</strong> is <strong>acitretin</strong>, an oral retinoid, due to its effectiveness in reducing inflammation and promoting skin turnover. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Acitretin is especially useful in controlling severe, systemic forms of psoriasis like pustular psoriasis and is typically used in acute flares.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-170421.png\" style=\"height:309px; width:300px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Psoralen + UV therapy (PUVA):&nbsp;</span></strong><span style=\"font-size:14.0pt\">PUVA therapy is used for plaque psoriasis and some chronic forms of the disease, but it is not recommended in <strong>acute generalized pustular psoriasis</strong> due to the patient&#39;s systemic symptoms and the need for rapid intervention.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Systemic steroid:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Although systemic corticosteroids can rapidly suppress inflammation, they are <strong>not recommended</strong> in pustular psoriasis because their withdrawal can lead to severe <strong>rebound flares</strong> of the disease, worsening the patient&#39;s condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Methotrexate:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Methotrexate is another systemic option used for severe psoriasis, but in the case of <strong>acute generalized pustular psoriasis</strong>, <strong>acitretin</strong> is preferred as the first-line treatment. Methotrexate may be considered if acitretin is not suitable, but it is not the primary choice in this situation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Acitretin</span></strong><span style=\"font-size:14.0pt\">, an oral retinoid, is the treatment of choice for <strong>generalized pustular psoriasis</strong> due to its effectiveness in controlling severe inflammatory flares and promoting skin healing. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>",
      "correct_choice_id": 247959,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        18
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62130,
      "choices": [
        {
          "id": 247781,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lorlatinib</span></span></p>"
        },
        {
          "id": 247782,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nilotinib</span></span></p>"
        },
        {
          "id": 247783,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Osimertinib</span></span></p>"
        },
        {
          "id": 247784,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ruxolitinib</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old patient with chronic myeloid leukemia (CML) is being considered for targeted therapy due to resistance to first-line treatment. The oncologist wants to use a medication that specifically targets the BCR-ABL tyrosine kinase. Which of the following drugs is most appropriate for this mechanism of action? </span></span></p>",
      "unique_key": "Q1509159",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Ans. B) Nilotinib</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Nilotinib&nbsp;</span></strong><span style=\"font-size:14.0pt\">is a <strong>tyrosine kinase inhibitor (TKI)</strong> that specifically targets the <strong>BCR-ABL fusion protein</strong>, which is a hallmark of <strong>chronic myeloid leukemia (CML)</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is designed to inhibit the activity of the abnormal tyrosine kinase created by the <strong>Philadelphia chromosome</strong> translocation (t(9;22)). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Nilotinib is used in cases where patients are resistant to or intolerant of first-generation TKIs like imatinib.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Lorlatinib</span></strong><span style=\"font-size:14.0pt\">: Lorlatinib is a <strong>tyrosine kinase inhibitor</strong> that targets <strong>ALK</strong> (Anaplastic Lymphoma Kinase) and <strong>ROS1</strong> rearrangements, making it effective in certain types of <strong>non-small cell lung cancer (NSCLC)</strong>, not CML.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Osimertinib</span></strong><span style=\"font-size:14.0pt\">: Osimertinib is a <strong>third-generation EGFR inhibitor</strong> used in patients with <strong>EGFR-mutated non-small cell lung cancer</strong>. It is effective against tumors with <strong>EGFR T790M mutations</strong> but does not target BCR-ABL.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Ruxolitinib</span></strong><span style=\"font-size:14.0pt\">: Ruxolitinib is a <strong>JAK 1 and 2 inhibitor</strong> used in the management of <strong>myeloproliferative disorders</strong> such as <strong>myelofibrosis</strong> and <strong>polycythemia vera</strong>. It is not effective against the BCR-ABL fusion protein.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Nilotinib&nbsp;</span></strong><span style=\"font-size:14.0pt\">is a <strong>BCR-ABL tyrosine kinase inhibitor</strong> specifically used in <strong>chronic myeloid leukemia (CML)</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Lorlatinib&nbsp;</span></strong><span style=\"font-size:14.0pt\">targets <strong>ALK</strong> mutations, while <strong>Osimertinib</strong> targets <strong>EGFR</strong> mutations, both in <strong>non-small cell lung cancer</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ruxolitinib&nbsp;</span></strong><span style=\"font-size:14.0pt\">is a <strong>JAK 1, 2 inhibitor</strong> used for conditions like <strong>myelofibrosis</strong> and <strong>polycythemia vera</strong>.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247782,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62195,
      "choices": [
        {
          "id": 248037,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Intralesional curettage</span></span></span></p>"
        },
        {
          "id": 248038,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Wide resection</span></span></span></p>"
        },
        {
          "id": 248039,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Amputation</span></span></span></p>"
        },
        {
          "id": 248040,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Radiation therapy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following describes the typical surgical approach for a patient with a giant cell tumour of the bone? </span></span></p>",
      "unique_key": "Q4983091",
      "difficulty_level": "intermediate",
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">A) Intralesional curettage</span></strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Intralesional curettage is the preferred surgical approach for treating giant cell tumours of the bone, particularly when the tumour is not highly aggressive and is located in a place where complete resection is difficult. </span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This procedure involves scraping out the tumour from the bone while preserving as much surrounding healthy tissue as possible. </span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">To minimize the chance of recurrence, the cavity left after curettage is often filled with bone graft material or cement, and additional treatments such as cryotherapy or phenol may be used to destroy residual tumour cells. </span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Intralesional curettage is effective in treating GCTs and has a relatively low complication rate.</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Wide resection:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Wide resection involves removing the tumour along with a margin of healthy surrounding tissue. This approach is generally reserved for aggressive or recurrent giant cell tumours or when the tumour is located in a critical area where complete excision is feasible without compromising function. While wide resection can reduce the risk of local recurrence, it may also result in significant loss of bone and necessitate reconstruction or rehabilitation. This option is not the first line of treatment for typical GCTs.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Amputation:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Amputation is rarely required for giant cell tumours of the bone, as most cases can be managed with less invasive procedures. It is considered only in extreme cases where the tumour is extensively aggressive, recurrent, or if it involves the joint in a way that prevents functional preservation. The decision to amputate is very case-specific and is generally avoided if possible.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Radiation therapy:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Radiation therapy is not a primary treatment modality for giant cell tumours. While it can be used in cases where surgical options are limited or to treat recurrent tumours, it is generally considered less effective as a standalone treatment. GCTs are generally responsive to surgical interventions, and the use of radiation is typically limited to specific situations, such as in patients who are not surgical candidates or in cases of incomplete resection where there is a high risk of recurrence.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Intralesional curettage is the standard approach for managing giant cell tumours, allowing for effective removal with a lower risk of complications.</span></span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248037,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62207,
      "choices": [
        {
          "id": 248085,
          "text": "<p><span style=\"font-size:14.0pt;\">Conduction</span></p>"
        },
        {
          "id": 248086,
          "text": "<p><span style=\"font-size:14.0pt;\">Convection</span></p>"
        },
        {
          "id": 248087,
          "text": "<p><span style=\"font-size:14.0pt;\">Radiation</span></p>"
        },
        {
          "id": 248088,
          "text": "<p><span style=\"font-size:14.0pt;\">Induction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 2-day-old neonate in the neonatal intensive care unit (NICU) requires thermoregulation due to low birth weight and inability to maintain body temperature. The healthcare provider decides to use the device shown in the image to regulate the infant’s body temperature. This device operates primarily through which of the following mechanisms?</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-174522.png\" alt=\"\" width=\"300\" height=\"574\"></p>",
      "unique_key": "Q1397340",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"background-color:hsl(0,0%,100%);font-size:14.0pt;\"><strong>Ans. C) Radiation</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"background-color:hsl(0,0%,100%);font-size:14.0pt;\">The device in the image is a <i>radiant warmer</i>, which is commonly used in the NICU for thermoregulation in neonates.&nbsp;</span></li><li><span style=\"background-color:hsl(0,0%,100%);font-size:14.0pt;\">It works by using radiant heat to maintain a stable body temperature in infants who are unable to do so themselves, particularly those who are premature or of low birth weight.</span></li><li><span style=\"background-color:hsl(0,0%,100%);font-size:14.0pt;\">Radiant warmers emit infrared radiation to warm the surface of the neonate’s body directly without needing the surrounding air to be heated. This method is effective for maintaining skin temperature in a controlled manner.</span></li><li><span style=\"background-color:hsl(0,0%,100%);font-size:14.0pt;\">Radiant warmers are set in servo-control mode, maintaining the temperature between <strong>36.5°C to 37°C</strong> to ensure the neonate remains within a safe and comfortable temperature range.</span><br>&nbsp;</li></ul><p><span style=\"background-color:hsl(0,0%,100%);font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"background-color:hsl(0,0%,100%);font-size:14.0pt;\"><strong>Option A. Conduction</strong>: Refers to heat transfer through direct contact with a warmer surface. It is not the primary mechanism of radiant warmers.</span></p><p>&nbsp;</p><p><span style=\"background-color:hsl(0,0%,100%);font-size:14.0pt;\"><strong>Option B. Convection</strong>: Involves heat transfer through air movement. Incubators use convective heating to maintain a warm environment for the infant, but this is different from the radiant warmer.</span></p><p>&nbsp;</p><p><span style=\"background-color:hsl(0,0%,100%);font-size:14.0pt;\"><strong>Option D. Induction</strong>: Is a process where heat is generated through electromagnetic fields, commonly used in cooking but not applicable in this context.</span></p><p>&nbsp;</p><p><span style=\"background-color:hsl(0,0%,100%);font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"background-color:hsl(0,0%,100%);font-size:14.0pt;\">Radiant warmers provide effective thermoregulation for neonates by using radiant heat to directly warm the skin.&nbsp;</span></li><li><span style=\"background-color:hsl(0,0%,100%);font-size:14.0pt;\">This method is particularly useful in the NICU setting for infants who cannot maintain their own body temperature, such as those born prematurely or with low birth weight.</span></li></ul>",
      "correct_choice_id": 248087,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62125,
      "choices": [
        {
          "id": 247761,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Subcostal nerve (T12) and anterior branches of L1-L4</span></span></span></p>"
        },
        {
          "id": 247762,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Femoral nerve</span></span></span></p>"
        },
        {
          "id": 247763,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Obturator nerve</span></span></span></p>"
        },
        {
          "id": 247764,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ilioinguinal nerve</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 40-year-old man presents with lower back pain that worsens with bending and twisting movements. Physical examination reveals tenderness over the lower lumbar region, particularly around the lateral abdominal wall, suggesting involvement of a muscle that stabilizes the lumbar spine and aids in lateral flexion of the trunk. Which of the following nerves most likely innervates the affected muscle? </span></span></p>",
      "unique_key": "Q6025569",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Subcostal nerve (T12) and anterior branches of L1-L4</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The <strong>quadratus lumborum</strong> muscle is innervated by the <strong>subcostal nerve (T12)</strong> and the <strong>anterior branches of the lumbar nerves L1-L4</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This muscle is located in the <strong>posterior abdominal wall</strong> and extends from the <strong>12th rib</strong> to the <strong>iliac crest</strong>, attaching to the <strong>transverse processes of the lumbar vertebrae</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Its functions include <strong>stabilizing the lumbar spine</strong>, assisting in <strong>lateral flexion of the trunk</strong>, and <strong>fixing the 12th rib</strong> during forced expiration. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Injury or strain to the quadratus lumborum can result in lower back pain, particularly with movements that involve bending or twisting, as these actions engage this muscle.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-161903.png\" style=\"height:446px; width:400px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Femoral nerve</span></strong><span style=\"font-size:14.0pt\">: Incorrect. The <strong>femoral nerve</strong> originates from <strong>L2-L4</strong> and innervates muscles of the <strong>anterior thigh</strong>, such as the <strong>quadriceps femoris</strong> and <strong>iliopsoas</strong>. It is not involved in innervating the <strong>quadratus lumborum</strong>, which is located in the posterior abdominal wall.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Obturator nerve</span></strong><span style=\"font-size:14.0pt\">: Incorrect. The <strong>obturator nerve</strong> arises from <strong>L2-L4</strong> and supplies the <strong>medial compartment of the thigh</strong>, innervating muscles like the <strong>adductors</strong>. It does not contribute to the innervation of the <strong>quadratus lumborum</strong>.</span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Ilioinguinal nerve</span></strong><span style=\"font-size:14.0pt\">: Incorrect. The <strong>ilioinguinal nerve</strong> arises from <strong>L1</strong> and provides sensory innervation to the <strong>inguinal region</strong> and <strong>lower abdominal wall</strong>. Although it is in proximity to the quadratus lumborum, it does not innervate this muscle directly.</span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The <strong>quadratus lumborum</strong> muscle is innervated by the <strong>subcostal nerve (T12)</strong> and the <strong>anterior branches of L1-L4</strong> from the lumbar plexus. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It plays a key role in <strong>stabilizing the lumbar spine</strong>, <strong>lateral flexion</strong> of the trunk, and <strong>fixing the 12th rib</strong> during respiration.</span></span></span>&nbsp;</li>\r\n</ul>",
      "correct_choice_id": 247761,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62136,
      "choices": [
        {
          "id": 247805,
          "text": "<p style=\"margin-left:6px;\"><span style=\"font-size:14.0pt;\">The sense strand of DNA is the strand used by RNA polymerase during transcription.</span></p>"
        },
        {
          "id": 247806,
          "text": "<p style=\"margin-left:6px;\"><span style=\"font-size:14.0pt;\">The antisense DNA strand is identical to the RNA transcript except that the DNA strand contains thymine and the RNA strand contains uracil.</span></p>"
        },
        {
          "id": 247807,
          "text": "<p style=\"margin-left:6px;\"><span style=\"font-size:14.0pt;\">The first RNA form produced contains both intron and exon sequences.</span></p>"
        },
        {
          "id": 247808,
          "text": "<p style=\"margin-left:6px;\"><span style=\"font-size:14.0pt;\">Mature mRNA contains a cap at the 5′-end, a poly(A) tail at the 3′ end, introns, and exons.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">The production of mRNA in eukaryotic cells requires a large number of steps, and drugs targeted to any of these steps could block mRNA production. Which one of the following accurately describes a part of the process of producing mRNA from a eukaryotic gene?</span></p>",
      "unique_key": "Q5720955",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) The first RNA form produced contains both intron and exon sequences.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The sense (or coding) strand of DNA is identical to the mRNA produced, with the exception of the DNA containing thymine and the RNA containing uracil.</span></li><li><span style=\"font-size:14.0pt;\">The template (or antisense) strand of DNA is the strand that is used by RNA polymerase to produce a complementary RNA sequence to the template strand (thus, the antisense strand is complementary to the mRNA produced and is not identical to it).</span></li><li><span style=\"font-size:14.0pt;\">The first RNA form produced by RNA polymerase is hnRNA, which contains both intron (noncoding) and exon (coding sequences) sequences.</span></li><li><span style=\"font-size:14.0pt;\">hnRNA is modified by the addition of a cap to the 5′-end, a poly(A) tail added to the 3′-end, and all introns removed.</span></li><li><span style=\"font-size:14.0pt;\">During processing, the intron sequences are removed from the hnRNA to produce the mature mRNA.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. The sense strand of DNA is the strand used by RNA polymerase during transcription:&nbsp;</strong>This statement is incorrect. RNA polymerase uses the <i>antisense</i> strand of DNA (the template strand) to synthesize the mRNA. The sense strand, also called the coding strand, has a sequence that matches the RNA transcript (except that thymine in DNA is replaced by uracil in RNA). The antisense strand is the template for RNA polymerase to generate a complementary RNA strand.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. The antisense DNA strand is identical to the RNA transcript except that the DNA strand contains thymine and the RNA strand contains uracil:&nbsp;</strong>This statement is incorrect. The <i>sense</i> strand (coding strand) of DNA, not the antisense strand, is nearly identical to the RNA transcript, with the exception that thymine (T) is replaced by uracil (U) in RNA. The antisense strand is complementary to both the sense strand and the mRNA transcript, not identical to the RNA.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Mature mRNA contains a cap at the 5′-end, a poly(A) tail at the 3′ end, introns, and exons:</strong> This statement is incorrect because mature mRNA does not contain introns. The process of splicing removes introns from the pre-mRNA, leaving only the exons in the mature mRNA. While mature mRNA does indeed have a 5′ cap and a 3′ poly(A) tail, it contains only exons, not introns.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The primary transcript of mRNA in eukaryotic cells contains both introns and exons, and introns are spliced out during processing to form the mature mRNA.</span></p>",
      "correct_choice_id": 247807,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62127,
      "choices": [
        {
          "id": 247769,
          "text": "<p><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose</span></span></p>"
        },
        {
          "id": 247770,
          "text": "<p><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amino acids</span></span></p>"
        },
        {
          "id": 247771,
          "text": "<p><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bicarbonate</span></span></p>"
        },
        {
          "id": 247772,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chloride</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old man with recurrent kidney stones undergoes a metabolic evaluation, which reveals elevated concentrations of various solutes in his urine. Which of the following solutes does not decrease in concentration as filtrate flows through the proximal convoluted tubule?</span></span></p>",
      "unique_key": "Q6714847",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Chloride</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">As filtrate moves through the proximal convoluted tubule (PCT), the concentration of most solutes decreases due to their reabsorption. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">However, <strong>chloride</strong> behaves differently from other solutes. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Initially, water is reabsorbed more rapidly than chloride, causing its concentration to increase transiently. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Although chloride is later reabsorbed, its concentration does not decrease as significantly compared to other solutes like glucose, amino acids, or bicarbonate in the early PCT.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Glucose</span></strong><span style=\"font-size:14.0pt\">: Incorrect. Glucose is almost entirely reabsorbed in the PCT, leading to a rapid decrease in its concentration as the filtrate passes through the tubule.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Amino acids</span></strong><span style=\"font-size:14.0pt\">: Incorrect. Amino acids are also almost completely reabsorbed in the PCT, causing a sharp decline in their concentration in the filtrate.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Bicarbonate</span></strong><span style=\"font-size:14.0pt\">: Incorrect. Bicarbonate is reabsorbed in the PCT to help regulate acid-base balance, resulting in a decreased concentration of bicarbonate in the filtrate.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In the proximal convoluted tubule, the concentration of solutes such as <strong>glucose</strong>, <strong>amino acids</strong>, and <strong>bicarbonate</strong> decreases due to reabsorption. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Chloride</span></strong><span style=\"font-size:14.0pt\"> concentration initially increases due to faster water reabsorption before being reabsorbed later, resulting in a different concentration profile.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247772,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62183,
      "choices": [
        {
          "id": 247993,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">3.57 and 0.4</span></span></span></p>"
        },
        {
          "id": 247994,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">4.5 and 0.6</span></span></span></p>"
        },
        {
          "id": 247995,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">2.33 and 0.75</span></span></span></p>"
        },
        {
          "id": 247996,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">5.0 and 0.8</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A study is conducted to assess the accuracy of rapid antigen testing in diagnosing influenza in a group of patients presenting with flu-like symptoms. A total of 180 patients were tested using the rapid antigen test, and their diagnosis was confirmed by a PCR test (gold standard). Out of 70 patients who tested positive on the rapid antigen test, 50 were confirmed to have influenza by PCR. Among the 110 patients who tested negative on the rapid test, 90 were confirmed to be free of influenza by PCR. Calculate the Positive Likelihood Ratio (LR+) and Negative Likelihood Ratio (LR&minus;) for the rapid antigen test. </span></span></p>",
      "unique_key": "Q9004631",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) 3.57 and 0.4</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">To calculate the Positive Likelihood Ratio (LR+) and Negative Likelihood Ratio (LR&minus;), we need to determine sensitivity and specificity based on the given data:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Step-by-step calculations:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">True Positives (TP) = 50 (patients who tested positive on the rapid antigen test and were confirmed positive by PCR)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">False Positives (FP) = 70 - 50 = 20 (patients who tested positive on the rapid test but were negative by PCR)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">True Negatives (TN) = 90 (patients who tested negative on the rapid test and were confirmed negative by PCR)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">False Negatives (FN) = 110 - 90 = 20 (patients who tested negative on the rapid test but were confirmed positive by PCR)</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1. Calculating Sensitivity and Specificity:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Sensitivity = TP / (TP + FN) = 50 / (50 + 20) = 50 / 70 = 0.714</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Specificity = TN / (TN + FP) = 90 / (90 + 20) = 90 / 110 = 0.818</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:96px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">2. Calculating Positive Likelihood Ratio (LR+):</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-171812.png\" style=\"height:74px; width:400px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">3. Calculating Negative Likelihood Ratio (LR&minus;):</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-171824.png\" style=\"height:75px; width:400px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective</span></strong><span style=\"font-size:14.0pt\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Positive Likelihood Ratio (LR+) quantifies how much more likely a positive test result is in those with the disease compared to those without the disease.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Negative Likelihood Ratio (LR&minus;) indicates how much less likely a negative test result is in those with the disease compared to those without the disease.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">For the rapid antigen test in diagnosing influenza, an LR+ of 3.57 means that a positive test result is about 3.57 times more likely in a patient with the disease, and an LR&minus; of 0.4 means that a negative result decreases the likelihood of the disease to 40% of the baseline probability.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247993,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62178,
      "choices": [
        {
          "id": 247973,
          "text": "<p><span style=\"font-size:14.0pt;\">Eisenmenger syndrome</span></p>"
        },
        {
          "id": 247974,
          "text": "<p><span style=\"font-size:14.0pt;\">Ventricular septal defect (VSD)</span></p>"
        },
        {
          "id": 247975,
          "text": "<p><span style=\"font-size:14.0pt;\">Atrial septal defect (ASD)</span></p>"
        },
        {
          "id": 247976,
          "text": "<p><span style=\"font-size:14.0pt;\">Patent ductus arteriosus (PDA)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old male presents with intermittent cyanosis and exercise intolerance that began 6 months ago and has progressively worsened. He has a history of a congenital heart defect, diagnosed shortly after birth, but no interventions were performed. On physical examination, there is cyanosis of the lips and digital clubbing. Cardiac catheterization reveals the following oxygen saturations:</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Right Atrium: 72%</span></li><li><span style=\"font-size:14.0pt;\">Right Ventricle: 74%</span></li><li><span style=\"font-size:14.0pt;\">Pulmonary Artery: 73%</span></li><li><span style=\"font-size:14.0pt;\">Left Atrium: 92%</span></li><li><span style=\"font-size:14.0pt;\">Left Ventricle: 92%</span></li><li><span style=\"font-size:14.0pt;\">Aorta: 85%</span></li></ul><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\">Which of the following is the most likely explanation for these findings?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7296118",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A) Eisenmenger syndrome</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient’s cyanosis, exercise intolerance, and the pattern of oxygen saturations strongly suggest <strong>Eisenmenger syndrome</strong>, which is a complication of an unrepaired congenital heart defect that initially causes a left-to-right shunt.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Over time, the increased pulmonary blood flow leads to <strong>pulmonary hypertension</strong>, causing a reversal of the shunt (right-to-left), which results in <strong>cyanosis</strong> and systemic oxygen desaturation (as seen in the lower oxygen saturation in the aorta compared to the left atrium and left ventricle).</span></li></ul><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\">The patient's cardiac catheterization findings support this diagnosis:</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The saturation difference between the left heart (92%) and the aorta (85%) indicates <strong>right-to-left shunting</strong> at some point after the left ventricle.</span></li><li><span style=\"font-size:14.0pt;\">The relatively low saturations in the right heart (72-74%) without a significant increase in oxygen saturation in the pulmonary artery (73%) suggests there is no left-to-right shunt.</span></li><li><span style=\"font-size:14.0pt;\">In <strong>Eisenmenger syndrome</strong>, long-standing left-to-right shunts, such as from a <strong>ventricular septal defect (VSD)</strong>, atrial septal defect (ASD), or patent ductus arteriosus (PDA), lead to pulmonary vascular disease and eventual reversal of the shunt to right-to-left, causing systemic hypoxia and cyanosis.</span></li></ul><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ventricular septal defect (VSD)</strong>: A simple VSD would cause a left-to-right shunt, leading to increased oxygen saturation in the right heart chambers and pulmonary artery. However, the findings here indicate a right-to-left shunt, consistent with Eisenmenger syndrome.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Atrial septal defect (ASD)</strong>: Similar to a VSD, an ASD would initially cause a left-to-right shunt, increasing oxygen saturation in the right atrium, which is not seen here. The progression to Eisenmenger syndrome (A) is a more accurate explanation for this case.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Patent ductus arteriosus (PDA)</strong>: A PDA would lead to increased oxygenation in the pulmonary artery due to a left-to-right shunt, which is not observed here. Once the PDA causes pulmonary hypertension and a right-to-left shunt, it would lead to Eisenmenger syndrome.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Eisenmenger syndrome</strong> results from the reversal of an initially left-to-right shunt due to progressive pulmonary hypertension, leading to right-to-left shunting, cyanosis, and systemic hypoxemia.</span></p>",
      "correct_choice_id": 247973,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62233,
      "choices": [
        {
          "id": 248189,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A-1, B-2, C-3, D-4 </span></span></span></p>"
        },
        {
          "id": 248190,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A-3, B-1, C-2, D-4 </span></span></span></p>"
        },
        {
          "id": 248191,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A-2, B-3, C-1, D-4 </span></span></span></p>"
        },
        {
          "id": 248192,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A-1, B-2, C-4, D-3</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the condition with the appropriate diagnostic test: </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-181816.jpg\" style=\"height:278px; width:1000px\" /></span></span></p>",
      "unique_key": "Q7716115",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">A-1, B-2, C-3, D-4</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">A-1.</span></strong><span style=\"font-size:14.0pt\"> Hirschsprung&#39;s disease is diagnosed by rectal biopsy, which is the gold standard diagnostic test for this condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">B-2</span></strong><span style=\"font-size:14.0pt\">. Posterior urethral valve is diagnosed by micturating cystourethrogram, which is a radiographic imaging test of the bladder and urethra during voiding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">C-3.</span></strong><span style=\"font-size:14.0pt\"> Choledochal cyst is diagnosed by MRCP, which is a non-invasive imaging test that uses magnetic resonance imaging to visualize the biliary tree.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">D-4.</span></strong><span style=\"font-size:14.0pt\"> Intussusception is diagnosed by CT scan, which is a diagnostic imaging test that provides detailed images of the abdominal organs and structures.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Explanation</span></strong><span style=\"font-size:14.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">A. Hirschsprung&#39;s disease</span></strong><span style=\"font-size:14.0pt\">: This is a congenital disorder in which nerve cells (ganglion cells) are absent from a segment of the bowel, usually the rectum or sigmoid colon, leading to a functional obstruction. Infants with Hirschsprung&#39;s typically have difficulty with bowel movements within the first days of life. The symptoms can include constipation, abdominal distension, and vomiting. It is diagnosed often in the neonatal period with a barium enema and confirmed with suction rectal biopsy showing the absence of ganglion cells.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">B.</span></strong><span style=\"font-size:14.0pt\"> <strong>Posterior urethral valve (PUV)</strong>: PUV is a congenital malformation in male child where an abnormality of the posterior urethra prevents urine outflow. This can lead to urinary obstruction, distension of the bladder, and can subsequently cause damage to the kidneys. Common symptoms include weak urine stream, difficulty in urination, recurrent urinary tract infections, and failure to thrive. Diagnosis is usually made with a voiding cystourethrogram (VCUG).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">C.</span></strong><span style=\"font-size:14.0pt\"> <strong>Choledochal cyst</strong>: This is a congenital dilation of the bile ducts, often causing obstruction. Patients may present with the classic triad of abdominal pain, jaundice, and an abdominal mass, although not all these signs may be evident. Over time, choledochal cysts can lead to complications like cholangitis, pancreatitis, or even malignancy. Diagnosis is typically done with imaging like ultrasound or MRCP, and definitive treatment is surgical removal.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D.</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Intussusception</strong>: This is a medical condition in which a part of the intestine telescopes into another section, leading to bowel obstruction. It is the most common cause of bowel obstruction in children between the ages of 6 months and 3 years. Symptoms include sudden, severe abdominal pain, vomiting, and &quot;currant jelly&quot; stools (due to mucus and blood). The diagnosis can often be made with an ultrasound or CT abdomen showing the characteristic &quot;target sign&quot; and is typically treated with high pressure enema, although some cases may require surgical intervention.</span></span></p>",
      "correct_choice_id": 248189,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62123,
      "choices": [
        {
          "id": 247753,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Iodine transport into follicular cells</span></span></p>"
        },
        {
          "id": 247754,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Trapping of iodine into the colloid</span></span></p>"
        },
        {
          "id": 247755,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thyroglobulin synthesis</span></span></p>"
        },
        {
          "id": 247756,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oxidation of iodide</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 42-year-old woman comes to the clinic with complaints of fatigue, weight gain, and swelling in his neck. Physical examination reveals a significantly enlarged thyroid gland. His blood tests show decreased levels of T3 and T4. A deficiency in dietary iodine is suspected as the underlying cause of her condition. Which of the following best describes the function of thyroid peroxidase in thyroid hormone synthesis?</span></span></p>",
      "unique_key": "Q6503412",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Oxidation of iodide</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Thyroid peroxidase is a key enzyme involved in the production of thyroid hormones. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It catalyzes the <strong>oxidation of iodide</strong> to iodine, which is necessary for the iodination of tyrosine residues on thyroglobulin. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This process is essential for the formation of monoiodotyrosine (MIT) and diiodotyrosine (DIT), precursors to the thyroid hormones T3 and T4. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Iodine deficiency limits the substrate available for this process, leading to reduced production of thyroid hormones and resulting in hypothyroidism, as seen in this patient.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Iodine transport into follicular cells</span></strong><span style=\"font-size:14.0pt\">: Incorrect. The transport of iodine into thyroid follicular cells is mediated by the <strong>sodium-iodide symporter (NIS)</strong>, not thyroid peroxidase. NIS transports iodide across the cell membrane into the follicular cells, where it is then oxidized by thyroid peroxidase.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Trapping of iodine into the colloid</span></strong><span style=\"font-size:14.0pt\">: Iodine is trapped in the colloid within the thyroid follicles after being oxidized and organified into the thyroglobulin molecule. This step follows the oxidation of iodide and is not a function of thyroid peroxidase.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Thyroglobulin synthesis</span></strong><span style=\"font-size:14.0pt\">: Thyroglobulin is synthesized by the follicular cells of the thyroid and released into the colloid where it acts as a scaffold for thyroid hormone production. However, its synthesis is not directly related to the function of thyroid peroxidase.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Thyroid peroxidase&nbsp;</span></strong><span style=\"font-size:14.0pt\">is responsible for <strong>oxidation of iodide</strong> to iodine, a critical step in the synthesis of thyroid hormones. </span></span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In cases of <strong>iodine deficiency</strong>, reduced availability of iodide results in decreased production of T3 and T4, leading to hypothyroidism and thyroid enlargement.</span></span></li>\r\n</ul>",
      "correct_choice_id": 247756,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62176,
      "choices": [
        {
          "id": 247965,
          "text": "<p><span style=\"font-size:14.0pt;\">Life is adjusted for the presence of disease.</span></p>"
        },
        {
          "id": 247966,
          "text": "<p><span style=\"font-size:14.0pt;\">Premature death is adjusted for the degree of disability.</span></p>"
        },
        {
          "id": 247967,
          "text": "<p><span style=\"font-size:14.0pt;\">Life expectancy free of disability.</span></p>"
        },
        {
          "id": 247968,
          "text": "<p><span style=\"font-size:14.0pt;\">Years lost to premature death and years lived with disability, adjusted for the severity of the disability.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A public health researcher is studying the global burden of disease and focuses on metrics that combine information about mortality and disability. Which of the following best describes Disability-Adjusted Life Years (DALYs)?</span></p>",
      "unique_key": "Q1942653",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Years lost to premature death and years lived with disability, adjusted for the severity of the disability.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Disability-Adjusted Life Years (DALYs) is a measure that quantifies the burden of disease by combining two components:</span><ul><li><span style=\"font-size:14.0pt;\">Years of Life Lost (YLL) due to premature death, which accounts for the years lost if an individual die earlier than the standard life expectancy.</span></li><li><span style=\"font-size:14.0pt;\">Years Lived with Disability (YLD), which considers the time spent living with a disability or condition, adjusted by a disability weight that reflects the severity of the condition.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">By adding these two components, DALYs measure both the impact of early mortality and the burden of living with disease in a single value. It provides a comprehensive view of overall disease burden in a population.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Life is adjusted for the presence of disease</strong>: Incorrect. This option does not fully capture the two components of DALYs (YLL and YLD) and the focus is on both premature death and disability.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Premature death is adjusted for the degree of disability</strong>: Incorrect. While DALYs do account for premature death and disability, they do not directly adjust premature death for the degree of disability.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Life expectancy free of disability</strong>: Incorrect. This definition is more aligned with Healthy Life Expectancy (HALE), which estimates life expectancy in terms of years lived without disability.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Disability-Adjusted Life Years (DALYs) are a measure that combines years lost due to premature death and years lived with disability, adjusted for severity.</span></li><li><span style=\"font-size:14.0pt;\">DALYs are a key metric in assessing the burden of disease and help guide public health priorities by highlighting the impact of different conditions on a population's health.</span></li></ul>",
      "correct_choice_id": 247968,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62213,
      "choices": [
        {
          "id": 248109,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3</span></p>"
        },
        {
          "id": 248110,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 5</span></p>"
        },
        {
          "id": 248111,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 4 and 5</span></p>"
        },
        {
          "id": 248112,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3, 4 and 5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 42-year-old man with a family history of hypertension visits the clinic for a routine health check-up. He is currently asymptomatic, with a blood pressure of 120/75 mm Hg. The physician discusses strategies for preventing hypertension with him. Which of the following measures would be appropriate as primary prevention for hypertension in this patient?</span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">1. Weight reduction</span></p><p><span style=\"font-size:14.0pt;\">2. Dietary salt reduction</span></p><p><span style=\"font-size:14.0pt;\">3. Exercise promotion</span></p><p><span style=\"font-size:14.0pt;\">4. Early diagnosis</span></p><p><span style=\"font-size:14.0pt;\">5. Antihypertensive drugs</span></p>",
      "unique_key": "Q7648746",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1, 2, 3</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Primary prevention of hypertension encompasses measures that can be implemented before the onset of high blood pressure to maintain normal blood pressure levels and reduce the risk of future hypertension. This includes:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1. Weight reduction</strong>: Maintaining a healthy weight helps reduce the risk of developing hypertension.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2. Dietary salt reduction</strong>: Reducing sodium intake can help prevent the increase in blood pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3. Exercise promotion</strong>: Regular physical activity helps maintain a healthy cardiovascular system and prevents hypertension.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4. Early diagnosis</strong>: Early diagnosis is part of secondary prevention.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>5. Antihypertensive drugs</strong>: Medications are reserved for secondary prevention or treatment once hypertension has been diagnosed.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Primary prevention of hypertension focuses on lifestyle modifications such as weight reduction, salt restriction, and exercise.</span></li><li><span style=\"font-size:14.0pt;\">Antihypertensive medications are used for treatment or secondary prevention after hypertension is diagnosed, not for primary prevention in individuals with normal blood pressure.</span></li></ul>",
      "correct_choice_id": 248109,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62190,
      "choices": [
        {
          "id": 248021,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 4</span></p>"
        },
        {
          "id": 248022,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 5</span></p>"
        },
        {
          "id": 248023,
          "text": "<p><span style=\"font-size:14.0pt;\">3</span></p>"
        },
        {
          "id": 248024,
          "text": "<p><span style=\"font-size:14.0pt;\">All are risk factors</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old male with a long-standing history of smoking presents with weight loss, jaundice, and new-onset diabetes. CT scan reveals a pancreatic mass. Which of the following is not considered a risk factor for pancreatic cancer?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">1. Chronic pancreatitis</span></p><p><span style=\"font-size:14.0pt;\">2. BRCA2 mutation</span></p><p><span style=\"font-size:14.0pt;\">3. Female gender</span></p><p><span style=\"font-size:14.0pt;\">4. Cigarette smoking</span></p><p><span style=\"font-size:14.0pt;\">5. Obesity</span></p>",
      "unique_key": "Q2212628",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 3</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Female gender is not considered a significant risk factor for pancreatic cancer, whereas cigarette smoking is one of the most well-established risk factors.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. 2 and 4:</strong> BRCA2 mutations increase the risk of pancreatic cancer, especially in families with a strong history of breast and ovarian cancers. Cigarette smoking is also a strong risk factor for pancreatic cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. 1 and 5:</strong> Chronic pancreatitis and obesity are associated with an&nbsp;increased risk of pancreatic cancer due to the prolonged inflammation and metabolic factors involved.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. All risk factors:</strong> Female gender alone is not a risk factor. Risk is higher in males</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Pancreatic cancer has multiple risk factors, including chronic pancreatitis, smoking, diabetes, and genetic mutations (such as BRCA2).</span></li><li><span style=\"font-size:14.0pt;\">Female gender is not considered a significant risk factor, unlike male gender or advanced age.</span></li></ul>",
      "correct_choice_id": 248023,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62177,
      "choices": [
        {
          "id": 247969,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Sociodemographic reasons for migration of a population</span></span></span></p>"
        },
        {
          "id": 247970,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Prevalence of disease in a population</span></span></span></p>"
        },
        {
          "id": 247971,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Environmental and genetic factors in a disease in population</span></span></span></p>"
        },
        {
          "id": 247972,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Diseases with long incubation periods</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A researcher is studying the incidence of certain types of cancer among Japanese individuals who have migrated to the United States compared to those who remained in Japan. This study aims to assess how the risk of cancer changes based on the different environments. Which of the following is most likely being evaluated in this migration study? </span></span></p>",
      "unique_key": "Q4369144",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Environmental and genetic factors in a disease in population</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Migration studies are used to assess the role of environmental and genetic factors in the development of diseases. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">By comparing populations who migrate with those who remain in their original location, researchers can determine how much of the disease burden is influenced by changes in environment (such as diet, lifestyle, or exposure to pollutants) versus genetic predisposition. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">For example, an increase in cancer rates in a migrant population that matches the rates in the host country suggests a stronger environmental influence.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options</span></strong><span style=\"font-size:14.0pt\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Sociodemographic reasons for migration of a population</span></strong><span style=\"font-size:14.0pt\">: Incorrect. Migration studies are not typically used to study the reasons behind migration but rather to evaluate the health impact of migration.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Prevalence of disease in a population</span></strong><span style=\"font-size:14.0pt\">: Incorrect. Cross-sectional studies are more suitable for determining prevalence.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Diseases with long incubation periods</span></strong><span style=\"font-size:14.0pt\">: Incorrect. While some migration studies might involve diseases with long incubation periods, the primary focus is on the interaction of genetic and environmental factors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective</span></strong><span style=\"font-size:14.0pt\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Migration studies are valuable for understanding how environmental changes affect the incidence of diseases in populations with similar genetic backgrounds. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">They help distinguish between genetic predisposition and environmental influences on disease development.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247971,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62228,
      "choices": [
        {
          "id": 248169,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medroxyprogesterone acetate</span></span></p>"
        },
        {
          "id": 248170,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Levonorgestrel-releasing intrauterine device (IUD)</span></span></p>"
        },
        {
          "id": 248171,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Radiotherapy</span></span></p>"
        },
        {
          "id": 248172,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Simple hysterectomy</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old postmenopausal woman presents with abnormal uterine bleeding. A biopsy reveals simple hyperplasia of the endometrium with atypia. Which of the following is the most appropriate treatment option?</span></span></p>",
      "unique_key": "Q3866773",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Simple hysterectomy</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Endometrial hyperplasia with atypia&nbsp;</span></strong><span style=\"font-size:14.0pt\">carries a significant risk of progression to <strong>endometrial carcinoma</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The presence of atypia is concerning, especially in postmenopausal women like this patient. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In this case, <strong>hysterectomy</strong> is considered the best definitive treatment option, as it eliminates the risk of progression to malignancy.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">For women who are postmenopausal and have atypical hyperplasia, hysterectomy is the ideal treatment to prevent the development of endometrial cancer. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This patient is 55 years old, postmenopausal, and desires definitive treatment, making <strong>simple hysterectomy</strong> the appropriate choice.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Medroxyprogesterone acetate:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Incorrect. <strong>Progestins</strong> like medroxyprogesterone acetate can be used in the treatment of endometrial hyperplasia, particularly in women who wish to preserve fertility or are poor surgical candidates. However, in a postmenopausal woman with atypical hyperplasia, this is not the first-line treatment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Levonorgestrel-releasing intrauterine device (IUD):&nbsp;</span></strong><span style=\"font-size:14.0pt\">Incorrect. The <strong>levonorgestrel IUD</strong> can be used to treat endometrial hyperplasia without atypia, particularly in premenopausal women. However, in this postmenopausal woman with atypia, a hysterectomy is preferred to eliminate the risk of progression to malignancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Radiotherapy:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Incorrect. <strong>Radiotherapy</strong> is typically used for the treatment of advanced or recurrent endometrial cancer but is not indicated for simple hyperplasia with atypia. Hysterectomy is the definitive treatment in this scenario.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">For postmenopausal women with <strong>endometrial hyperplasia with atypia</strong>, the recommended and most definitive treatment is <strong>simple hysterectomy</strong> to prevent the risk of progression to endometrial cancer. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Progestin therapy is an option for patients who are not surgical candidates or who wish to preserve fertility, but hysterectomy is preferred in this context.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248172,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62165,
      "choices": [
        {
          "id": 247921,
          "text": "<p><span style=\"font-size:14.0pt;\">Colonoscopy</span></p>"
        },
        {
          "id": 247922,
          "text": "<p><span style=\"font-size:14.0pt;\">Fecal calprotectin</span></p>"
        },
        {
          "id": 247923,
          "text": "<p><span style=\"font-size:14.0pt;\">Liver biopsy</span></p>"
        },
        {
          "id": 247924,
          "text": "<p><span style=\"font-size:14.0pt;\">Serum AMA</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 40-year-old male presents with fatigue and dark urine. He has a history of diarrhea for 3 months. On physical examination, scleral icterus is noted, and there is mild right upper quadrant tenderness. Laboratory tests reveal the following:</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Total bilirubin: 2.2 mg/dL</span></li><li><span style=\"font-size:14.0pt;\">Direct bilirubin: 1.6 mg/dL</span></li><li><span style=\"font-size:14.0pt;\">ALP: 422 U/L</span></li><li><span style=\"font-size:14.0pt;\">ALT: 80 U/L</span></li><li><span style=\"font-size:14.0pt;\">Anti-HBs: positive</span></li></ul><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\">MRCP was done and it is shown. What is the next step?<strong>&nbsp;</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-165655.png\" alt=\"\" width=\"300\" height=\"297\"></span></p>",
      "unique_key": "Q5679693",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A)&nbsp;Colonoscopy</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Primary sclerosing cholangitis (PSC)</strong> is characterized by chronic inflammation and fibrosis of the bile ducts, leading to bile duct strictures, which is typically seen on <strong>MRCP</strong> (magnetic resonance cholangiopancreatography).</span></li><li><span style=\"font-size:14.0pt;\">PSC is strongly associated with <strong>ulcerative colitis</strong> (UC), and many patients with PSC also have underlying IBD. Given this patient’s <strong>history of chronic diarrhea</strong>, it is essential to evaluate for UC or other forms of IBD.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Colonoscopy</strong> with biopsy is the next best step to assess for the presence of IBD, particularly UC, which would guide the management of both conditions.</span></li></ul><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Fecal calprotectin</strong>: This can be used as a non-invasive marker for IBD activity, but it is not as definitive or necessary as <strong>colonoscopy</strong> with biopsy for diagnosis in this case.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Liver biopsy</strong>: While liver biopsy can confirm PSC, it is not necessary if characteristic findings are present on MRCP, which is the <strong>gold standard</strong> imaging for PSC.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Serum AMA (Antimitochondrial antibody)</strong>: This is used to diagnose <strong>primary biliary cholangitis (PBC)</strong>, not PSC. The clinical picture and MRCP findings are more consistent with <strong>PSC</strong> rather than PBC.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In a patient with <strong>cholestatic liver function abnormalities</strong> (elevated ALP), <strong>positive anti-HBs</strong>, and <strong>MRCP findings</strong> suggestive of bile duct strictures, <strong>colonoscopy</strong> is the next best step to evaluate for the presence of <strong>inflammatory bowel disease</strong> (IBD), particularly <strong>ulcerative colitis</strong>, which is commonly associated with <strong>primary sclerosing cholangitis (PSC)</strong>.&nbsp;</span></li></ul>",
      "correct_choice_id": 247921,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62197,
      "choices": [
        {
          "id": 248045,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Margin </span></span></span></p>"
        },
        {
          "id": 248046,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Echogenicity</span></span></span></p>"
        },
        {
          "id": 248047,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Vascularity </span></span></span></p>"
        },
        {
          "id": 248048,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Shape</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A radiology resident is reviewing a thyroid ultrasound for evaluation of a nodule. Which of the following is not included in the American College of Radiology&#39;s Thyroid Imaging Reporting and Data System (ACR TI-RADS) criteria? </span></span></p>",
      "unique_key": "Q4535131",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Vascularity </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Vascularity&nbsp;</span></strong><span style=\"font-size:14.0pt\">refers to the <strong>blood flow</strong> within a <strong>nodule</strong> as seen on <strong>Doppler ultrasound</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">While <strong>vascularity is assessed in thyroid nodules</strong>, it is not part of the <strong>ACR TI-RADS</strong>. <strong>TI-RADS</strong> is based on the <strong>nodule&#39;s composition</strong>, <strong>echogenicity</strong>, shape, margin, and echogenic foci, not vascularity.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Margin:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Margins are <strong>evaluated in thyroid nodules</strong> to determine the <strong>risk of malignancy</strong>. TI-RADS includes margin assessment with descriptors like smooth, ill-defined, lobulated, or irregular to score the nodules.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Echogenicity:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Echogenicity describes the <strong>brightness of a thyroid nodule </strong>compared to the <strong>surrounding thyroid tissue</strong>. TI-RADS uses echogenicity as a criterion, including anechoic, hyperechoic, isoechoic, and hypoechoic as descriptors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Shape:&nbsp;</span></strong><span style=\"font-size:14.0pt\">The shape of a <strong>nodule</strong>, whether it is <strong>wider than tall</strong> or <strong>taller-than-wide</strong>, is a significant factor in TI-RADS. A taller-than-wide shape is more concerning for malignancy and is thus included in the TI-RADS scoring system.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Vascularity&nbsp;</span></strong><span style=\"font-size:14.0pt\">is not included in the <strong>ACR TI-RADS</strong> criteria for <strong>thyroid nodules.</strong> <strong>TI-RADS</strong> is <strong>utilized to stratify</strong> the risk of <strong>thyroid nodules</strong> based on their <strong>ultrasound characteristics</strong>, excluding <strong>vascularity</strong>, which aids medical students and residents in identifying nodules that may require further evaluation or intervention.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248047,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62430,
      "choices": [
        {
          "id": 248969,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gelle&rsquo;s Test</span></span></p>"
        },
        {
          "id": 248970,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Audiometry</span></span></p>"
        },
        {
          "id": 248971,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schwabach Test</span></span></p>"
        },
        {
          "id": 248972,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tympanometry</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old woman presents to the clinic with a history of progressive hearing loss in her right ear over the past year. She reports no significant ear pain, discharge, or vertigo. Physical examination reveals normal-appearing tympanic membranes. The Weber test lateralizes to the right ear, and the Rinne test shows bone conduction greater than air conduction in the right ear. A diagnosis of otosclerosis is suspected. Which of the following tests would be most useful to confirm this diagnosis in a clinical setting? </span></span></p>",
      "unique_key": "Q4811443",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans</span></strong><span style=\"font-size:14.0pt\">. <strong>A) Gelle&rsquo;s Test</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Gelle&rsquo;s test is a tuning fork test historically used to confirm the presence of otosclerosis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is based on the principle that increasing pressure in the external auditory canal would normally result in the stapes footplate being pushed medially, halting sound transmission. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In otosclerosis, where the stapes footplate is fixed due to abnormal bone growth, this maneuver does not stop sound transmission, and the test remains positive. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This is because the stapes footplate remains fixed despite the pressure changes.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options</span></strong><span style=\"font-size:14.0pt\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Audiometry</span></strong><span style=\"font-size:14.0pt\">: While audiometry can confirm the type and degree of hearing loss, it does not specifically diagnose otosclerosis without additional clinical tests.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Schwabach Test</span></strong><span style=\"font-size:14.0pt\">: This test compares the patient&#39;s bone conduction with that of the examiner, which helps in identifying the type of hearing loss but is less specific for otosclerosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Tympanometry</span></strong><span style=\"font-size:14.0pt\">: This test assesses the mobility of the tympanic membrane and middle ear pressure but is not specific for detecting stapes fixation seen in otosclerosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective</span></strong><span style=\"font-size:14.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Gelle&rsquo;s test is useful for diagnosing otosclerosis by assessing the fixation of the stapes footplate. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It remains a positive test when the stapes is immobile, unlike in cases of normal middle ear function or sensorineural hearing loss.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248969,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62182,
      "choices": [
        {
          "id": 247989,
          "text": "<p><span style=\"font-size:14.0pt;\">HBV and HDV coinfection.</span></p>"
        },
        {
          "id": 247990,
          "text": "<p><span style=\"font-size:14.0pt;\">HDV superinfection.</span></p>"
        },
        {
          "id": 247991,
          "text": "<p><span style=\"font-size:14.0pt;\">Chronic HBV.</span></p>"
        },
        {
          "id": 247992,
          "text": "<p><span style=\"font-size:14.0pt;\">HBV in the window period.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 40-year-old man presents with jaundice. Serological tests reveal the following results:</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">HBsAg positive</span></li><li><span style=\"font-size:14.0pt;\">Anti-HBs negative</span></li><li><span style=\"font-size:14.0pt;\">Anti-HBc (Total) - Positive</span></li><li><span style=\"font-size:14.0pt;\">Anti-HBc (IgM) - Positive</span></li><li><span style=\"font-size:14.0pt;\">Anti-HDV positive</span></li></ul><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\">What do you infer from the above findings?</span></p>",
      "unique_key": "Q1964414",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A)&nbsp;HBV and HDV coinfection.</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This serological profile is consistent with <strong>acute coinfection</strong> of both <strong>hepatitis B virus (HBV)</strong> and <strong>hepatitis D virus (HDV)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">HDV can only replicate in the presence of HBV, and when both viruses are acquired simultaneously, it is referred to as an <strong>HBV and HDV coinfection</strong>.</span></li></ul><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\">Key findings supporting this:</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>HBsAg positive</strong>: Indicates active hepatitis B infection.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Anti-HBs negative</strong>: No immunity to HBV (either from recovery or vaccination).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Anti-HBc (IgM) positive</strong>: Indicates acute HBV infection.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Anti-HDV positive</strong>: Confirms the presence of hepatitis D virus.</span></li><li><span style=\"font-size:14.0pt;\">In coinfection, both HBV and HDV are acquired at the same time, leading to acute hepatitis. <strong>Anti-HBc IgM</strong> and <strong>Anti-HDV</strong> are both positive, suggesting the patient is in the acute phase of the disease.</span></li></ul><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option B. HDV superinfection</strong>: HDV superinfection occurs when a person with <strong>chronic HBV</strong> later acquires HDV. In this case, the <strong>Anti-HBc IgM</strong> would not be positive, as the infection would be chronic (Anti-HBc IgG would be positive instead).</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Chronic HBV</strong>: In chronic HBV infection, <strong>Anti-HBc IgM</strong> would not be positive, as the acute phase has resolved. Instead, <strong>Anti-HBc (IgG)</strong> and <strong>HBsAg</strong> would be present for more than 6 months.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option D. HBV in the window period</strong>: In the window period, <strong>HBsAg</strong> would be negative, and only <strong>Anti-HBc (IgM)</strong> would be positive. Additionally, <strong>Anti-HBs</strong> would begin to appear as the patient recovers from acute HBV infection.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>HBV and HDV coinfection</strong> occurs when both viruses are acquired simultaneously.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This is confirmed by the presence of <strong>HBsAg</strong>, <strong>Anti-HBc (IgM)</strong>, and <strong>Anti-HDV</strong> antibodies.</span></li></ul>",
      "correct_choice_id": 247989,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62171,
      "choices": [
        {
          "id": 247945,
          "text": "<p><span style=\"font-size:14.0pt;\">t(9;22)</span></p>"
        },
        {
          "id": 247946,
          "text": "<p><span style=\"font-size:14.0pt;\">del(13q)</span></p>"
        },
        {
          "id": 247947,
          "text": "<p><span style=\"font-size:14.0pt;\">t(14;18)</span></p>"
        },
        {
          "id": 247948,
          "text": "<p><span style=\"font-size:14.0pt;\">del(17p)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 67-year-old man presents with chronic, progressive fatigue, unintentional weight loss, left-sided abdominal discomfort, and left shoulder pain. On physical examination, nontender bilateral axillary and right-sided inguinal lymphadenopathy are noted, along with hepatosplenomegaly. A peripheral smear shows the presence of abnormal lymphocytes. Which of the following is the most common cytogenetic abnormality associated with this condition?<strong>&nbsp;</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-170129.png\" alt=\"\" width=\"300\" height=\"202\"></span></p>",
      "unique_key": "Q1724037",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) del(13q)</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Del(13q) is the most common cytogenetic abnormality associated with Chronic Lymphocytic Leukemia (CLL).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This deletion is often linked to a better prognosis in CLL patients.</span></li></ul><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option A. t(9;22):</strong> This translocation is characteristic of Chronic Myeloid Leukemia (CML) and some cases of acute lymphoblastic leukemia, not CLL.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option C. t(14;18):</strong> This translocation is commonly associated with follicular lymphoma and some cases of diffuse large B-cell lymphoma, rather than CLL.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option D. del(17p):</strong> While del(17p) is associated with poor prognosis in CLL, it is not the most common cytogenetic abnormality seen in this condition.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Del(13q) is the most frequently observed cytogenetic abnormality in Chronic Lymphocytic Leukemia (CLL) and is associated with a relatively favorable prognosis compared to other cytogenetic abnormalities in this malignancy.</span></li></ul>",
      "correct_choice_id": 247946,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62129,
      "choices": [
        {
          "id": 247777,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&delta;-Aminolevulinic acid synthase</span></span></span></p>"
        },
        {
          "id": 247778,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ferrochelatase</span></span></span></p>"
        },
        {
          "id": 247779,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Heme oxygenase</span></span></span></p>"
        },
        {
          "id": 247780,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Porphobilinogen synthase</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 2-year-old child was brought to his paediatrician for evaluation of gastrointestinal problems. The parents report that the boy has been listless for the last few weeks. Lab tests reveal a microcytic, hypochromic anaemia. Blood lead levels are elevated. Which of the enzymes listed below is most likely to have higher-than-normal activity in the liver of this child? </span></span></p>",
      "unique_key": "Q9906773",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) &delta;-Aminolevulinic acid synthase</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This child has the acquired porphyria of lead poisoning. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Lead inhibits both d-aminolevulinic acid dehydratase (Porphobilinogen synthase) and ferrochelatase and, consequently, heme synthesis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The decrease in heme increases &delta;- aminolevulinic acid synthase activity. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The decrease in heme also results in decreased hemoglobin synthesis, and anemia is seen. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ferrochelatase is directly inhibited by lead. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Heme oxygenase is enzymes of heme degradation.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Ferrochelatase:</span></strong><span style=\"font-size:14.0pt\"> Ferrochelatase is an enzyme involved in the final step of heme synthesis, where it catalyzes the insertion of iron into protoporphyrin IX to form heme. In lead poisoning, ferrochelatase is inhibited by lead. This inhibition leads to an accumulation of protoporphyrin IX and a decrease in heme production. Therefore, ferrochelatase activity is decreased, not increased, in cases of lead poisoning.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Heme oxygenase:</span></strong><span style=\"font-size:14.0pt\"> Heme oxygenase is the enzyme responsible for breaking down heme into biliverdin, releasing iron and carbon monoxide in the process. This enzyme is part of the heme degradation pathway, not the synthesis pathway. In lead poisoning, the problem lies in the synthesis of heme, not its breakdown, so the activity of heme oxygenase is not directly affected and would not be expected to increase.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Porphobilinogen synthase (ALA dehydratase):</span></strong><span style=\"font-size:14.0pt\"> Porphobilinogen synthase catalyzes the conversion of &delta;-aminolevulinic acid (ALA) to porphobilinogen, an essential step in heme synthesis. Lead poisoning directly inhibits this enzyme, causing an accumulation of ALA. Therefore, its activity is decreased in lead poisoning, not increased. This makes it an incorrect option.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">In cases of lead poisoning, lead inhibits key enzymes in the heme synthesis pathway, particularly ferrochelatase and porphobilinogen synthase. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">As a result, there is a compensatory increase in the activity of &delta;-aminolevulinic acid synthase due to reduced feedback inhibition from heme.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247777,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62356,
      "choices": [
        {
          "id": 248677,
          "text": "<p><span style=\"font-size:14.0pt;\">Hydrogen peroxide (H₂O₂)</span></p>"
        },
        {
          "id": 248678,
          "text": "<p><span style=\"font-size:14.0pt;\">Nitrous oxide (N₂O)</span></p>"
        },
        {
          "id": 248679,
          "text": "<p><span style=\"font-size:14.0pt;\">Ozone</span></p>"
        },
        {
          "id": 248680,
          "text": "<p><span style=\"font-size:14.0pt;\">Ethylene oxide (EtO)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old male is working as an operating room technician at a hospital. He was trained to use STERRAD, a gas plasma sterilizer used for disinfecting operation theatre articles and sensitive instruments that are unsuitable for traditional autoclaving. Which of the following is the active agent used in the STERRAD system?</span></p>",
      "unique_key": "Q3736474",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Hydrogen peroxide (H₂O₂)</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul><li><span style=\"font-size:14.0pt;\"><strong>Hydrogen peroxide (H₂O₂)</strong> is the active agent used in the STERRAD gas plasma sterilizer.</span></li><li><span style=\"font-size:14.0pt;\">In this system, hydrogen peroxide is vaporized and then subjected to an electrical field to form reactive plasma.</span></li><li><span style=\"font-size:14.0pt;\">This plasma effectively sterilizes the medical instruments by disrupting the cellular components of microorganisms.</span></li><li><span style=\"font-size:14.0pt;\">The advantage of STERRAD is its ability to sterilize instruments at low temperatures, which is particularly useful for temperature-sensitive surgical equipment and materials.</span></li></ul><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Nitrous oxide (N₂O)</strong>: Nitrous oxide is used primarily as an anesthetic and analgesic agent. It is not used in sterilizers due to its lack of antimicrobial properties.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Ozone</strong>: Ozone is used in some sterilization systems because of its strong oxidizing properties, but it is not the active agent in STERRAD systems.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Ethylene oxide (EtO)</strong>: Ethylene oxide is used as a sterilizing gas in a different kind of sterilization process, mainly for heat-sensitive materials. However, it is not the active agent in the STERRAD gas plasma sterilizer.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul><li><span style=\"font-size:14.0pt;\"><strong>STERRAD is a gas plasma sterilizer that uses vaporized hydrogen peroxide (H₂O₂) as the active agent.</strong></span></li><li><span style=\"font-size:14.0pt;\">This sterilization method is effective for temperature-sensitive equipment and is commonly used in healthcare settings to ensure safe disinfection of delicate surgical instruments.</span></li></ul>",
      "correct_choice_id": 248677,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62143,
      "choices": [
        {
          "id": 247833,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Chlamydia trachomatis</span></span></span></p>"
        },
        {
          "id": 247834,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Haemophilus ducreyi</span></span></span></p>"
        },
        {
          "id": 247835,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Treponema pallidum</span></span></span></p>"
        },
        {
          "id": 247836,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Neisseria gonorrhoeae</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old male presents to a sexually transmitted disease (STD) clinic with complaints of urethral discharge and dysuria. He reports unprotected sexual intercourse with a new partner approximately 2 weeks ago. A Gram stain of the urethral discharge reveals numerous polymorphonuclear leukocytes, but no microorganisms are seen. A culture of the discharge is also negative on routine laboratory media. Which of the following organisms is the most likely cause of this patient&#39;s symptoms? </span></span></p>",
      "unique_key": "Q9698459",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Chlamydia trachomatis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Chlamydia trachomatis is the most common cause of nongonococcal urethritis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is an obligate intracellular bacterium, meaning it cannot be visualized with a Gram stain, and it also cannot be cultured on routine media. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In patients with urethritis, the absence of visible microorganisms on Gram stain and a negative culture makes Chlamydia trachomatis the most likely culprit.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Haemophilus ducreyi</span></strong><span style=\"font-size:14.0pt\">: This bacterium causes chancroid, characterized by painful genital ulcers rather than urethral discharge. It is usually diagnosed by culture or PCR and is not the most common cause of urethritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Treponema pallidum</span></strong><span style=\"font-size:14.0pt\">: Treponema pallidum, the causative agent of syphilis, is not usually associated with urethritis and urethral discharge. It causes painless genital ulcers (chancres). Treponema pallidum cannot be visualized with Gram stain but requires special dark-field microscopy or serological testing for diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Neisseria gonorrhoeae</span></strong><span style=\"font-size:14.0pt\">: Gonorrhea commonly presents with urethral discharge and can be visualized on a Gram stain, appearing as Gram-negative intracellular diplococci. It also grows readily on culture media such as Thayer-Martin agar.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Chlamydia trachomatis is the most common cause of nongonococcal urethritis and cannot be visualized with Gram stain or cultured on routine media. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In cases of urethritis with negative Gram stain and culture, Chlamydia trachomatis should be strongly considered.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247833,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62189,
      "choices": [
        {
          "id": 248017,
          "text": "<p><span style=\"font-size:14.0pt;\">Endometrial carcinoma</span></p>"
        },
        {
          "id": 248018,
          "text": "<p><span style=\"font-size:14.0pt;\">Sarcoma botryoides</span></p>"
        },
        {
          "id": 248019,
          "text": "<p><span style=\"font-size:14.0pt;\">Clear cell adenocarcinoma</span></p>"
        },
        {
          "id": 248020,
          "text": "<p><span style=\"font-size:14.0pt;\">Squamous cell carcinoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old woman presents for a routine gynecological examination. She reports that her mother took a medication called diethylstilbestrol (DES) during pregnancy. Which of the following conditions is this patient at an increased risk for due to her mother's exposure to diethylstilbestrol (DES)?</span></p>",
      "unique_key": "Q4026831",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Clear cell adenocarcinoma</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Diethylstilbestrol (DES)&nbsp;</strong>was a synthetic estrogen used between the 1940s and 1970s to prevent miscarriage and premature labor.</span></li><li><span style=\"font-size:14.0pt;\">Daughters of women who were exposed to DES during pregnancy are at an increased risk of developing <strong>clear cell adenocarcinoma of the vagina and cervix</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This is a rare but serious condition that has been strongly associated with in-utero DES exposure.</span></li><li><span style=\"font-size:14.0pt;\">These women may also have other reproductive tract abnormalities, such as vaginal adenosis, and an increased risk of infertility or ectopic pregnancy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Endometrial carcinoma:&nbsp;</strong>Incorrect. <strong>Endometrial carcinoma</strong> is not linked to <strong>DES</strong> exposure. It is more commonly associated with factors like unopposed estrogen exposure, obesity, and polycystic ovarian syndrome (PCOS).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Sarcoma botryoides:&nbsp;</strong>Incorrect. <strong>Sarcoma botryoides</strong> is a subtype of <strong>rhabdomyosarcoma</strong> that typically affects children and presents as a grape-like mass in the vagina or bladder. It is not related to DES exposure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Squamous cell carcinoma:&nbsp;</strong>Incorrect. <strong>Squamous cell carcinoma</strong> is more commonly associated with <strong>HPV</strong> infection and is not linked to DES exposure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Daughters of women exposed to <strong>diethylstilbestrol (DES)&nbsp;</strong>during pregnancy are at an increased risk for developing <strong>clear cell adenocarcinoma</strong> of the vagina and cervix.</span></li><li><span style=\"font-size:14.0pt;\">These women require regular gynecologic monitoring due to their elevated cancer risk.</span></li></ul>",
      "correct_choice_id": 248019,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62372,
      "choices": [
        {
          "id": 248737,
          "text": "<p><span style=\"font-size:14.0pt;\">Decreased cerebellar function due to neurodegeneration</span></p>"
        },
        {
          "id": 248738,
          "text": "<p><span style=\"font-size:14.0pt;\">Genetic anticipation due to trinucleotide repeat expansion</span></p>"
        },
        {
          "id": 248739,
          "text": "<p><span style=\"font-size:14.0pt;\">Mitochondrial inheritance pattern of the disorder</span></p>"
        },
        {
          "id": 248740,
          "text": "<p><span style=\"font-size:14.0pt;\">Reduced penetrance of the mutant allele in successive generations</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 16-year-old male presents with worsening gait instability and frequent falls. He has a history of progressive difficulty with balance and coordination since early childhood. His younger sibling, now 12 years old, also recently started showing similar symptoms at an earlier age. On physical examination, the patient exhibits dysarthria, loss of deep tendon reflexes, and bilateral lower extremity weakness. Other examination finding are shown. Which of the following best explains the earlier onset of symptoms in the patient's sibling?</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/22/screenshot-2024-10-22-122024.png\" alt=\"\" width=\"300\" height=\"139\"></span></p>",
      "unique_key": "Q6180656",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Genetic anticipation due to trinucleotide repeat expansion</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Friedreich's ataxia</strong> is an autosomal recessive disorder caused by a GAA trinucleotide repeat expansion in the <strong>FXN gene</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The disease is characterized by progressive ataxia, dysarthria, and loss of proprioception, with early onset during childhood or adolescence.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The phenomenon of <strong>genetic anticipation</strong> refers to the tendency for the symptoms of certain genetic disorders to appear at an earlier age and often with increased severity in successive generations.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In trinucleotide repeat disorders like Friedreich's ataxia, anticipation occurs due to an increase in the number of repeats with each successive generation, leading to earlier onset of symptoms in younger family members.</span></li></ul><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Decreased cerebellar function due to neurodegeneration:</strong> This describes part of the pathology of Friedreich's ataxia but does not explain the earlier onset of symptoms in successive generations (which is due to anticipation).</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Mitochondrial inheritance pattern of the disorder:</strong> Friedreich's ataxia is inherited in an <strong>autosomal recessive</strong> manner, not through mitochondrial inheritance, which would be transmitted exclusively through the maternal line.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Reduced penetrance of the mutant allele in successive generations:</strong> Reduced penetrance refers to individuals carrying a mutation but not expressing the phenotype. This is not relevant here, as both the patient and his sibling exhibit symptoms, and the key issue is the earlier onset in successive generations.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Friedreich's ataxia</strong> is a trinucleotide repeat disorder associated with <strong>genetic anticipation</strong>, where successive generations experience earlier onset and potentially more severe symptoms due to an expansion in the number of GAA repeats in the FXN gene.</span></li></ul>",
      "correct_choice_id": 248738,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62407,
      "choices": [
        {
          "id": 248877,
          "text": "<p><span style=\"color:black;font-size:14.0pt;\">Ringer’s Lactate</span></p>"
        },
        {
          "id": 248878,
          "text": "<p><span style=\"color:black;font-size:14.0pt;\">Normal Saline</span></p>"
        },
        {
          "id": 248879,
          "text": "<p><span style=\"color:black;font-size:14.0pt;\">Colloids</span></p>"
        },
        {
          "id": 248880,
          "text": "<p><span style=\"color:black;font-size:14.0pt;\">Blood products</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:14.0pt;\">Which of these intra-venous therapies is preferred while performing damage control resuscitation in traumatic hemorrhage?</span></p>",
      "unique_key": "Q1850023",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"color:black;font-size:14.0pt;\"><strong>Ans. D) Blood products</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:14.0pt;\">Blood products, including packed red blood cells, plasma, and platelets, are the preferred choice in damage control resuscitation (DCR) because they provide essential clotting factors, maintain oxygen-carrying capacity, and help avoid dilutional coagulopathy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Ringer’s Lactate: </strong>Ringer's Lactate is a crystalloid solution used for fluid resuscitation. While it can be used in the initial management of hemorrhagic shock, it does not contain clotting factors or carry oxygen and can lead to dilutional coagulopathy if used excessively.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Normal Saline: </strong>Normal Saline is another crystalloid solution. Similar to Ringer’s Lactate, it can be used for initial volume expansion but is associated with hyperchloremic acidosis and does not contain blood clotting factors or oxygen-carrying capacity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Colloids: </strong>Colloids, such as hydroxyethyl starch, are sometimes used for volume expansion, but they can interfere with hemostasis and do not provide oxygen-carrying capacity or clotting factors.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">During damage control resuscitation in traumatic hemorrhage, the preferred intravenous therapy is blood products, as they help maintain hemostasis, oxygenation, and coagulation without causing dilutional coagulopathy.</span></li></ul>",
      "correct_choice_id": 248880,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62394,
      "choices": [
        {
          "id": 248825,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1, 3 and 4</span></span></span></p>"
        },
        {
          "id": 248826,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">2, 4 and 5</span></span></span></p>"
        },
        {
          "id": 248827,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1, 4 and 5</span></span></span></p>"
        },
        {
          "id": 248828,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">2, 3 and 5</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A public health engineer is evaluating the use of septic tanks as a solution for wastewater management in a rural community. The community lacks a public sewerage system, and the engineer is explaining how septic tanks function. Which of the following statements are true about the functioning and characteristics of a septic tank? </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Treatment of household sewage</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Suitable in presence of public sewerage system</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Aerobic oxidation occurs outside the septic tank</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Anaerobic digestion takes place inside the septic tank</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Retention period is approximately 6 hours</span></span></span></li>\r\n</ol>",
      "unique_key": "Q2054566",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) 1, 3 and 4</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The following statements accurately describe the functioning of a septic tank:</span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">1. Treatment of household sewage</span></strong><span style=\"font-size:14.0pt\">: Correct. Septic tanks are designed to provide primary treatment of household sewage, particularly in rural or remote areas where there is no access to public sewerage systems.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">3. Aerobic oxidation occurs outside the septic tank</span></strong><span style=\"font-size:14.0pt\">: Correct. After the effluent leaves the septic tank, it flows into a drain field or soak-away area, where aerobic bacteria further break down the organic matter in the presence of oxygen.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">4. Anaerobic digestion takes place inside the septic tank</span></strong><span style=\"font-size:14.0pt\">: Correct. Inside the septic tank, anaerobic bacteria decompose organic matter in the absence of oxygen, which helps break down sludge and organic waste.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options</span></strong><span style=\"font-size:14.0pt\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">2. Suitable in presence of public sewerage system:</span></strong><span style=\"font-size:14.0pt\"> Incorrect. Septic tanks are not suitable when a public sewerage system is available. They are used as an alternative when such a system is absent.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">5. Retention period is approximately 6 hours:</span></strong><span style=\"font-size:14.0pt\"> Incorrect. The retention period in a septic tank can vary but is typically 24 hours for effective treatment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">SEPTIC TANK:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Is a water-tight masonary tank into which household sewage is admitted for treatment</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Is a satisfactory method of disposing liquid and excreta wastes from individual dwellings, small groups of houses or institutions which have &lsquo;adequate water supply but do not have access to a public sewerage system&rsquo;</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Design features of a septic tank: &ndash; Ideal retention period: 24 hours</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Steps of purification in a septic tank:</span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Anaerobic digestion: Takes place in septic tank proper</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Aerobic oxidation: Takes place in sub-soil (outside septic tank)</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248825,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62415,
      "choices": [
        {
          "id": 248909,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"ES\" style=\"font-size:14.0pt\">2&gt;1&gt;3</span></span></span></p>"
        },
        {
          "id": 248910,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">4&gt;1&gt;2</span></span></span></p>"
        },
        {
          "id": 248911,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1&gt;2&gt;4</span></span></span></p>"
        },
        {
          "id": 248912,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">2&gt; 1&gt; 4</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A pediatrician is reviewing mortality trends among children aged between 1-4 years based on verbal autopsy reports from the years 2020-2024. She wants to educate parents on the primary causes of death to improve preventive measures in her community. From the list provided below, which sequence correctly represents the leading causes of death in a ascending order for this age group? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"ES\" style=\"font-size:14.0pt\">Neonatal infections </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"ES\" style=\"font-size:14.0pt\">Prematurity </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"ES\" style=\"font-size:14.0pt\">Malaria</span></span></span></li>\r\n\t<li><span dir=\"ltr\" lang=\"ES\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Birth asphyxia</span></span></li>\r\n</ol>",
      "unique_key": "Q4568773",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) 2&gt;1&gt;4</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">According to the verbal autopsy report of 2020-2024, leading cause of death among 1&ndash;4-year-old children in a developing country like India in descending order is Prematurity, neonatal infections &amp; birth asphyxia.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Leading causes of under 5 mortality and neonatal mortality are:</span></span></span></li>\r\n</ul>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Prematurity </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Neonatal infections </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Birth asphyxia </span></span></span></li>\r\n</ol>",
      "correct_choice_id": 248912,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62405,
      "choices": [
        {
          "id": 248869,
          "text": "<p><span style=\"font-size:14.0pt;\">All zone 1 injury to be treated conservatively</span></p>"
        },
        {
          "id": 248870,
          "text": "<p><span style=\"font-size:14.0pt;\">Zone 3 injury, whether blunt or penetrative, should always be explored</span></p>"
        },
        {
          "id": 248871,
          "text": "<p><span style=\"font-size:14.0pt;\">Zone 2 injury with expanding hematoma should be treated surgically</span></p>"
        },
        {
          "id": 248872,
          "text": "<p><span style=\"font-size:14.0pt;\">Mattox maneuver is when the ascending colon is mobilized to visualize the IVC</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Identify the true statement regarding retroperitoneal trauma:</span></p>",
      "unique_key": "Q3175206",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Zone 2 injury with expanding hematoma should be treated surgically</strong></span><br><span style=\"font-size:11pt;\">&nbsp;</span></p><ul><li><span style=\"font-size:14.0pt;\">Zone 2 hematomas occur in the flank region and typically involve the kidneys.</span></li><li><span style=\"font-size:14.0pt;\">Most Zone 2 hematomas can be managed conservatively unless the hematoma is expanding.</span></li><li><span style=\"font-size:14.0pt;\">If expansion occurs, surgical intervention is necessary to prevent further complications or hemorrhage.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. All zone 1 injury to be treated conservatively</strong>: Zone 1 refers to the central retroperitoneal area, where vital structures like the abdominal aorta and IVC are located. Since these structures are crucial and any injury here can be life-threatening, all Zone 1 hematomas should be surgically explored rather than treated conservatively.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Zone 3 injury, whether blunt or penetrative, should always be explored:</strong> Zone 3 involves the pelvic area. Blunt trauma to this zone is typically managed conservatively using pelvic binders or external fixation. Exploration is usually avoided due to the high risk of causing additional harm. Surgical exploration is indicated only in cases of expanding hematomas or severe trauma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Mattox maneuver is when the ascending colon is mobilized to visualize the IVC.</strong> The Mattox maneuver is a surgical technique that mobilizes the left-sided abdominal organs medially to allow visualization of the abdominal aorta. This is performed in trauma cases or emergencies to gain access to the retroperitoneum and the aorta.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Retroperitoneal injuries are managed differently depending on the zone of injury.</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Zone 1</strong> (Midline Retroperitoneum): Injuries in this area involve major vessels and require immediate surgical exploration.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Zone 2</strong> (Lateral Retroperitoneum): Injuries can usually be managed conservatively unless the hematoma is expanding, in which case surgery is indicated.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Zone 3</strong> (Pelvic Region): Most injuries in this zone are managed conservatively due to the risk of complications during surgery, except when there are expanding hematomas or severe injuries.</span></li></ul></li></ul>",
      "correct_choice_id": 248871,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62350,
      "choices": [
        {
          "id": 248653,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Hepatitis B surface antibody</span></p>"
        },
        {
          "id": 248654,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Anti–streptolysin O antibody</span></p>"
        },
        {
          "id": 248655,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\">C3 nephritic factor</span></p>"
        },
        {
          "id": 248656,
          "text": "<p><span style=\"font-size:16px;\">Anti–glomerular basement membrane antibody</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A 26-year-old previously healthy man has noticed blood in his urine for the past 2 days. He reports no dysuria, frequency, or hesitancy of urination. On physical examination, there are no abnormal findings. Laboratory findings show a serum urea nitrogen level of 42 mg/dL and creatinine level of 4.5 mg/dL. A renal biopsy specimen is obtained; the immunofluorescence pattern of staining with antibody against human IgG is shown in the figure. Which of the following serologic findings is most likely to be present in this patient?</span></p><p><span style=\"font-size:16px;\">&nbsp;</span></p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/22/screenshot-2024-10-22-115243.png\" alt=\"\" width=\"300\" height=\"254\"></span></p>",
      "unique_key": "Q6399121",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) Anti–glomerular basement membrane antibody</strong></span></p><p><span style=\"font-size:16px;\">&nbsp;</span></p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">The linear pattern of staining shown in the figure indicates the presence of anti–glomerular basement membrane antibodies (directed against the non-collagenous domain of the α3 chain of type IV collagen).</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Such antibodies are typically seen in Goodpasture syndrome, a form of rapidly progressive glomerulonephritis (GN) that has a bimodal pattern of occurrence in younger and older men.</span></p></li></ul><p><span style=\"font-size:16px;\">&nbsp;</span></p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Hepatitis B surface antibody: </strong>Incorrect. Hepatitis B is associated with <strong>membranous nephropathy</strong> or <strong>polyarteritis nodosa</strong>, neither of which presents with the linear IgG deposition seen here.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option B. Anti–streptolysin O antibody: </strong>Incorrect. This is associated with <strong>post-streptococcal glomerulonephritis</strong>, which typically shows a <strong>granular</strong> immune complex deposition pattern, not the linear pattern seen in this case.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option C. C3 nephritic factor: </strong>Incorrect. C3 nephritic factor is associated with <strong>membranoproliferative glomerulonephritis</strong> and <strong>dense deposit disease</strong>, which show <strong>C3 deposits</strong>, not the linear IgG deposits seen here.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Goodpasture syndrome </strong>is characterized by <strong>anti–glomerular basement membrane antibodies</strong> that cause a <strong>linear IgG deposition</strong> pattern on immunofluorescence and result in <strong>rapidly progressive glomerulonephritis</strong>.</span></p></li></ul>",
      "correct_choice_id": 248656,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62232,
      "choices": [
        {
          "id": 248185,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thoracic outlet syndrome</span></span></p>"
        },
        {
          "id": 248186,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fracture of first rib</span></span></p>"
        },
        {
          "id": 248187,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acromioclavicular joint injury</span></span></p>"
        },
        {
          "id": 248188,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fracture clavicle</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical test shown in the image is positive in which of the following conditions? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-160903.jpg\" style=\"height:530px; width:400px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>",
      "unique_key": "Q1067538",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>A) Thoracic outlet syndrome</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The test being performed in the image is known as <strong>Adson&#39;s test</strong>, which is commonly used to diagnose <strong>thoracic outlet syndrome (TOS)</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Adson&#39;s test</span></strong><span style=\"font-size:14.0pt\"> is a provocative test that involves the compression of the subclavian artery by structures such as a cervical rib or tight anterior and middle scalene muscles, leading to a reduction in blood flow.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In the test, the patient is asked to take a deep breath, extend, abduct, and externally rotate the affected arm while rotating the head to the ipsilateral side with the neck extended.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The radial pulse is palpated during the maneuver, and the test is considered positive if there is a significant reduction or disappearance of the pulse, suggesting compression of the subclavian vessels.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Fracture of the first rib:</span></strong><span style=\"font-size:14.0pt\"> This would not involve vascular compression, and a specific fracture test or imaging would be more appropriate for diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Acromioclavicular joint injury:</span></strong><span style=\"font-size:14.0pt\"> It is typically diagnosed through localized pain and physical maneuvers specific to the joint itself (e.g., cross-arm test or O&#39;Brien&#39;s test).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Clavicle fracture:</span></strong><span style=\"font-size:14.0pt\"> This would present with local swelling, deformity, and tenderness over the fracture site. Adson&#39;s test is unrelated to clavicle fractures.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Adson&rsquo;s test is used to diagnose thoracic outlet syndrome, a condition characterized by compression of neurovascular structures (subclavian artery, vein, and brachial plexus) as they pass through the thoracic outlet.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248185,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62151,
      "choices": [
        {
          "id": 247865,
          "text": "<p><span style=\"font-size:14.0pt;\">For hormone receptor (HR)-positive metastatic breast cancer in postmenopausal women</span></p>"
        },
        {
          "id": 247866,
          "text": "<p><span style=\"font-size:14.0pt;\">As a selective progesterone receptor modulator</span></p>"
        },
        {
          "id": 247867,
          "text": "<p><span style=\"font-size:14.0pt;\">In hormone replacement therapy (HRT)</span></p>"
        },
        {
          "id": 247868,
          "text": "<p><span style=\"font-size:14.0pt;\">In male breast cancer</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is the most appropriate indication for fulvestrant?</span></p>",
      "unique_key": "Q7638322",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) For hormone receptor (HR)-positive metastatic breast cancer in postmenopausal women</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Fulvestrant </strong>is a <strong>selective estrogen receptor downregulator (SERD)</strong> that is used in the treatment of <strong>hormone receptor (HR)-positive metastatic breast cancer</strong> in <strong>postmenopausal women</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It works by binding to estrogen receptors and promoting their degradation, thus reducing the growth-promoting effects of estrogen in breast cancer cells.</span></li><li><span style=\"font-size:14.0pt;\">It is often used when other hormonal therapies, such as aromatase inhibitors or tamoxifen, are no longer effective.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. As a selective progesterone receptor modulator</strong>: This is incorrect. <strong>Fulvestrant</strong> specifically targets <strong>estrogen receptors</strong>, not progesterone receptors. <strong>Selective progesterone receptor modulators</strong> (e.g., mifepristone) are used for different indications, such as uterine fibroids or as abortifacients.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. In hormone replacement therapy (HRT)</strong>: This is incorrect. <strong>Fulvestrant</strong> is not used in <strong>HRT</strong> because it antagonizes estrogen receptors, which would be counterproductive in hormone replacement therapy aimed at providing estrogen.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. In male breast cancer</strong>: While <strong>hormone therapy</strong> is sometimes used for <strong>male breast cancer</strong>, <strong>fulvestrant</strong> is not specifically indicated for this purpose. Male breast cancer is typically managed with <strong>tamoxifen</strong> or other medications that inhibit estrogen activity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Fulvestrant&nbsp;</strong>is a <strong>selective estrogen receptor downregulator (SERD)</strong> used for <strong>HR-positive metastatic breast cancer</strong> in <strong>postmenopausal women</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is not used as a <strong>progesterone receptor modulator</strong> or for <strong>hormone replacement therapy (HRT)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is not a standard treatment for <strong>male breast cancer</strong>, where <strong>tamoxifen</strong> is more commonly used.</span></li></ul>",
      "correct_choice_id": 247865,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62148,
      "choices": [
        {
          "id": 247853,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Squamous cell carcinoma</span></span></p>"
        },
        {
          "id": 247854,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Small cell carcinoma</span></span></p>"
        },
        {
          "id": 247855,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Large cell carcinoma</span></span></p>"
        },
        {
          "id": 247856,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adenocarcinoma</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 58-year-old woman presents with a chronic cough and shortness of breath. She has never smoked and works as a librarian. A chest CT shows a 3 cm mass in the periphery of the right lung. A biopsy of the lesion reveals glandular structures and mucin production. Molecular testing reveals a mutation in the EGFR gene. Which of the following is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q6496868",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans. D) Adenocarcinoma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The patient has a peripheral lung tumor with glandular differentiation and mucin production, which is characteristic of <strong>adenocarcinoma of the lung</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Adenocarcinoma&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">is the most common type of lung cancer in <strong>nonsmokers</strong> and is often associated with <strong>EGFR mutations</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Squamous cell carcinoma:</span></strong><span style=\"font-size:14.0pt\"> Incorrect. Squamous cell carcinoma is usually centrally located and associated with a history of smoking. It is characterized by keratin pearls and intercellular bridges, not glandular structures or mucin production.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Small cell carcinoma:</span></strong><span style=\"font-size:14.0pt\"> Incorrect. Small cell carcinoma is strongly associated with smoking and presents with small, round cells, often centrally located in the lungs. It does not typically produce mucin or glandular structures.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Large cell carcinoma:</span></strong><span style=\"font-size:14.0pt\"> Incorrect. Large cell carcinoma is a poorly differentiated lung cancer that lacks the glandular differentiation or mucin production seen in adenocarcinoma. It also tends to be located peripherally, but the biopsy findings do not match large cell carcinoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Adenocarcinoma of the lung&nbsp;</span></strong><span style=\"font-size:14.0pt\">is the most common lung cancer in <strong>nonsmokers</strong> and is often associated with <strong>EGFR mutations</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is characterized by <strong>glandular differentiation</strong> and <strong>mucin production</strong> and typically occurs in the <strong>periphery</strong> of the lungs.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247856,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62138,
      "choices": [
        {
          "id": 247813,
          "text": "<p><span style=\"font-size:14.0pt;\">Drug A is most efficacious.</span></p>"
        },
        {
          "id": 247814,
          "text": "<p><span style=\"font-size:14.0pt;\">Drug B and drug C are equipotent.</span></p>"
        },
        {
          "id": 247815,
          "text": "<p><span style=\"font-size:14.0pt;\">Drug D is most effective.</span></p>"
        },
        {
          "id": 247816,
          "text": "<p><span style=\"font-size:14.0pt;\">Drug B is less potent but more efficacious than drug A.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">The graph shows the log dose-response curves (DRC) for four drugs: A, B, C, and D. Which of the following statements about these drugs is true?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-163127.jpg\" alt=\"\" width=\"300\" height=\"219\"></span></p>",
      "unique_key": "Q1914721",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Drug B is less potent but more efficacious than drug A.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Potency&nbsp;</strong>refers to the <strong>dose</strong> of a drug required to produce a certain effect, and is indicated by the position of the curve along the <strong>x-axis</strong>.</span></li><li><span style=\"font-size:14.0pt;\">A drug whose curve is further to the <strong>left</strong> is <strong>more potent</strong> because it requires a <strong>lower dose</strong> to achieve the same effect.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Efficacy&nbsp;</strong>is reflected by the <strong>maximum response</strong> that a drug can produce, shown by the <strong>height</strong> of the curve on the <strong>y-axis</strong>.</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Drug A&nbsp;</strong>has a <strong>lower maximal response</strong> than <strong>Drug B</strong>, meaning it is <strong>less efficacious</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Drug B&nbsp;</strong>reaches a higher maximum effect than <strong>Drug A</strong>, indicating <strong>higher efficacy</strong>, but <strong>Drug A</strong> achieves its response at a <strong>lower dose</strong>, making it <strong>more potent</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Drug B&nbsp;</strong>is positioned <strong>to the right</strong> of <strong>Drug A</strong>, indicating <strong>lower potency</strong>.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Drug A is most efficacious</strong>: This is incorrect because <strong>efficacy</strong> is determined by the <strong>maximum height</strong> of the response curve. <strong>Drug B</strong> has a higher maximal response than <strong>Drug A</strong>, making <strong>Drug B</strong> more efficacious.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Drug B and drug C are equipotent</strong>: This is incorrect because <strong>potency</strong> is determined by the <strong>position</strong> of the curve along the <strong>x-axis</strong>. <strong>Drug C</strong> is further to the <strong>right</strong> than <strong>Drug B</strong>, indicating that <strong>Drug C</strong> is <strong>less potent</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Drug D is most effective</strong>: While <strong>Drug D</strong> is the most efficacious, not most effective. DRC of the drug can tell about efficacy not effectiveness.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Potency&nbsp;</strong>is determined by the <strong>position</strong> of the dose-response curve along the <strong>x-axis</strong>: further left means <strong>more potent</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Efficacy&nbsp;</strong>is determined by the <strong>height</strong> of the curve along the <strong>y-axis</strong>: higher means <strong>more efficacious</strong>.</span></li><li><span style=\"font-size:14.0pt;\">A drug can be <strong>more potent</strong> but <strong>less efficacious</strong> than another, as shown in the comparison between <strong>Drug A</strong> and <strong>Drug B</strong>.</span></li></ul>",
      "correct_choice_id": 247816,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62246,
      "choices": [
        {
          "id": 248241,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"color:black\">Reassure</span></span></span></span></p>"
        },
        {
          "id": 248242,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"color:black\">Cholecystectomy</span></span></span></span></p>"
        },
        {
          "id": 248243,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"color:black\">Right Nephrectomy</span></span></span></span></p>"
        },
        {
          "id": 248244,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"color:black\">DSA and coiling</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">An incidental finding was noted on a NCCT abdomen performed for suspected renal calculus. What would be the next step? </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-183145.jpg\" style=\"height:258px; width:350px\" /></p>",
      "unique_key": "Q4728667",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Cholecystectomy </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp;</strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"color:black\">The above given image shows <strong>curvilinear calcification</strong> of the <strong>gallbladder</strong> known as a <strong>&quot;Porcelain gallbladder&quot;.</strong></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"color:#0d0d0d\">Cholecystectomy</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"color:#0d0d0d\"> - Due to the <strong>increased risk of gallbladder cancer</strong> in patients with a <strong>porcelain gallbladder</strong>, <strong>prophylactic cholecystectomy</strong> is often recommended. The removal of the gallbladder can mitigate the risk of developing carcinoma.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Other Options:</span></span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"color:black\">Option A. Reassure:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"color:black\">While <strong>reassurance </strong>might be the<strong> next</strong> step for<strong> benign andnon-consequential findings,</strong> a <strong>porcelain gallbladde</strong>r is associated with a<strong> higherrisk of gallbladder carcinoma,</strong> and reassurance alone is not appropriate in thiscase.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"color:black\">Option C. Right Nephrectomy:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"color:black\">This would be an <strong>incorrect </strong>and <strong>excessive step</strong> as the finding is related to the <strong>gallbladder </strong>and <strong>not the kidney</strong>. There is no indication for nephrectomy based on the finding of a porcelain gallbladder.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><span style=\"color:black\"><strong>Option D. DSA and coiling:</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"color:black\"><strong>Digital subtraction angiography</strong> (DSA) and <strong>coiling</strong> are interventions used for vascular abnormalities such as <strong>aneurysms </strong>or <strong>active</strong> <strong>bleeding,</strong> not for the management of a porcelain gallbladder.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"color:black\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The correct management for a <strong>porcelain gallbladder</strong>, characterized by <strong>gallbladder wall calcification </strong>and associated with an <strong>increased risk ofcancer, </strong>is<strong> prophylactic cholecystectomy.</strong></span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This approach is to prevent the potential development of gallbladder carcinoma.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248242,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        17
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62202,
      "choices": [
        {
          "id": 248065,
          "text": "<p><span style=\"font-size:14.0pt;\">L1-L2</span></p>"
        },
        {
          "id": 248066,
          "text": "<p><span style=\"font-size:14.0pt;\">T2-L4</span></p>"
        },
        {
          "id": 248067,
          "text": "<p><span style=\"font-size:14.0pt;\">S3-S4</span></p>"
        },
        {
          "id": 248068,
          "text": "<p><span style=\"font-size:14.0pt;\">S1-S2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 50-year-old man presents for evaluation of persistent sciatica. He reports low back pain that radiates down the back of his left leg, which began weeks after he sustained a fall. On physical examination of the left leg, he has 4/5 strength with plantar flexion and a 1+ ankle jerk reflex. The right leg has normal strength (5/5) and full reflexes. Based on these findings, which of the following myotomes is most likely affected?</span></p>",
      "unique_key": "Q4889742",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;D) S1-S2</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient's symptoms, including radiating pain down the back of the leg (sciatica), reduced strength in plantar flexion, and a diminished ankle jerk reflex (S1 reflex), suggest involvement of the <strong>S1-S2 nerve roots</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>S1 myotome</strong> is responsible for ankle plantar flexion and the Achilles reflex. Weakness in plantar flexion and a diminished ankle jerk reflex are classic findings associated with <strong>S1 radiculopathy</strong>, often due to a herniated disc compressing the nerve root at L5-S1.</span></li></ul><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option A. L1-L2:</strong> L1-L2 myotomes are involved in hip flexion, not plantar flexion. Sciatica affecting these myotomes would cause pain in the anterior thigh, not the posterior leg.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option B. T2-L4:</strong> This option is incorrect as the T2-L4 myotomes control movements of the upper thigh (L2, L3) and knee extension (L4), but not plantar flexion or the Achilles reflex.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option C. S3-S4:</strong> S3-S4 myotomes are responsible for bowel, bladder, and some pelvic floor functions, not leg movement or reflexes.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>S1 radiculopathy</strong> typically presents with pain radiating down the posterior leg, weakness in plantar flexion, and a diminished Achilles (ankle jerk) reflex.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This is often caused by compression of the S1 nerve root, commonly due to a herniated disc at L5-S1.</span></li></ul>",
      "correct_choice_id": 248068,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62139,
      "choices": [
        {
          "id": 247817,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ethylene glycol</span></span></p>"
        },
        {
          "id": 247818,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypoglycin</span></span></p>"
        },
        {
          "id": 247819,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methyl alcohol</span></span></p>"
        },
        {
          "id": 247820,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ethyl alcohol</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 40-year-old man is brought to the emergency department with symptoms of blurred vision, severe abdominal pain, vomiting, and altered sensorium. He was found unconscious at home, and his family mentions that he had consumed illicit homemade liquor the previous evening. Physical examination reveals metabolic acidosis. Suspecting poisoning from contaminated alcohol, which of the following substances is most likely responsible for this patient&#39;s symptoms?</span></span></p>",
      "unique_key": "Q7098155",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Methyl alcohol</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The scenario described here is characteristic of a <strong>hooch tragedy</strong>, which refers to incidents of poisoning due to the consumption of <strong>illicit homemade liquor</strong> that is contaminated with <strong>methyl alcohol (methanol)</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Methanol poisoning&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">can result in severe <strong>metabolic acidosis</strong>, <strong>blindness</strong>, <strong>severe abdominal pain</strong>, and <strong>altered sensorium.</strong> </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Methanol is metabolized in the liver by <strong>alcohol dehydrogenase</strong> to <strong>formaldehyde</strong> and then to <strong>formic acid</strong>, which is highly toxic to the <strong>optic nerve</strong> and central nervous system. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">In cases of methanol poisoning, rapid intervention is necessary to prevent complications, including <strong>blindness</strong> and <strong>death</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Ethylene glycol</span></strong><span style=\"font-size:14.0pt\">: Incorrect. <strong>Ethylene glycol</strong> is another toxic alcohol often found in antifreeze. It is metabolized into <strong>glycolic acid</strong> and <strong>oxalic acid</strong>, leading to <strong>severe metabolic acidosis</strong>, <strong>renal failure</strong>, and <strong>calcium oxalate crystal deposition</strong> in the kidneys. However, it is not typically associated with <strong>illicit alcohol consumption</strong> like methanol.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Hypoglycin</span></strong><span style=\"font-size:14.0pt\">: Incorrect. <strong>Hypoglycin</strong> is a naturally occurring toxin found in <strong>unripe ackee fruit</strong> and can cause <strong>Jamaican vomiting sickness</strong>. It is not related to <strong>illicit alcohol consumption</strong> or <strong>Hooch tragedy</strong> incidents. Hypoglycin poisoning presents with <strong>severe hypoglycemia</strong> and <strong>vomiting</strong> but does not cause <strong>metabolic acidosis</strong> from alcohol toxicity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Ethyl alcohol</span></strong><span style=\"font-size:14.0pt\">: Incorrect. <strong>Ethyl alcohol (ethanol)</strong> is the primary alcohol present in <strong>commercial and consumable alcoholic beverages</strong>. While ethanol toxicity can occur, it is less likely to cause <strong>severe metabolic acidosis</strong> compared to <strong>methanol</strong>. Illicit or contaminated alcohol is more likely to contain <strong>methanol</strong>, leading to the symptoms described.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Methanol poisoning&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">is a critical consideration in cases of <strong>illicit alcohol consumption</strong> or <strong>Hooch tragedy</strong> events. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Methanol is metabolized into toxic metabolites, such as <strong>formaldehyde</strong> and <strong>formic acid</strong>, leading to <strong>metabolic acidosis</strong>, <strong>visual disturbances</strong>, and potential <strong>neurological damage</strong>.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247819,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62370,
      "choices": [
        {
          "id": 248729,
          "text": "<p><span style=\"font-size:14.0pt;\">Codon 129 polymorphism in PRNP gene</span></p>"
        },
        {
          "id": 248730,
          "text": "<p><span style=\"font-size:14.0pt;\">V122I mutation in TTR gene</span></p>"
        },
        {
          "id": 248731,
          "text": "<p><span style=\"font-size:14.0pt;\">G2019S mutation in LRRK2 gene</span></p>"
        },
        {
          "id": 248732,
          "text": "<p><span style=\"font-size:14.0pt;\">H63D mutation in HFE gene</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old man presents with progressive forgetfulness over the past 2 months. He exhibits intermittent jerky movements in his legs. On physical examination, he has significant cognitive impairment. He has horizontal nystagmus in all directions, ataxia, and intermittent large-amplitude jerking movements. His EEG is shown below. Given this presentation, which of the following genetic changes is most likely responsible for the patient's underlying condition?</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/22/screenshot-2024-10-22-121840.png\" alt=\"\" width=\"300\" height=\"179\"></span></p>",
      "unique_key": "Q2513121",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A) Codon 129 polymorphism in PRNP gene</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The clinical presentation, including rapid cognitive decline, myoclonus, ataxia, and horizontal nystagmus, is indicative of <strong>Creutzfeldt-Jakob Disease (CJD)</strong>, a prion disease.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>PRNP gene</strong>, responsible for encoding prion protein, has a codon 129 polymorphism, which is associated with susceptibility to CJD and related disorders.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The symptoms align with the neurodegenerative effects of prion diseases.</span></li></ul><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option B. V122I mutation in TTR gene:</strong> This mutation is linked to transthyretin amyloidosis, which primarily presents with neuropathy and cardiac issues, rather than the neurological symptoms presented in this case.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option C. G2019S mutation in LRRK2 gene:</strong> This mutation is associated with familial and sporadic Parkinson’s disease, characterized by tremors and rigidity rather than the rapid cognitive decline and myoclonus observed here.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option D. H63D mutation in HFE gene:</strong> This mutation is linked to hereditary hemochromatosis, which typically leads to iron overload and associated complications, but does not explain the neurological symptoms seen in this patient.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\">In cases presenting with rapidly progressive dementia and myoclonus, the <strong>PRNP gene</strong> polymorphism at codon 129 is a crucial factor to consider, indicating a potential diagnosis of Creutzfeldt-Jakob Disease.</span></p>",
      "correct_choice_id": 248729,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62193,
      "choices": [
        {
          "id": 248029,
          "text": "<p><span style=\"font-size:14.0pt;\">1-b, 2-c, 3-d, 4-a</span></p>"
        },
        {
          "id": 248030,
          "text": "<p><span style=\"font-size:14.0pt;\">1-c, 2b, 3-d, 4-a</span></p>"
        },
        {
          "id": 248031,
          "text": "<p><span style=\"font-size:14.0pt;\">1-b, 2-d, 3-c, 4-a</span></p>"
        },
        {
          "id": 248032,
          "text": "<p><span style=\"font-size:14.0pt;\">1-d, 2-b, 3-a, 4-c</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match each device listed in Column A with the maximum FiO2 it delivers, as shown in Column B</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-173119.png\" alt=\"\" width=\"1000\" height=\"180\"></span></p>",
      "unique_key": "Q3570445",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) 1-b, 2-c, 3-d, 4-a</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">1. High Flow Nasal Cannula (HFNC) - b. 90% -100 % FiO2</span><br><span style=\"font-size:14.0pt;\">2. Non-Rebreather Mask (NRBM)- c. Up to 80% FiO2</span><br><span style=\"font-size:14.0pt;\">3. Hudson Mask - d. 40-60% FiO2</span><br><span style=\"font-size:14.0pt;\">4. Nasal Cannula at 3 L/min Oxygen Flow - a. 30-35% FiO2</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>High Flow Nasal Cannula (HFNC)</strong> can deliver up to 100 % FiO2 depending on the device settings and patient's inspiratory flow rate, offering a high level of oxygen delivery and humidification.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Non-Rebreather Mask (NRBM)</strong> provides up to 80% FiO2 when properly fitted and the reservoir bag is kept inflated, ensuring a high concentration of oxygen is available for the patient.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Hudson Mask</strong>, also known as a simple mask, can deliver FiO2 levels between 40-60% based on the oxygen flow rate.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Nasal Cannula at 3 L/min Oxygen Flow</strong> typically provides 32% FiO2, making it suitable for patients requiring low to moderate additional oxygen.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Oxygen delivery devices are an essential aspect of managing patients with respiratory distress or hypoxemia.</span></li></ul>",
      "correct_choice_id": 248029,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62241,
      "choices": [
        {
          "id": 248221,
          "text": "<p><span style=\"font-size:14.0pt;\">Septic arthritis</span></p>"
        },
        {
          "id": 248222,
          "text": "<p><span style=\"font-size:14.0pt;\">TB arthritis</span></p>"
        },
        {
          "id": 248223,
          "text": "<p><span style=\"font-size:14.0pt;\">Behçet’s disease</span></p>"
        },
        {
          "id": 248224,
          "text": "<p><span style=\"font-size:14.0pt;\">Psoriatic arthritis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Fibrous ankylosis is caused by which of the following?</span></p>",
      "unique_key": "Q4490720",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) TB arthritis</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Tuberculous arthritis</strong> is a manifestation of extrapulmonary tuberculosis, where the bacteria Mycobacterium tuberculosis infects the joints.</span></li><li><span style=\"font-size:14.0pt;\">This condition leads to chronic synovitis and the formation of a granulomatous tissue response in the joint.</span></li><li><span style=\"font-size:14.0pt;\">TB arthritis often affects the hip and knee joints, leading to erosion of bone and cartilage.</span></li><li><span style=\"font-size:14.0pt;\">The resultant fibrous tissue formation around the joint can lead to fibrous ankylosis, restricting movement.</span></li><li><span style=\"font-size:14.0pt;\">This is a significant characteristic of TB arthritis, making it a prominent cause of this type of ankylosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Septic Arthritis:&nbsp;</strong>Septic arthritis is an infection in the joint space, usually caused by bacteria, though it can also be due to fungi or viruses. The infection causes acute inflammation, leading to pain, swelling, and redness. If not treated promptly, septic arthritis can lead to significant joint destruction and deformities. Chronic cases can result in joint instability and secondary complications like fibrous ankylosis due to scarring from the inflammatory process. However, it is typically more associated with irreversible damage rather than isolated fibrous ankylosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Behçet’s Disease:&nbsp;</strong>Behçet’s disease is a systemic vasculitis characterized by recurrent oral and genital ulcers, uveitis, and skin lesions. It can cause arthritis, typically non-erosive, affecting the knees, ankles, and wrists. The arthritis is usually transient and does not typically lead to permanent joint damage or fibrous ankylosis. While joint pain and swelling can occur, Behçet's disease does not generally result in fibrous ankylosis in the same way TB arthritis does.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Psoriatic Arthritis:&nbsp;</strong>Psoriatic arthritis is an inflammatory arthritis associated with psoriasis. It can lead to both peripheral and axial joint involvement and is characterized by flares of inflammation. Over time, it can cause erosive changes in the joints and sometimes leads to fusion of joints (ankylosis), particularly in the spine. While psoriatic arthritis can lead to ankylosis, it is more typically associated with bony ankylosis due to erosive changes rather than purely fibrous ankylosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">TB arthritis<strong> </strong>is the most directly associated with fibrous ankylosis due to the chronic inflammatory processes and tissue scarring it induces around the affected joint.</span></li></ul>",
      "correct_choice_id": 248222,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62403,
      "choices": [
        {
          "id": 248861,
          "text": "<p><span style=\"font-size:14.0pt;\">Vaginal hydrocele</span></p>"
        },
        {
          "id": 248862,
          "text": "<p><span style=\"font-size:14.0pt;\">Epididymal cyst</span></p>"
        },
        {
          "id": 248863,
          "text": "<p><span style=\"font-size:14.0pt;\">Meningocele</span></p>"
        },
        {
          "id": 248864,
          "text": "<p><span style=\"font-size:14.0pt;\">Lymphadenopathy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 5-year-old boy presents with a soft, painless swelling in the scrotal area that becomes more prominent during the day. On physical examination, the swelling is found to be transilluminant. Which of the following swellings is not expected to transilluminate brightly?</span></p>",
      "unique_key": "Q4590525",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Lymphadenopathy</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Unlike the other swellings, lymphadenopathy does not transilluminate because lymph nodes are solid structures rather than fluid-filled.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Vaginal hydrocele</strong>: This is a fluid-filled swelling in the scrotum that brilliantly transilluminates due to the presence of clear fluid.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Epididymal cyst</strong>: These are benign cysts that arise from the epididymis and contain clear fluid, which allows for brilliant transillumination.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Meningocele</strong>: This is a congenital defect where meninges protrude through a defect in the spine or skull, and it typically transilluminates brightly due to the fluid content within the meningeal sac.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Only fluid-filled swellings such as hydroceles, cysts, and meningoceles transilluminate brightly, while solid masses like lymphadenopathy do not.</span></li><li><span style=\"font-size:14.0pt;\">Understanding the differential diagnosis of transilluminating masses helps narrow down potential causes in clinical practice.</span></li></ul>",
      "correct_choice_id": 248864,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62377,
      "choices": [
        {
          "id": 248757,
          "text": "<p><span style=\"font-size:14.0pt;\">HLA-B27</span></p>"
        },
        {
          "id": 248758,
          "text": "<p><span style=\"font-size:14.0pt;\">HLA-B8</span></p>"
        },
        {
          "id": 248759,
          "text": "<p><span style=\"font-size:14.0pt;\">HLA-BW22</span></p>"
        },
        {
          "id": 248760,
          "text": "<p><span style=\"font-size:14.0pt;\">HLA-DR4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 56-year-old woman presents with progressive pain and stiffness in the joints of her hands. Physical examination reveals swelling and limited range of motion in the metacarpophalangeal and proximal interphalangeal joints bilaterally, with sparing of the distal interphalangeal joints. Ulnar deviation is noted. She reports that the stiffness is particularly severe in the morning but improves throughout the day. Which of the following HLA subtypes is most strongly associated with this patient’s condition?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3683648",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;D) HLA-DR4</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient's symptoms—pain and stiffness affecting the <strong>metacarpophalangeal (MCP)</strong> and <strong>proximal interphalangeal (PIP)</strong> joints, with <strong>distal interphalangeal (DIP) joint sparing</strong>—along with morning stiffness and ulnar deviation, are highly indicative of <strong>rheumatoid arthritis (RA)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">RA typically spares the DIP joints and instead affects the MCP and PIP joints. <strong>HLA-DR4</strong> is the HLA subtype most strongly associated with rheumatoid arthritis, an autoimmune disease that leads to chronic inflammation and progressive joint damage.</span></li></ul><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option A. HLA-B27:</strong> This HLA subtype is linked to <strong>seronegative spondyloarthropathies</strong>, including ankylosing spondylitis and psoriatic arthritis, which can involve DIP joints.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option B. HLA-B8:</strong> HLA-B8 is associated with conditions like <strong>myasthenia gravis</strong> and <strong>Graves' disease</strong>, but not rheumatoid arthritis.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option C. HLA-BW22:</strong> This HLA subtype is not associated with rheumatoid arthritis or related autoimmune conditions.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Rheumatoid arthritis</strong> typically affects the <strong>MCP</strong> and <strong>PIP</strong> joints, sparing the DIP joints, and is strongly associated with <strong>HLA-DR4</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This autoimmune disease presents with morning stiffness and progressive joint deformities such as ulnar deviation.</span></li></ul>",
      "correct_choice_id": 248760,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62166,
      "choices": [
        {
          "id": 247925,
          "text": "<p><span style=\"font-size:14.0pt;\">Mesenteric vein thrombosis</span></p>"
        },
        {
          "id": 247926,
          "text": "<p><span style=\"font-size:14.0pt;\">Dysphagia</span></p>"
        },
        {
          "id": 247927,
          "text": "<p><span style=\"font-size:14.0pt;\">Aplastic anemia</span></p>"
        },
        {
          "id": 247928,
          "text": "<p><span style=\"font-size:14.0pt;\">Positive Direct Coombs Test (DCT)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 26-year-old woman presents with reddish urine. Laboratory results show a hemoglobin level of 7.8 g/dL, elevated serum LDH, and unconjugated bilirubin. A peripheral smear reveals pancytopenia. Flow cytometry is done and shown. Which of the following is unlikely in this patient?<strong>&nbsp;</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-165818.png\" alt=\"\" width=\"300\" height=\"152\"></span></p>",
      "unique_key": "Q4182249",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;D) Positive Direct Coombs Test (DCT)</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient's presentation, including elevated LDH and unconjugated bilirubin, suggests hemolytic anemia rather than aplastic anemia.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">While a positive Direct Coombs Test (DCT) can indicate autoimmune hemolytic anemia, it is unlikely that a positive result would be found if the primary issue were aplastic anemia, as the peripheral smear findings and clinical picture align more with hemolysis.</span></li></ul><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Mesenteric vein thrombosis:</strong> This can occur in hypercoagulable states, including some types of hemolytic anemia, making it a possible complication.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Dysphagia:</strong> Dysphagia can occur in various contexts but is less likely to be directly related to the hemolytic process without additional systemic or neurological involvement.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Aplastic anemia:</strong> While aplastic anemia presents with pancytopenia, the specific hemolytic indicators in this case suggest that this diagnosis is less likely when combined with the findings of hemolysis.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In patients presenting with hemolytic anemia and evidence of increased hemolysis (elevated LDH and unconjugated bilirubin), a positive Direct Coombs Test is unlikely if the primary pathology is aplastic anemia, emphasizing the importance of differentiating between hemolytic anemia and aplastic anemia in clinical practice.</span></li></ul>",
      "correct_choice_id": 247928,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62071,
      "choices": [
        {
          "id": 247545,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Connexin</span></span></span></p>"
        },
        {
          "id": 247546,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Desmoglein</span></span></span></p>"
        },
        {
          "id": 247547,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Claudin</span></span></span></p>"
        },
        {
          "id": 247548,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Integrin</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old man presents with chronic diarrhea, weight loss, and hypoalbuminemia. Biopsy of his small intestine shows disrupted epithelial tight junctions. Which of the following proteins is most likely involved in maintaining the structure and function of the tight junctions in this patient&rsquo;s epithelial cells? </span></span></p>",
      "unique_key": "Q5699023",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Claudin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Claudin is a key component of tight junctions, also known as zonula occludens, which are responsible for regulating paracellular transport and maintaining the epithelial barrier. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tight junctions are crucial in tissues like the gastrointestinal tract, where they prevent the passage of harmful substances between epithelial cells. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Claudins, along with other proteins like occludin, are integral to the formation and function of tight junctions. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Disruption in these proteins, such as seen in this patient, leads to increased intestinal permeability, resulting in conditions like chronic diarrhea and malabsorption syndromes, evidenced by the patient&#39;s hypoalbuminemia and weight loss. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The biopsy showing disruption of the tight junctions further indicates that the primary defect lies in these structural proteins, particularly claudin, leading to the patient&rsquo;s clinical presentation.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Connexin</span></strong><span style=\"font-size:14.0pt\">: Incorrect. Connexins are proteins that form gap junctions, which are responsible for communication between cells by allowing the passage of ions and small molecules. These proteins are not involved in tight junctions and do not play a role in maintaining the epithelial barrier. Therefore, connexin is not related to the pathology of this patient&#39;s condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Desmoglein</span></strong><span style=\"font-size:14.0pt\">: Incorrect. Desmogleins are components of desmosomes, which are cell structures that function in cell-cell adhesion. Desmosomes provide mechanical strength to tissues like the skin and heart. While they are important for cellular adhesion, they do not regulate paracellular transport or maintain the tight junction barrier as claudins do. This makes desmoglein unrelated to the patient&rsquo;s issue of intestinal permeability.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Integrin</span></strong><span style=\"font-size:14.0pt\">: Incorrect. Integrins are transmembrane proteins that mediate the adhesion of cells to the extracellular matrix. They are involved in cell-extracellular matrix interactions, rather than cell-cell adhesion or tight junction formation. Thus, integrins do not maintain the epithelial barrier or regulate paracellular transport as claudins do.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Claudins&nbsp;</span></strong><span style=\"font-size:14.0pt\">are critical proteins in <strong>tight junctions (zonula occludens)</strong> that help maintain epithelial barrier integrity by regulating paracellular transport. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Disruption of claudins can lead to increased intestinal permeability, resulting in conditions like chronic diarrhea and malabsorption.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 247547,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62239,
      "choices": [
        {
          "id": 248213,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">1, 2, 3</span></span></span></p>"
        },
        {
          "id": 248214,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">1, 2, 3, 4, 5</span></span></span></p>"
        },
        {
          "id": 248215,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">1, 2, 3, 4</span></span></span></p>"
        },
        {
          "id": 248216,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">1, 2, 3, 5</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Which of the following statements are true regarding high-quality CPR for adults?&nbsp;</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Push hard (5-6cm depth)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Push fast (100-120/min frequency)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Allow for complete chest recoil</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Minimize interruptions in compressions &le;20 seconds</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Rotate compressor every 5 min. or earlier if fatigued</span></span></span></li>\r\n</ol>",
      "unique_key": "Q9007173",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans. A) 1, 2, 3</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">High-quality CPR (Cardiopulmonary Resuscitation) for adults involves several key components that are essential for improving the likelihood of survival and outcomes after cardiac arrest. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">These components include:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Adequate Compression Depth</span></strong><span style=\"font-size:14.0pt\">: Compressions should be at least 5 cm (2 inches) deep but not more than 6 cm (2.4 inches).</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Proper Compression Rate</span></strong><span style=\"font-size:14.0pt\">: The rate of compressions should be between 100 and 120 compressions per minute.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Allow Complete Chest Recoil</span></strong><span style=\"font-size:14.0pt\">: It&#39;s crucial to let the chest return to its normal position completely after each compression to allow the heart to refill with blood.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Minimize Interruptions</span></strong><span style=\"font-size:14.0pt\">: Interruptions in chest compressions should be kept to less than 10 seconds to maximize blood flow during CPR.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Avoid Excessive Ventilation</span></strong><span style=\"font-size:14.0pt\">: Over-ventilation can be harmful. It is recommended to avoid excessive ventilation to prevent increasing intrathoracic pressure and reducing venous return to the heart.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Rotation of Compressors</span></strong><span style=\"font-size:14.0pt\">: To prevent fatigue and maintain the quality of compressions, it is recommended to rotate the compressor every 2 minutes or sooner if the compressor is tired.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Compression-Ventilation Ratio</span></strong><span style=\"font-size:14.0pt\">: If no advanced airway is in place, a compression-to-ventilation ratio of 30:2 should be used.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Educational Objective</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">High-quality CPR for adults requires all the specified techniques to ensure optimal outcomes. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Compressing at a depth of 5-6 cm and a rate of 100-120 compressions per minute, allowing for complete chest recoil, minimizing interruptions in compressions to under 10 seconds, and avoiding excessive ventilation are all recommended practices to maximize the effectiveness of cardiopulmonary resuscitation.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248213,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62402,
      "choices": [
        {
          "id": 248857,
          "text": "<p><span style=\"font-size:14.0pt;\">Free flap</span></p>"
        },
        {
          "id": 248858,
          "text": "<p><span style=\"font-size:14.0pt;\">Pedicle flap</span></p>"
        },
        {
          "id": 248859,
          "text": "<p><span style=\"font-size:14.0pt;\">Full-thickness graft</span></p>"
        },
        {
          "id": 248860,
          "text": "<p><span style=\"font-size:14.0pt;\">Composite graft</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old man presents with a 6-mm basal cell carcinoma on the tip of his nose. He is scheduled to undergo excision of the tumor in the operating room with repair of the defect using skin and subcutaneous tissue from his earlobe. Which of the following terms most appropriately describes this form of reconstructive surgery?</span></p>",
      "unique_key": "Q8578094",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"background-color:hsl(0,0%,100%);font-size:14.0pt;\"><strong>Ans. D) Composite graft</strong></span></p><p>&nbsp;</p><ul><li><span style=\"background-color:hsl(0,0%,100%);font-size:14.0pt;\">A composite tissue graft contains tissue in addition to the epidermis and dermis. Depending on the donor site, it can contain subcutaneous fat, cartilage, and even muscle.</span></li><li><span style=\"background-color:hsl(0,0%,100%);font-size:14.0pt;\">This makes it ideal for deeper defects in which a partial-thickness or full-thickness skin graft would give a poor cosmetic outcome.</span></li></ul><p>&nbsp;</p><p><span style=\"background-color:hsl(0,0%,100%);font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"background-color:hsl(0,0%,100%);font-size:14.0pt;\"><strong>Option A. Free flap and B. Pedicle flap:</strong> A flap is a vascularized piece of tissue that is mobilized from its original site to another location. A free tissue flap involves severing the original blood supply with anastomosis to blood vessels in the recipient site. The remaining defect in this patient is too small to warrant the need for a flap.</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"background-color:hsl(0,0%,100%);font-size:14.0pt;\"><strong>Option C. Full-thickness graft:</strong> Full thickness graft contains the&nbsp;entire thickness of skin, but not any other tissue.</span></p><p>&nbsp;</p><p><span style=\"background-color:hsl(0,0%,100%);font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"background-color:hsl(0,0%,100%);font-size:14.0pt;\">A composite tissue graft contains tissue in addition to the epidermis and dermis.</span></li></ul>",
      "correct_choice_id": 248860,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62187,
      "choices": [
        {
          "id": 248009,
          "text": "<p><span style=\"font-size:14.0pt;\">Neural tube defects</span></p>"
        },
        {
          "id": 248010,
          "text": "<p><span style=\"font-size:14.0pt;\">Polyhydramnios</span></p>"
        },
        {
          "id": 248011,
          "text": "<p><span style=\"font-size:14.0pt;\">Selective fetal growth restriction</span></p>"
        },
        {
          "id": 248012,
          "text": "<p><span style=\"font-size:14.0pt;\">Twin-to-twin transfusion syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old woman at 24 weeks gestation presents for a routine prenatal visit. She is pregnant with monochorionic twins. During the ultrasound, there is a concern for a complication specific to this type of twin pregnancy.&nbsp; Which of the following complications is specific to monochorionic twins?</span></p>",
      "unique_key": "Q1823606",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Twin-to-twin transfusion syndrome</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Twin-to-twin transfusion syndrome (TTTS) </strong>is a specific complication of <strong>monochorionic twin pregnancies</strong>, where the twins share a single placenta.</span></li><li><span style=\"font-size:14.0pt;\">TTTS occurs due to abnormal vascular connections within the shared placenta, leading to unequal blood flow between the twins.</span></li><li><span style=\"font-size:14.0pt;\">One twin (the <strong>donor</strong>) becomes volume-depleted and experiences oligohydramnios and growth restriction, while the other twin (the <strong>recipient</strong>) becomes volume-overloaded, often developing polyhydramnios and heart complications.</span></li><li><span style=\"font-size:14.0pt;\">TTTS is unique to monochorionic twins due to their shared placental circulation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Neural tube defects:</strong> Incorrect. Neural tube defects are not specific to monochorionic twins and can occur in any pregnancy. They are related to issues with early fetal development, not the chorionicity of the pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Polyhydramnios:&nbsp;</strong>Incorrect. <strong>Polyhydramnios</strong> can occur in any pregnancy and is not specific to monochorionic twins. While it can be a feature in TTTS (affecting the recipient twin), it is not specific to monochorionic pregnancies by itself.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Selective fetal growth restriction: </strong>Incorrect. <strong>Selective fetal growth restriction (sFGR)</strong> can occur in both monochorionic and dichorionic twin pregnancies. It refers to one twin having significant growth restriction compared to the other, but this is not exclusive to monochorionic twins.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Twin-to-twin transfusion syndrome (TTTS)&nbsp;</strong>is a specific complication of <strong>monochorionic twin pregnancies</strong>, where abnormal vascular connections within the shared placenta result in unequal blood flow between the twins, leading to complications in both the donor and recipient twins.</span></p>",
      "correct_choice_id": 248012,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62238,
      "choices": [
        {
          "id": 248209,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tidal volume should be set at 4-6 ml/kg of ideal body weight (IBW). </span></span></span></p>"
        },
        {
          "id": 248210,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Respiratory rate should be initially set at 12-16 breaths per minute. </span></span></span></p>"
        },
        {
          "id": 248211,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Initial FiO2 should be set at 100% and reduced as tolerated to avoid oxygen toxicity. </span></span></p>"
        },
        {
          "id": 248212,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PEEP should be set at 5 cm H2O and not adjusted.</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 57-year-old patient develops acute respiratory distress syndrome (ARDS) after being admitted for severe pneumonia. He is being prepared for mechanical ventilation in the intensive care unit. Which of the following statements about lung-protective ventilatory settings is not true? </span></span></p>",
      "unique_key": "Q8572804",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) PEEP should be set at 5 cm H2O and not adjusted</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">PEEP is initially set at 5 cm H2O to prevent alveolar collapse at end expiration. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">However, in the setting of cardiac surgery and concerns about impairing ventricular filling, careful titration of PEEP above the initial setting is advised to optimize oxygenation and ventilation without compromising hemodynamics.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Tidal volume should be set at 4-6 ml/kg of ideal body weight (IBW):</strong> True. The recommended initial tidal volume for mechanical ventilation is 4-6 ml/kg based on the patient&rsquo;s ideal body weight to prevent barotrauma and volutrauma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Respiratory rate should be initially set at 12-16 breaths per minute:</strong> True. A respiratory rate of 12 to 16 breaths per minute is a common initial setting which can be adjusted based on the patient&#39;s gas exchange and acid-base status.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Initial FiO2 should be set at 100% and reduced as tolerated to avoid oxygen toxicity:</strong> True. Starting with an FiO2 of 100% is a typical approach in critically ill patients to ensure adequate oxygenation. The FiO2 is usually titrated down to avoid oxygen toxicity, depending on arterial blood gases and oxygen saturation.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">When initiating mechanical ventilation, it is critical to start with safe settings tailored to the patient&rsquo;s lung mechanics and underlying pathology. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The initial PEEP setting should be low but requires careful adjustment, to balance lung recruitment and cardiac output.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248212,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62212,
      "choices": [
        {
          "id": 248105,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Protection of Children from Sexual Offences (POCSO) Act - 2012</span></span></p>"
        },
        {
          "id": 248106,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Sexual Harassment of Women at Workplace (Prevention, Prohibition, and Redressal) Act - 2013</span></span></p>"
        },
        {
          "id": 248107,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Pre-conception and Pre-natal Diagnostic Techniques (Prohibition of Sex Selection) [PNDT] Act - 2002</span></span></p>"
        },
        {
          "id": 248108,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The Protection of Women from Domestic Violence Act - 2005</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The following laws have been enacted in India to protect the rights of women and children. Identify the pair that is incorrectly matched with its year of enactment: </span></span></p>",
      "unique_key": "Q8789806",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) The Pre-conception and Pre-natal Diagnostic Techniques (Prohibition of Sex Selection) [PNDT] Act - 2002</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This is incorrect because the Pre-conception and Pre-natal Diagnostic Techniques (Prohibition of Sex Selection) [PNDT] Act was actually enacted in 1994. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This act aims to prevent sex-selective abortions and curb the declining female sex ratio by regulating the use of pre-natal diagnostic techniques.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options</span></strong><span style=\"font-size:14.0pt\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. The Protection of Children from Sexual Offences (POCSO) Act - 2012:</span></strong><span style=\"font-size:14.0pt\"> Correct. The POCSO Act was enacted in 2012 to protect children from sexual abuse and exploitation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. The Sexual Harassment of Women at Workplace (Prevention, Prohibition, and Redressal) Act - 2013:</span></strong><span style=\"font-size:14.0pt\"> Correct. This act was enacted in 2013 to address sexual harassment faced by women in workplaces and to ensure a safe working environment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. The Protection of Women from Domestic Violence Act - 2005</span></strong><span style=\"font-size:14.0pt\">: Correct. The Protection of Women from Domestic Violence Act came into effect in 2005 and provides protection to women against domestic abuse and violence.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective</span></strong><span style=\"font-size:14.0pt\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The PNDT Act was enacted in 1994 to prevent sex-selective practices.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The POCSO Act (2012) and Sexual Harassment Act (2013) address child protection and workplace safety, respectively.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The Protection of Women from Domestic Violence Act (2005) provides a legal framework for addressing domestic violence against women.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 248107,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62070,
      "choices": [
        {
          "id": 247541,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hypoplasia or absence of clavicles</span></span></span></p>"
        },
        {
          "id": 247542,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Craniosynostosis with premature fusion of sutures</span></span></span></p>"
        },
        {
          "id": 247543,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Absence of radius and thumb</span></span></span></p>"
        },
        {
          "id": 247544,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Multiple exostoses (bony outgrowths) on long bones</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 12-year-old boy is brought to the clinic by his parents due to concerns about delayed eruption of his permanent teeth and abnormal appearance of his shoulders. Physical examination reveals a wide, flat skull, midface hypoplasia, and the ability to bring his shoulders together in front of his chest. X-rays of the chest are shown below. Which of the following skeletal abnormalities is most characteristic of this condition? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-135500.jpg\" style=\"height:292px; width:300px\" /></p>",
      "unique_key": "Q3735422",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Hypoplasia or absence of clavicles</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The X-ray image of the chest in this case shows <strong>underdeveloped or absent clavicles</strong>, which is a hallmark feature of <strong>cleidocranial dysostosis (also known as cleidocranial dysplasia).</strong> </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In a normal chest X-ray, the clavicles (collarbones) are clearly visible as long, horizontal bones at the top of the rib cage, just beneath the shoulders. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">However, in this patient, the clavicles appear hypoplastic (underdeveloped) or absent, allowing the patient to approximate their shoulders in front of the chest&mdash;a characteristic finding in this condition.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This feature allows affected individuals to approximate their shoulders in front of their chest, which is a classic finding. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The condition also presents with other skeletal anomalies, including a <strong>wide, flat skull (brachycephaly)</strong>, <strong>midface hypoplasia</strong>, and <strong>delayed eruption of permanent teeth</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The skeletal abnormalities stem from mutations in the <strong>RUNX2</strong> gene, which is critical for osteoblast differentiation and proper bone formation, particularly impacting the development of the <strong>clavicles</strong> and <strong>craniofacial bones</strong>.</span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-135636.jpg\" style=\"height:165px; width:700px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Craniosynostosis with premature fusion of sutures</span></strong><span style=\"font-size:14.0pt\">: Incorrect. <strong>Craniosynostosis</strong> involves the premature fusion of skull sutures, leading to restricted skull growth and an abnormal head shape. In contrast, cleidocranial dysostosis is characterized by <strong>delayed closure of fontanelles</strong>, resulting in a broad, flat skull, not early suture closure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Absence of radius and thumb</span></strong><span style=\"font-size:14.0pt\">: Incorrect. The <strong>absence of the radius and thumb</strong> is typically seen in <strong>radial ray anomalies</strong>, which are features of conditions like <strong>Holt-Oram syndrome</strong> or <strong>Fanconi anemia</strong>. These are not characteristic findings in cleidocranial dysostosis, which primarily affects the clavicles and skull bones.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Multiple exostoses (bony outgrowths) on long bones</span></strong><span style=\"font-size:14.0pt\">: Incorrect. <strong>Multiple exostoses</strong> are a hallmark of <strong>hereditary multiple exostoses (osteochondromatosis)</strong>, where patients develop benign bony outgrowths. This is not seen in cleidocranial dysostosis, where skeletal involvement is more focused on the <strong>clavicles</strong> and <strong>craniofacial bones</strong>.</span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Cleidocranial dysostosis&nbsp;</span></strong><span style=\"font-size:14.0pt\">is characterized by <strong>hypoplasia or absence of clavicles</strong>, which allows for excessive shoulder mobility, <strong>delayed closure of the fontanelles</strong>, and <strong>dental abnormalities</strong> such as delayed tooth eruption. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is caused by mutations in the <strong>RUNX2</strong> gene, which is essential for normal bone formation and osteoblast differentiation. </span></span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recognizing these skeletal features is critical for diagnosing the condition.</span></span></li>\r\n</ul>",
      "correct_choice_id": 247541,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62137,
      "choices": [
        {
          "id": 247809,
          "text": "<p><span style=\"font-size:14.0pt;\">Expression of CD23</span></p>"
        },
        {
          "id": 247810,
          "text": "<p><span style=\"font-size:14.0pt;\">Deletion of 17p involving the TP53 gene</span></p>"
        },
        {
          "id": 247811,
          "text": "<p><span style=\"font-size:14.0pt;\">Presence of trisomy 12</span></p>"
        },
        {
          "id": 247812,
          "text": "<p><span style=\"font-size:14.0pt;\">Hypermutation of the immunoglobulin heavy chain variable region (IGHV)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 67-year-old man presents to the clinic with fatigue and night sweats. On physical examination, he has cervical lymphadenopathy and splenomegaly. Laboratory studies reveal lymphocytosis with the peripheral blood smear image as shown. Flow cytometry confirms the presence of clonal CD5+ CD19+ B cells. A bone marrow biopsy shows infiltration with small, mature lymphocytes. He is diagnosed with chronic lymphocytic leukemia (CLL). Which of the following is most strongly associated with poor prognosis in this patient?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/22/screenshot-2024-10-22-151509.png\" alt=\"\" width=\"300\" height=\"196\"></span></p>",
      "unique_key": "Q8466308",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Deletion of 17p involving the TP53 gene</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">This patient has <strong>CLL</strong>, and his prognosis depends on various genetic and molecular factors. A <strong>deletion of 17p</strong>, which involves the <strong>TP53 gene</strong>, is associated with <strong>poor prognosis</strong> because it affects the tumor suppressor gene TP53, leading to resistance to standard chemotherapy and more aggressive disease.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Expression of CD23:</strong> Incorrect. Expression of CD23 is common in CLL and helps distinguish it from other B-cell malignancies, but it is not a marker of poor prognosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Presence of trisomy 12:&nbsp;</strong>Incorrect. Trisomy 12 is a cytogenetic abnormality seen in CLL and is generally associated with an <strong>intermediate prognosis</strong>, not a poor prognosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Hypermutation of the immunoglobulin heavy chain variable region (IGHV):&nbsp;</strong>Incorrect. Hypermutation of the IGHV region is associated with a <strong>better prognosis</strong> in CLL, not a poor prognosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Deletion of 17p</strong>, involving the <strong>TP53 gene</strong>, is strongly associated with a <strong>poor prognosis</strong> in patients with <strong>chronic lymphocytic leukemia (CLL)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This mutation leads to a more aggressive disease and poorer treatment response.</span></li></ul>",
      "correct_choice_id": 247810,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}